id	sid	tid	token	lemma	pos
admet-2901	1	1	new	new	PROPN
admet-2901	1	2	xanthone	xanthone	PROPN
admet-2901	1	3	and	and	CCONJ
admet-2901	1	4	chemical	chemical	NOUN
admet-2901	1	5	constituents	constituent	NOUN
admet-2901	1	6	from	from	ADP
admet-2901	1	7	the	the	DET
admet-2901	1	8	aerial	aerial	ADJ
admet-2901	1	9	parts	part	NOUN
admet-2901	1	10	of	of	ADP
admet-2901	1	11	mallotus	mallotus	NOUN
admet-2901	1	12	glomerulatus	glomerulatus	NOUN
admet-2901	1	13	and	and	CCONJ
admet-2901	1	14	their	their	PRON
admet-2901	1	15	cytotoxicity	cytotoxicity	NOUN
admet-2901	1	16	in	in	ADP
admet-2901	1	17	mcf-7	mcf-7	PUNCT
admet-2901	1	18	and	and	CCONJ
admet-2901	1	19	mda	mda	PROPN
admet-2901	1	20	-	-	PUNCT
admet-2901	1	21	mb-231	mb-231	PROPN
admet-2901	1	22	breast	breast	NOUN
admet-2901	1	23	cancer	cancer	NOUN
admet-2901	1	24	cells	cell	NOUN
admet-2901	1	25	doi	doi	NOUN
admet-2901	1	26	:	:	PUNCT
admet-2901	1	27	https://dx.doi.org/10.5599/admet.2901	https://dx.doi.org/10.5599/admet.2901	PROPN
admet-2901	1	28	1	1	NUM
admet-2901	1	29	admet	admet	X
admet-2901	1	30	&	&	CCONJ
admet-2901	1	31	dmpk	dmpk	PROPN
admet-2901	1	32	13(5	13(5	NUM
admet-2901	1	33	)	)	PUNCT
admet-2901	1	34	(	(	PUNCT
admet-2901	1	35	2025	2025	NUM
admet-2901	1	36	)	)	PUNCT
admet-2901	1	37	2901	2901	NUM
admet-2901	1	38	;	;	PUNCT
admet-2901	1	39	doi	doi	NOUN
admet-2901	1	40	:	:	PUNCT
admet-2901	1	41	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	NOUN
admet-2901	1	42	open	open	ADJ
admet-2901	1	43	access	access	NOUN
admet-2901	1	44	:	:	PUNCT
admet-2901	1	45	issn	issn	PROPN
admet-2901	1	46	:	:	PUNCT
admet-2901	1	47	1848	1848	NUM
admet-2901	1	48	-	-	SYM
admet-2901	1	49	7718	7718	NUM
admet-2901	1	50	http://www.pub.iapchem.org/ojs/index.ph-p/admet/index	http://www.pub.iapchem.org/ojs/index.ph-p/admet/index	PROPN
admet-2901	1	51	original	original	ADJ
admet-2901	1	52	scientific	scientific	ADJ
admet-2901	1	53	paper	paper	NOUN
admet-2901	1	54	new	new	ADJ
admet-2901	1	55	xanthone	xanthone	PROPN
admet-2901	1	56	and	and	CCONJ
admet-2901	1	57	chemical	chemical	NOUN
admet-2901	1	58	constituents	constituent	NOUN
admet-2901	1	59	from	from	ADP
admet-2901	1	60	the	the	DET
admet-2901	1	61	aerial	aerial	ADJ
admet-2901	1	62	parts	part	NOUN
admet-2901	1	63	of	of	ADP
admet-2901	1	64	mallotus	mallotus	NOUN
admet-2901	1	65	glomerulatus	glomerulatus	NOUN
admet-2901	1	66	and	and	CCONJ
admet-2901	1	67	their	their	PRON
admet-2901	1	68	cytotoxicity	cytotoxicity	NOUN
admet-2901	1	69	in	in	ADP
admet-2901	1	70	mcf-7	mcf-7	PUNCT
admet-2901	1	71	and	and	CCONJ
admet-2901	1	72	mdamb-231	mdamb-231	ADJ
admet-2901	1	73	breast	breast	NOUN
admet-2901	1	74	cancer	cancer	NOUN
admet-2901	1	75	cells	cell	NOUN
admet-2901	1	76	napason	napason	PROPN
admet-2901	1	77	chabang1	chabang1	PROPN
admet-2901	1	78	,	,	PUNCT
admet-2901	1	79	chanikarn	chanikarn	ADJ
admet-2901	1	80	wongwitayasombat2	wongwitayasombat2	PROPN
admet-2901	1	81	,	,	PUNCT
admet-2901	1	82	patoomratana	patoomratana	VERB
admet-2901	1	83	tuchinda3	tuchinda3	NOUN
admet-2901	1	84	,	,	PUNCT
admet-2901	1	85	bamroong	bamroong	PROPN
admet-2901	1	86	munyoo3	munyoo3	PROPN
admet-2901	1	87	,	,	PUNCT
admet-2901	1	88	niwat	niwat	NOUN
admet-2901	1	89	kangwanrangsan4	kangwanrangsan4	PROPN
admet-2901	1	90	,	,	PUNCT
admet-2901	1	91	suradej	suradej	VERB
admet-2901	1	92	hongeng5	hongeng5	NOUN
admet-2901	1	93	,	,	PUNCT
admet-2901	1	94	bodee	bodee	NOUN
admet-2901	1	95	nutho6	nutho6	VERB
admet-2901	1	96	,	,	PUNCT
admet-2901	1	97	sitthivut	sitthivut	PROPN
admet-2901	1	98	charoensutthivarakul1,6,7	charoensutthivarakul1,6,7	PROPN
admet-2901	1	99	and	and	CCONJ
admet-2901	1	100	phongthon	phongthon	PROPN
admet-2901	1	101	kanjanasirirat4	kanjanasirirat4	PROPN
admet-2901	1	102	,	,	PUNCT
admet-2901	1	103	*	*	PROPN
admet-2901	2	1	1school	1school	NUM
admet-2901	2	2	of	of	ADP
admet-2901	2	3	bioinnovation	bioinnovation	NOUN
admet-2901	2	4	and	and	CCONJ
admet-2901	2	5	bio	bio	NOUN
admet-2901	2	6	-	-	PUNCT
admet-2901	2	7	based	base	VERB
admet-2901	2	8	product	product	NOUN
admet-2901	2	9	intelligence	intelligence	NOUN
admet-2901	2	10	,	,	PUNCT
admet-2901	2	11	faculty	faculty	NOUN
admet-2901	2	12	of	of	ADP
admet-2901	2	13	science	science	NOUN
admet-2901	2	14	,	,	PUNCT
admet-2901	2	15	mahidol	mahidol	PROPN
admet-2901	2	16	university	university	PROPN
admet-2901	2	17	,	,	PUNCT
admet-2901	2	18	bangkok	bangkok	PROPN
admet-2901	2	19	,	,	PUNCT
admet-2901	2	20	thailand	thailand	PROPN
admet-2901	2	21	2biomedical	2biomedical	PROPN
admet-2901	2	22	science	science	NOUN
admet-2901	2	23	program	program	NOUN
admet-2901	2	24	,	,	PUNCT
admet-2901	2	25	faculty	faculty	NOUN
admet-2901	2	26	of	of	ADP
admet-2901	2	27	science	science	NOUN
admet-2901	2	28	,	,	PUNCT
admet-2901	2	29	mahidol	mahidol	PROPN
admet-2901	2	30	university	university	PROPN
admet-2901	2	31	,	,	PUNCT
admet-2901	2	32	bangkok	bangkok	PROPN
admet-2901	2	33	,	,	PUNCT
admet-2901	2	34	thailand	thailand	PROPN
admet-2901	2	35	3excellent	3excellent	NUM
admet-2901	2	36	center	center	NOUN
admet-2901	2	37	for	for	ADP
admet-2901	2	38	drug	drug	NOUN
admet-2901	2	39	discovery	discovery	NOUN
admet-2901	2	40	,	,	PUNCT
admet-2901	2	41	faculty	faculty	NOUN
admet-2901	2	42	of	of	ADP
admet-2901	2	43	science	science	NOUN
admet-2901	2	44	,	,	PUNCT
admet-2901	2	45	mahidol	mahidol	PROPN
admet-2901	2	46	university	university	PROPN
admet-2901	2	47	,	,	PUNCT
admet-2901	2	48	bangkok	bangkok	PROPN
admet-2901	2	49	,	,	PUNCT
admet-2901	2	50	thailand	thailand	PROPN
admet-2901	2	51	4department	4department	NUM
admet-2901	2	52	of	of	ADP
admet-2901	2	53	pathobiology	pathobiology	NOUN
admet-2901	2	54	,	,	PUNCT
admet-2901	2	55	faculty	faculty	NOUN
admet-2901	2	56	of	of	ADP
admet-2901	2	57	science	science	NOUN
admet-2901	2	58	,	,	PUNCT
admet-2901	2	59	mahidol	mahidol	PROPN
admet-2901	2	60	university	university	PROPN
admet-2901	2	61	,	,	PUNCT
admet-2901	2	62	bangkok	bangkok	PROPN
admet-2901	2	63	,	,	PUNCT
admet-2901	2	64	thailand	thailand	PROPN
admet-2901	2	65	5department	5department	NUM
admet-2901	2	66	of	of	ADP
admet-2901	2	67	pediatrics	pediatric	NOUN
admet-2901	2	68	,	,	PUNCT
admet-2901	2	69	faculty	faculty	NOUN
admet-2901	2	70	of	of	ADP
admet-2901	2	71	medicine	medicine	NOUN
admet-2901	2	72	ramathibodi	ramathibodi	PROPN
admet-2901	2	73	hospital	hospital	NOUN
admet-2901	2	74	,	,	PUNCT
admet-2901	2	75	mahidol	mahidol	PROPN
admet-2901	2	76	university	university	PROPN
admet-2901	2	77	,	,	PUNCT
admet-2901	2	78	bangkok	bangkok	PROPN
admet-2901	2	79	,	,	PUNCT
admet-2901	2	80	thailand	thailand	PROPN
admet-2901	2	81	6department	6department	NUM
admet-2901	2	82	of	of	ADP
admet-2901	2	83	pharmacology	pharmacology	NOUN
admet-2901	2	84	,	,	PUNCT
admet-2901	2	85	faculty	faculty	NOUN
admet-2901	2	86	of	of	ADP
admet-2901	2	87	science	science	NOUN
admet-2901	2	88	,	,	PUNCT
admet-2901	2	89	mahidol	mahidol	PROPN
admet-2901	2	90	university	university	PROPN
admet-2901	2	91	,	,	PUNCT
admet-2901	2	92	bangkok	bangkok	PROPN
admet-2901	2	93	,	,	PUNCT
admet-2901	2	94	thailand	thailand	PROPN
admet-2901	2	95	7center	7center	PROPN
admet-2901	2	96	for	for	ADP
admet-2901	2	97	neuroscience	neuroscience	NOUN
admet-2901	2	98	,	,	PUNCT
admet-2901	2	99	faculty	faculty	NOUN
admet-2901	2	100	of	of	ADP
admet-2901	2	101	science	science	NOUN
admet-2901	2	102	,	,	PUNCT
admet-2901	2	103	mahidol	mahidol	PROPN
admet-2901	2	104	university	university	PROPN
admet-2901	2	105	,	,	PUNCT
admet-2901	2	106	bangkok	bangkok	PROPN
admet-2901	2	107	,	,	PUNCT
admet-2901	2	108	thailand	thailand	PROPN
admet-2901	2	109	*	*	PUNCT
admet-2901	2	110	corresponding	correspond	VERB
admet-2901	2	111	author	author	NOUN
admet-2901	2	112	:	:	PUNCT
admet-2901	2	113	e	e	NOUN
admet-2901	2	114	-	-	NOUN
admet-2901	2	115	mail	mail	NOUN
admet-2901	2	116	:	:	PUNCT
admet-2901	3	1	phongthon.kan@mahidol.ac.th	phongthon.kan@mahidol.ac.th	NOUN
admet-2901	3	2	,	,	PUNCT
admet-2901	3	3	tel	tel	PROPN
admet-2901	3	4	.	.	PROPN
admet-2901	3	5	:	:	PUNCT
admet-2901	4	1	+66	+66	NUM
admet-2901	4	2	-	-	PUNCT
admet-2901	4	3	2	2	NUM
admet-2901	4	4	-	-	PUNCT
admet-2901	4	5	201	201	NUM
admet-2901	4	6	-	-	SYM
admet-2901	4	7	5550	5550	NUM
admet-2901	4	8	received	receive	VERB
admet-2901	4	9	:	:	PUNCT
admet-2901	4	10	july	july	PROPN
admet-2901	4	11	1	1	NUM
admet-2901	4	12	,	,	PUNCT
admet-2901	4	13	2025	2025	NUM
admet-2901	4	14	;	;	PUNCT
admet-2901	4	15	revised	revise	VERB
admet-2901	4	16	:	:	PUNCT
admet-2901	4	17	august	august	PROPN
admet-2901	4	18	27	27	NUM
admet-2901	4	19	,	,	PUNCT
admet-2901	4	20	2025	2025	NUM
admet-2901	4	21	;	;	PUNCT
admet-2901	4	22	published	publish	VERB
admet-2901	4	23	:	:	PUNCT
admet-2901	4	24	september	september	PROPN
admet-2901	4	25	21	21	NUM
admet-2901	4	26	,	,	PUNCT
admet-2901	4	27	2025	2025	NUM
admet-2901	4	28	abstract	abstract	ADJ
admet-2901	4	29	background	background	NOUN
admet-2901	4	30	and	and	CCONJ
admet-2901	4	31	purpose	purpose	NOUN
admet-2901	4	32	:	:	PUNCT
admet-2901	4	33	breast	breast	NOUN
admet-2901	4	34	cancer	cancer	NOUN
admet-2901	4	35	remains	remain	VERB
admet-2901	4	36	a	a	DET
admet-2901	4	37	significant	significant	ADJ
admet-2901	4	38	global	global	ADJ
admet-2901	4	39	health	health	NOUN
admet-2901	4	40	burden	burden	NOUN
admet-2901	4	41	,	,	PUNCT
admet-2901	4	42	especially	especially	ADV
admet-2901	4	43	in	in	ADP
admet-2901	4	44	lowresource	lowresource	PROPN
admet-2901	4	45	settings	setting	NOUN
admet-2901	4	46	where	where	SCONJ
admet-2901	4	47	standard	standard	ADJ
admet-2901	4	48	therapies	therapy	NOUN
admet-2901	4	49	are	be	AUX
admet-2901	4	50	limited	limited	ADJ
admet-2901	4	51	.	.	PUNCT
admet-2901	5	1	this	this	DET
admet-2901	5	2	study	study	NOUN
admet-2901	5	3	aimed	aim	VERB
admet-2901	5	4	to	to	PART
admet-2901	5	5	explore	explore	VERB
admet-2901	5	6	mallotus	mallotus	NOUN
admet-2901	5	7	glomerulatus	glomerulatus	NOUN
admet-2901	5	8	,	,	PUNCT
admet-2901	5	9	a	a	DET
admet-2901	5	10	lesser	lesser	ADV
admet-2901	5	11	-	-	PUNCT
admet-2901	5	12	known	know	VERB
admet-2901	5	13	thai	thai	ADJ
admet-2901	5	14	medicinal	medicinal	ADJ
admet-2901	5	15	plant	plant	NOUN
admet-2901	5	16	,	,	PUNCT
admet-2901	5	17	as	as	ADP
admet-2901	5	18	a	a	DET
admet-2901	5	19	potential	potential	ADJ
admet-2901	5	20	source	source	NOUN
admet-2901	5	21	of	of	ADP
admet-2901	5	22	novel	novel	ADJ
admet-2901	5	23	anti	anti	ADJ
admet-2901	5	24	-	-	ADJ
admet-2901	5	25	breast	breast	ADJ
admet-2901	5	26	cancer	cancer	NOUN
admet-2901	5	27	agents	agent	NOUN
admet-2901	5	28	.	.	PUNCT
admet-2901	6	1	experimental	experimental	ADJ
admet-2901	6	2	approach	approach	NOUN
admet-2901	6	3	:	:	PUNCT
admet-2901	6	4	a	a	DET
admet-2901	6	5	phytochemical	phytochemical	ADJ
admet-2901	6	6	investigation	investigation	NOUN
admet-2901	6	7	of	of	ADP
admet-2901	6	8	m.	m.	NOUN
admet-2901	6	9	glomerulatus	glomerulatus	NOUN
admet-2901	6	10	resulted	result	VERB
admet-2901	6	11	in	in	ADP
admet-2901	6	12	the	the	DET
admet-2901	6	13	isolation	isolation	NOUN
admet-2901	6	14	and	and	CCONJ
admet-2901	6	15	structural	structural	ADJ
admet-2901	6	16	characterization	characterization	NOUN
admet-2901	6	17	of	of	ADP
admet-2901	6	18	a	a	DET
admet-2901	6	19	novel	novel	NOUN
admet-2901	6	20	xanthone	xanthone	PROPN
admet-2901	6	21	(	(	PUNCT
admet-2901	6	22	compound	compound	NOUN
admet-2901	6	23	1	1	NUM
admet-2901	6	24	)	)	PUNCT
admet-2901	6	25	and	and	CCONJ
admet-2901	6	26	cleistanthin	cleistanthin	VERB
admet-2901	6	27	a	a	DET
admet-2901	6	28	(	(	PUNCT
admet-2901	6	29	compound	compound	NOUN
admet-2901	6	30	10	10	NUM
admet-2901	6	31	)	)	PUNCT
admet-2901	6	32	using	use	VERB
admet-2901	6	33	uv	uv	NOUN
admet-2901	6	34	,	,	PUNCT
admet-2901	6	35	ir	ir	PROPN
admet-2901	6	36	,	,	PUNCT
admet-2901	6	37	nmr	nmr	NOUN
admet-2901	6	38	,	,	PUNCT
admet-2901	6	39	and	and	CCONJ
admet-2901	6	40	hrms	hrm	VERB
admet-2901	6	41	techniques	technique	NOUN
admet-2901	6	42	.	.	PUNCT
admet-2901	7	1	cytotoxicity	cytotoxicity	NOUN
admet-2901	7	2	of	of	ADP
admet-2901	7	3	the	the	DET
admet-2901	7	4	compounds	compound	NOUN
admet-2901	7	5	was	be	AUX
admet-2901	7	6	evaluated	evaluate	VERB
admet-2901	7	7	in	in	ADP
admet-2901	7	8	vitro	vitro	X
admet-2901	7	9	against	against	ADP
admet-2901	7	10	mcf-7	mcf-7	NOUN
admet-2901	7	11	(	(	PUNCT
admet-2901	7	12	er	er	INTJ
admet-2901	7	13	-	-	PUNCT
admet-2901	7	14	positive	positive	ADJ
admet-2901	7	15	)	)	PUNCT
admet-2901	7	16	and	and	CCONJ
admet-2901	7	17	mda	mda	PROPN
admet-2901	7	18	-	-	PUNCT
admet-2901	7	19	mb-231	mb-231	PROPN
admet-2901	7	20	(	(	PUNCT
admet-2901	7	21	triple	triple	ADJ
admet-2901	7	22	-	-	PUNCT
admet-2901	7	23	negative	negative	ADJ
admet-2901	7	24	)	)	PUNCT
admet-2901	7	25	breast	breast	NOUN
admet-2901	7	26	cancer	cancer	NOUN
admet-2901	7	27	cell	cell	NOUN
admet-2901	7	28	lines	line	NOUN
admet-2901	7	29	,	,	PUNCT
admet-2901	7	30	along	along	ADP
admet-2901	7	31	with	with	ADP
admet-2901	7	32	hepg2	hepg2	NOUN
admet-2901	7	33	liver	liver	NOUN
admet-2901	7	34	cells	cell	NOUN
admet-2901	7	35	.	.	PUNCT
admet-2901	8	1	molecular	molecular	ADJ
admet-2901	8	2	docking	docking	NOUN
admet-2901	8	3	studies	study	NOUN
admet-2901	8	4	were	be	AUX
admet-2901	8	5	conducted	conduct	VERB
admet-2901	8	6	to	to	PART
admet-2901	8	7	assess	assess	VERB
admet-2901	8	8	their	their	PRON
admet-2901	8	9	interaction	interaction	NOUN
admet-2901	8	10	with	with	ADP
admet-2901	8	11	vacuolar	vacuolar	ADJ
admet-2901	8	12	h+-atpase	h+-atpase	PROPN
admet-2901	8	13	(	(	PUNCT
admet-2901	8	14	v	v	NOUN
admet-2901	8	15	-	-	PUNCT
admet-2901	8	16	atpase	atpase	NOUN
admet-2901	8	17	)	)	PUNCT
admet-2901	8	18	.	.	PUNCT
admet-2901	9	1	key	key	ADJ
admet-2901	9	2	results	result	NOUN
admet-2901	9	3	:	:	PUNCT
admet-2901	9	4	compound	compound	NOUN
admet-2901	9	5	1	1	NUM
admet-2901	9	6	demonstrated	demonstrate	VERB
admet-2901	9	7	selective	selective	ADJ
admet-2901	9	8	cytotoxicity	cytotoxicity	NOUN
admet-2901	9	9	toward	toward	ADP
admet-2901	9	10	mcf-7	mcf-7	NOUN
admet-2901	9	11	cells	cell	NOUN
admet-2901	9	12	,	,	PUNCT
admet-2901	9	13	whereas	whereas	SCONJ
admet-2901	9	14	cleistanthin	cleistanthin	PROPN
admet-2901	9	15	a	a	DET
admet-2901	9	16	exhibited	exhibit	VERB
admet-2901	9	17	potent	potent	ADJ
admet-2901	9	18	cytotoxicity	cytotoxicity	NOUN
admet-2901	9	19	against	against	ADP
admet-2901	9	20	both	both	DET
admet-2901	9	21	breast	breast	NOUN
admet-2901	9	22	cancer	cancer	NOUN
admet-2901	9	23	lines	line	NOUN
admet-2901	9	24	,	,	PUNCT
admet-2901	9	25	with	with	ADP
admet-2901	9	26	nanomolar	nanomolar	ADJ
admet-2901	9	27	ic50	ic50	PROPN
admet-2901	9	28	values	value	NOUN
admet-2901	9	29	and	and	CCONJ
admet-2901	9	30	a	a	DET
admet-2901	9	31	high	high	ADJ
admet-2901	9	32	selectivity	selectivity	NOUN
admet-2901	9	33	index	index	NOUN
admet-2901	9	34	(	(	PUNCT
admet-2901	9	35	>	>	NOUN
admet-2901	9	36	100	100	NUM
admet-2901	9	37	)	)	PUNCT
admet-2901	9	38	for	for	ADP
admet-2901	9	39	mda	mda	PROPN
admet-2901	9	40	-	-	PUNCT
admet-2901	9	41	mb-231	mb-231	PROPN
admet-2901	9	42	compared	compare	VERB
admet-2901	9	43	to	to	ADP
admet-2901	9	44	hepg2	hepg2	NOUN
admet-2901	9	45	cells	cell	NOUN
admet-2901	9	46	.	.	PUNCT
admet-2901	10	1	docking	dock	VERB
admet-2901	10	2	analysis	analysis	NOUN
admet-2901	10	3	revealed	reveal	VERB
admet-2901	10	4	favourable	favourable	ADJ
admet-2901	10	5	binding	binding	NOUN
admet-2901	10	6	of	of	ADP
admet-2901	10	7	both	both	DET
admet-2901	10	8	compounds	compound	NOUN
admet-2901	10	9	at	at	ADP
admet-2901	10	10	the	the	DET
admet-2901	10	11	a	a	NOUN
admet-2901	10	12	–	–	PUNCT
admet-2901	10	13	c	c	NOUN
admet-2901	10	14	subunit	subunit	NOUN
admet-2901	10	15	interface	interface	NOUN
admet-2901	10	16	of	of	ADP
admet-2901	10	17	v	v	NOUN
admet-2901	10	18	-	-	PUNCT
admet-2901	10	19	atpase	atpase	NOUN
admet-2901	10	20	,	,	PUNCT
admet-2901	10	21	suggesting	suggest	VERB
admet-2901	10	22	a	a	DET
admet-2901	10	23	mechanism	mechanism	NOUN
admet-2901	10	24	involving	involve	VERB
admet-2901	10	25	proton	proton	NOUN
admet-2901	10	26	pump	pump	NOUN
admet-2901	10	27	inhibition	inhibition	NOUN
admet-2901	10	28	and	and	CCONJ
admet-2901	10	29	lysosomal	lysosomal	ADJ
admet-2901	10	30	dysfunction	dysfunction	NOUN
admet-2901	10	31	.	.	PUNCT
admet-2901	11	1	conclusion	conclusion	NOUN
admet-2901	11	2	:	:	PUNCT
admet-2901	11	3	the	the	DET
admet-2901	11	4	findings	finding	NOUN
admet-2901	11	5	highlight	highlight	VERB
admet-2901	11	6	m.	m.	NOUN
admet-2901	11	7	glomerulatus	glomerulatus	NOUN
admet-2901	11	8	,	,	PUNCT
admet-2901	11	9	particularly	particularly	ADV
admet-2901	11	10	cleistanthin	cleistanthin	VERB
admet-2901	11	11	a	a	PRON
admet-2901	11	12	,	,	PUNCT
admet-2901	11	13	as	as	ADP
admet-2901	11	14	a	a	DET
admet-2901	11	15	promising	promising	ADJ
admet-2901	11	16	source	source	NOUN
admet-2901	11	17	of	of	ADP
admet-2901	11	18	safe	safe	ADJ
admet-2901	11	19	and	and	CCONJ
admet-2901	11	20	affordable	affordable	ADJ
admet-2901	11	21	anti	anti	ADJ
admet-2901	11	22	-	-	ADJ
admet-2901	11	23	breast	breast	ADJ
admet-2901	11	24	cancer	cancer	NOUN
admet-2901	11	25	compounds	compound	NOUN
admet-2901	11	26	with	with	ADP
admet-2901	11	27	potential	potential	ADJ
admet-2901	11	28	therapeutic	therapeutic	ADJ
admet-2901	11	29	value	value	NOUN
admet-2901	11	30	.	.	PUNCT
admet-2901	12	1	further	further	ADJ
admet-2901	12	2	studies	study	NOUN
admet-2901	12	3	on	on	ADP
admet-2901	12	4	the	the	DET
admet-2901	12	5	mechanism	mechanism	NOUN
admet-2901	12	6	and	and	CCONJ
admet-2901	12	7	in	in	ADP
admet-2901	12	8	vivo	vivo	ADJ
admet-2901	12	9	efficacy	efficacy	NOUN
admet-2901	12	10	are	be	AUX
admet-2901	12	11	warranted	warrant	VERB
admet-2901	12	12	.	.	PUNCT
admet-2901	13	1	©	©	PROPN
admet-2901	13	2	2025	2025	NUM
admet-2901	13	3	by	by	ADP
admet-2901	13	4	the	the	DET
admet-2901	13	5	authors	author	NOUN
admet-2901	13	6	.	.	PUNCT
admet-2901	14	1	this	this	DET
admet-2901	14	2	article	article	NOUN
admet-2901	14	3	is	be	AUX
admet-2901	14	4	an	an	DET
admet-2901	14	5	open	open	ADJ
admet-2901	14	6	-	-	PUNCT
admet-2901	14	7	access	access	NOUN
admet-2901	14	8	article	article	NOUN
admet-2901	14	9	distributed	distribute	VERB
admet-2901	14	10	under	under	ADP
admet-2901	14	11	the	the	DET
admet-2901	14	12	terms	term	NOUN
admet-2901	14	13	and	and	CCONJ
admet-2901	14	14	conditions	condition	NOUN
admet-2901	14	15	of	of	ADP
admet-2901	14	16	the	the	DET
admet-2901	14	17	creative	creative	ADJ
admet-2901	14	18	commons	common	NOUN
admet-2901	14	19	attribution	attribution	NOUN
admet-2901	14	20	license	license	NOUN
admet-2901	14	21	(	(	PUNCT
admet-2901	14	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-2901	14	23	)	)	PUNCT
admet-2901	14	24	.	.	PUNCT
admet-2901	15	1	keywords	keyword	NOUN
admet-2901	15	2	cleistanthin	cleistanthin	VERB
admet-2901	15	3	a	a	PRON
admet-2901	15	4	;	;	PUNCT
admet-2901	15	5	xanthone	xanthone	PROPN
admet-2901	15	6	;	;	PUNCT
admet-2901	15	7	breast	breast	NOUN
admet-2901	15	8	cancer	cancer	NOUN
admet-2901	15	9	;	;	PUNCT
admet-2901	15	10	v	v	X
admet-2901	15	11	-	-	PUNCT
admet-2901	15	12	atpase	atpase	PROPN
admet-2901	15	13	introduction	introduction	NOUN
admet-2901	15	14	breast	breast	NOUN
admet-2901	15	15	cancer	cancer	NOUN
admet-2901	15	16	is	be	AUX
admet-2901	15	17	the	the	DET
admet-2901	15	18	most	most	ADV
admet-2901	15	19	common	common	ADJ
admet-2901	15	20	type	type	NOUN
admet-2901	15	21	of	of	ADP
admet-2901	15	22	cancer	cancer	NOUN
admet-2901	15	23	with	with	ADP
admet-2901	15	24	the	the	DET
admet-2901	15	25	highest	high	ADJ
admet-2901	15	26	incidence	incidence	NOUN
admet-2901	15	27	and	and	CCONJ
admet-2901	15	28	lethality	lethality	NOUN
admet-2901	15	29	rate	rate	NOUN
admet-2901	15	30	among	among	ADP
admet-2901	15	31	women	woman	NOUN
admet-2901	15	32	worldwide	worldwide	ADV
admet-2901	15	33	,	,	PUNCT
admet-2901	15	34	accounting	account	VERB
admet-2901	15	35	for	for	ADP
admet-2901	15	36	23.8	23.8	NUM
admet-2901	15	37	and	and	CCONJ
admet-2901	15	38	15.8	15.8	NUM
admet-2901	15	39	%	%	NOUN
admet-2901	15	40	,	,	PUNCT
admet-2901	15	41	respectively	respectively	ADV
admet-2901	15	42	[	[	X
admet-2901	15	43	1	1	NUM
admet-2901	15	44	]	]	PUNCT
admet-2901	15	45	.	.	PUNCT
admet-2901	16	1	while	while	SCONJ
admet-2901	16	2	southeast	southeast	PROPN
admet-2901	16	3	asia	asia	PROPN
admet-2901	16	4	reports	report	VERB
admet-2901	16	5	the	the	DET
admet-2901	16	6	lowest	low	ADJ
admet-2901	16	7	overall	overall	ADJ
admet-2901	16	8	incidence	incidence	NOUN
admet-2901	16	9	of	of	ADP
admet-2901	16	10	breast	breast	NOUN
admet-2901	16	11	cancer	cancer	NOUN
admet-2901	16	12	globally	globally	ADV
admet-2901	16	13	,	,	PUNCT
admet-2901	16	14	thailand	thailand	PROPN
admet-2901	16	15	exhibits	exhibit	VERB
admet-2901	16	16	the	the	DET
admet-2901	16	17	highest	high	ADJ
admet-2901	16	18	rate	rate	NOUN
admet-2901	16	19	within	within	ADP
admet-2901	16	20	the	the	DET
admet-2901	16	21	region	region	NOUN
admet-2901	16	22	,	,	PUNCT
admet-2901	16	23	followed	follow	VERB
admet-2901	16	24	by	by	ADP
admet-2901	16	25	https://dx.doi.org/10.5599/admet.2901	https://dx.doi.org/10.5599/admet.2901	PROPN
admet-2901	16	26	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	PROPN
admet-2901	16	27	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-2901	16	28	mailto:phongthon.kan@mahidol.ac.th	mailto:phongthon.kan@mahidol.ac.th	PROPN
admet-2901	16	29	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-2901	16	30	n.	n.	PROPN
admet-2901	16	31	chabang	chabang	PROPN
admet-2901	16	32	et	et	PROPN
admet-2901	16	33	al	al	PROPN
admet-2901	16	34	.	.	PROPN
admet-2901	16	35	admet	admet	PROPN
admet-2901	16	36	&	&	CCONJ
admet-2901	16	37	dmpk	dmpk	PROPN
admet-2901	16	38	13(5	13(5	NUM
admet-2901	16	39	)	)	PUNCT
admet-2901	16	40	(	(	PUNCT
admet-2901	16	41	2025	2025	NUM
admet-2901	16	42	)	)	PUNCT
admet-2901	16	43	2901	2901	NUM
admet-2901	16	44	2	2	NUM
admet-2901	16	45	singapore	singapore	NOUN
admet-2901	16	46	and	and	CCONJ
admet-2901	16	47	malaysia	malaysia	NOUN
admet-2901	17	1	[	[	X
admet-2901	17	2	2	2	NUM
admet-2901	17	3	]	]	PUNCT
admet-2901	17	4	.	.	PUNCT
admet-2901	18	1	this	this	DET
admet-2901	18	2	contrast	contrast	NOUN
admet-2901	18	3	highlights	highlight	VERB
admet-2901	18	4	the	the	DET
admet-2901	18	5	considerable	considerable	ADJ
admet-2901	18	6	burden	burden	NOUN
admet-2901	18	7	of	of	ADP
admet-2901	18	8	breast	breast	NOUN
admet-2901	18	9	cancer	cancer	NOUN
admet-2901	18	10	in	in	ADP
admet-2901	18	11	thailand	thailand	PROPN
admet-2901	18	12	,	,	PUNCT
admet-2901	18	13	suggesting	suggest	VERB
admet-2901	18	14	the	the	DET
admet-2901	18	15	presence	presence	NOUN
admet-2901	18	16	of	of	ADP
admet-2901	18	17	localized	localized	ADJ
admet-2901	18	18	factors	factor	NOUN
admet-2901	18	19	that	that	PRON
admet-2901	18	20	may	may	AUX
admet-2901	18	21	influence	influence	VERB
admet-2901	18	22	disease	disease	NOUN
admet-2901	18	23	prevalence[2	prevalence[2	PROPN
admet-2901	18	24	]	]	PUNCT
admet-2901	18	25	.	.	PUNCT
admet-2901	19	1	breast	breast	NOUN
admet-2901	19	2	cancer	cancer	NOUN
admet-2901	19	3	treatment	treatment	NOUN
admet-2901	19	4	varies	vary	VERB
admet-2901	19	5	according	accord	VERB
admet-2901	19	6	to	to	ADP
admet-2901	19	7	the	the	DET
admet-2901	19	8	tumour	tumour	NOUN
admet-2901	19	9	stage	stage	NOUN
admet-2901	19	10	and	and	CCONJ
admet-2901	19	11	may	may	AUX
admet-2901	19	12	involve	involve	VERB
admet-2901	19	13	surgery	surgery	NOUN
admet-2901	19	14	,	,	PUNCT
admet-2901	19	15	radiotherapy	radiotherapy	NOUN
admet-2901	19	16	,	,	PUNCT
admet-2901	19	17	endocrine	endocrine	NOUN
admet-2901	19	18	therapy	therapy	NOUN
admet-2901	19	19	,	,	PUNCT
admet-2901	19	20	targeted	target	VERB
admet-2901	19	21	therapy	therapy	NOUN
admet-2901	19	22	,	,	PUNCT
admet-2901	19	23	or	or	CCONJ
admet-2901	19	24	adjuvant	adjuvant	ADJ
admet-2901	19	25	chemotherapy[3	chemotherapy[3	NOUN
admet-2901	19	26	]	]	PUNCT
admet-2901	19	27	.	.	PUNCT
admet-2901	20	1	in	in	ADP
admet-2901	20	2	stage	stage	NOUN
admet-2901	20	3	iv	iv	NUM
admet-2901	20	4	breast	breast	NOUN
admet-2901	20	5	cancer	cancer	NOUN
admet-2901	20	6	,	,	PUNCT
admet-2901	20	7	treatment	treatment	NOUN
admet-2901	20	8	typically	typically	ADV
admet-2901	20	9	relies	rely	VERB
admet-2901	20	10	on	on	ADP
admet-2901	20	11	systemic	systemic	ADJ
admet-2901	20	12	therapies	therapy	NOUN
admet-2901	20	13	such	such	ADJ
admet-2901	20	14	as	as	ADP
admet-2901	20	15	chemotherapy	chemotherapy	NOUN
admet-2901	20	16	,	,	PUNCT
admet-2901	20	17	often	often	ADV
admet-2901	20	18	in	in	ADP
admet-2901	20	19	combination	combination	NOUN
admet-2901	20	20	with	with	ADP
admet-2901	20	21	targeted	target	VERB
admet-2901	20	22	or	or	CCONJ
admet-2901	20	23	immunotherapy	immunotherapy	NOUN
admet-2901	20	24	,	,	PUNCT
admet-2901	20	25	to	to	PART
admet-2901	20	26	manage	manage	VERB
admet-2901	20	27	metastases	metastasis	NOUN
admet-2901	20	28	[	[	X
admet-2901	20	29	4,5	4,5	NUM
admet-2901	20	30	]	]	PUNCT
admet-2901	20	31	.	.	PUNCT
admet-2901	21	1	surgery	surgery	NOUN
admet-2901	21	2	may	may	AUX
admet-2901	21	3	be	be	AUX
admet-2901	21	4	considered	consider	VERB
admet-2901	21	5	for	for	ADP
admet-2901	21	6	palliative	palliative	ADJ
admet-2901	21	7	purposes	purpose	NOUN
admet-2901	21	8	in	in	ADP
admet-2901	21	9	certain	certain	ADJ
admet-2901	21	10	cases	case	NOUN
admet-2901	21	11	[	[	X
admet-2901	21	12	3	3	NUM
admet-2901	21	13	]	]	PUNCT
admet-2901	21	14	.	.	PUNCT
admet-2901	22	1	access	access	NOUN
admet-2901	22	2	to	to	ADP
admet-2901	22	3	standard	standard	ADJ
admet-2901	22	4	breast	breast	NOUN
admet-2901	22	5	cancer	cancer	NOUN
admet-2901	22	6	therapies	therapy	NOUN
admet-2901	22	7	,	,	PUNCT
admet-2901	22	8	particularly	particularly	ADV
admet-2901	22	9	chemotherapy	chemotherapy	NOUN
admet-2901	22	10	for	for	ADP
admet-2901	22	11	patients	patient	NOUN
admet-2901	22	12	with	with	ADP
admet-2901	22	13	advanced	advanced	ADJ
admet-2901	22	14	-	-	PUNCT
admet-2901	22	15	stage	stage	NOUN
admet-2901	22	16	disease	disease	NOUN
admet-2901	22	17	,	,	PUNCT
admet-2901	22	18	is	be	AUX
admet-2901	22	19	frequently	frequently	ADV
admet-2901	22	20	constrained	constrain	VERB
admet-2901	22	21	by	by	ADP
admet-2901	22	22	high	high	ADJ
admet-2901	22	23	costs	cost	NOUN
admet-2901	22	24	[	[	X
admet-2901	22	25	6	6	NUM
admet-2901	22	26	]	]	PUNCT
admet-2901	22	27	.	.	PUNCT
admet-2901	23	1	this	this	DET
admet-2901	23	2	challenge	challenge	NOUN
admet-2901	23	3	is	be	AUX
admet-2901	23	4	especially	especially	ADV
admet-2901	23	5	severe	severe	ADJ
admet-2901	23	6	in	in	ADP
admet-2901	23	7	rural	rural	ADJ
admet-2901	23	8	areas	area	NOUN
admet-2901	23	9	of	of	ADP
admet-2901	23	10	thailand	thailand	PROPN
admet-2901	23	11	,	,	PUNCT
admet-2901	23	12	where	where	SCONJ
admet-2901	23	13	financial	financial	ADJ
admet-2901	23	14	and	and	CCONJ
admet-2901	23	15	healthcare	healthcare	NOUN
admet-2901	23	16	resource	resource	NOUN
admet-2901	23	17	limitations	limitation	NOUN
admet-2901	23	18	contribute	contribute	VERB
admet-2901	23	19	to	to	ADP
admet-2901	23	20	persistently	persistently	ADV
admet-2901	23	21	low	low	ADJ
admet-2901	23	22	survival	survival	NOUN
admet-2901	23	23	rates	rate	NOUN
admet-2901	23	24	among	among	ADP
admet-2901	23	25	breast	breast	NOUN
admet-2901	23	26	cancer	cancer	NOUN
admet-2901	23	27	patients	patient	NOUN
admet-2901	23	28	[	[	X
admet-2901	23	29	7,8	7,8	NUM
admet-2901	23	30	]	]	PUNCT
admet-2901	23	31	.	.	PUNCT
admet-2901	24	1	therefore	therefore	ADV
admet-2901	24	2	,	,	PUNCT
admet-2901	24	3	there	there	PRON
admet-2901	24	4	is	be	VERB
admet-2901	24	5	an	an	DET
admet-2901	24	6	urgent	urgent	ADJ
admet-2901	24	7	need	need	NOUN
admet-2901	24	8	to	to	PART
admet-2901	24	9	explore	explore	VERB
admet-2901	24	10	and	and	CCONJ
admet-2901	24	11	develop	develop	VERB
admet-2901	24	12	novel	novel	ADJ
admet-2901	24	13	therapeutic	therapeutic	ADJ
admet-2901	24	14	agents	agent	NOUN
admet-2901	24	15	derived	derive	VERB
admet-2901	24	16	from	from	ADP
admet-2901	24	17	local	local	ADJ
admet-2901	24	18	natural	natural	ADJ
admet-2901	24	19	resources	resource	NOUN
admet-2901	24	20	,	,	PUNCT
admet-2901	24	21	which	which	PRON
admet-2901	24	22	may	may	AUX
admet-2901	24	23	provide	provide	VERB
admet-2901	24	24	more	more	ADV
admet-2901	24	25	accessible	accessible	ADJ
admet-2901	24	26	and	and	CCONJ
admet-2901	24	27	cost	cost	NOUN
admet-2901	24	28	-	-	PUNCT
admet-2901	24	29	effective	effective	ADJ
admet-2901	24	30	treatment	treatment	NOUN
admet-2901	24	31	alternatives	alternative	NOUN
admet-2901	24	32	for	for	ADP
admet-2901	24	33	these	these	DET
admet-2901	24	34	patients	patient	NOUN
admet-2901	24	35	.	.	PUNCT
admet-2901	25	1	thailand	thailand	PROPN
admet-2901	25	2	is	be	AUX
admet-2901	25	3	located	locate	VERB
admet-2901	25	4	in	in	ADP
admet-2901	25	5	a	a	DET
admet-2901	25	6	tropical	tropical	ADJ
admet-2901	25	7	area	area	NOUN
admet-2901	25	8	with	with	ADP
admet-2901	25	9	several	several	ADJ
admet-2901	25	10	critical	critical	ADJ
admet-2901	25	11	natural	natural	ADJ
admet-2901	25	12	resources	resource	NOUN
admet-2901	25	13	worldwide	worldwide	ADV
admet-2901	25	14	,	,	PUNCT
admet-2901	25	15	particularly	particularly	ADV
admet-2901	25	16	mallotus	mallotus	NOUN
admet-2901	25	17	[	[	X
admet-2901	25	18	9	9	NUM
admet-2901	25	19	]	]	PUNCT
admet-2901	25	20	.	.	PUNCT
admet-2901	26	1	several	several	ADJ
admet-2901	26	2	species	specie	NOUN
admet-2901	26	3	within	within	ADP
admet-2901	26	4	the	the	DET
admet-2901	26	5	mallotus	mallotus	ADJ
admet-2901	26	6	genus	genus	NOUN
admet-2901	26	7	have	have	AUX
admet-2901	26	8	long	long	ADV
admet-2901	26	9	been	be	AUX
admet-2901	26	10	utilized	utilize	VERB
admet-2901	26	11	in	in	ADP
admet-2901	26	12	traditional	traditional	ADJ
admet-2901	26	13	medicine	medicine	NOUN
admet-2901	26	14	across	across	ADP
admet-2901	26	15	southeast	southeast	PROPN
admet-2901	26	16	asia	asia	PROPN
admet-2901	26	17	to	to	PART
admet-2901	26	18	treat	treat	VERB
admet-2901	26	19	conditions	condition	NOUN
admet-2901	26	20	such	such	ADJ
admet-2901	26	21	as	as	ADP
admet-2901	26	22	liver	liver	NOUN
admet-2901	26	23	disorders	disorder	NOUN
admet-2901	26	24	,	,	PUNCT
admet-2901	26	25	skin	skin	NOUN
admet-2901	26	26	ailments	ailment	NOUN
admet-2901	26	27	,	,	PUNCT
admet-2901	26	28	fever	fever	NOUN
admet-2901	26	29	,	,	PUNCT
admet-2901	26	30	and	and	CCONJ
admet-2901	26	31	malaria	malaria	NOUN
admet-2901	27	1	[	[	X
admet-2901	27	2	10,11	10,11	NOUN
admet-2901	27	3	]	]	PUNCT
admet-2901	27	4	.	.	PUNCT
admet-2901	28	1	compounds	compound	NOUN
admet-2901	28	2	isolated	isolate	VERB
admet-2901	28	3	from	from	ADP
admet-2901	28	4	mallotus	mallotus	ADJ
admet-2901	28	5	extracts	extract	NOUN
admet-2901	28	6	have	have	AUX
admet-2901	28	7	demonstrated	demonstrate	VERB
admet-2901	28	8	a	a	DET
admet-2901	28	9	range	range	NOUN
admet-2901	28	10	of	of	ADP
admet-2901	28	11	bioactivities	bioactivitie	NOUN
admet-2901	28	12	,	,	PUNCT
admet-2901	28	13	such	such	ADJ
admet-2901	28	14	as	as	ADP
admet-2901	28	15	antioxidant	antioxidant	ADJ
admet-2901	28	16	,	,	PUNCT
admet-2901	28	17	antiviral	antiviral	ADJ
admet-2901	28	18	,	,	PUNCT
admet-2901	28	19	antimicrobial	antimicrobial	ADJ
admet-2901	28	20	,	,	PUNCT
admet-2901	28	21	anti	anti	ADJ
admet-2901	28	22	-	-	ADJ
admet-2901	28	23	inflammatory	inflammatory	ADJ
admet-2901	28	24	,	,	PUNCT
admet-2901	28	25	and	and	CCONJ
admet-2901	28	26	cytotoxic	cytotoxic	ADJ
admet-2901	28	27	effects	effect	NOUN
admet-2901	28	28	[	[	X
admet-2901	28	29	12,13	12,13	NUM
admet-2901	28	30	]	]	PUNCT
admet-2901	28	31	.	.	PUNCT
admet-2901	29	1	notably	notably	ADV
admet-2901	29	2	,	,	PUNCT
admet-2901	29	3	a	a	DET
admet-2901	29	4	methanol	methanol	NOUN
admet-2901	29	5	extract	extract	NOUN
admet-2901	29	6	derived	derive	VERB
admet-2901	29	7	from	from	ADP
admet-2901	29	8	the	the	DET
admet-2901	29	9	leaves	leave	NOUN
admet-2901	29	10	of	of	ADP
admet-2901	29	11	m.	m.	NOUN
admet-2901	29	12	peltatus	peltatus	NOUN
admet-2901	29	13	has	have	AUX
admet-2901	29	14	been	be	AUX
admet-2901	29	15	evaluated	evaluate	VERB
admet-2901	29	16	for	for	ADP
admet-2901	29	17	its	its	PRON
admet-2901	29	18	activity	activity	NOUN
admet-2901	29	19	against	against	ADP
admet-2901	29	20	herpes	herpe	NOUN
admet-2901	29	21	viruses	virus	NOUN
admet-2901	29	22	[	[	X
admet-2901	29	23	14	14	NUM
admet-2901	29	24	]	]	PUNCT
admet-2901	29	25	.	.	PUNCT
admet-2901	30	1	the	the	DET
admet-2901	30	2	ethanolic	ethanolic	ADJ
admet-2901	30	3	extract	extract	NOUN
admet-2901	30	4	of	of	ADP
admet-2901	30	5	red	red	ADJ
admet-2901	30	6	hairy	hairy	ADJ
admet-2901	30	7	substance	substance	NOUN
admet-2901	30	8	from	from	ADP
admet-2901	30	9	the	the	DET
admet-2901	30	10	fruits	fruit	NOUN
admet-2901	30	11	of	of	ADP
admet-2901	30	12	m.	m.	NOUN
admet-2901	30	13	philippensis	philippensis	NOUN
admet-2901	30	14	showed	show	VERB
admet-2901	30	15	strong	strong	ADJ
admet-2901	30	16	antibacterial	antibacterial	ADJ
admet-2901	30	17	activity	activity	NOUN
admet-2901	30	18	against	against	ADP
admet-2901	30	19	selected	select	VERB
admet-2901	30	20	gramnegative	gramnegative	ADJ
admet-2901	30	21	and	and	CCONJ
admet-2901	30	22	gram	gram	NOUN
admet-2901	30	23	-	-	PUNCT
admet-2901	30	24	positive	positive	ADJ
admet-2901	30	25	bacteria	bacteria	NOUN
admet-2901	30	26	[	[	X
admet-2901	30	27	15,16	15,16	NUM
admet-2901	30	28	]	]	PUNCT
admet-2901	30	29	.	.	PUNCT
admet-2901	31	1	finally	finally	ADV
admet-2901	31	2	,	,	PUNCT
admet-2901	31	3	the	the	DET
admet-2901	31	4	leaf	leaf	NOUN
admet-2901	31	5	extract	extract	NOUN
admet-2901	31	6	of	of	ADP
admet-2901	31	7	m.	m.	NOUN
admet-2901	31	8	repandus	repandus	PROPN
admet-2901	31	9	has	have	AUX
admet-2901	31	10	been	be	AUX
admet-2901	31	11	shown	show	VERB
admet-2901	31	12	to	to	PART
admet-2901	31	13	possess	possess	VERB
admet-2901	31	14	analgesic	analgesic	ADJ
admet-2901	31	15	and	and	CCONJ
admet-2901	31	16	anti	anti	ADJ
admet-2901	31	17	-	-	ADJ
admet-2901	31	18	inflammatory	inflammatory	ADJ
admet-2901	31	19	activities	activity	NOUN
admet-2901	31	20	[	[	X
admet-2901	31	21	17	17	NUM
admet-2901	31	22	]	]	PUNCT
admet-2901	31	23	.	.	PUNCT
admet-2901	32	1	moreover	moreover	ADV
admet-2901	32	2	,	,	PUNCT
admet-2901	32	3	m.	m.	NOUN
admet-2901	32	4	philippensis	philippensis	NOUN
admet-2901	32	5	and	and	CCONJ
admet-2901	32	6	m.	m.	NOUN
admet-2901	32	7	repandus	repandus	NOUN
admet-2901	32	8	have	have	AUX
admet-2901	32	9	been	be	AUX
admet-2901	32	10	demonstrated	demonstrate	VERB
admet-2901	32	11	to	to	PART
admet-2901	32	12	exhibit	exhibit	VERB
admet-2901	32	13	anti	anti	ADJ
admet-2901	32	14	-	-	ADJ
admet-2901	32	15	cancer	cancer	ADJ
admet-2901	32	16	properties	property	NOUN
admet-2901	32	17	against	against	ADP
admet-2901	32	18	lung	lung	NOUN
admet-2901	32	19	cancer	cancer	NOUN
admet-2901	32	20	cells	cell	NOUN
admet-2901	32	21	,	,	PUNCT
admet-2901	32	22	colorectal	colorectal	ADJ
admet-2901	32	23	cancer	cancer	NOUN
admet-2901	32	24	cells	cell	NOUN
admet-2901	32	25	,	,	PUNCT
admet-2901	32	26	breast	breast	NOUN
admet-2901	32	27	cancer	cancer	NOUN
admet-2901	32	28	cells	cell	NOUN
admet-2901	32	29	,	,	PUNCT
admet-2901	32	30	and	and	CCONJ
admet-2901	32	31	cholangiocarcinoma	cholangiocarcinoma	ADJ
admet-2901	32	32	cells	cell	NOUN
admet-2901	32	33	[	[	X
admet-2901	32	34	18,19	18,19	X
admet-2901	32	35	]	]	PUNCT
admet-2901	32	36	.	.	PUNCT
admet-2901	33	1	however	however	ADV
admet-2901	33	2	,	,	PUNCT
admet-2901	33	3	although	although	SCONJ
admet-2901	33	4	m.	m.	NOUN
admet-2901	33	5	glomerulatus	glomerulatus	NOUN
admet-2901	33	6	is	be	AUX
admet-2901	33	7	a	a	DET
admet-2901	33	8	shrubby	shrubby	ADJ
admet-2901	33	9	species	specie	NOUN
admet-2901	33	10	found	find	VERB
admet-2901	33	11	in	in	ADP
admet-2901	33	12	northeastern	northeastern	ADJ
admet-2901	33	13	and	and	CCONJ
admet-2901	33	14	central	central	ADJ
admet-2901	33	15	thailand	thailand	PROPN
admet-2901	33	16	[	[	X
admet-2901	33	17	9	9	NUM
admet-2901	33	18	]	]	PUNCT
admet-2901	33	19	,	,	PUNCT
admet-2901	33	20	its	its	PRON
admet-2901	33	21	phytochemical	phytochemical	ADJ
admet-2901	33	22	composition	composition	NOUN
admet-2901	33	23	and	and	CCONJ
admet-2901	33	24	biological	biological	ADJ
admet-2901	33	25	activities	activity	NOUN
admet-2901	33	26	remain	remain	VERB
admet-2901	33	27	largely	largely	ADV
admet-2901	33	28	unexplored	unexplored	ADJ
admet-2901	33	29	,	,	PUNCT
admet-2901	33	30	leaving	leave	VERB
admet-2901	33	31	its	its	PRON
admet-2901	33	32	pharmacological	pharmacological	ADJ
admet-2901	33	33	potential	potential	NOUN
admet-2901	33	34	poorly	poorly	ADV
admet-2901	33	35	characterized	characterize	VERB
admet-2901	33	36	.	.	PUNCT
admet-2901	34	1	therefore	therefore	ADV
admet-2901	34	2	,	,	PUNCT
admet-2901	34	3	local	local	ADJ
admet-2901	34	4	natural	natural	ADJ
admet-2901	34	5	resources	resource	NOUN
admet-2901	34	6	are	be	AUX
admet-2901	34	7	the	the	DET
admet-2901	34	8	best	good	ADJ
admet-2901	34	9	option	option	NOUN
admet-2901	34	10	for	for	SCONJ
admet-2901	34	11	urgent	urgent	ADJ
admet-2901	34	12	drug	drug	NOUN
admet-2901	34	13	development	development	NOUN
admet-2901	34	14	to	to	PART
admet-2901	34	15	treat	treat	VERB
admet-2901	34	16	breast	breast	NOUN
admet-2901	34	17	cancer	cancer	NOUN
admet-2901	34	18	patients	patient	NOUN
admet-2901	34	19	in	in	ADP
admet-2901	34	20	the	the	DET
admet-2901	34	21	country	country	NOUN
admet-2901	34	22	.	.	PUNCT
admet-2901	35	1	based	base	VERB
admet-2901	35	2	on	on	ADP
admet-2901	35	3	the	the	DET
admet-2901	35	4	above	above	ADJ
admet-2901	35	5	information	information	NOUN
admet-2901	35	6	,	,	PUNCT
admet-2901	35	7	it	it	PRON
admet-2901	35	8	is	be	AUX
admet-2901	35	9	hypothesized	hypothesize	VERB
admet-2901	35	10	that	that	SCONJ
admet-2901	35	11	compounds	compound	NOUN
admet-2901	35	12	isolated	isolate	VERB
admet-2901	35	13	from	from	ADP
admet-2901	35	14	m.	m.	NOUN
admet-2901	35	15	glomerulatus	glomerulatus	NOUN
admet-2901	35	16	may	may	AUX
admet-2901	35	17	be	be	AUX
admet-2901	35	18	developed	develop	VERB
admet-2901	35	19	into	into	ADP
admet-2901	35	20	effective	effective	ADJ
admet-2901	35	21	treatment	treatment	NOUN
admet-2901	35	22	agents	agent	NOUN
admet-2901	35	23	for	for	ADP
admet-2901	35	24	breast	breast	NOUN
admet-2901	35	25	cancer	cancer	NOUN
admet-2901	35	26	,	,	PUNCT
admet-2901	35	27	reducing	reduce	VERB
admet-2901	35	28	reliance	reliance	NOUN
admet-2901	35	29	on	on	ADP
admet-2901	35	30	imported	import	VERB
admet-2901	35	31	chemotherapy	chemotherapy	NOUN
admet-2901	35	32	drugs	drug	NOUN
admet-2901	35	33	,	,	PUNCT
admet-2901	35	34	especially	especially	ADV
admet-2901	35	35	for	for	ADP
admet-2901	35	36	those	those	PRON
admet-2901	35	37	with	with	ADP
admet-2901	35	38	limited	limited	ADJ
admet-2901	35	39	financial	financial	ADJ
admet-2901	35	40	resources	resource	NOUN
admet-2901	35	41	in	in	ADP
admet-2901	35	42	rural	rural	ADJ
admet-2901	35	43	thailand	thailand	PROPN
admet-2901	35	44	.	.	PUNCT
admet-2901	36	1	this	this	DET
admet-2901	36	2	study	study	NOUN
admet-2901	36	3	aims	aim	VERB
admet-2901	36	4	to	to	PART
admet-2901	36	5	identify	identify	VERB
admet-2901	36	6	bioactive	bioactive	ADJ
admet-2901	36	7	compounds	compound	NOUN
admet-2901	36	8	that	that	PRON
admet-2901	36	9	reduce	reduce	VERB
admet-2901	36	10	breast	breast	NOUN
admet-2901	36	11	cancer	cancer	NOUN
admet-2901	36	12	cell	cell	NOUN
admet-2901	36	13	viability	viability	NOUN
admet-2901	36	14	by	by	ADP
admet-2901	36	15	screening	screen	VERB
admet-2901	36	16	natural	natural	ADJ
admet-2901	36	17	products	product	NOUN
admet-2901	36	18	isolated	isolate	VERB
admet-2901	36	19	from	from	ADP
admet-2901	36	20	m.	m.	NOUN
admet-2901	36	21	glomerulatus	glomerulatus	NOUN
admet-2901	36	22	.	.	PUNCT
admet-2901	37	1	the	the	DET
admet-2901	37	2	screening	screening	NOUN
admet-2901	37	3	was	be	AUX
admet-2901	37	4	conducted	conduct	VERB
admet-2901	37	5	in	in	ADP
admet-2901	37	6	both	both	CCONJ
admet-2901	37	7	low	low	ADJ
admet-2901	37	8	-	-	PUNCT
admet-2901	37	9	aggressiveness	aggressiveness	NOUN
admet-2901	37	10	(	(	PUNCT
admet-2901	37	11	mcf-7	mcf-7	NOUN
admet-2901	37	12	)	)	PUNCT
admet-2901	37	13	and	and	CCONJ
admet-2901	37	14	high	high	ADJ
admet-2901	37	15	-	-	PUNCT
admet-2901	37	16	aggressiveness	aggressiveness	NOUN
admet-2901	37	17	(	(	PUNCT
admet-2901	37	18	mda	mda	PROPN
admet-2901	37	19	-	-	PUNCT
admet-2901	37	20	mb-231	mb-231	PROPN
admet-2901	37	21	)	)	PUNCT
admet-2901	37	22	breast	breast	NOUN
admet-2901	37	23	cancer	cancer	NOUN
admet-2901	37	24	cell	cell	NOUN
admet-2901	37	25	lines	line	NOUN
admet-2901	37	26	[	[	X
admet-2901	37	27	20	20	NUM
admet-2901	37	28	-	-	SYM
admet-2901	37	29	23	23	NUM
admet-2901	37	30	]	]	PUNCT
admet-2901	37	31	to	to	PART
admet-2901	37	32	evaluate	evaluate	VERB
admet-2901	37	33	differential	differential	ADJ
admet-2901	37	34	efficacy	efficacy	NOUN
admet-2901	37	35	across	across	ADP
admet-2901	37	36	cancer	cancer	NOUN
admet-2901	37	37	subtypes	subtype	NOUN
admet-2901	37	38	.	.	PUNCT
admet-2901	38	1	given	give	VERB
admet-2901	38	2	the	the	DET
admet-2901	38	3	critical	critical	ADJ
admet-2901	38	4	role	role	NOUN
admet-2901	38	5	of	of	ADP
admet-2901	38	6	vacuolar	vacuolar	ADJ
admet-2901	38	7	h+-atpase	h+-atpase	PROPN
admet-2901	38	8	(	(	PUNCT
admet-2901	38	9	v	v	NOUN
admet-2901	38	10	-	-	PUNCT
admet-2901	38	11	atpase	atpase	NOUN
admet-2901	38	12	)	)	PUNCT
admet-2901	38	13	in	in	ADP
admet-2901	38	14	regulating	regulate	VERB
admet-2901	38	15	lysosomal	lysosomal	ADJ
admet-2901	38	16	acidification	acidification	NOUN
admet-2901	38	17	,	,	PUNCT
admet-2901	38	18	as	as	ADV
admet-2901	38	19	well	well	ADV
admet-2901	38	20	as	as	ADP
admet-2901	38	21	its	its	PRON
admet-2901	38	22	involvement	involvement	NOUN
admet-2901	38	23	in	in	ADP
admet-2901	38	24	cancer	cancer	NOUN
admet-2901	38	25	progression	progression	NOUN
admet-2901	38	26	[	[	X
admet-2901	38	27	24	24	NUM
admet-2901	38	28	]	]	PUNCT
admet-2901	38	29	,	,	PUNCT
admet-2901	38	30	metastasis	metastasis	NOUN
admet-2901	38	31	[	[	X
admet-2901	38	32	25	25	NUM
admet-2901	38	33	]	]	PUNCT
admet-2901	38	34	,	,	PUNCT
admet-2901	38	35	and	and	CCONJ
admet-2901	38	36	frequent	frequent	ADJ
admet-2901	38	37	overexpression	overexpression	NOUN
admet-2901	38	38	in	in	ADP
admet-2901	38	39	aggressive	aggressive	ADJ
admet-2901	38	40	breast	breast	NOUN
admet-2901	38	41	cancers	cancer	NOUN
admet-2901	38	42	[	[	X
admet-2901	38	43	26,27	26,27	NUM
admet-2901	38	44	]	]	PUNCT
admet-2901	38	45	,	,	PUNCT
admet-2901	38	46	we	we	PRON
admet-2901	38	47	hypothesized	hypothesize	VERB
admet-2901	38	48	that	that	SCONJ
admet-2901	38	49	active	active	ADJ
admet-2901	38	50	compounds	compound	NOUN
admet-2901	38	51	from	from	ADP
admet-2901	38	52	m.	m.	NOUN
admet-2901	38	53	glomerulatus	glomerulatus	NOUN
admet-2901	38	54	may	may	AUX
admet-2901	38	55	exert	exert	VERB
admet-2901	38	56	their	their	PRON
admet-2901	38	57	effects	effect	NOUN
admet-2901	38	58	by	by	ADP
admet-2901	38	59	targeting	target	VERB
admet-2901	38	60	this	this	DET
admet-2901	38	61	proton	proton	NOUN
admet-2901	38	62	pump	pump	NOUN
admet-2901	38	63	.	.	PUNCT
admet-2901	39	1	therefore	therefore	ADV
admet-2901	39	2	,	,	PUNCT
admet-2901	39	3	v	v	X
admet-2901	39	4	-	-	PUNCT
admet-2901	39	5	atpase	atpase	PROPN
admet-2901	39	6	was	be	AUX
admet-2901	39	7	selected	select	VERB
admet-2901	39	8	as	as	ADP
admet-2901	39	9	the	the	DET
admet-2901	39	10	docking	docking	NOUN
admet-2901	39	11	target	target	NOUN
admet-2901	39	12	to	to	PART
admet-2901	39	13	explore	explore	VERB
admet-2901	39	14	whether	whether	SCONJ
admet-2901	39	15	the	the	DET
admet-2901	39	16	isolated	isolate	VERB
admet-2901	39	17	compounds	compound	NOUN
admet-2901	39	18	could	could	AUX
admet-2901	39	19	disrupt	disrupt	VERB
admet-2901	39	20	this	this	DET
admet-2901	39	21	cancer	cancer	NOUN
admet-2901	39	22	-	-	PUNCT
admet-2901	39	23	associated	associate	VERB
admet-2901	39	24	mechanism	mechanism	NOUN
admet-2901	39	25	and	and	CCONJ
admet-2901	39	26	contribute	contribute	VERB
admet-2901	39	27	to	to	ADP
admet-2901	39	28	the	the	DET
admet-2901	39	29	observed	observe	VERB
admet-2901	39	30	cytotoxicity	cytotoxicity	NOUN
admet-2901	39	31	.	.	PUNCT
admet-2901	40	1	experimental	experimental	ADJ
admet-2901	40	2	general	general	ADJ
admet-2901	40	3	experimental	experimental	ADJ
admet-2901	40	4	procedures	procedure	NOUN
admet-2901	40	5	melting	melt	VERB
admet-2901	40	6	points	point	NOUN
admet-2901	40	7	were	be	AUX
admet-2901	40	8	recorded	record	VERB
admet-2901	40	9	(	(	PUNCT
admet-2901	40	10	uncorrected	uncorrected	ADJ
admet-2901	40	11	)	)	PUNCT
admet-2901	40	12	and	and	CCONJ
admet-2901	40	13	determined	determine	VERB
admet-2901	40	14	on	on	ADP
admet-2901	40	15	a	a	DET
admet-2901	40	16	digital	digital	ADJ
admet-2901	40	17	electrothermal	electrothermal	ADJ
admet-2901	40	18	melting	melting	NOUN
admet-2901	40	19	apparatus	apparatus	NOUN
admet-2901	40	20	.	.	PUNCT
admet-2901	41	1	infrared	infrared	PROPN
admet-2901	41	2	spectra	spectra	PROPN
admet-2901	41	3	were	be	AUX
admet-2901	41	4	recorded	record	VERB
admet-2901	41	5	by	by	ADP
admet-2901	41	6	using	use	VERB
admet-2901	41	7	perkin	perkin	PROPN
admet-2901	41	8	elmer	elmer	PROPN
admet-2901	41	9	system	system	PROPN
admet-2901	41	10	2000	2000	NUM
admet-2901	41	11	ft	ft	NOUN
admet-2901	41	12	-	-	PUNCT
admet-2901	41	13	ir	ir	NOUN
admet-2901	41	14	,	,	PUNCT
admet-2901	41	15	whereas	whereas	SCONJ
admet-2901	41	16	the	the	DET
admet-2901	41	17	major	major	ADJ
admet-2901	41	18	bands	band	NOUN
admet-2901	41	19	(	(	PUNCT
admet-2901	41	20	νmax	νmax	PROPN
admet-2901	41	21	)	)	PUNCT
admet-2901	41	22	were	be	AUX
admet-2901	41	23	recorded	record	VERB
admet-2901	41	24	in	in	ADP
admet-2901	41	25	wave	wave	NOUN
admet-2901	41	26	numbers	number	NOUN
admet-2901	41	27	,	,	PUNCT
admet-2901	41	28	cm-1	cm-1	PROPN
admet-2901	41	29	.	.	PUNCT
admet-2901	42	1	optical	optical	ADJ
admet-2901	42	2	rotations	rotation	NOUN
admet-2901	42	3	were	be	AUX
admet-2901	42	4	measured	measure	VERB
admet-2901	42	5	using	use	VERB
admet-2901	42	6	a	a	DET
admet-2901	42	7	jasco	jasco	ADJ
admet-2901	42	8	dip-370	dip-370	NOUN
admet-2901	42	9	digital	digital	ADJ
admet-2901	42	10	polarimeter	polarimeter	NOUN
admet-2901	42	11	with	with	ADP
admet-2901	42	12	a	a	DET
admet-2901	42	13	50	50	NUM
admet-2901	42	14	mm	mm	NOUN
admet-2901	42	15	microcell	microcell	NOUN
admet-2901	42	16	(	(	PUNCT
admet-2901	42	17	1	1	NUM
admet-2901	42	18	ml	ml	NOUN
admet-2901	42	19	)	)	PUNCT
admet-2901	42	20	.	.	PUNCT
admet-2901	43	1	ultraviolet	ultraviolet	ADJ
admet-2901	43	2	absorption	absorption	NOUN
admet-2901	43	3	spectra	spectra	NOUN
admet-2901	43	4	were	be	AUX
admet-2901	43	5	measured	measure	VERB
admet-2901	43	6	in	in	ADP
admet-2901	43	7	ethanol	ethanol	NOUN
admet-2901	43	8	,	,	PUNCT
admet-2901	43	9	chloroform	chloroform	NOUN
admet-2901	43	10	,	,	PUNCT
admet-2901	43	11	and	and	CCONJ
admet-2901	43	12	methanol	methanol	NOUN
admet-2901	43	13	solutions	solution	NOUN
admet-2901	43	14	on	on	ADP
admet-2901	43	15	a	a	DET
admet-2901	43	16	jasco	jasco	ADJ
admet-2901	43	17	530	530	NUM
admet-2901	43	18	spectrophotometer	spectrophotometer	NOUN
admet-2901	43	19	.	.	PUNCT
admet-2901	44	1	the	the	DET
admet-2901	44	2	principal	principal	ADJ
admet-2901	44	3	bands	band	NOUN
admet-2901	44	4	(	(	PUNCT
admet-2901	44	5	λmax	λmax	NOUN
admet-2901	44	6	)	)	PUNCT
admet-2901	44	7	were	be	AUX
admet-2901	44	8	reported	report	VERB
admet-2901	44	9	as	as	ADP
admet-2901	44	10	admet	admet	PROPN
admet-2901	44	11	&	&	CCONJ
admet-2901	44	12	dmpk	dmpk	PROPN
admet-2901	44	13	13(5	13(5	NOUN
admet-2901	44	14	)	)	PUNCT
admet-2901	44	15	(	(	PUNCT
admet-2901	44	16	2025	2025	NUM
admet-2901	44	17	)	)	PUNCT
admet-2901	44	18	2901	2901	NUM
admet-2901	44	19	new	new	ADJ
admet-2901	44	20	xanthone	xanthone	PROPN
admet-2901	44	21	and	and	CCONJ
admet-2901	44	22	chemical	chemical	NOUN
admet-2901	44	23	constituents	constituent	NOUN
admet-2901	44	24	from	from	ADP
admet-2901	44	25	mallotus	mallotus	ADJ
admet-2901	44	26	glomerulatus	glomerulatus	NOUN
admet-2901	44	27	doi	doi	PROPN
admet-2901	44	28	:	:	PUNCT
admet-2901	44	29	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	NOUN
admet-2901	44	30	3	3	NUM
admet-2901	44	31	wavelengths	wavelength	NOUN
admet-2901	44	32	and	and	CCONJ
admet-2901	44	33	log	log	VERB
admet-2901	44	34	ε	ε	PROPN
admet-2901	44	35	.	.	PUNCT
admet-2901	44	36	low	low	ADJ
admet-2901	44	37	-	-	PUNCT
admet-2901	44	38	resolution	resolution	NOUN
admet-2901	44	39	ei	ei	NOUN
admet-2901	44	40	mass	mass	ADJ
admet-2901	44	41	spectra	spectra	PROPN
admet-2901	44	42	were	be	AUX
admet-2901	44	43	recorded	record	VERB
admet-2901	44	44	at	at	ADP
admet-2901	44	45	70	70	NUM
admet-2901	44	46	ev	ev	PROPN
admet-2901	44	47	(	(	PUNCT
admet-2901	44	48	probe	probe	NOUN
admet-2901	44	49	)	)	PUNCT
admet-2901	44	50	on	on	ADP
admet-2901	44	51	a	a	DET
admet-2901	44	52	thermo	thermo	NOUN
admet-2901	44	53	finnigan	finnigan	PROPN
admet-2901	44	54	polaris	polaris	PROPN
admet-2901	44	55	q	q	PROPN
admet-2901	44	56	mass	mass	PROPN
admet-2901	44	57	spectrometer	spectrometer	NOUN
admet-2901	44	58	.	.	PUNCT
admet-2901	45	1	the	the	DET
admet-2901	45	2	high	high	ADJ
admet-2901	45	3	-	-	PUNCT
admet-2901	45	4	resolution	resolution	NOUN
admet-2901	45	5	mass	mass	ADJ
admet-2901	45	6	spectra	spectra	NOUN
admet-2901	45	7	(	(	PUNCT
admet-2901	45	8	hrms	hrm	NOUN
admet-2901	45	9	)	)	PUNCT
admet-2901	45	10	were	be	AUX
admet-2901	45	11	recorded	record	VERB
admet-2901	45	12	on	on	ADP
admet-2901	45	13	a	a	DET
admet-2901	45	14	micromass	micromass	NOUN
admet-2901	45	15	model	model	NOUN
admet-2901	45	16	vq	vq	PROPN
admet-2901	45	17	-	-	PROPN
admet-2901	45	18	tof2	tof2	PROPN
admet-2901	45	19	.	.	PUNCT
admet-2901	46	1	the	the	DET
admet-2901	46	2	high	high	ADJ
admet-2901	46	3	-	-	PUNCT
admet-2901	46	4	resolution	resolution	NOUN
admet-2901	46	5	nuclear	nuclear	ADJ
admet-2901	46	6	magnetic	magnetic	ADJ
admet-2901	46	7	resonance	resonance	NOUN
admet-2901	46	8	spectra	spectra	NOUN
admet-2901	46	9	were	be	AUX
admet-2901	46	10	mainly	mainly	ADV
admet-2901	46	11	recorded	record	VERB
admet-2901	46	12	on	on	ADP
admet-2901	46	13	bruker	bruker	NOUN
admet-2901	46	14	ascendtm	ascendtm	VERB
admet-2901	46	15	400	400	NUM
admet-2901	46	16	and	and	CCONJ
admet-2901	46	17	bruker	bruker	ADJ
admet-2901	46	18	advance-500	advance-500	ADJ
admet-2901	46	19	spectrometers	spectrometer	NOUN
admet-2901	46	20	at	at	ADP
admet-2901	46	21	the	the	DET
admet-2901	46	22	department	department	NOUN
admet-2901	46	23	of	of	ADP
admet-2901	46	24	chemistry	chemistry	NOUN
admet-2901	46	25	,	,	PUNCT
admet-2901	46	26	faculty	faculty	NOUN
admet-2901	46	27	of	of	ADP
admet-2901	46	28	science	science	NOUN
admet-2901	46	29	,	,	PUNCT
admet-2901	46	30	mahidol	mahidol	PROPN
admet-2901	46	31	university	university	NOUN
admet-2901	46	32	.	.	PUNCT
admet-2901	47	1	solvents	solvent	NOUN
admet-2901	47	2	for	for	ADP
admet-2901	47	3	extraction	extraction	NOUN
admet-2901	47	4	,	,	PUNCT
admet-2901	47	5	chromatography	chromatography	NOUN
admet-2901	47	6	,	,	PUNCT
admet-2901	47	7	and	and	CCONJ
admet-2901	47	8	recrystallization	recrystallization	NOUN
admet-2901	47	9	were	be	AUX
admet-2901	47	10	distilled	distil	VERB
admet-2901	47	11	prior	prior	ADV
admet-2901	47	12	to	to	ADP
admet-2901	47	13	use	use	NOUN
admet-2901	47	14	at	at	ADP
admet-2901	47	15	their	their	PRON
admet-2901	47	16	boiling	boiling	NOUN
admet-2901	47	17	point	point	NOUN
admet-2901	47	18	ranges	range	NOUN
admet-2901	47	19	.	.	PUNCT
admet-2901	48	1	a	a	DET
admet-2901	48	2	pre	pre	ADJ
admet-2901	48	3	-	-	ADJ
admet-2901	48	4	coated	coated	ADJ
admet-2901	48	5	tlc	tlc	NOUN
admet-2901	48	6	aluminium	aluminium	NOUN
admet-2901	48	7	sheet	sheet	NOUN
admet-2901	48	8	of	of	ADP
admet-2901	48	9	silica	silica	NOUN
admet-2901	48	10	gel	gel	NOUN
admet-2901	48	11	60	60	NUM
admet-2901	48	12	pf254	pf254	PROPN
admet-2901	48	13	(	(	PUNCT
admet-2901	48	14	2020	2020	NUM
admet-2901	48	15	cm	cm	NUM
admet-2901	48	16	,	,	PUNCT
admet-2901	48	17	merck	merck	PROPN
admet-2901	48	18	)	)	PUNCT
admet-2901	48	19	was	be	AUX
admet-2901	48	20	used	use	VERB
admet-2901	48	21	for	for	ADP
admet-2901	48	22	analytical	analytical	ADJ
admet-2901	48	23	purposes	purpose	NOUN
admet-2901	48	24	,	,	PUNCT
admet-2901	48	25	and	and	CCONJ
admet-2901	48	26	the	the	DET
admet-2901	48	27	bands	band	NOUN
admet-2901	48	28	were	be	AUX
admet-2901	48	29	visualized	visualize	VERB
admet-2901	48	30	by	by	ADP
admet-2901	48	31	ultraviolet	ultraviolet	ADJ
admet-2901	48	32	light	light	NOUN
admet-2901	48	33	or	or	CCONJ
admet-2901	48	34	anisaldehyde	anisaldehyde	NOUN
admet-2901	48	35	solution	solution	NOUN
admet-2901	48	36	.	.	PUNCT
admet-2901	49	1	vacuum	vacuum	NOUN
admet-2901	49	2	column	column	PROPN
admet-2901	49	3	chromatography	chromatography	NOUN
admet-2901	49	4	was	be	AUX
admet-2901	49	5	performed	perform	VERB
admet-2901	49	6	using	use	VERB
admet-2901	49	7	silica	silica	NOUN
admet-2901	49	8	gel	gel	NOUN
admet-2901	49	9	60h	60h	X
admet-2901	49	10	(	(	PUNCT
admet-2901	49	11	230	230	NUM
admet-2901	49	12	-	-	SYM
admet-2901	49	13	400	400	NUM
admet-2901	49	14	mesh	mesh	NOUN
admet-2901	49	15	astm	astm	NOUN
admet-2901	49	16	,	,	PUNCT
admet-2901	49	17	art	art	NOUN
admet-2901	49	18	.	.	PUNCT
admet-2901	50	1	no	no	INTJ
admet-2901	50	2	.	.	NOUN
admet-2901	51	1	7736	7736	NUM
admet-2901	51	2	,	,	PUNCT
admet-2901	51	3	e.	e.	PROPN
admet-2901	51	4	merck	merck	PROPN
admet-2901	51	5	)	)	PUNCT
admet-2901	51	6	,	,	PUNCT
admet-2901	51	7	and	and	CCONJ
admet-2901	51	8	column	column	NOUN
admet-2901	51	9	chromatography	chromatography	NOUN
admet-2901	51	10	was	be	AUX
admet-2901	51	11	performed	perform	VERB
admet-2901	51	12	using	use	VERB
admet-2901	51	13	silica	silica	NOUN
admet-2901	51	14	gel	gel	NOUN
admet-2901	51	15	60h	60h	X
admet-2901	51	16	(	(	PUNCT
admet-2901	51	17	70	70	NUM
admet-2901	51	18	-	-	SYM
admet-2901	51	19	230	230	NUM
admet-2901	51	20	mesh	mesh	NOUN
admet-2901	51	21	astm	astm	NOUN
admet-2901	51	22	,	,	PUNCT
admet-2901	51	23	cat	cat	NOUN
admet-2901	51	24	.	.	PUNCT
admet-2901	52	1	no	no	INTJ
admet-2901	52	2	.	.	NOUN
admet-2901	53	1	7734	7734	NUM
admet-2901	53	2	,	,	PUNCT
admet-2901	53	3	e.	e.	PROPN
admet-2901	53	4	merck	merck	PROPN
admet-2901	53	5	)	)	PUNCT
admet-2901	53	6	.	.	PUNCT
admet-2901	54	1	plant	plant	NOUN
admet-2901	54	2	material	material	NOUN
admet-2901	54	3	the	the	DET
admet-2901	54	4	aerial	aerial	ADJ
admet-2901	54	5	parts	part	NOUN
admet-2901	54	6	of	of	ADP
admet-2901	54	7	mallotus	mallotus	NOUN
admet-2901	54	8	glomerulatus	glomerulatus	NOUN
admet-2901	54	9	were	be	AUX
admet-2901	54	10	collected	collect	VERB
admet-2901	54	11	in	in	ADP
admet-2901	54	12	august	august	PROPN
admet-2901	54	13	2011	2011	NUM
admet-2901	54	14	from	from	ADP
admet-2901	54	15	tat	tat	NOUN
admet-2901	54	16	pho	pho	NOUN
admet-2901	54	17	waterfall	waterfall	NOUN
admet-2901	54	18	,	,	PUNCT
admet-2901	54	19	phu	phu	PROPN
admet-2901	54	20	langka	langka	PROPN
admet-2901	54	21	national	national	PROPN
admet-2901	54	22	park	park	PROPN
admet-2901	54	23	,	,	PUNCT
admet-2901	54	24	ban	ban	VERB
admet-2901	54	25	phaeng	phaeng	NOUN
admet-2901	54	26	district	district	NOUN
admet-2901	54	27	,	,	PUNCT
admet-2901	54	28	nakhon	nakhon	PROPN
admet-2901	54	29	phanom	phanom	PROPN
admet-2901	54	30	,	,	PUNCT
admet-2901	54	31	thailand	thailand	PROPN
admet-2901	54	32	.	.	PUNCT
admet-2901	55	1	a	a	DET
admet-2901	55	2	voucher	voucher	ADJ
admet-2901	55	3	specimen	speciman	NOUN
admet-2901	55	4	(	(	PUNCT
admet-2901	55	5	bkf	bkf	NOUN
admet-2901	55	6	180558	180558	NUM
admet-2901	55	7	)	)	PUNCT
admet-2901	55	8	has	have	AUX
admet-2901	55	9	been	be	AUX
admet-2901	55	10	deposited	deposit	VERB
admet-2901	55	11	at	at	ADP
admet-2901	55	12	the	the	DET
admet-2901	55	13	forest	forest	NOUN
admet-2901	55	14	herbarium	herbarium	NOUN
admet-2901	55	15	,	,	PUNCT
admet-2901	55	16	department	department	NOUN
admet-2901	55	17	of	of	ADP
admet-2901	55	18	national	national	ADJ
admet-2901	55	19	parks	park	NOUN
admet-2901	55	20	,	,	PUNCT
admet-2901	55	21	wildlife	wildlife	NOUN
admet-2901	55	22	and	and	CCONJ
admet-2901	55	23	conservation	conservation	NOUN
admet-2901	55	24	,	,	PUNCT
admet-2901	55	25	bangkok	bangkok	PROPN
admet-2901	55	26	,	,	PUNCT
admet-2901	55	27	thailand	thailand	PROPN
admet-2901	55	28	.	.	PUNCT
admet-2901	56	1	extraction	extraction	NOUN
admet-2901	56	2	and	and	CCONJ
admet-2901	56	3	isolation	isolation	NOUN
admet-2901	56	4	of	of	ADP
admet-2901	56	5	mallotus	mallotus	NOUN
admet-2901	56	6	glomerulatus	glomerulatus	NOUN
admet-2901	56	7	dried	dry	VERB
admet-2901	56	8	and	and	CCONJ
admet-2901	56	9	finely	finely	ADV
admet-2901	56	10	powdered	powder	VERB
admet-2901	56	11	aerial	aerial	ADJ
admet-2901	56	12	parts	part	NOUN
admet-2901	56	13	of	of	ADP
admet-2901	56	14	mallotus	mallotus	NOUN
admet-2901	56	15	glomerulatus	glomerulatus	NOUN
admet-2901	56	16	(	(	PUNCT
admet-2901	56	17	4.4	4.4	NUM
admet-2901	56	18	kg	kg	NOUN
admet-2901	56	19	)	)	PUNCT
admet-2901	56	20	were	be	AUX
admet-2901	56	21	percolated	percolate	VERB
admet-2901	56	22	with	with	ADP
admet-2901	56	23	meoh	meoh	PROPN
admet-2901	56	24	(	(	PUNCT
admet-2901	56	25	24	24	NUM
admet-2901	56	26	l30	l30	PROPN
admet-2901	56	27	days5	days5	NOUN
admet-2901	56	28	times	time	NOUN
admet-2901	56	29	)	)	PUNCT
admet-2901	56	30	at	at	ADP
admet-2901	56	31	room	room	NOUN
admet-2901	56	32	temperature	temperature	NOUN
admet-2901	56	33	to	to	PART
admet-2901	56	34	give	give	VERB
admet-2901	56	35	a	a	DET
admet-2901	56	36	crude	crude	ADJ
admet-2901	56	37	methanol	methanol	NOUN
admet-2901	56	38	(	(	PUNCT
admet-2901	56	39	meoh	meoh	NOUN
admet-2901	56	40	)	)	PUNCT
admet-2901	56	41	extract	extract	NOUN
admet-2901	56	42	(	(	PUNCT
admet-2901	56	43	317.8	317.8	NUM
admet-2901	56	44	g	g	NOUN
admet-2901	56	45	)	)	PUNCT
admet-2901	56	46	.	.	PUNCT
admet-2901	57	1	after	after	ADP
admet-2901	57	2	dissolving	dissolve	VERB
admet-2901	57	3	in	in	ADP
admet-2901	57	4	meoh	meoh	NOUN
admet-2901	57	5	-	-	PUNCT
admet-2901	57	6	etoac	etoac	ADJ
admet-2901	57	7	(	(	PUNCT
admet-2901	57	8	1:1	1:1	NUM
admet-2901	57	9	,	,	PUNCT
admet-2901	57	10	6	6	NUM
admet-2901	57	11	l	l	NOUN
admet-2901	57	12	)	)	PUNCT
admet-2901	57	13	and	and	CCONJ
admet-2901	57	14	solvent	solvent	NOUN
admet-2901	57	15	removal	removal	NOUN
admet-2901	57	16	,	,	PUNCT
admet-2901	57	17	the	the	DET
admet-2901	57	18	crude	crude	NOUN
admet-2901	57	19	meoh	meoh	NOUN
admet-2901	57	20	-	-	PUNCT
admet-2901	57	21	etoac	etoac	ADJ
admet-2901	57	22	(	(	PUNCT
admet-2901	57	23	1:1	1:1	NUM
admet-2901	57	24	)	)	PUNCT
admet-2901	57	25	soluble	soluble	ADJ
admet-2901	57	26	fraction	fraction	NOUN
admet-2901	57	27	(	(	PUNCT
admet-2901	57	28	166.9	166.9	NUM
admet-2901	57	29	g	g	NOUN
admet-2901	57	30	)	)	PUNCT
admet-2901	57	31	was	be	AUX
admet-2901	57	32	separated	separate	VERB
admet-2901	57	33	by	by	ADP
admet-2901	57	34	silica	silica	NOUN
admet-2901	57	35	gel	gel	NOUN
admet-2901	57	36	column	column	NOUN
admet-2901	57	37	(	(	PUNCT
admet-2901	57	38	sio2	sio2	PROPN
admet-2901	57	39	,	,	PUNCT
admet-2901	57	40	2	2	NUM
admet-2901	57	41	kg	kg	NOUN
admet-2901	57	42	,	,	PUNCT
admet-2901	57	43	ch2cl2	ch2cl2	NOUN
admet-2901	57	44	-	-	ADJ
admet-2901	57	45	hexane	hexane	ADJ
admet-2901	57	46	and	and	CCONJ
admet-2901	57	47	meoh	meoh	NOUN
admet-2901	57	48	-	-	PUNCT
admet-2901	57	49	ch2cl2	ch2cl2	NOUN
admet-2901	57	50	gradients	gradient	NOUN
admet-2901	57	51	)	)	PUNCT
admet-2901	57	52	to	to	PART
admet-2901	57	53	give	give	VERB
admet-2901	57	54	eight	eight	NUM
admet-2901	57	55	fractions	fraction	NOUN
admet-2901	57	56	(	(	PUNCT
admet-2901	57	57	a1	a1	NOUN
admet-2901	57	58	-	-	PUNCT
admet-2901	57	59	a8	a8	NOUN
admet-2901	57	60	)	)	PUNCT
admet-2901	57	61	.	.	PUNCT
admet-2901	58	1	fraction	fraction	NOUN
admet-2901	58	2	a3	a3	NOUN
admet-2901	58	3	(	(	PUNCT
admet-2901	58	4	16.9	16.9	NUM
admet-2901	58	5	g	g	NOUN
admet-2901	58	6	)	)	PUNCT
admet-2901	58	7	was	be	AUX
admet-2901	58	8	fractionated	fractionate	VERB
admet-2901	58	9	using	use	VERB
admet-2901	58	10	a	a	DET
admet-2901	58	11	silica	silica	NOUN
admet-2901	58	12	gel	gel	NOUN
admet-2901	58	13	column	column	NOUN
admet-2901	58	14	with	with	ADP
admet-2901	58	15	an	an	DET
admet-2901	58	16	isocratic	isocratic	ADJ
admet-2901	58	17	elution	elution	NOUN
admet-2901	58	18	mixture	mixture	NOUN
admet-2901	58	19	of	of	ADP
admet-2901	58	20	10	10	NUM
admet-2901	58	21	%	%	NOUN
admet-2901	58	22	etoac	etoac	ADJ
admet-2901	58	23	in	in	ADP
admet-2901	58	24	hexane	hexane	NOUN
admet-2901	58	25	as	as	ADP
admet-2901	58	26	the	the	DET
admet-2901	58	27	eluent	eluent	NOUN
admet-2901	58	28	to	to	PART
admet-2901	58	29	obtain	obtain	VERB
admet-2901	58	30	nine	nine	NUM
admet-2901	58	31	fractions	fraction	NOUN
admet-2901	58	32	(	(	PUNCT
admet-2901	58	33	b1	b1	NOUN
admet-2901	58	34	-	-	PUNCT
admet-2901	58	35	b9	b9	NOUN
admet-2901	58	36	)	)	PUNCT
admet-2901	58	37	.	.	PUNCT
admet-2901	59	1	fraction	fraction	NOUN
admet-2901	59	2	b1	b1	NOUN
admet-2901	59	3	(	(	PUNCT
admet-2901	59	4	509.1	509.1	NUM
admet-2901	59	5	mg	mg	PROPN
admet-2901	59	6	,	,	PUNCT
admet-2901	59	7	eluted	elute	VERB
admet-2901	59	8	with	with	ADP
admet-2901	59	9	10	10	NUM
admet-2901	59	10	%	%	NOUN
admet-2901	59	11	etoachexanes	etoachexane	NOUN
admet-2901	59	12	)	)	PUNCT
admet-2901	59	13	gave	give	VERB
admet-2901	59	14	white	white	ADJ
admet-2901	59	15	colourless	colourless	ADJ
admet-2901	59	16	plates	plate	NOUN
admet-2901	59	17	after	after	ADP
admet-2901	59	18	recrystallization	recrystallization	NOUN
admet-2901	59	19	from	from	ADP
admet-2901	59	20	etoac	etoac	ADJ
admet-2901	59	21	-	-	NOUN
admet-2901	59	22	hexanes	hexane	NOUN
admet-2901	59	23	,	,	PUNCT
admet-2901	59	24	and	and	CCONJ
admet-2901	59	25	was	be	AUX
admet-2901	59	26	identified	identify	VERB
admet-2901	59	27	as	as	ADP
admet-2901	59	28	friedelin	friedelin	PROPN
admet-2901	59	29	(	(	PUNCT
admet-2901	59	30	3	3	NUM
admet-2901	59	31	)	)	PUNCT
admet-2901	59	32	.	.	PUNCT
admet-2901	60	1	fraction	fraction	NOUN
admet-2901	60	2	b4	b4	NOUN
admet-2901	60	3	(	(	PUNCT
admet-2901	60	4	17.0	17.0	NUM
admet-2901	60	5	g	g	NOUN
admet-2901	60	6	,	,	PUNCT
admet-2901	60	7	eluted	elute	VERB
admet-2901	60	8	with	with	ADP
admet-2901	60	9	20	20	NUM
admet-2901	60	10	%	%	NOUN
admet-2901	60	11	etoac	etoac	ADJ
admet-2901	60	12	-	-	ADJ
admet-2901	60	13	ch2cl2	ch2cl2	NOUN
admet-2901	60	14	)	)	PUNCT
admet-2901	60	15	affords	afford	VERB
admet-2901	60	16	four	four	NUM
admet-2901	60	17	fractions	fraction	NOUN
admet-2901	60	18	(	(	PUNCT
admet-2901	60	19	c1	c1	NOUN
admet-2901	60	20	-	-	PUNCT
admet-2901	60	21	c4	c4	NOUN
admet-2901	60	22	)	)	PUNCT
admet-2901	60	23	after	after	SCONJ
admet-2901	60	24	si	si	NOUN
admet-2901	60	25	-	-	PUNCT
admet-2901	60	26	gel	gel	PROPN
admet-2901	60	27	cc	cc	PROPN
admet-2901	60	28	.	.	PROPN
admet-2901	60	29	fraction	fraction	PROPN
admet-2901	60	30	c3	c3	PROPN
admet-2901	60	31	(	(	PUNCT
admet-2901	60	32	2.33	2.33	NUM
admet-2901	60	33	g	g	NOUN
admet-2901	60	34	)	)	PUNCT
admet-2901	60	35	provided	provide	VERB
admet-2901	60	36	glomerulatusin	glomerulatusin	NOUN
admet-2901	60	37	(	(	PUNCT
admet-2901	60	38	2	2	NUM
admet-2901	60	39	)	)	PUNCT
admet-2901	60	40	(	(	PUNCT
admet-2901	60	41	863.0	863.0	NUM
admet-2901	60	42	mg	mg	NOUN
admet-2901	60	43	)	)	PUNCT
admet-2901	60	44	after	after	ADP
admet-2901	60	45	recrystallization	recrystallization	NOUN
admet-2901	60	46	from	from	ADP
admet-2901	60	47	etoac	etoac	ADJ
admet-2901	60	48	.	.	PUNCT
admet-2901	61	1	fraction	fraction	NOUN
admet-2901	61	2	c4	c4	NOUN
admet-2901	61	3	(	(	PUNCT
admet-2901	61	4	3.32	3.32	NUM
admet-2901	61	5	g	g	NOUN
admet-2901	61	6	)	)	PUNCT
admet-2901	61	7	was	be	AUX
admet-2901	61	8	recrystallized	recrystallize	VERB
admet-2901	61	9	from	from	ADP
admet-2901	61	10	ch2cl2	ch2cl2	PUNCT
admet-2901	61	11	to	to	PART
admet-2901	61	12	afford	afford	VERB
admet-2901	61	13	anomaluone	anomaluone	PROPN
admet-2901	61	14	(	(	PUNCT
admet-2901	61	15	4	4	NUM
admet-2901	61	16	)	)	PUNCT
admet-2901	61	17	(	(	PUNCT
admet-2901	61	18	431.0	431.0	NUM
admet-2901	61	19	mg	mg	NOUN
admet-2901	61	20	)	)	PUNCT
admet-2901	61	21	.	.	PUNCT
admet-2901	62	1	fraction	fraction	NOUN
admet-2901	62	2	b9	b9	PROPN
admet-2901	62	3	(	(	PUNCT
admet-2901	62	4	2.13	2.13	NUM
admet-2901	62	5	g	g	NOUN
admet-2901	62	6	)	)	PUNCT
admet-2901	62	7	yielded	yield	VERB
admet-2901	62	8	six	six	NUM
admet-2901	62	9	fractions	fraction	NOUN
admet-2901	62	10	(	(	PUNCT
admet-2901	62	11	d1	d1	NOUN
admet-2901	62	12	-	-	PUNCT
admet-2901	62	13	d6	d6	NOUN
admet-2901	62	14	)	)	PUNCT
admet-2901	62	15	after	after	ADP
admet-2901	62	16	si	si	NOUN
admet-2901	62	17	-	-	ADJ
admet-2901	62	18	gel	gel	NOUN
admet-2901	62	19	cc	cc	PROPN
admet-2901	62	20	(	(	PUNCT
admet-2901	62	21	20	20	NUM
admet-2901	62	22	%	%	NOUN
admet-2901	62	23	etoac	etoac	ADJ
admet-2901	62	24	-	-	ADJ
admet-2901	62	25	ch2cl2	ch2cl2	NOUN
admet-2901	62	26	)	)	PUNCT
admet-2901	62	27	.	.	PUNCT
admet-2901	63	1	fraction	fraction	NOUN
admet-2901	63	2	d1	d1	PROPN
admet-2901	63	3	(	(	PUNCT
admet-2901	63	4	30.10	30.10	NUM
admet-2901	63	5	mg	mg	NUM
admet-2901	63	6	)	)	PUNCT
admet-2901	63	7	provided	provide	VERB
admet-2901	63	8	pinostrobin	pinostrobin	NOUN
admet-2901	63	9	(	(	PUNCT
admet-2901	63	10	7	7	NUM
admet-2901	63	11	)	)	PUNCT
admet-2901	63	12	(	(	PUNCT
admet-2901	63	13	21.1	21.1	NUM
admet-2901	63	14	mg	mg	NOUN
admet-2901	63	15	)	)	PUNCT
admet-2901	63	16	after	after	ADP
admet-2901	63	17	recrystallization	recrystallization	NOUN
admet-2901	63	18	from	from	ADP
admet-2901	63	19	meoh	meoh	PROPN
admet-2901	63	20	.	.	PUNCT
admet-2901	64	1	fraction	fraction	NOUN
admet-2901	64	2	d3	d3	PROPN
admet-2901	64	3	(	(	PUNCT
admet-2901	64	4	1.23	1.23	NUM
admet-2901	64	5	g	g	NOUN
admet-2901	64	6	)	)	PUNCT
admet-2901	64	7	provided	provide	VERB
admet-2901	64	8	pinocembrin	pinocembrin	NOUN
admet-2901	64	9	(	(	PUNCT
admet-2901	64	10	6	6	NUM
admet-2901	64	11	)	)	PUNCT
admet-2901	64	12	(	(	PUNCT
admet-2901	64	13	16.8	16.8	NUM
admet-2901	64	14	mg	mg	NOUN
admet-2901	64	15	)	)	PUNCT
admet-2901	64	16	after	after	ADP
admet-2901	64	17	recrystallization	recrystallization	NOUN
admet-2901	64	18	from	from	ADP
admet-2901	64	19	ch2cl2	ch2cl2	NOUN
admet-2901	64	20	.	.	PUNCT
admet-2901	65	1	fraction	fraction	PROPN
admet-2901	65	2	a5	a5	PROPN
admet-2901	65	3	(	(	PUNCT
admet-2901	65	4	7.97	7.97	NUM
admet-2901	65	5	g	g	NOUN
admet-2901	65	6	,	,	PUNCT
admet-2901	65	7	eluted	elute	VERB
admet-2901	65	8	with	with	ADP
admet-2901	65	9	70	70	NUM
admet-2901	65	10	-	-	SYM
admet-2901	65	11	90	90	NUM
admet-2901	65	12	%	%	NOUN
admet-2901	65	13	ch2cl2	ch2cl2	NOUN
admet-2901	65	14	-	-	NOUN
admet-2901	65	15	hexanes	hexane	NOUN
admet-2901	65	16	)	)	PUNCT
admet-2901	65	17	was	be	AUX
admet-2901	65	18	rechromatographed	rechromatographe	VERB
admet-2901	65	19	on	on	ADP
admet-2901	65	20	a	a	DET
admet-2901	65	21	silica	silica	NOUN
admet-2901	65	22	gel	gel	NOUN
admet-2901	65	23	column	column	NOUN
admet-2901	65	24	(	(	PUNCT
admet-2901	65	25	220	220	NUM
admet-2901	65	26	g	g	NOUN
admet-2901	65	27	,	,	PUNCT
admet-2901	65	28	merck	merck	NOUN
admet-2901	65	29	art	art	NOUN
admet-2901	65	30	.	.	PUNCT
admet-2901	66	1	no	no	INTJ
admet-2901	66	2	.	.	NOUN
admet-2901	67	1	7734	7734	NUM
admet-2901	67	2	,	,	PUNCT
admet-2901	67	3	520	520	NUM
admet-2901	67	4	cm	cm	NOUN
admet-2901	67	5	)	)	PUNCT
admet-2901	67	6	,	,	PUNCT
admet-2901	67	7	eluting	elute	VERB
admet-2901	67	8	with	with	ADP
admet-2901	67	9	20	20	NUM
admet-2901	67	10	%	%	NOUN
admet-2901	67	11	acetone	acetone	NOUN
admet-2901	67	12	-	-	PUNCT
admet-2901	67	13	hexanes	hexane	NOUN
admet-2901	67	14	and	and	CCONJ
admet-2901	67	15	finally	finally	ADV
admet-2901	67	16	with	with	ADP
admet-2901	67	17	methanol	methanol	NOUN
admet-2901	67	18	.	.	PUNCT
admet-2901	68	1	the	the	DET
admet-2901	68	2	solvents	solvent	NOUN
admet-2901	68	3	were	be	AUX
admet-2901	68	4	evaporated	evaporate	VERB
admet-2901	68	5	to	to	PART
admet-2901	68	6	dryness	dryness	VERB
admet-2901	68	7	,	,	PUNCT
admet-2901	68	8	affording	afford	VERB
admet-2901	68	9	six	six	NUM
admet-2901	68	10	fractions	fraction	NOUN
admet-2901	68	11	(	(	PUNCT
admet-2901	68	12	e1	e1	NOUN
admet-2901	68	13	-	-	PUNCT
admet-2901	68	14	e6	e6	NOUN
admet-2901	68	15	)	)	PUNCT
admet-2901	68	16	.	.	PUNCT
admet-2901	69	1	fraction	fraction	NOUN
admet-2901	69	2	e5	e5	PROPN
admet-2901	69	3	(	(	PUNCT
admet-2901	69	4	3.40	3.40	NUM
admet-2901	69	5	g	g	NOUN
admet-2901	69	6	,	,	PUNCT
admet-2901	69	7	eluted	elute	VERB
admet-2901	69	8	with	with	ADP
admet-2901	69	9	20	20	NUM
admet-2901	69	10	%	%	NOUN
admet-2901	69	11	acetone	acetone	NOUN
admet-2901	69	12	-	-	PUNCT
admet-2901	69	13	hexanes	hexane	NOUN
admet-2901	69	14	)	)	PUNCT
admet-2901	69	15	was	be	AUX
admet-2901	69	16	rechromatographed	rechromatographe	VERB
admet-2901	69	17	on	on	ADP
admet-2901	69	18	a	a	DET
admet-2901	69	19	sephadex	sephadex	NOUN
admet-2901	69	20	lh-20	lh-20	NOUN
admet-2901	69	21	column	column	NOUN
admet-2901	69	22	(	(	PUNCT
admet-2901	69	23	113	113	NUM
admet-2901	69	24	g	g	NOUN
admet-2901	69	25	,	,	PUNCT
admet-2901	69	26	319	319	PROPN
admet-2901	69	27	cm	cm	NOUN
admet-2901	69	28	,	,	PUNCT
admet-2901	69	29	3	3	NUM
admet-2901	69	30	times	time	NOUN
admet-2901	69	31	)	)	PUNCT
admet-2901	69	32	,	,	PUNCT
admet-2901	69	33	eluting	elute	VERB
admet-2901	69	34	with	with	ADP
admet-2901	69	35	methanol	methanol	NOUN
admet-2901	69	36	to	to	PART
admet-2901	69	37	give	give	VERB
admet-2901	69	38	three	three	NUM
admet-2901	69	39	fractions	fraction	NOUN
admet-2901	69	40	(	(	PUNCT
admet-2901	69	41	f1	f1	NOUN
admet-2901	69	42	-	-	PUNCT
admet-2901	69	43	f3	f3	NOUN
admet-2901	69	44	)	)	PUNCT
admet-2901	69	45	.	.	PUNCT
admet-2901	70	1	fraction	fraction	NOUN
admet-2901	70	2	f2	f2	PRON
admet-2901	70	3	(	(	PUNCT
admet-2901	70	4	3.21	3.21	NUM
admet-2901	70	5	g	g	NOUN
admet-2901	70	6	,	,	PUNCT
admet-2901	70	7	eluted	elute	VERB
admet-2901	70	8	with	with	ADP
admet-2901	70	9	meoh	meoh	NOUN
admet-2901	70	10	)	)	PUNCT
admet-2901	70	11	was	be	AUX
admet-2901	70	12	crystallized	crystallize	VERB
admet-2901	70	13	with	with	ADP
admet-2901	70	14	meohch2cl2	meohch2cl2	NOUN
admet-2901	70	15	to	to	PART
admet-2901	70	16	give	give	VERB
admet-2901	70	17	5	5	NUM
admet-2901	70	18	-	-	PUNCT
admet-2901	70	19	hydroxy-6,7,3',4',5'-pentamethoxyflavone	hydroxy-6,7,3',4',5'-pentamethoxyflavone	NOUN
admet-2901	70	20	(	(	PUNCT
admet-2901	70	21	8)	8)	NUM
admet-2901	70	22	(	(	PUNCT
admet-2901	70	23	95.9	95.9	NUM
admet-2901	70	24	mg	mg	NOUN
admet-2901	70	25	)	)	PUNCT
admet-2901	70	26	,	,	PUNCT
admet-2901	70	27	as	as	ADP
admet-2901	70	28	a	a	DET
admet-2901	70	29	yellow	yellow	ADJ
admet-2901	70	30	powder	powder	NOUN
admet-2901	70	31	.	.	PUNCT
admet-2901	71	1	the	the	DET
admet-2901	71	2	residue	residue	NOUN
admet-2901	71	3	of	of	ADP
admet-2901	71	4	fraction	fraction	NOUN
admet-2901	71	5	f2	f2	PROPN
admet-2901	71	6	(	(	PUNCT
admet-2901	71	7	3.17	3.17	NUM
admet-2901	71	8	g	g	NOUN
admet-2901	71	9	)	)	PUNCT
admet-2901	71	10	was	be	AUX
admet-2901	71	11	rechromatographed	rechromatographe	VERB
admet-2901	71	12	on	on	ADP
admet-2901	71	13	a	a	DET
admet-2901	71	14	silica	silica	NOUN
admet-2901	71	15	gel	gel	NOUN
admet-2901	71	16	column	column	NOUN
admet-2901	71	17	(	(	PUNCT
admet-2901	71	18	113	113	NUM
admet-2901	71	19	g	g	NOUN
admet-2901	71	20	,	,	PUNCT
admet-2901	71	21	merck	merck	NOUN
admet-2901	71	22	art	art	NOUN
admet-2901	71	23	.	.	PUNCT
admet-2901	72	1	no	no	INTJ
admet-2901	72	2	.	.	NOUN
admet-2901	73	1	7734	7734	NUM
admet-2901	73	2	,	,	PUNCT
admet-2901	73	3	319	319	PROPN
admet-2901	73	4	cm	cm	NOUN
admet-2901	73	5	)	)	PUNCT
admet-2901	73	6	,	,	PUNCT
admet-2901	73	7	eluting	elute	VERB
admet-2901	73	8	with	with	ADP
admet-2901	73	9	2	2	NUM
admet-2901	73	10	%	%	NOUN
admet-2901	73	11	meoh	meoh	NOUN
admet-2901	73	12	-	-	PUNCT
admet-2901	73	13	ch2cl2	ch2cl2	NOUN
admet-2901	73	14	and	and	CCONJ
admet-2901	73	15	finally	finally	ADV
admet-2901	73	16	with	with	ADP
admet-2901	73	17	methanol	methanol	NOUN
admet-2901	73	18	.	.	PUNCT
admet-2901	74	1	the	the	DET
admet-2901	74	2	solvents	solvent	NOUN
admet-2901	74	3	were	be	AUX
admet-2901	74	4	evaporated	evaporate	VERB
admet-2901	74	5	to	to	PART
admet-2901	74	6	dryness	dryness	VERB
admet-2901	74	7	,	,	PUNCT
admet-2901	74	8	affording	afford	VERB
admet-2901	74	9	five	five	NUM
admet-2901	74	10	subfractions	subfraction	NOUN
admet-2901	74	11	(	(	PUNCT
admet-2901	74	12	g1	g1	NOUN
admet-2901	74	13	-	-	PUNCT
admet-2901	74	14	g5	g5	NOUN
admet-2901	74	15	)	)	PUNCT
admet-2901	74	16	.	.	PUNCT
admet-2901	75	1	fraction	fraction	NOUN
admet-2901	75	2	g3	g3	PROPN
admet-2901	75	3	(	(	PUNCT
admet-2901	75	4	2.65	2.65	NUM
admet-2901	75	5	g	g	NOUN
admet-2901	75	6	)	)	PUNCT
admet-2901	75	7	was	be	AUX
admet-2901	75	8	crystallized	crystallize	VERB
admet-2901	75	9	with	with	ADP
admet-2901	75	10	meoh	meoh	NOUN
admet-2901	75	11	-	-	PUNCT
admet-2901	75	12	ch2cl2	ch2cl2	NOUN
admet-2901	75	13	to	to	PART
admet-2901	75	14	give	give	VERB
admet-2901	75	15	3,6	3,6	NUM
admet-2901	75	16	-	-	PUNCT
admet-2901	75	17	phenanthrenedione	phenanthrenedione	ADJ
admet-2901	75	18	(	(	PUNCT
admet-2901	75	19	5	5	NUM
admet-2901	75	20	)	)	PUNCT
admet-2901	75	21	(	(	PUNCT
admet-2901	75	22	24.10	24.10	NUM
admet-2901	75	23	mg	mg	NUM
admet-2901	75	24	)	)	PUNCT
admet-2901	75	25	,	,	PUNCT
admet-2901	75	26	as	as	ADP
admet-2901	75	27	a	a	DET
admet-2901	75	28	colourless	colourless	ADJ
admet-2901	75	29	plate	plate	NOUN
admet-2901	75	30	.	.	PUNCT
admet-2901	76	1	fraction	fraction	NOUN
admet-2901	76	2	g5	g5	NOUN
admet-2901	76	3	(	(	PUNCT
admet-2901	76	4	382.0	382.0	NUM
admet-2901	76	5	mg	mg	NOUN
admet-2901	76	6	)	)	PUNCT
admet-2901	76	7	was	be	AUX
admet-2901	76	8	obtained	obtain	VERB
admet-2901	76	9	as	as	ADP
admet-2901	76	10	green	green	ADJ
admet-2901	76	11	powder	powder	NOUN
admet-2901	76	12	and	and	CCONJ
admet-2901	76	13	identified	identify	VERB
admet-2901	76	14	as	as	ADP
admet-2901	76	15	cleistanthin	cleistanthin	NOUN
admet-2901	76	16	a	a	DET
admet-2901	76	17	(	(	PUNCT
admet-2901	76	18	10	10	NUM
admet-2901	76	19	)	)	PUNCT
admet-2901	76	20	after	after	ADP
admet-2901	76	21	recrystallization	recrystallization	NOUN
admet-2901	76	22	from	from	ADP
admet-2901	76	23	etoh	etoh	NOUN
admet-2901	76	24	.	.	PUNCT
admet-2901	77	1	fraction	fraction	NOUN
admet-2901	77	2	a7	a7	PROPN
admet-2901	77	3	(	(	PUNCT
admet-2901	77	4	53.3	53.3	NUM
admet-2901	77	5	g	g	NOUN
admet-2901	77	6	,	,	PUNCT
admet-2901	77	7	eluted	elute	VERB
admet-2901	77	8	with	with	ADP
admet-2901	77	9	10	10	NUM
admet-2901	77	10	to	to	PART
admet-2901	77	11	40	40	NUM
admet-2901	77	12	%	%	NOUN
admet-2901	77	13	meoh	meoh	NOUN
admet-2901	77	14	-	-	PUNCT
admet-2901	77	15	ch2cl2	ch2cl2	NOUN
admet-2901	77	16	)	)	PUNCT
admet-2901	77	17	was	be	AUX
admet-2901	77	18	crystallized	crystallize	VERB
admet-2901	77	19	with	with	ADP
admet-2901	77	20	methanol	methanol	NOUN
admet-2901	77	21	to	to	PART
admet-2901	77	22	give	give	VERB
admet-2901	77	23	chrysin	chrysin	NOUN
admet-2901	77	24	(	(	PUNCT
admet-2901	77	25	9	9	NUM
admet-2901	77	26	)	)	PUNCT
admet-2901	77	27	(	(	PUNCT
admet-2901	77	28	103.2	103.2	NUM
admet-2901	77	29	mg	mg	NOUN
admet-2901	77	30	)	)	PUNCT
admet-2901	77	31	,	,	PUNCT
admet-2901	77	32	as	as	ADP
admet-2901	77	33	green	green	ADJ
admet-2901	77	34	powder	powder	NOUN
admet-2901	77	35	.	.	PUNCT
admet-2901	78	1	the	the	DET
admet-2901	78	2	residue	residue	NOUN
admet-2901	78	3	of	of	ADP
admet-2901	78	4	fraction	fraction	NOUN
admet-2901	78	5	a7	a7	PROPN
admet-2901	78	6	(	(	PUNCT
admet-2901	78	7	51.92	51.92	NUM
admet-2901	78	8	g	g	NOUN
admet-2901	78	9	)	)	PUNCT
admet-2901	78	10	was	be	AUX
admet-2901	78	11	separated	separate	VERB
admet-2901	78	12	by	by	ADP
admet-2901	78	13	column	column	NOUN
admet-2901	78	14	chromatography	chromatography	NOUN
admet-2901	78	15	over	over	ADP
admet-2901	78	16	silica	silica	NOUN
admet-2901	78	17	gel	gel	NOUN
admet-2901	78	18	,	,	PUNCT
admet-2901	78	19	eluting	elute	VERB
admet-2901	78	20	with	with	ADP
admet-2901	78	21	hexane	hexane	NOUN
admet-2901	78	22	and	and	CCONJ
admet-2901	78	23	gradually	gradually	ADV
admet-2901	78	24	enriching	enrich	VERB
admet-2901	78	25	with	with	ADP
admet-2901	78	26	ch2cl2	ch2cl2	NOUN
admet-2901	78	27	in	in	ADP
admet-2901	78	28	hexane	hexane	NOUN
admet-2901	78	29	until	until	SCONJ
admet-2901	78	30	pure	pure	ADJ
admet-2901	78	31	ch2cl2	ch2cl2	NOUN
admet-2901	78	32	was	be	AUX
admet-2901	78	33	obtained	obtain	VERB
admet-2901	78	34	.	.	PUNCT
admet-2901	79	1	this	this	PRON
admet-2901	79	2	was	be	AUX
admet-2901	79	3	followed	follow	VERB
admet-2901	79	4	by	by	ADP
admet-2901	79	5	increasing	increase	VERB
admet-2901	79	6	amounts	amount	NOUN
admet-2901	79	7	of	of	ADP
admet-2901	79	8	methanol	methanol	NOUN
admet-2901	79	9	in	in	ADP
admet-2901	79	10	ch2cl2	ch2cl2	NOUN
admet-2901	79	11	and	and	CCONJ
admet-2901	79	12	finally	finally	ADV
admet-2901	79	13	with	with	ADP
admet-2901	79	14	pure	pure	ADJ
admet-2901	79	15	methanol	methanol	NOUN
admet-2901	79	16	.	.	PUNCT
admet-2901	80	1	the	the	DET
admet-2901	80	2	solvents	solvent	NOUN
admet-2901	80	3	were	be	AUX
admet-2901	80	4	evaporated	evaporate	VERB
admet-2901	80	5	to	to	PART
admet-2901	80	6	dryness	dryness	VERB
admet-2901	80	7	,	,	PUNCT
admet-2901	80	8	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	NOUN
admet-2901	80	9	n.	n.	NOUN
admet-2901	80	10	chabang	chabang	PROPN
admet-2901	80	11	et	et	PROPN
admet-2901	80	12	al	al	PROPN
admet-2901	80	13	.	.	PROPN
admet-2901	80	14	admet	admet	PROPN
admet-2901	80	15	&	&	CCONJ
admet-2901	80	16	dmpk	dmpk	PROPN
admet-2901	80	17	13(5	13(5	NUM
admet-2901	80	18	)	)	PUNCT
admet-2901	80	19	(	(	PUNCT
admet-2901	80	20	2025	2025	NUM
admet-2901	80	21	)	)	PUNCT
admet-2901	80	22	2901	2901	NUM
admet-2901	80	23	4	4	NUM
admet-2901	80	24	affording	afford	VERB
admet-2901	80	25	four	four	NUM
admet-2901	80	26	fractions	fraction	NOUN
admet-2901	80	27	(	(	PUNCT
admet-2901	80	28	j1	j1	PROPN
admet-2901	80	29	-	-	PUNCT
admet-2901	80	30	j4	j4	PROPN
admet-2901	80	31	)	)	PUNCT
admet-2901	80	32	.	.	PUNCT
admet-2901	81	1	recrystallization	recrystallization	NOUN
admet-2901	81	2	of	of	ADP
admet-2901	81	3	fraction	fraction	NOUN
admet-2901	81	4	j1	j1	NOUN
admet-2901	81	5	(	(	PUNCT
admet-2901	81	6	2.11	2.11	NUM
admet-2901	81	7	g	g	NOUN
admet-2901	81	8	)	)	PUNCT
admet-2901	81	9	from	from	ADP
admet-2901	81	10	methanol	methanol	NOUN
admet-2901	81	11	afforded	afford	VERB
admet-2901	81	12	pinostrobin	pinostrobin	NOUN
admet-2901	81	13	(	(	PUNCT
admet-2901	81	14	7	7	NUM
admet-2901	81	15	)	)	PUNCT
admet-2901	81	16	(	(	PUNCT
admet-2901	81	17	480.4	480.4	NUM
admet-2901	81	18	mg	mg	NOUN
admet-2901	81	19	)	)	PUNCT
admet-2901	81	20	and	and	CCONJ
admet-2901	81	21	pinocembrin	pinocembrin	NOUN
admet-2901	81	22	(	(	PUNCT
admet-2901	81	23	6	6	NUM
admet-2901	81	24	)	)	PUNCT
admet-2901	81	25	(	(	PUNCT
admet-2901	81	26	103.2	103.2	NUM
admet-2901	81	27	mg	mg	NUM
admet-2901	81	28	)	)	PUNCT
admet-2901	81	29	.	.	PUNCT
admet-2901	82	1	fraction	fraction	NOUN
admet-2901	82	2	j2	j2	NOUN
admet-2901	82	3	(	(	PUNCT
admet-2901	82	4	3.17	3.17	NUM
admet-2901	82	5	g	g	NOUN
admet-2901	82	6	)	)	PUNCT
admet-2901	82	7	,	,	PUNCT
admet-2901	82	8	eluted	elute	VERB
admet-2901	82	9	with	with	ADP
admet-2901	82	10	80	80	NUM
admet-2901	82	11	to	to	PART
admet-2901	82	12	100	100	NUM
admet-2901	82	13	%	%	NOUN
admet-2901	82	14	ch2cl2	ch2cl2	PUNCT
admet-2901	82	15	-hexanes	-hexane	NOUN
admet-2901	82	16	,	,	PUNCT
admet-2901	82	17	was	be	AUX
admet-2901	82	18	subjected	subject	VERB
admet-2901	82	19	to	to	ADP
admet-2901	82	20	column	column	NOUN
admet-2901	82	21	chromatography	chromatography	NOUN
admet-2901	82	22	on	on	ADP
admet-2901	82	23	silica	silica	NOUN
admet-2901	82	24	gel	gel	NOUN
admet-2901	82	25	using	use	VERB
admet-2901	82	26	20	20	NUM
admet-2901	82	27	%	%	NOUN
admet-2901	82	28	acetone	acetone	NOUN
admet-2901	82	29	-	-	PUNCT
admet-2901	82	30	hexanes	hexane	NOUN
admet-2901	82	31	,	,	PUNCT
admet-2901	82	32	followed	follow	VERB
admet-2901	82	33	by	by	ADP
admet-2901	82	34	methanol	methanol	NOUN
admet-2901	82	35	,	,	PUNCT
admet-2901	82	36	resulting	result	VERB
admet-2901	82	37	in	in	ADP
admet-2901	82	38	eight	eight	NUM
admet-2901	82	39	subfractions	subfraction	NOUN
admet-2901	82	40	(	(	PUNCT
admet-2901	82	41	k1	k1	NOUN
admet-2901	82	42	-	-	PUNCT
admet-2901	82	43	k8	k8	NOUN
admet-2901	82	44	)	)	PUNCT
admet-2901	82	45	.	.	PUNCT
admet-2901	83	1	recrystallization	recrystallization	NOUN
admet-2901	83	2	of	of	ADP
admet-2901	83	3	fraction	fraction	NOUN
admet-2901	83	4	k8	k8	NOUN
admet-2901	83	5	(	(	PUNCT
admet-2901	83	6	56.10	56.10	NUM
admet-2901	83	7	mg	mg	NOUN
admet-2901	83	8	)	)	PUNCT
admet-2901	83	9	from	from	ADP
admet-2901	83	10	methanol	methanol	NOUN
admet-2901	83	11	afforded	afford	VERB
admet-2901	83	12	pure	pure	ADJ
admet-2901	83	13	pinostrobin	pinostrobin	NOUN
admet-2901	83	14	(	(	PUNCT
admet-2901	83	15	7	7	NUM
admet-2901	83	16	)	)	PUNCT
admet-2901	83	17	(	(	PUNCT
admet-2901	83	18	56.10	56.10	NUM
admet-2901	83	19	mg	mg	NOUN
admet-2901	83	20	)	)	PUNCT
admet-2901	83	21	.	.	PUNCT
admet-2901	84	1	fraction	fraction	NOUN
admet-2901	84	2	j3	j3	PROPN
admet-2901	84	3	(	(	PUNCT
admet-2901	84	4	23.75	23.75	NUM
admet-2901	84	5	g	g	NOUN
admet-2901	84	6	,	,	PUNCT
admet-2901	84	7	eluted	elute	VERB
admet-2901	84	8	with	with	ADP
admet-2901	84	9	1to	1to	ADJ
admet-2901	84	10	3	3	NUM
admet-2901	84	11	%	%	NOUN
admet-2901	84	12	meoh	meoh	NOUN
admet-2901	84	13	-	-	PUNCT
admet-2901	84	14	ch2cl2	ch2cl2	NOUN
admet-2901	84	15	)	)	PUNCT
admet-2901	84	16	was	be	AUX
admet-2901	84	17	separated	separate	VERB
admet-2901	84	18	by	by	ADP
admet-2901	84	19	column	column	NOUN
admet-2901	84	20	chromatography	chromatography	NOUN
admet-2901	84	21	on	on	ADP
admet-2901	84	22	silica	silica	NOUN
admet-2901	84	23	gel	gel	NOUN
admet-2901	84	24	,	,	PUNCT
admet-2901	84	25	eluting	elute	VERB
admet-2901	84	26	with	with	ADP
admet-2901	84	27	50	50	NUM
admet-2901	84	28	%	%	NOUN
admet-2901	84	29	etoac	etoac	ADJ
admet-2901	84	30	-	-	ADJ
admet-2901	84	31	hexane	hexane	ADJ
admet-2901	84	32	and	and	CCONJ
admet-2901	84	33	finally	finally	ADV
admet-2901	84	34	with	with	ADP
admet-2901	84	35	methanol	methanol	NOUN
admet-2901	84	36	.	.	PUNCT
admet-2901	85	1	the	the	DET
admet-2901	85	2	solvents	solvent	NOUN
admet-2901	85	3	were	be	AUX
admet-2901	85	4	evaporated	evaporate	VERB
admet-2901	85	5	to	to	PART
admet-2901	85	6	dryness	dryness	VERB
admet-2901	85	7	,	,	PUNCT
admet-2901	85	8	affording	afford	VERB
admet-2901	85	9	four	four	NUM
admet-2901	85	10	subfractions	subfraction	NOUN
admet-2901	85	11	(	(	PUNCT
admet-2901	85	12	l1	l1	PROPN
admet-2901	85	13	-	-	PUNCT
admet-2901	85	14	l4	l4	PROPN
admet-2901	85	15	)	)	PUNCT
admet-2901	85	16	.	.	PUNCT
admet-2901	86	1	fraction	fraction	NOUN
admet-2901	86	2	l3	l3	PROPN
admet-2901	86	3	(	(	PUNCT
admet-2901	86	4	9.34	9.34	NUM
admet-2901	86	5	g	g	NOUN
admet-2901	86	6	,	,	PUNCT
admet-2901	86	7	eluted	elute	VERB
admet-2901	86	8	with	with	ADP
admet-2901	86	9	50	50	NUM
admet-2901	86	10	%	%	NOUN
admet-2901	86	11	etoac	etoac	ADJ
admet-2901	86	12	-	-	NOUN
admet-2901	86	13	hexanes	hexane	NOUN
admet-2901	86	14	)	)	PUNCT
admet-2901	86	15	was	be	AUX
admet-2901	86	16	crystallized	crystallize	VERB
admet-2901	86	17	with	with	ADP
admet-2901	86	18	methanol	methanol	NOUN
admet-2901	86	19	to	to	PART
admet-2901	86	20	give	give	VERB
admet-2901	86	21	a	a	DET
admet-2901	86	22	new	new	ADJ
admet-2901	86	23	compound	compound	NOUN
admet-2901	86	24	,	,	PUNCT
admet-2901	86	25	(	(	PUNCT
admet-2901	86	26	3,4,5)-trihydroxy	3,4,5)-trihydroxy	NUM
admet-2901	86	27	-6	-6	ADV
admet-2901	86	28	-	-	PUNCT
admet-2901	86	29	methoxy-2,7	methoxy-2,7	NOUN
admet-2901	86	30	-	-	PUNCT
admet-2901	86	31	bis(3	bis(3	NOUN
admet-2901	86	32	-	-	PUNCT
admet-2901	86	33	methylbut-2	methylbut-2	NUM
admet-2901	86	34	-	-	PUNCT
admet-2901	86	35	en-1	en-1	NOUN
admet-2901	86	36	-	-	PUNCT
admet-2901	86	37	yl)-9h	yl)-9h	NOUN
admet-2901	86	38	-	-	PUNCT
admet-2901	86	39	xanthen-9	xanthen-9	NUM
admet-2901	86	40	-	-	PUNCT
admet-2901	86	41	one	one	NUM
admet-2901	86	42	(	(	PUNCT
admet-2901	86	43	1	1	NUM
admet-2901	86	44	)	)	PUNCT
admet-2901	86	45	(	(	PUNCT
admet-2901	86	46	186.2	186.2	NUM
admet-2901	86	47	mg	mg	NOUN
admet-2901	86	48	)	)	PUNCT
admet-2901	86	49	.	.	PUNCT
admet-2901	87	1	cell	cell	NOUN
admet-2901	87	2	culture	culture	NOUN
admet-2901	87	3	the	the	DET
admet-2901	87	4	human	human	ADJ
admet-2901	87	5	breast	breast	NOUN
admet-2901	87	6	cancer	cancer	NOUN
admet-2901	87	7	cell	cell	NOUN
admet-2901	87	8	lines	line	NOUN
admet-2901	87	9	(	(	PUNCT
admet-2901	87	10	mcf-7	mcf-7	X
admet-2901	87	11	and	and	CCONJ
admet-2901	87	12	mda	mda	PROPN
admet-2901	87	13	-	-	PUNCT
admet-2901	87	14	mb-231	mb-231	PROPN
admet-2901	87	15	)	)	PUNCT
admet-2901	87	16	were	be	AUX
admet-2901	87	17	purchased	purchase	VERB
admet-2901	87	18	from	from	ADP
admet-2901	87	19	atcc	atcc	PROPN
admet-2901	87	20	(	(	PUNCT
admet-2901	87	21	manassas	manassas	PROPN
admet-2901	87	22	,	,	PUNCT
admet-2901	87	23	va	va	PROPN
admet-2901	87	24	,	,	PUNCT
admet-2901	87	25	usa	usa	PROPN
admet-2901	87	26	)	)	PUNCT
admet-2901	87	27	.	.	PUNCT
admet-2901	88	1	mcf-7	mcf-7	NOUN
admet-2901	88	2	cells	cell	NOUN
admet-2901	88	3	were	be	AUX
admet-2901	88	4	cultured	cultured	ADJ
admet-2901	88	5	in	in	ADP
admet-2901	88	6	dulbecco	dulbecco	NOUN
admet-2901	88	7	's	's	PART
admet-2901	88	8	modified	modify	VERB
admet-2901	88	9	eagle	eagle	PROPN
admet-2901	88	10	medium	medium	ADJ
admet-2901	88	11	/	/	SYM
admet-2901	88	12	nutrient	nutrient	NOUN
admet-2901	88	13	mixture	mixture	NOUN
admet-2901	88	14	f-12	f-12	NOUN
admet-2901	88	15	(	(	PUNCT
admet-2901	88	16	dmem	dmem	VERB
admet-2901	88	17	/	/	SYM
admet-2901	88	18	f-12	f-12	NOUN
admet-2901	88	19	)	)	PUNCT
admet-2901	88	20	(	(	PUNCT
admet-2901	88	21	gibco	gibco	NOUN
admet-2901	88	22	,	,	PUNCT
admet-2901	88	23	new	new	PROPN
admet-2901	88	24	york	york	PROPN
admet-2901	88	25	,	,	PUNCT
admet-2901	88	26	usa	usa	PROPN
admet-2901	88	27	)	)	PUNCT
admet-2901	88	28	,	,	PUNCT
admet-2901	88	29	which	which	PRON
admet-2901	88	30	was	be	AUX
admet-2901	88	31	supplemented	supplement	VERB
admet-2901	88	32	with	with	ADP
admet-2901	88	33	10	10	NUM
admet-2901	88	34	%	%	NOUN
admet-2901	88	35	fetal	fetal	ADJ
admet-2901	88	36	bovine	bovine	NOUN
admet-2901	88	37	serum	serum	NOUN
admet-2901	88	38	(	(	PUNCT
admet-2901	88	39	fbs	fbs	PROPN
admet-2901	88	40	)	)	PUNCT
admet-2901	88	41	(	(	PUNCT
admet-2901	88	42	gibco	gibco	NOUN
admet-2901	88	43	,	,	PUNCT
admet-2901	88	44	new	new	PROPN
admet-2901	88	45	york	york	PROPN
admet-2901	88	46	,	,	PUNCT
admet-2901	88	47	usa	usa	PROPN
admet-2901	88	48	)	)	PUNCT
admet-2901	88	49	and	and	CCONJ
admet-2901	88	50	1	1	NUM
admet-2901	88	51	%	%	NOUN
admet-2901	88	52	penicillin	penicillin	NOUN
admet-2901	88	53	-	-	PUNCT
admet-2901	88	54	streptomycin	streptomycin	PROPN
admet-2901	88	55	(	(	PUNCT
admet-2901	88	56	p	p	X
admet-2901	88	57	/	/	SYM
admet-2901	88	58	s	s	NOUN
admet-2901	88	59	)	)	PUNCT
admet-2901	88	60	(	(	PUNCT
admet-2901	88	61	gibco	gibco	NOUN
admet-2901	88	62	,	,	PUNCT
admet-2901	88	63	new	new	PROPN
admet-2901	88	64	york	york	PROPN
admet-2901	88	65	,	,	PUNCT
admet-2901	88	66	usa	usa	PROPN
admet-2901	88	67	)	)	PUNCT
admet-2901	88	68	.	.	PUNCT
admet-2901	89	1	mda	mda	PROPN
admet-2901	89	2	-	-	PUNCT
admet-2901	89	3	mb-231	mb-231	PROPN
admet-2901	89	4	cells	cell	NOUN
admet-2901	89	5	were	be	AUX
admet-2901	89	6	cultured	cultured	ADJ
admet-2901	89	7	in	in	ADP
admet-2901	89	8	dmem	dmem	VERB
admet-2901	89	9	high	high	ADJ
admet-2901	89	10	glucose	glucose	NOUN
admet-2901	89	11	(	(	PUNCT
admet-2901	89	12	gibco	gibco	NOUN
admet-2901	89	13	,	,	PUNCT
admet-2901	89	14	new	new	PROPN
admet-2901	89	15	york	york	PROPN
admet-2901	89	16	,	,	PUNCT
admet-2901	89	17	usa	usa	PROPN
admet-2901	89	18	)	)	PUNCT
admet-2901	89	19	,	,	PUNCT
admet-2901	89	20	supplemented	supplement	VERB
admet-2901	89	21	with	with	ADP
admet-2901	89	22	10	10	NUM
admet-2901	89	23	%	%	NOUN
admet-2901	89	24	fbs	fbs	ADJ
admet-2901	89	25	and	and	CCONJ
admet-2901	89	26	1	1	NUM
admet-2901	89	27	%	%	NOUN
admet-2901	89	28	p	p	X
admet-2901	89	29	/	/	SYM
admet-2901	89	30	s.	s.	PROPN
admet-2901	89	31	primary	primary	NOUN
admet-2901	89	32	and	and	CCONJ
admet-2901	89	33	secondary	secondary	ADJ
admet-2901	89	34	screening	screening	NOUN
admet-2901	89	35	of	of	ADP
admet-2901	89	36	m.	m.	NOUN
admet-2901	89	37	glomerulatus	glomerulatus	NOUN
admet-2901	89	38	-	-	PUNCT
admet-2901	89	39	isolated	isolate	VERB
admet-2901	89	40	compounds	compound	NOUN
admet-2901	89	41	against	against	ADP
admet-2901	89	42	breast	breast	NOUN
admet-2901	89	43	cancer	cancer	NOUN
admet-2901	89	44	cell	cell	NOUN
admet-2901	89	45	lines	line	NOUN
admet-2901	89	46	mcf-7	mcf-7	PUNCT
admet-2901	89	47	and	and	CCONJ
admet-2901	89	48	mda	mda	PROPN
admet-2901	89	49	-	-	PUNCT
admet-2901	89	50	mb-231	mb-231	PROPN
admet-2901	89	51	human	human	ADJ
admet-2901	89	52	breast	breast	NOUN
admet-2901	89	53	cancer	cancer	NOUN
admet-2901	89	54	cell	cell	NOUN
admet-2901	89	55	lines	line	NOUN
admet-2901	89	56	were	be	AUX
admet-2901	89	57	seeded	seed	VERB
admet-2901	89	58	into	into	ADP
admet-2901	89	59	96	96	NUM
admet-2901	89	60	-	-	PUNCT
admet-2901	89	61	well	well	NOUN
admet-2901	89	62	plates	plate	NOUN
admet-2901	89	63	(	(	PUNCT
admet-2901	89	64	corning	corning	NOUN
admet-2901	89	65	,	,	PUNCT
admet-2901	89	66	acton	acton	PROPN
admet-2901	89	67	,	,	PUNCT
admet-2901	89	68	ma	ma	PROPN
admet-2901	89	69	,	,	PUNCT
admet-2901	89	70	usa	usa	PROPN
admet-2901	89	71	)	)	PUNCT
admet-2901	89	72	at	at	ADP
admet-2901	89	73	a	a	DET
admet-2901	89	74	density	density	NOUN
admet-2901	89	75	of	of	ADP
admet-2901	89	76	10⁴	10⁴	NUM
admet-2901	89	77	cells	cell	NOUN
admet-2901	89	78	/	/	SYM
admet-2901	89	79	well	well	ADV
admet-2901	89	80	.	.	PUNCT
admet-2901	90	1	mcf-7	mcf-7	NOUN
admet-2901	90	2	cells	cell	NOUN
admet-2901	90	3	were	be	AUX
admet-2901	90	4	cultured	cultured	ADJ
admet-2901	90	5	in	in	ADP
admet-2901	90	6	dmem	dmem	VERB
admet-2901	90	7	/	/	SYM
admet-2901	90	8	f-12	f-12	NOUN
admet-2901	90	9	,	,	PUNCT
admet-2901	90	10	while	while	SCONJ
admet-2901	90	11	mda	mda	PROPN
admet-2901	90	12	-	-	PUNCT
admet-2901	90	13	mb-231	mb-231	PROPN
admet-2901	90	14	cells	cell	NOUN
admet-2901	90	15	were	be	AUX
admet-2901	90	16	maintained	maintain	VERB
admet-2901	90	17	in	in	ADP
admet-2901	90	18	high	high	ADJ
admet-2901	90	19	-	-	PUNCT
admet-2901	90	20	glucose	glucose	NOUN
admet-2901	90	21	dmem	dmem	VERB
admet-2901	90	22	.	.	PUNCT
admet-2901	91	1	both	both	DET
admet-2901	91	2	media	medium	NOUN
admet-2901	91	3	were	be	AUX
admet-2901	91	4	supplemented	supplement	VERB
admet-2901	91	5	with	with	ADP
admet-2901	91	6	10	10	NUM
admet-2901	91	7	%	%	NOUN
admet-2901	91	8	foetal	foetal	ADJ
admet-2901	91	9	bovine	bovine	NOUN
admet-2901	91	10	serum	serum	NOUN
admet-2901	91	11	(	(	PUNCT
admet-2901	91	12	fbs	fbs	PROPN
admet-2901	91	13	)	)	PUNCT
admet-2901	91	14	and	and	CCONJ
admet-2901	91	15	1	1	NUM
admet-2901	91	16	%	%	NOUN
admet-2901	91	17	penicillin	penicillin	NOUN
admet-2901	91	18	/	/	SYM
admet-2901	91	19	streptomycin	streptomycin	PROPN
admet-2901	91	20	(	(	PUNCT
admet-2901	91	21	p	p	X
admet-2901	91	22	/	/	SYM
admet-2901	91	23	s	s	NOUN
admet-2901	91	24	)	)	PUNCT
admet-2901	91	25	.	.	PUNCT
admet-2901	92	1	cells	cell	NOUN
admet-2901	92	2	were	be	AUX
admet-2901	92	3	incubated	incubate	VERB
admet-2901	92	4	for	for	ADP
admet-2901	92	5	24	24	NUM
admet-2901	92	6	h	h	NOUN
admet-2901	92	7	at	at	ADP
admet-2901	92	8	37	37	NUM
admet-2901	92	9	 	 	SPACE
admet-2901	92	10	°	°	NOUN
admet-2901	92	11	c	c	NOUN
admet-2901	92	12	in	in	ADP
admet-2901	92	13	a	a	DET
admet-2901	92	14	humidified	humidify	VERB
admet-2901	92	15	atmosphere	atmosphere	NOUN
admet-2901	92	16	with	with	ADP
admet-2901	92	17	5	5	NUM
admet-2901	92	18	%	%	NOUN
admet-2901	92	19	co₂.	co₂.	NOUN
admet-2901	92	20	for	for	ADP
admet-2901	92	21	primary	primary	ADJ
admet-2901	92	22	screening	screening	NOUN
admet-2901	92	23	,	,	PUNCT
admet-2901	92	24	test	test	NOUN
admet-2901	92	25	compounds	compound	NOUN
admet-2901	92	26	isolated	isolate	VERB
admet-2901	92	27	from	from	ADP
admet-2901	92	28	m.	m.	NOUN
admet-2901	92	29	glomerulatus	glomerulatus	NOUN
admet-2901	92	30	were	be	AUX
admet-2901	92	31	added	add	VERB
admet-2901	92	32	to	to	ADP
admet-2901	92	33	the	the	DET
admet-2901	92	34	culture	culture	NOUN
admet-2901	92	35	medium	medium	NOUN
admet-2901	92	36	at	at	ADP
admet-2901	92	37	a	a	DET
admet-2901	92	38	final	final	ADJ
admet-2901	92	39	concentration	concentration	NOUN
admet-2901	92	40	of	of	ADP
admet-2901	92	41	50	50	NUM
admet-2901	92	42	 	 	SPACE
admet-2901	92	43	μm	μm	NOUN
admet-2901	92	44	.	.	PUNCT
admet-2901	93	1	doxorubicin	doxorubicin	PROPN
admet-2901	93	2	was	be	AUX
admet-2901	93	3	used	use	VERB
admet-2901	93	4	as	as	ADP
admet-2901	93	5	a	a	DET
admet-2901	93	6	positive	positive	ADJ
admet-2901	93	7	control	control	NOUN
admet-2901	93	8	.	.	PUNCT
admet-2901	94	1	following	follow	VERB
admet-2901	94	2	compound	compound	NOUN
admet-2901	94	3	treatment	treatment	NOUN
admet-2901	94	4	,	,	PUNCT
admet-2901	94	5	cells	cell	NOUN
admet-2901	94	6	were	be	AUX
admet-2901	94	7	incubated	incubate	VERB
admet-2901	94	8	for	for	ADP
admet-2901	94	9	72	72	NUM
admet-2901	94	10	h	h	NOUN
admet-2901	94	11	under	under	ADP
admet-2901	94	12	standard	standard	ADJ
admet-2901	94	13	culture	culture	NOUN
admet-2901	94	14	conditions	condition	NOUN
admet-2901	94	15	.	.	PUNCT
admet-2901	95	1	after	after	ADP
admet-2901	95	2	treatment	treatment	NOUN
admet-2901	95	3	,	,	PUNCT
admet-2901	95	4	the	the	DET
admet-2901	95	5	medium	medium	NOUN
admet-2901	95	6	was	be	AUX
admet-2901	95	7	replaced	replace	VERB
admet-2901	95	8	with	with	ADP
admet-2901	95	9	serum	serum	NOUN
admet-2901	95	10	-	-	PUNCT
admet-2901	95	11	free	free	ADJ
admet-2901	95	12	medium	medium	NOUN
admet-2901	95	13	containing	contain	VERB
admet-2901	95	14	0.5	0.5	NUM
admet-2901	95	15	 	 	SPACE
admet-2901	95	16	mg	mg	PROPN
admet-2901	95	17	ml-1	ml-1	PRON
admet-2901	95	18	of	of	ADP
admet-2901	95	19	3-(4,5	3-(4,5	PROPN
admet-2901	95	20	-	-	PUNCT
admet-2901	95	21	dimethylthiazol-2	dimethylthiazol-2	NUM
admet-2901	95	22	-	-	PUNCT
admet-2901	95	23	yl)-2,5	yl)-2,5	NOUN
admet-2901	95	24	-diphenyltetrazolium	-diphenyltetrazolium	NOUN
admet-2901	95	25	bromide	bromide	NOUN
admet-2901	95	26	(	(	PUNCT
admet-2901	95	27	mtt	mtt	NOUN
admet-2901	95	28	)	)	PUNCT
admet-2901	95	29	,	,	PUNCT
admet-2901	95	30	and	and	CCONJ
admet-2901	95	31	cells	cell	NOUN
admet-2901	95	32	were	be	AUX
admet-2901	95	33	incubated	incubate	VERB
admet-2901	95	34	for	for	ADP
admet-2901	95	35	an	an	DET
admet-2901	95	36	additional	additional	ADJ
admet-2901	95	37	3	3	NUM
admet-2901	95	38	h.	h.	NOUN
admet-2901	95	39	the	the	DET
admet-2901	95	40	mtt	mtt	NOUN
admet-2901	95	41	solution	solution	NOUN
admet-2901	95	42	was	be	AUX
admet-2901	95	43	then	then	ADV
admet-2901	95	44	removed	remove	VERB
admet-2901	95	45	,	,	PUNCT
admet-2901	95	46	and	and	CCONJ
admet-2901	95	47	dimethyl	dimethyl	NOUN
admet-2901	95	48	sulfoxide	sulfoxide	NOUN
admet-2901	95	49	(	(	PUNCT
admet-2901	95	50	dmso	dmso	NOUN
admet-2901	95	51	)	)	PUNCT
admet-2901	95	52	was	be	AUX
admet-2901	95	53	added	add	VERB
admet-2901	95	54	to	to	PART
admet-2901	95	55	solubilize	solubilize	VERB
admet-2901	95	56	the	the	DET
admet-2901	95	57	formazan	formazan	ADJ
admet-2901	95	58	crystals	crystal	NOUN
admet-2901	95	59	.	.	PUNCT
admet-2901	96	1	absorbance	absorbance	NOUN
admet-2901	96	2	was	be	AUX
admet-2901	96	3	measured	measure	VERB
admet-2901	96	4	at	at	ADP
admet-2901	96	5	595	595	NUM
admet-2901	96	6	 	 	SPACE
admet-2901	96	7	nm	nm	NOUN
admet-2901	96	8	using	use	VERB
admet-2901	96	9	a	a	DET
admet-2901	96	10	microplate	microplate	NOUN
admet-2901	96	11	spectrophotometer	spectrophotometer	NOUN
admet-2901	96	12	mr-850	mr-850	PROPN
admet-2901	96	13	bioplate	bioplate	VERB
admet-2901	96	14	reader	reader	NOUN
admet-2901	96	15	(	(	PUNCT
admet-2901	96	16	biometrics	biometric	NOUN
admet-2901	96	17	technologies	technology	NOUN
admet-2901	96	18	,	,	PUNCT
admet-2901	96	19	wilmington	wilmington	PROPN
admet-2901	96	20	,	,	PUNCT
admet-2901	96	21	de	de	PROPN
admet-2901	96	22	,	,	PUNCT
admet-2901	96	23	usa	usa	PROPN
admet-2901	96	24	)	)	PUNCT
admet-2901	96	25	.	.	PUNCT
admet-2901	97	1	compounds	compound	VERB
admet-2901	97	2	that	that	PRON
admet-2901	97	3	reduced	reduce	VERB
admet-2901	97	4	cell	cell	NOUN
admet-2901	97	5	viability	viability	NOUN
admet-2901	97	6	to	to	ADP
admet-2901	97	7	≤20	≤20	PROPN
admet-2901	97	8	%	%	NOUN
admet-2901	97	9	compared	compare	VERB
admet-2901	97	10	to	to	ADP
admet-2901	97	11	untreated	untreated	ADJ
admet-2901	97	12	controls	control	NOUN
admet-2901	97	13	were	be	AUX
admet-2901	97	14	identified	identify	VERB
admet-2901	97	15	as	as	ADP
admet-2901	97	16	hits	hit	NOUN
admet-2901	97	17	for	for	ADP
admet-2901	97	18	subsequent	subsequent	ADJ
admet-2901	97	19	dose	dose	NOUN
admet-2901	97	20	-	-	PUNCT
admet-2901	97	21	response	response	NOUN
admet-2901	97	22	analysis	analysis	NOUN
admet-2901	97	23	.	.	PUNCT
admet-2901	98	1	for	for	ADP
admet-2901	98	2	secondary	secondary	ADJ
admet-2901	98	3	screening	screening	NOUN
admet-2901	98	4	,	,	PUNCT
admet-2901	98	5	hit	hit	VERB
admet-2901	98	6	compounds	compound	NOUN
admet-2901	98	7	were	be	AUX
admet-2901	98	8	tested	test	VERB
admet-2901	98	9	at	at	ADP
admet-2901	98	10	varying	vary	VERB
admet-2901	98	11	concentrations	concentration	NOUN
admet-2901	98	12	using	use	VERB
admet-2901	98	13	two	two	NUM
admet-2901	98	14	dilution	dilution	NOUN
admet-2901	98	15	schemes	scheme	NOUN
admet-2901	98	16	:	:	PUNCT
admet-2901	98	17	a	a	DET
admet-2901	98	18	10	10	NUM
admet-2901	98	19	-	-	ADJ
admet-2901	98	20	fold	fold	ADJ
admet-2901	98	21	series	series	NOUN
admet-2901	98	22	(	(	PUNCT
admet-2901	98	23	100	100	NUM
admet-2901	98	24	to	to	PART
admet-2901	98	25	0.00001	0.00001	NUM
admet-2901	98	26	 	 	SPACE
admet-2901	98	27	μm	μm	NUM
admet-2901	98	28	)	)	PUNCT
admet-2901	98	29	and	and	CCONJ
admet-2901	98	30	a	a	DET
admet-2901	98	31	4	4	NUM
admet-2901	98	32	-	-	ADJ
admet-2901	98	33	fold	fold	ADJ
admet-2901	98	34	series	series	NOUN
admet-2901	98	35	(	(	PUNCT
admet-2901	98	36	100	100	NUM
admet-2901	98	37	to	to	ADP
admet-2901	98	38	0.0061035	0.0061035	NUM
admet-2901	98	39	 	 	SPACE
admet-2901	98	40	μm	μm	NUM
admet-2901	98	41	)	)	PUNCT
admet-2901	98	42	.	.	PUNCT
admet-2901	99	1	treated	treat	VERB
admet-2901	99	2	cells	cell	NOUN
admet-2901	99	3	were	be	AUX
admet-2901	99	4	incubated	incubate	VERB
admet-2901	99	5	for	for	ADP
admet-2901	99	6	72	72	NUM
admet-2901	99	7	h	h	NOUN
admet-2901	99	8	,	,	PUNCT
admet-2901	99	9	followed	follow	VERB
admet-2901	99	10	by	by	ADP
admet-2901	99	11	an	an	DET
admet-2901	99	12	mtt	mtt	NOUN
admet-2901	99	13	assay	assay	NOUN
admet-2901	99	14	as	as	SCONJ
admet-2901	99	15	described	describe	VERB
admet-2901	99	16	above	above	ADV
admet-2901	99	17	.	.	PUNCT
admet-2901	100	1	the	the	DET
admet-2901	100	2	absorbance	absorbance	NOUN
admet-2901	100	3	at	at	ADP
admet-2901	100	4	595	595	NUM
admet-2901	100	5	 	 	SPACE
admet-2901	100	6	nm	nm	NOUN
admet-2901	100	7	was	be	AUX
admet-2901	100	8	recorded	record	VERB
admet-2901	100	9	,	,	PUNCT
admet-2901	100	10	and	and	CCONJ
admet-2901	100	11	ic₅₀	ic₅₀	PROPN
admet-2901	100	12	values	value	NOUN
admet-2901	100	13	were	be	AUX
admet-2901	100	14	determined	determine	VERB
admet-2901	100	15	using	use	VERB
admet-2901	100	16	graphpad	graphpad	NOUN
admet-2901	100	17	prism	prism	NOUN
admet-2901	100	18	9	9	NUM
admet-2901	100	19	(	(	PUNCT
admet-2901	100	20	graphpad	graphpad	NOUN
admet-2901	100	21	software	software	NOUN
admet-2901	100	22	,	,	PUNCT
admet-2901	100	23	san	san	PROPN
admet-2901	100	24	diego	diego	PROPN
admet-2901	100	25	,	,	PUNCT
admet-2901	100	26	ca	ca	PROPN
admet-2901	100	27	,	,	PUNCT
admet-2901	100	28	usa	usa	PROPN
admet-2901	100	29	)	)	PUNCT
admet-2901	100	30	.	.	PUNCT
admet-2901	101	1	cytotoxicity	cytotoxicity	NOUN
admet-2901	101	2	test	test	NOUN
admet-2901	101	3	in	in	ADP
admet-2901	101	4	human	human	ADJ
admet-2901	101	5	liver	liver	NOUN
admet-2901	101	6	cells	cell	NOUN
admet-2901	101	7	the	the	DET
admet-2901	101	8	human	human	ADJ
admet-2901	101	9	liver	liver	NOUN
admet-2901	101	10	cells	cell	NOUN
admet-2901	101	11	(	(	PUNCT
admet-2901	101	12	hepg2	hepg2	NOUN
admet-2901	101	13	cells	cell	NOUN
admet-2901	101	14	)	)	PUNCT
admet-2901	101	15	were	be	AUX
admet-2901	101	16	seeded	seed	VERB
admet-2901	101	17	into	into	ADP
admet-2901	101	18	a	a	DET
admet-2901	101	19	96	96	NUM
admet-2901	101	20	-	-	PUNCT
admet-2901	101	21	well	well	NOUN
admet-2901	101	22	plate	plate	NOUN
admet-2901	101	23	at	at	ADP
admet-2901	101	24	a	a	DET
admet-2901	101	25	cell	cell	NOUN
admet-2901	101	26	density	density	NOUN
admet-2901	101	27	of	of	ADP
admet-2901	101	28	104	104	NUM
admet-2901	101	29	cells	cell	NOUN
admet-2901	101	30	/	/	SYM
admet-2901	101	31	well	well	ADV
admet-2901	101	32	and	and	CCONJ
admet-2901	101	33	were	be	AUX
admet-2901	101	34	incubated	incubate	VERB
admet-2901	101	35	with	with	ADP
admet-2901	101	36	dmem	dmem	ADJ
admet-2901	101	37	/	/	SYM
admet-2901	101	38	f-12	f-12	NOUN
admet-2901	101	39	with	with	ADP
admet-2901	101	40	10	10	NUM
admet-2901	101	41	%	%	NOUN
admet-2901	101	42	fbs	fbs	ADJ
admet-2901	101	43	and	and	CCONJ
admet-2901	101	44	1	1	NUM
admet-2901	101	45	%	%	NOUN
admet-2901	101	46	p	p	X
admet-2901	101	47	/	/	SYM
admet-2901	101	48	s	s	PROPN
admet-2901	101	49	for	for	ADP
admet-2901	101	50	24	24	NUM
admet-2901	101	51	hours	hour	NOUN
admet-2901	101	52	in	in	ADP
admet-2901	101	53	an	an	DET
admet-2901	101	54	incubator	incubator	NOUN
admet-2901	101	55	(	(	PUNCT
admet-2901	101	56	37	37	NUM
admet-2901	101	57	°	°	NUM
admet-2901	101	58	c	c	NOUN
admet-2901	101	59	and	and	CCONJ
admet-2901	101	60	5	5	NUM
admet-2901	101	61	%	%	NOUN
admet-2901	101	62	co2	co2	NOUN
admet-2901	101	63	)	)	PUNCT
admet-2901	101	64	.	.	PUNCT
admet-2901	102	1	after	after	ADP
admet-2901	102	2	this	this	DET
admet-2901	102	3	incubation	incubation	NOUN
admet-2901	102	4	period	period	NOUN
admet-2901	102	5	,	,	PUNCT
admet-2901	102	6	the	the	DET
admet-2901	102	7	effective	effective	ADJ
admet-2901	102	8	compounds	compound	NOUN
admet-2901	102	9	were	be	AUX
admet-2901	102	10	added	add	VERB
admet-2901	102	11	to	to	ADP
admet-2901	102	12	the	the	DET
admet-2901	102	13	cell	cell	NOUN
admet-2901	102	14	plate	plate	NOUN
admet-2901	102	15	in	in	ADP
admet-2901	102	16	a	a	DET
admet-2901	102	17	dose	dose	NOUN
admet-2901	102	18	-	-	PUNCT
admet-2901	102	19	dependent	dependent	ADJ
admet-2901	102	20	manner	manner	NOUN
admet-2901	102	21	,	,	PUNCT
admet-2901	102	22	mixing	mix	VERB
admet-2901	102	23	with	with	ADP
admet-2901	102	24	culture	culture	NOUN
admet-2901	102	25	media	medium	NOUN
admet-2901	102	26	at	at	ADP
admet-2901	102	27	concentrations	concentration	NOUN
admet-2901	102	28	of	of	ADP
admet-2901	102	29	100	100	NUM
admet-2901	102	30	,	,	PUNCT
admet-2901	102	31	10	10	NUM
admet-2901	102	32	,	,	PUNCT
admet-2901	102	33	1	1	NUM
admet-2901	102	34	,	,	PUNCT
admet-2901	102	35	0.1	0.1	NUM
admet-2901	102	36	,	,	PUNCT
admet-2901	102	37	0.01	0.01	NUM
admet-2901	102	38	,	,	PUNCT
admet-2901	102	39	0.001	0.001	NUM
admet-2901	102	40	,	,	PUNCT
admet-2901	102	41	0.0001	0.0001	NUM
admet-2901	102	42	,	,	PUNCT
admet-2901	102	43	and	and	CCONJ
admet-2901	102	44	0.00001	0.00001	NUM
admet-2901	102	45	μm	μm	NOUN
admet-2901	102	46	.	.	PUNCT
admet-2901	103	1	then	then	ADV
admet-2901	103	2	,	,	PUNCT
admet-2901	103	3	they	they	PRON
admet-2901	103	4	were	be	AUX
admet-2901	103	5	additionally	additionally	ADV
admet-2901	103	6	incubated	incubate	VERB
admet-2901	103	7	for	for	ADP
admet-2901	103	8	72	72	NUM
admet-2901	103	9	hours	hour	NOUN
admet-2901	103	10	.	.	PUNCT
admet-2901	104	1	after	after	ADP
admet-2901	104	2	72	72	NUM
admet-2901	104	3	hours	hour	NOUN
admet-2901	104	4	of	of	ADP
admet-2901	104	5	incubation	incubation	NOUN
admet-2901	104	6	,	,	PUNCT
admet-2901	104	7	the	the	DET
admet-2901	104	8	culture	culture	NOUN
admet-2901	104	9	media	medium	NOUN
admet-2901	104	10	containing	contain	VERB
admet-2901	104	11	the	the	DET
admet-2901	104	12	compounds	compound	NOUN
admet-2901	104	13	were	be	AUX
admet-2901	104	14	removed	remove	VERB
admet-2901	104	15	,	,	PUNCT
admet-2901	104	16	and	and	CCONJ
admet-2901	104	17	serum	serum	NOUN
admet-2901	104	18	-	-	PUNCT
admet-2901	104	19	free	free	ADJ
admet-2901	104	20	media	medium	NOUN
admet-2901	104	21	containing	contain	VERB
admet-2901	104	22	mtt	mtt	NOUN
admet-2901	104	23	was	be	AUX
admet-2901	104	24	added	add	VERB
admet-2901	104	25	instead	instead	ADV
admet-2901	104	26	,	,	PUNCT
admet-2901	104	27	with	with	ADP
admet-2901	104	28	an	an	DET
admet-2901	104	29	additional	additional	ADJ
admet-2901	104	30	3	3	NUM
admet-2901	104	31	hours	hour	NOUN
admet-2901	104	32	of	of	ADP
admet-2901	104	33	incubation	incubation	NOUN
admet-2901	104	34	at	at	ADP
admet-2901	104	35	37	37	NUM
admet-2901	104	36	°	°	NOUN
admet-2901	104	37	c	c	NOUN
admet-2901	104	38	and	and	CCONJ
admet-2901	104	39	5	5	NUM
admet-2901	104	40	%	%	NOUN
admet-2901	104	41	co2	co2	NOUN
admet-2901	104	42	.	.	PUNCT
admet-2901	105	1	after	after	ADP
admet-2901	105	2	3	3	NUM
admet-2901	105	3	hours	hour	NOUN
admet-2901	105	4	of	of	ADP
admet-2901	105	5	incubation	incubation	NOUN
admet-2901	105	6	,	,	PUNCT
admet-2901	105	7	the	the	DET
admet-2901	105	8	mtt	mtt	NOUN
admet-2901	105	9	-	-	PUNCT
admet-2901	105	10	containing	contain	VERB
admet-2901	105	11	media	medium	NOUN
admet-2901	105	12	was	be	AUX
admet-2901	105	13	removed	remove	VERB
admet-2901	105	14	and	and	CCONJ
admet-2901	105	15	dmso	dmso	NOUN
admet-2901	105	16	was	be	AUX
admet-2901	105	17	added	add	VERB
admet-2901	105	18	to	to	ADP
admet-2901	105	19	the	the	DET
admet-2901	105	20	assay	assay	NOUN
admet-2901	105	21	plates	plate	NOUN
admet-2901	105	22	,	,	PUNCT
admet-2901	105	23	resulting	result	VERB
admet-2901	105	24	in	in	ADP
admet-2901	105	25	different	different	ADJ
admet-2901	105	26	shades	shade	NOUN
admet-2901	105	27	of	of	ADP
admet-2901	105	28	purple	purple	ADJ
admet-2901	105	29	colour	colour	NOUN
admet-2901	105	30	admet	admet	PROPN
admet-2901	105	31	&	&	CCONJ
admet-2901	105	32	dmpk	dmpk	PROPN
admet-2901	105	33	13(5	13(5	NOUN
admet-2901	105	34	)	)	PUNCT
admet-2901	105	35	(	(	PUNCT
admet-2901	105	36	2025	2025	NUM
admet-2901	105	37	)	)	PUNCT
admet-2901	105	38	2901	2901	NUM
admet-2901	105	39	new	new	ADJ
admet-2901	105	40	xanthone	xanthone	PROPN
admet-2901	105	41	and	and	CCONJ
admet-2901	105	42	chemical	chemical	NOUN
admet-2901	105	43	constituents	constituent	NOUN
admet-2901	105	44	from	from	ADP
admet-2901	105	45	mallotus	mallotus	ADJ
admet-2901	105	46	glomerulatus	glomerulatus	NOUN
admet-2901	105	47	doi	doi	PROPN
admet-2901	105	48	:	:	PUNCT
admet-2901	105	49	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	NOUN
admet-2901	105	50	5	5	NUM
admet-2901	105	51	measured	measure	VERB
admet-2901	105	52	by	by	ADP
admet-2901	105	53	microplate	microplate	NOUN
admet-2901	105	54	spectrophotometer	spectrophotometer	PROPN
admet-2901	105	55	mr-850	mr-850	PROPN
admet-2901	105	56	bioplate	bioplate	VERB
admet-2901	105	57	reader	reader	NOUN
admet-2901	105	58	.	.	PUNCT
admet-2901	106	1	the	the	DET
admet-2901	106	2	calculation	calculation	NOUN
admet-2901	106	3	of	of	ADP
admet-2901	106	4	cc50	cc50	PROPN
admet-2901	106	5	was	be	AUX
admet-2901	106	6	analysed	analyse	VERB
admet-2901	106	7	by	by	ADP
admet-2901	106	8	using	use	VERB
admet-2901	106	9	graphpad	graphpad	NOUN
admet-2901	106	10	prism	prism	NOUN
admet-2901	106	11	9	9	NUM
admet-2901	106	12	.	.	X
admet-2901	106	13	molecular	molecular	ADJ
admet-2901	106	14	docking	docking	NOUN
admet-2901	106	15	of	of	ADP
admet-2901	106	16	(	(	PUNCT
admet-2901	106	17	3,4,5)-trihydroxy-6	3,4,5)-trihydroxy-6	NUM
admet-2901	106	18	-	-	PUNCT
admet-2901	106	19	methoxy-2,7	methoxy-2,7	NOUN
admet-2901	106	20	-	-	PUNCT
admet-2901	106	21	bis(3	bis(3	NOUN
admet-2901	106	22	-	-	PUNCT
admet-2901	106	23	methylbut-2	methylbut-2	NUM
admet-2901	106	24	-	-	PUNCT
admet-2901	106	25	en-1	en-1	NOUN
admet-2901	106	26	-	-	PUNCT
admet-2901	106	27	yl)-9h	yl)-9h	NOUN
admet-2901	106	28	-	-	PUNCT
admet-2901	106	29	xanthen-9	xanthen-9	NUM
admet-2901	106	30	-	-	PUNCT
admet-2901	106	31	one	one	NUM
admet-2901	106	32	and	and	CCONJ
admet-2901	106	33	cleistanthin	cleistanthin	VERB
admet-2901	106	34	a	a	PRON
admet-2901	106	35	to	to	ADP
admet-2901	106	36	vacuolar	vacuolar	ADJ
admet-2901	106	37	h+-atpase	h+-atpase	PROPN
admet-2901	106	38	(	(	PUNCT
admet-2901	106	39	v	v	NOUN
admet-2901	106	40	-	-	PUNCT
admet-2901	106	41	atpase	atpase	NOUN
admet-2901	106	42	)	)	PUNCT
admet-2901	106	43	the	the	DET
admet-2901	106	44	three	three	NUM
admet-2901	106	45	-	-	PUNCT
admet-2901	106	46	dimensional	dimensional	ADJ
admet-2901	106	47	(	(	PUNCT
admet-2901	106	48	3d	3d	NOUN
admet-2901	106	49	)	)	PUNCT
admet-2901	106	50	structure	structure	NOUN
admet-2901	106	51	of	of	ADP
admet-2901	106	52	yeast	yeast	NOUN
admet-2901	106	53	vo	vo	X
admet-2901	106	54	v	v	PROPN
admet-2901	106	55	-	-	PROPN
admet-2901	106	56	atpase	atpase	PROPN
admet-2901	106	57	(	(	PUNCT
admet-2901	106	58	pdb	pdb	PROPN
admet-2901	106	59	i	i	PROPN
admet-2901	106	60	d	d	PROPN
admet-2901	106	61	:	:	PUNCT
admet-2901	107	1	7tao	7tao	NUM
admet-2901	108	1	[	[	X
admet-2901	108	2	28	28	NUM
admet-2901	108	3	]	]	PUNCT
admet-2901	108	4	)	)	PUNCT
admet-2901	108	5	was	be	AUX
admet-2901	108	6	obtained	obtain	VERB
admet-2901	108	7	from	from	ADP
admet-2901	108	8	a	a	DET
admet-2901	108	9	previous	previous	ADJ
admet-2901	108	10	study	study	NOUN
admet-2901	108	11	[	[	X
admet-2901	108	12	29	29	NUM
admet-2901	108	13	]	]	PUNCT
admet-2901	108	14	.	.	PUNCT
admet-2901	109	1	the	the	DET
admet-2901	109	2	chemical	chemical	ADJ
admet-2901	109	3	structure	structure	NOUN
admet-2901	109	4	of	of	ADP
admet-2901	109	5	cleistanthin	cleistanthin	PROPN
admet-2901	109	6	a	a	PRON
admet-2901	109	7	and	and	CCONJ
admet-2901	109	8	novel	novel	ADJ
admet-2901	109	9	xanthone	xanthone	PROPN
admet-2901	109	10	(	(	PUNCT
admet-2901	109	11	(	(	PUNCT
admet-2901	109	12	3,4,5)-trihydroxy-6	3,4,5)-trihydroxy-6	NUM
admet-2901	109	13	-methoxy-2,7	-methoxy-2,7	NOUN
admet-2901	109	14	-	-	PUNCT
admet-2901	109	15	bis(3	bis(3	NOUN
admet-2901	109	16	-	-	PUNCT
admet-2901	109	17	methylbut-2	methylbut-2	NUM
admet-2901	109	18	-	-	PUNCT
admet-2901	109	19	en-1	en-1	NOUN
admet-2901	109	20	-	-	PUNCT
admet-2901	109	21	yl)-9h	yl)-9h	NOUN
admet-2901	109	22	-	-	PUNCT
admet-2901	109	23	xanthen-9	xanthen-9	NUM
admet-2901	109	24	-	-	PUNCT
admet-2901	109	25	one	one	NUM
admet-2901	109	26	)	)	PUNCT
admet-2901	109	27	was	be	AUX
admet-2901	109	28	drawn	draw	VERB
admet-2901	109	29	using	use	VERB
admet-2901	109	30	perkinelmer	perkinelmer	NOUN
admet-2901	109	31	chemdraw	chemdraw	NOUN
admet-2901	109	32	and	and	CCONJ
admet-2901	109	33	subsequently	subsequently	ADV
admet-2901	109	34	converted	convert	VERB
admet-2901	109	35	into	into	ADP
admet-2901	109	36	a	a	DET
admet-2901	109	37	3d	3d	NUM
admet-2901	109	38	structure	structure	NOUN
admet-2901	109	39	using	use	VERB
admet-2901	109	40	chem3d	chem3d	NOUN
admet-2901	109	41	software	software	PROPN
admet-2901	109	42	.	.	PUNCT
admet-2901	110	1	the	the	DET
admet-2901	110	2	resulting	result	VERB
admet-2901	110	3	3d	3d	NUM
admet-2901	110	4	structure	structure	NOUN
admet-2901	110	5	was	be	AUX
admet-2901	110	6	then	then	ADV
admet-2901	110	7	energy	energy	NOUN
admet-2901	110	8	-	-	PUNCT
admet-2901	110	9	minimized	minimized	ADJ
admet-2901	110	10	using	use	VERB
admet-2901	110	11	the	the	DET
admet-2901	110	12	molecular	molecular	ADJ
admet-2901	110	13	mechanics	mechanic	NOUN
admet-2901	110	14	2	2	NUM
admet-2901	110	15	(	(	PUNCT
admet-2901	110	16	mm2	mm2	NOUN
admet-2901	110	17	)	)	PUNCT
admet-2901	110	18	force	force	NOUN
admet-2901	110	19	field	field	NOUN
admet-2901	110	20	implemented	implement	VERB
admet-2901	110	21	in	in	ADP
admet-2901	110	22	chem3d	chem3d	NOUN
admet-2901	110	23	.	.	PUNCT
admet-2901	111	1	following	follow	VERB
admet-2901	111	2	structure	structure	NOUN
admet-2901	111	3	preparation	preparation	NOUN
admet-2901	111	4	,	,	PUNCT
admet-2901	111	5	pdbqt	pdbqt	ADJ
admet-2901	111	6	files	file	NOUN
admet-2901	111	7	of	of	ADP
admet-2901	111	8	both	both	CCONJ
admet-2901	111	9	the	the	DET
admet-2901	111	10	protein	protein	NOUN
admet-2901	111	11	and	and	CCONJ
admet-2901	111	12	ligand	ligand	NOUN
admet-2901	111	13	were	be	AUX
admet-2901	111	14	generated	generate	VERB
admet-2901	111	15	using	use	VERB
admet-2901	111	16	the	the	DET
admet-2901	111	17	autodockfr	autodockfr	ADJ
admet-2901	111	18	1.0	1.0	NUM
admet-2901	111	19	software	software	NOUN
admet-2901	111	20	suite	suite	NOUN
admet-2901	111	21	[	[	X
admet-2901	111	22	30	30	NUM
admet-2901	111	23	]	]	PUNCT
admet-2901	111	24	.	.	PUNCT
admet-2901	112	1	molecular	molecular	ADJ
admet-2901	112	2	docking	docking	NOUN
admet-2901	112	3	was	be	AUX
admet-2901	112	4	performed	perform	VERB
admet-2901	112	5	with	with	ADP
admet-2901	112	6	autodock	autodock	PROPN
admet-2901	112	7	vina	vina	PROPN
admet-2901	112	8	version	version	PROPN
admet-2901	112	9	1.2.7	1.2.7	NUM
admet-2901	113	1	[	[	X
admet-2901	113	2	31	31	NUM
admet-2901	113	3	]	]	PUNCT
admet-2901	113	4	.	.	PUNCT
admet-2901	114	1	the	the	DET
admet-2901	114	2	grid	grid	PROPN
admet-2901	114	3	box	box	PROPN
admet-2901	114	4	was	be	AUX
admet-2901	114	5	centred	centre	VERB
admet-2901	114	6	at	at	ADP
admet-2901	114	7	coordinates	coordinate	NOUN
admet-2901	114	8	x	x	PUNCT
admet-2901	114	9	=	=	SYM
admet-2901	114	10	152.83	152.83	NUM
admet-2901	114	11	,	,	PUNCT
admet-2901	114	12	y	y	PROPN
admet-2901	114	13	=	=	PROPN
admet-2901	114	14	171.45	171.45	NUM
admet-2901	114	15	and	and	CCONJ
admet-2901	114	16	z	z	NOUN
admet-2901	114	17	=	=	PUNCT
admet-2901	114	18	133.06	133.06	NUM
admet-2901	114	19	,	,	PUNCT
admet-2901	114	20	with	with	ADP
admet-2901	114	21	the	the	DET
admet-2901	114	22	exhaustiveness	exhaustiveness	NOUN
admet-2901	114	23	parameter	parameter	NOUN
admet-2901	114	24	set	set	VERB
admet-2901	114	25	to	to	ADP
admet-2901	114	26	64	64	NUM
admet-2901	114	27	;	;	PUNCT
admet-2901	114	28	all	all	DET
admet-2901	114	29	other	other	ADJ
admet-2901	114	30	settings	setting	NOUN
admet-2901	114	31	were	be	AUX
admet-2901	114	32	maintained	maintain	VERB
admet-2901	114	33	at	at	ADP
admet-2901	114	34	default	default	NOUN
admet-2901	114	35	values	value	NOUN
admet-2901	114	36	.	.	PUNCT
admet-2901	115	1	the	the	DET
admet-2901	115	2	best	good	ADJ
admet-2901	115	3	docking	docking	NOUN
admet-2901	115	4	poses	pose	NOUN
admet-2901	115	5	of	of	ADP
admet-2901	115	6	cleistanthin	cleistanthin	NOUN
admet-2901	115	7	a	a	PRON
admet-2901	115	8	and	and	CCONJ
admet-2901	115	9	xanthone	xanthone	PROPN
admet-2901	115	10	bound	bind	VERB
admet-2901	115	11	to	to	ADP
admet-2901	115	12	v	v	NOUN
admet-2901	115	13	-	-	PUNCT
admet-2901	115	14	atpase	atpase	PROPN
admet-2901	115	15	were	be	AUX
admet-2901	115	16	visualized	visualize	VERB
admet-2901	115	17	using	use	VERB
admet-2901	115	18	ucsf	ucsf	ADJ
admet-2901	115	19	chimerax	chimerax	NOUN
admet-2901	116	1	[	[	X
admet-2901	116	2	32	32	NUM
admet-2901	116	3	]	]	PUNCT
admet-2901	116	4	,	,	PUNCT
admet-2901	116	5	while	while	SCONJ
admet-2901	116	6	2d	2d	NUM
admet-2901	116	7	interaction	interaction	NOUN
admet-2901	116	8	diagrams	diagram	NOUN
admet-2901	116	9	of	of	ADP
admet-2901	116	10	the	the	DET
admet-2901	116	11	protein	protein	NOUN
admet-2901	116	12	–	–	PUNCT
admet-2901	116	13	ligand	ligand	NOUN
admet-2901	116	14	complexes	complex	NOUN
admet-2901	116	15	were	be	AUX
admet-2901	116	16	generated	generate	VERB
admet-2901	116	17	using	use	VERB
admet-2901	116	18	discovery	discovery	NOUN
admet-2901	116	19	studio	studio	NOUN
admet-2901	116	20	visualizer	visualizer	NOUN
admet-2901	116	21	(	(	PUNCT
admet-2901	116	22	biovia	biovia	NOUN
admet-2901	116	23	,	,	PUNCT
admet-2901	116	24	san	san	PROPN
admet-2901	116	25	diego	diego	PROPN
admet-2901	116	26	,	,	PUNCT
admet-2901	116	27	ca	ca	PROPN
admet-2901	116	28	,	,	PUNCT
admet-2901	116	29	usa	usa	PROPN
admet-2901	116	30	)	)	PUNCT
admet-2901	116	31	.	.	PUNCT
admet-2901	117	1	statistical	statistical	ADJ
admet-2901	117	2	analysis	analysis	NOUN
admet-2901	117	3	data	datum	NOUN
admet-2901	117	4	analysis	analysis	NOUN
admet-2901	117	5	was	be	AUX
admet-2901	117	6	performed	perform	VERB
admet-2901	117	7	using	use	VERB
admet-2901	117	8	graphpad	graphpad	NOUN
admet-2901	117	9	prism	prism	NOUN
admet-2901	117	10	version	version	NOUN
admet-2901	117	11	9	9	NUM
admet-2901	117	12	(	(	PUNCT
admet-2901	117	13	graphpad	graphpad	NOUN
admet-2901	117	14	software	software	NOUN
admet-2901	117	15	,	,	PUNCT
admet-2901	117	16	san	san	PROPN
admet-2901	117	17	diego	diego	PROPN
admet-2901	117	18	,	,	PUNCT
admet-2901	117	19	ca	ca	PROPN
admet-2901	117	20	,	,	PUNCT
admet-2901	117	21	usa	usa	PROPN
admet-2901	117	22	)	)	PUNCT
admet-2901	117	23	.	.	PUNCT
admet-2901	118	1	one	one	NUM
admet-2901	118	2	-	-	PUNCT
admet-2901	118	3	way	way	NOUN
admet-2901	118	4	analysis	analysis	NOUN
admet-2901	118	5	of	of	ADP
admet-2901	118	6	variance	variance	NOUN
admet-2901	118	7	(	(	PUNCT
admet-2901	118	8	anova	anova	PROPN
admet-2901	118	9	)	)	PUNCT
admet-2901	118	10	was	be	AUX
admet-2901	118	11	used	use	VERB
admet-2901	118	12	to	to	PART
admet-2901	118	13	compare	compare	VERB
admet-2901	118	14	values	value	NOUN
admet-2901	118	15	across	across	ADP
admet-2901	118	16	multiple	multiple	ADJ
admet-2901	118	17	groups	group	NOUN
admet-2901	118	18	.	.	PUNCT
admet-2901	119	1	results	result	VERB
admet-2901	119	2	isolation	isolation	NOUN
admet-2901	119	3	and	and	CCONJ
admet-2901	119	4	structural	structural	ADJ
admet-2901	119	5	characterization	characterization	NOUN
admet-2901	119	6	of	of	ADP
admet-2901	119	7	a	a	DET
admet-2901	119	8	new	new	ADJ
admet-2901	119	9	xanthone	xanthone	NOUN
admet-2901	119	10	from	from	ADP
admet-2901	119	11	m.	m.	NOUN
admet-2901	119	12	glomerulatus	glomerulatus	PROPN
admet-2901	119	13	m.	m.	NOUN
admet-2901	119	14	glomerulatus	glomerulatus	NOUN
admet-2901	119	15	is	be	AUX
admet-2901	119	16	a	a	DET
admet-2901	119	17	shrubby	shrubby	ADJ
admet-2901	119	18	species	species	NOUN
admet-2901	119	19	native	native	ADJ
admet-2901	119	20	to	to	ADP
admet-2901	119	21	northeastern	northeastern	ADJ
admet-2901	119	22	and	and	CCONJ
admet-2901	119	23	central	central	ADJ
admet-2901	119	24	thailand	thailand	PROPN
admet-2901	119	25	.	.	PUNCT
admet-2901	120	1	despite	despite	SCONJ
admet-2901	120	2	its	its	PRON
admet-2901	120	3	regional	regional	ADJ
admet-2901	120	4	presence	presence	NOUN
admet-2901	120	5	,	,	PUNCT
admet-2901	120	6	the	the	DET
admet-2901	120	7	phytochemical	phytochemical	ADJ
admet-2901	120	8	profile	profile	NOUN
admet-2901	120	9	and	and	CCONJ
admet-2901	120	10	biological	biological	ADJ
admet-2901	120	11	properties	property	NOUN
admet-2901	120	12	of	of	ADP
admet-2901	120	13	this	this	DET
admet-2901	120	14	species	specie	NOUN
admet-2901	120	15	have	have	AUX
admet-2901	120	16	remained	remain	VERB
admet-2901	120	17	largely	largely	ADV
admet-2901	120	18	unexplored	unexplored	ADJ
admet-2901	120	19	.	.	PUNCT
admet-2901	121	1	in	in	ADP
admet-2901	121	2	the	the	DET
admet-2901	121	3	course	course	NOUN
admet-2901	121	4	of	of	ADP
admet-2901	121	5	our	our	PRON
admet-2901	121	6	phytochemical	phytochemical	ADJ
admet-2901	121	7	investigation	investigation	NOUN
admet-2901	121	8	,	,	PUNCT
admet-2901	121	9	a	a	DET
admet-2901	121	10	new	new	ADJ
admet-2901	121	11	xanthone	xanthone	PROPN
admet-2901	121	12	,	,	PUNCT
admet-2901	121	13	(	(	PUNCT
admet-2901	121	14	3,4,5)-trihydroxy-6	3,4,5)-trihydroxy-6	NUM
admet-2901	121	15	-	-	PUNCT
admet-2901	121	16	methoxy-2,7	methoxy-2,7	ADJ
admet-2901	121	17	-bis(3	-bis(3	NOUN
admet-2901	121	18	-	-	PUNCT
admet-2901	121	19	methylbut-2	methylbut-2	NUM
admet-2901	121	20	-	-	PUNCT
admet-2901	121	21	en-1	en-1	NOUN
admet-2901	121	22	-	-	PUNCT
admet-2901	121	23	yl)-9h	yl)-9h	NOUN
admet-2901	121	24	-	-	PUNCT
admet-2901	121	25	xanthen-9	xanthen-9	NUM
admet-2901	121	26	-	-	PUNCT
admet-2901	121	27	one	one	NUM
admet-2901	121	28	(	(	PUNCT
admet-2901	121	29	1	1	NUM
admet-2901	121	30	)	)	PUNCT
admet-2901	121	31	(	(	PUNCT
admet-2901	121	32	figure	figure	NOUN
admet-2901	121	33	1	1	NUM
admet-2901	121	34	)	)	PUNCT
admet-2901	121	35	,	,	PUNCT
admet-2901	121	36	and	and	CCONJ
admet-2901	121	37	a	a	DET
admet-2901	121	38	diterpenoid	diterpenoid	ADJ
admet-2901	121	39	,	,	PUNCT
admet-2901	121	40	glomerulatusin	glomerulatusin	NOUN
admet-2901	121	41	(	(	PUNCT
admet-2901	121	42	2	2	NUM
admet-2901	121	43	)	)	PUNCT
admet-2901	121	44	[	[	X
admet-2901	121	45	33,34	33,34	NOUN
admet-2901	121	46	]	]	PUNCT
admet-2901	121	47	,	,	PUNCT
admet-2901	121	48	were	be	AUX
admet-2901	121	49	isolated	isolate	VERB
admet-2901	121	50	from	from	ADP
admet-2901	121	51	the	the	DET
admet-2901	121	52	aerial	aerial	ADJ
admet-2901	121	53	parts	part	NOUN
admet-2901	121	54	of	of	ADP
admet-2901	121	55	the	the	DET
admet-2901	121	56	plant	plant	NOUN
admet-2901	121	57	.	.	PUNCT
admet-2901	122	1	figure	figure	NOUN
admet-2901	122	2	1	1	NUM
admet-2901	122	3	.	.	PUNCT
admet-2901	123	1	the	the	DET
admet-2901	123	2	structure	structure	NOUN
admet-2901	123	3	of	of	ADP
admet-2901	123	4	compounds	compound	NOUN
admet-2901	123	5	1	1	NUM
admet-2901	123	6	to	to	PART
admet-2901	123	7	11	11	NUM
admet-2901	123	8	isolated	isolate	VERB
admet-2901	123	9	from	from	ADP
admet-2901	123	10	the	the	DET
admet-2901	123	11	m	m	NOUN
admet-2901	123	12	glomerulatus	glomerulatus	NOUN
admet-2901	123	13	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	NOUN
admet-2901	123	14	n.	n.	PROPN
admet-2901	123	15	chabang	chabang	PROPN
admet-2901	123	16	et	et	PROPN
admet-2901	123	17	al	al	PROPN
admet-2901	123	18	.	.	PROPN
admet-2901	123	19	admet	admet	PROPN
admet-2901	123	20	&	&	CCONJ
admet-2901	123	21	dmpk	dmpk	PROPN
admet-2901	123	22	13(5	13(5	NUM
admet-2901	123	23	)	)	PUNCT
admet-2901	123	24	(	(	PUNCT
admet-2901	123	25	2025	2025	NUM
admet-2901	123	26	)	)	PUNCT
admet-2901	123	27	2901	2901	NUM
admet-2901	123	28	6	6	NUM
admet-2901	123	29	alongside	alongside	ADP
admet-2901	123	30	these	these	DET
admet-2901	123	31	novel	novel	ADJ
admet-2901	123	32	compounds	compound	NOUN
admet-2901	123	33	,	,	PUNCT
admet-2901	123	34	nine	nine	NUM
admet-2901	123	35	previously	previously	ADV
admet-2901	123	36	reported	report	VERB
admet-2901	123	37	constituents	constituent	NOUN
admet-2901	123	38	were	be	AUX
admet-2901	123	39	also	also	ADV
admet-2901	123	40	identified	identify	VERB
admet-2901	123	41	:	:	PUNCT
admet-2901	123	42	friedelin	friedelin	PROPN
admet-2901	123	43	(	(	PUNCT
admet-2901	123	44	3	3	NUM
admet-2901	123	45	)	)	PUNCT
admet-2901	124	1	[	[	X
admet-2901	124	2	35,6	35,6	NOUN
admet-2901	124	3	]	]	X
admet-2901	124	4	,	,	PUNCT
admet-2901	124	5	anomaluone	anomaluone	NOUN
admet-2901	124	6	(	(	PUNCT
admet-2901	124	7	4	4	NUM
admet-2901	124	8	)	)	PUNCT
admet-2901	125	1	[	[	X
admet-2901	125	2	33,37	33,37	NUM
admet-2901	125	3	]	]	PUNCT
admet-2901	125	4	,	,	PUNCT
admet-2901	125	5	3,6	3,6	NUM
admet-2901	125	6	-	-	PUNCT
admet-2901	125	7	phenanthrenedione	phenanthrenedione	ADJ
admet-2901	125	8	(	(	PUNCT
admet-2901	125	9	5	5	NUM
admet-2901	125	10	)	)	PUNCT
admet-2901	125	11	[	[	X
admet-2901	125	12	38	38	NUM
admet-2901	125	13	]	]	PUNCT
admet-2901	125	14	,	,	PUNCT
admet-2901	125	15	pinocembrin	pinocembrin	NOUN
admet-2901	125	16	(	(	PUNCT
admet-2901	125	17	6	6	NUM
admet-2901	125	18	)	)	PUNCT
admet-2901	126	1	[	[	X
admet-2901	126	2	39,40	39,40	NUM
admet-2901	126	3	]	]	X
admet-2901	126	4	,	,	PUNCT
admet-2901	126	5	pinostrobin	pinostrobin	NOUN
admet-2901	126	6	(	(	PUNCT
admet-2901	126	7	7	7	NUM
admet-2901	126	8	)	)	PUNCT
admet-2901	126	9	[	[	X
admet-2901	126	10	39,40	39,40	NUM
admet-2901	126	11	]	]	X
admet-2901	126	12	,	,	PUNCT
admet-2901	126	13	5	5	NUM
admet-2901	126	14	-	-	PUNCT
admet-2901	126	15	hydroxy-6,7,3',4',5′-pentametho	hydroxy-6,7,3',4',5′-pentametho	PROPN
admet-2901	126	16	-	-	NOUN
admet-2901	126	17	xyflavone	xyflavone	NOUN
admet-2901	126	18	(	(	PUNCT
admet-2901	126	19	8)	8)	NUM
admet-2901	126	20	[	[	X
admet-2901	126	21	41	41	NUM
admet-2901	126	22	]	]	PUNCT
admet-2901	126	23	,	,	PUNCT
admet-2901	126	24	chrysin	chrysin	NOUN
admet-2901	126	25	(	(	PUNCT
admet-2901	126	26	9	9	NUM
admet-2901	126	27	)	)	PUNCT
admet-2901	127	1	[	[	X
admet-2901	127	2	42	42	NUM
admet-2901	127	3	]	]	PUNCT
admet-2901	127	4	,	,	PUNCT
admet-2901	127	5	cleistanthin	cleistanthin	VERB
admet-2901	127	6	a	a	DET
admet-2901	127	7	(	(	PUNCT
admet-2901	127	8	10	10	NUM
admet-2901	127	9	)	)	PUNCT
admet-2901	128	1	[	[	X
admet-2901	128	2	43,44	43,44	X
admet-2901	128	3	]	]	X
admet-2901	128	4	,	,	PUNCT
admet-2901	128	5	and	and	CCONJ
admet-2901	128	6	4	4	NUM
admet-2901	128	7	-	-	NOUN
admet-2901	128	8	hydroxyacetophenone	hydroxyacetophenone	NOUN
admet-2901	128	9	(	(	PUNCT
admet-2901	128	10	11	11	NUM
admet-2901	128	11	)	)	PUNCT
admet-2901	129	1	[	[	X
admet-2901	129	2	45,46	45,46	NOUN
admet-2901	129	3	]	]	PUNCT
admet-2901	129	4	.	.	PUNCT
admet-2901	130	1	compound	compound	NOUN
admet-2901	130	2	1	1	NUM
admet-2901	130	3	was	be	AUX
admet-2901	130	4	obtained	obtain	VERB
admet-2901	130	5	as	as	ADP
admet-2901	130	6	a	a	DET
admet-2901	130	7	yellow	yellow	ADJ
admet-2901	130	8	powder	powder	NOUN
admet-2901	130	9	by	by	ADP
admet-2901	130	10	crystallization	crystallization	NOUN
admet-2901	130	11	from	from	ADP
admet-2901	130	12	meoh	meoh	PROPN
admet-2901	130	13	,	,	PUNCT
admet-2901	130	14	m.p	m.p	PROPN
admet-2901	130	15	.	.	PROPN
admet-2901	130	16	178	178	NUM
admet-2901	130	17	-	-	SYM
admet-2901	130	18	180	180	NUM
admet-2901	130	19	°	°	NOUN
admet-2901	130	20	c	c	NOUN
admet-2901	130	21	.	.	PUNCT
admet-2901	131	1	the	the	DET
admet-2901	131	2	molecular	molecular	ADJ
admet-2901	131	3	formula	formula	NOUN
admet-2901	131	4	was	be	AUX
admet-2901	131	5	determined	determine	VERB
admet-2901	131	6	as	as	ADP
admet-2901	131	7	c24h26o6	c24h26o6	PROPN
admet-2901	131	8	by	by	ADP
admet-2901	131	9	the	the	DET
admet-2901	131	10	high	high	ADJ
admet-2901	131	11	-	-	PUNCT
admet-2901	131	12	resolution	resolution	NOUN
admet-2901	131	13	mass	mass	NOUN
admet-2901	131	14	spectrometry	spectrometry	NOUN
admet-2901	131	15	(	(	PUNCT
admet-2901	131	16	hr	hr	NOUN
admet-2901	131	17	-	-	PUNCT
admet-2901	131	18	esi	esi	NOUN
admet-2901	131	19	-	-	PUNCT
admet-2901	131	20	ms	ms	NOUN
admet-2901	131	21	)	)	PUNCT
admet-2901	131	22	at	at	ADP
admet-2901	131	23	m	m	PROPN
admet-2901	131	24	/	/	SYM
admet-2901	131	25	z	z	PROPN
admet-2901	131	26	433.1625	433.1625	NUM
admet-2901	131	27	,	,	PUNCT
admet-2901	131	28	(	(	PUNCT
admet-2901	131	29	[	[	X
admet-2901	131	30	m+na]+	m+na]+	NOUN
admet-2901	131	31	)	)	PUNCT
admet-2901	131	32	(	(	PUNCT
admet-2901	131	33	calcd	calcd	NOUN
admet-2901	131	34	.	.	PUNCT
admet-2901	132	1	433.1627	433.1627	NUM
admet-2901	132	2	for	for	ADP
admet-2901	132	3	c24h26o6na	c24h26o6na	PROPN
admet-2901	132	4	)	)	PUNCT
admet-2901	132	5	.	.	PUNCT
admet-2901	133	1	the	the	DET
admet-2901	133	2	ei	ei	PROPN
admet-2901	133	3	mass	mass	PROPN
admet-2901	133	4	spectrum	spectrum	PROPN
admet-2901	133	5	showed	show	VERB
admet-2901	133	6	the	the	DET
admet-2901	133	7	ions	ion	NOUN
admet-2901	133	8	at	at	ADP
admet-2901	133	9	m	m	PROPN
admet-2901	133	10	/	/	SYM
admet-2901	133	11	z	z	PROPN
admet-2901	133	12	411	411	NUM
admet-2901	133	13	,	,	PUNCT
admet-2901	133	14	[	[	X
admet-2901	133	15	m+h]+	m+h]+	NOUN
admet-2901	133	16	,	,	PUNCT
admet-2901	133	17	and	and	CCONJ
admet-2901	133	18	410	410	NUM
admet-2901	133	19	,	,	PUNCT
admet-2901	133	20	[	[	X
admet-2901	133	21	m]+	m]+	NOUN
admet-2901	133	22	,	,	PUNCT
admet-2901	133	23	which	which	PRON
admet-2901	133	24	confirmed	confirm	VERB
admet-2901	133	25	the	the	DET
admet-2901	133	26	molecular	molecular	ADJ
admet-2901	133	27	formula	formula	NOUN
admet-2901	133	28	of	of	ADP
admet-2901	133	29	1	1	NUM
admet-2901	133	30	.	.	PUNCT
admet-2901	134	1	the	the	DET
admet-2901	134	2	ir	ir	PROPN
admet-2901	134	3	(	(	PUNCT
admet-2901	134	4	kbr	kbr	PROPN
admet-2901	134	5	)	)	PUNCT
admet-2901	134	6	spectrum	spectrum	NOUN
admet-2901	134	7	showed	show	VERB
admet-2901	134	8	the	the	DET
admet-2901	134	9	absorption	absorption	NOUN
admet-2901	134	10	bands	band	NOUN
admet-2901	134	11	at	at	ADP
admet-2901	134	12	max	max	SYM
admet-2901	134	13	3420	3420	NUM
admet-2901	134	14	(	(	PUNCT
admet-2901	134	15	o	o	NOUN
admet-2901	134	16	-	-	NOUN
admet-2901	134	17	h	h	ADJ
admet-2901	134	18	stretching	stretching	NOUN
admet-2901	134	19	of	of	ADP
admet-2901	134	20	phenol	phenol	NOUN
admet-2901	134	21	)	)	PUNCT
admet-2901	134	22	,	,	PUNCT
admet-2901	134	23	2925	2925	NUM
admet-2901	134	24	(	(	PUNCT
admet-2901	134	25	aliphatic	aliphatic	ADJ
admet-2901	134	26	c	c	NOUN
admet-2901	134	27	-	-	PUNCT
admet-2901	134	28	h	h	NOUN
admet-2901	134	29	stretching	stretching	NOUN
admet-2901	134	30	)	)	PUNCT
admet-2901	134	31	,	,	PUNCT
admet-2901	134	32	1644	1644	NUM
admet-2901	134	33	(	(	PUNCT
admet-2901	134	34	c	c	X
admet-2901	134	35	=	=	X
admet-2901	134	36	c	c	NOUN
admet-2901	134	37	stretching	stretching	NOUN
admet-2901	134	38	of	of	ADP
admet-2901	134	39	alkene	alkene	NOUN
admet-2901	134	40	)	)	PUNCT
admet-2901	134	41	,	,	PUNCT
admet-2901	134	42	1609	1609	NUM
admet-2901	134	43	(	(	PUNCT
admet-2901	134	44	c	c	X
admet-2901	134	45	=	=	NOUN
admet-2901	134	46	o	o	X
admet-2901	134	47	stretching	stretching	NOUN
admet-2901	134	48	of	of	ADP
admet-2901	134	49	ketone	ketone	NOUN
admet-2901	134	50	)	)	PUNCT
admet-2901	134	51	,	,	PUNCT
admet-2901	134	52	1583	1583	NUM
admet-2901	134	53	,	,	PUNCT
admet-2901	134	54	1455	1455	NUM
admet-2901	134	55	(	(	PUNCT
admet-2901	134	56	aromatic	aromatic	NOUN
admet-2901	134	57	c	c	NOUN
admet-2901	134	58	=	=	NOUN
admet-2901	134	59	c	c	NOUN
admet-2901	134	60	stretching	stretching	NOUN
admet-2901	134	61	)	)	PUNCT
admet-2901	134	62	and	and	CCONJ
admet-2901	134	63	1096	1096	NUM
admet-2901	134	64	,	,	PUNCT
admet-2901	134	65	1077	1077	NUM
admet-2901	134	66	,	,	PUNCT
admet-2901	134	67	1051	1051	NUM
admet-2901	134	68	(	(	PUNCT
admet-2901	134	69	c−o	c−o	NOUN
admet-2901	134	70	stretching	stretching	NOUN
admet-2901	134	71	of	of	ADP
admet-2901	134	72	phenol	phenol	NOUN
admet-2901	134	73	)	)	PUNCT
admet-2901	134	74	cm-1	cm-1	PROPN
admet-2901	134	75	.	.	PUNCT
admet-2901	135	1	the	the	DET
admet-2901	135	2	uv	uv	NOUN
admet-2901	135	3	spectrum	spectrum	NOUN
admet-2901	135	4	of	of	ADP
admet-2901	135	5	1	1	NUM
admet-2901	135	6	displayed	display	VERB
admet-2901	135	7	three	three	NUM
admet-2901	135	8	absorption	absorption	NOUN
admet-2901	135	9	bands	band	NOUN
admet-2901	135	10	at	at	ADP
admet-2901	135	11	243	243	NUM
admet-2901	135	12	,	,	PUNCT
admet-2901	135	13	258	258	NUM
admet-2901	135	14	,	,	PUNCT
admet-2901	135	15	316	316	NUM
admet-2901	135	16	,	,	PUNCT
admet-2901	135	17	and	and	CCONJ
admet-2901	135	18	354	354	NUM
admet-2901	135	19	nm	nm	NOUN
admet-2901	135	20	.	.	PUNCT
admet-2901	136	1	the	the	DET
admet-2901	136	2	500	500	NUM
admet-2901	136	3	mhz	mhz	NOUN
admet-2901	136	4	1h	1h	NUM
admet-2901	136	5	-	-	PUNCT
admet-2901	136	6	nmr	nmr	NOUN
admet-2901	136	7	spectrum	spectrum	NOUN
admet-2901	136	8	of	of	ADP
admet-2901	136	9	this	this	DET
admet-2901	136	10	compound	compound	NOUN
admet-2901	136	11	in	in	ADP
admet-2901	136	12	meod	meod	NOUN
admet-2901	136	13	(	(	PUNCT
admet-2901	136	14	table	table	NOUN
admet-2901	136	15	1	1	NUM
admet-2901	136	16	)	)	PUNCT
admet-2901	136	17	exhibited	exhibit	VERB
admet-2901	136	18	a	a	DET
admet-2901	136	19	sharp	sharp	ADJ
admet-2901	136	20	singlet	singlet	NOUN
admet-2901	136	21	at	at	ADP
admet-2901	136	22			NUM
admet-2901	136	23	3.62	3.62	NUM
admet-2901	136	24	(	(	PUNCT
admet-2901	136	25	3h	3h	NUM
admet-2901	136	26	,	,	PUNCT
admet-2901	136	27	s	s	NOUN
admet-2901	136	28	,	,	PUNCT
admet-2901	136	29	6och3	6och3	NUM
admet-2901	136	30	)	)	PUNCT
admet-2901	136	31	,	,	PUNCT
admet-2901	136	32	which	which	PRON
admet-2901	136	33	was	be	AUX
admet-2901	136	34	assigned	assign	VERB
admet-2901	136	35	to	to	ADP
admet-2901	136	36	the	the	DET
admet-2901	136	37	methoxyl	methoxyl	NOUN
admet-2901	136	38	protons	proton	NOUN
admet-2901	136	39	at	at	ADP
admet-2901	136	40	position	position	NOUN
admet-2901	136	41	6	6	NUM
admet-2901	136	42	.	.	PUNCT
admet-2901	137	1	the	the	DET
admet-2901	137	2	aromatic	aromatic	ADJ
admet-2901	137	3	signals	signal	NOUN
admet-2901	137	4	at	at	ADP
admet-2901	137	5			NUM
admet-2901	137	6	6.52	6.52	NUM
admet-2901	137	7	(	(	PUNCT
admet-2901	137	8	1h	1h	NUM
admet-2901	137	9	,	,	PUNCT
admet-2901	137	10	s	s	X
admet-2901	137	11	,	,	PUNCT
admet-2901	137	12	h-1	h-1	NOUN
admet-2901	137	13	)	)	PUNCT
admet-2901	137	14	and	and	CCONJ
admet-2901	137	15			NUM
admet-2901	137	16	6.07	6.07	NUM
admet-2901	137	17	(	(	PUNCT
admet-2901	137	18	1h	1h	NUM
admet-2901	137	19	,	,	PUNCT
admet-2901	137	20	s	s	NOUN
admet-2901	137	21	,	,	PUNCT
admet-2901	137	22	h-8	h-8	NOUN
admet-2901	137	23	)	)	PUNCT
admet-2901	137	24	ppm	ppm	NOUN
admet-2901	137	25	were	be	AUX
admet-2901	137	26	suggested	suggest	VERB
admet-2901	137	27	to	to	PART
admet-2901	137	28	be	be	AUX
admet-2901	137	29	the	the	DET
admet-2901	137	30	protons	proton	NOUN
admet-2901	137	31	of	of	ADP
admet-2901	137	32	a	a	DET
admet-2901	137	33	monosubstituted	monosubstitute	VERB
admet-2901	137	34	benzene	benzene	NOUN
admet-2901	137	35	ring	ring	NOUN
admet-2901	137	36	in	in	ADP
admet-2901	137	37	the	the	DET
admet-2901	137	38	molecule	molecule	NOUN
admet-2901	137	39	.	.	PUNCT
admet-2901	138	1	the	the	DET
admet-2901	138	2	lack	lack	NOUN
admet-2901	138	3	of	of	ADP
admet-2901	138	4	other	other	ADJ
admet-2901	138	5	aromatic	aromatic	ADJ
admet-2901	138	6	protons	proton	NOUN
admet-2901	138	7	suggested	suggest	VERB
admet-2901	138	8	that	that	SCONJ
admet-2901	138	9	another	another	DET
admet-2901	138	10	aromatic	aromatic	ADJ
admet-2901	138	11	ring	ring	NOUN
admet-2901	138	12	was	be	AUX
admet-2901	138	13	fully	fully	ADV
admet-2901	138	14	substituted	substitute	VERB
admet-2901	138	15	.	.	PUNCT
admet-2901	139	1	two	two	NUM
admet-2901	139	2	pairs	pair	NOUN
admet-2901	139	3	of	of	ADP
admet-2901	139	4	doublets	doublet	NOUN
admet-2901	139	5	at	at	ADP
admet-2901	139	6			NUM
admet-2901	139	7	3.91	3.91	NUM
admet-2901	139	8	(	(	PUNCT
admet-2901	139	9	2h	2h	NUM
admet-2901	139	10	,	,	PUNCT
admet-2901	139	11	d	d	NOUN
admet-2901	139	12	,	,	PUNCT
admet-2901	139	13	6.5	6.5	NUM
admet-2901	139	14	hz	hz	NOUN
admet-2901	139	15	,	,	PUNCT
admet-2901	139	16	h-1′)/	h-1′)/	NOUN
admet-2901	139	17	3.14	3.14	NUM
admet-2901	139	18	(	(	PUNCT
admet-2901	139	19	2h	2h	NUM
admet-2901	139	20	,	,	PUNCT
admet-2901	139	21	d	d	PROPN
admet-2901	139	22	,	,	PUNCT
admet-2901	139	23	7.2	7.2	NUM
admet-2901	139	24	hz	hz	VERB
admet-2901	139	25	,	,	PUNCT
admet-2901	139	26	h-1′′	h-1′′	PROPN
admet-2901	139	27	)	)	PUNCT
admet-2901	139	28	and	and	CCONJ
admet-2901	139	29			NUM
admet-2901	139	30	1.55	1.55	NUM
admet-2901	139	31	(	(	PUNCT
admet-2901	139	32	3h	3h	NUM
admet-2901	139	33	,	,	PUNCT
admet-2901	139	34	d	d	PROPN
admet-2901	139	35	,	,	PUNCT
admet-2901	139	36	0.9	0.9	NUM
admet-2901	139	37	hz	hz	NOUN
admet-2901	139	38	,	,	PUNCT
admet-2901	139	39	h-4′	h-4′	X
admet-2901	139	40	)	)	PUNCT
admet-2901	139	41	/	/	SYM
admet-2901	139	42	1.54	1.54	NUM
admet-2901	139	43	(	(	PUNCT
admet-2901	139	44	3h	3h	NUM
admet-2901	139	45	,	,	PUNCT
admet-2901	139	46	br	br	PROPN
admet-2901	139	47	d	d	NOUN
admet-2901	139	48	,	,	PUNCT
admet-2901	139	49	h-4′′	h-4′′	PRON
admet-2901	139	50	)	)	PUNCT
admet-2901	139	51	,	,	PUNCT
admet-2901	139	52	together	together	ADV
admet-2901	139	53	with	with	ADP
admet-2901	139	54	the	the	DET
admet-2901	139	55	broad	broad	ADJ
admet-2901	139	56	doublets	doublet	NOUN
admet-2901	139	57	at	at	ADP
admet-2901	139	58			NUM
admet-2901	139	59	1.70	1.70	NUM
admet-2901	139	60	(	(	PUNCT
admet-2901	139	61	3h	3h	NUM
admet-2901	139	62	,	,	PUNCT
admet-2901	139	63	d	d	PROPN
admet-2901	139	64	,	,	PUNCT
admet-2901	139	65	0.7	0.7	NUM
admet-2901	139	66	hz	hz	NOUN
admet-2901	139	67	,	,	PUNCT
admet-2901	139	68	h-5′	h-5′	NOUN
admet-2901	139	69	)	)	PUNCT
admet-2901	139	70	and	and	CCONJ
admet-2901	139	71	1.66	1.66	NUM
admet-2901	139	72	(	(	PUNCT
admet-2901	139	73	3h	3h	NUM
admet-2901	139	74	,	,	PUNCT
admet-2901	139	75	br	br	PROPN
admet-2901	139	76	d	d	PROPN
admet-2901	139	77	,	,	PUNCT
admet-2901	139	78	h-5′′	h-5′′	NUM
admet-2901	139	79	)	)	PUNCT
admet-2901	139	80	.	.	PUNCT
admet-2901	140	1	the	the	DET
admet-2901	140	2	125	125	NUM
admet-2901	140	3	mhz	mhz	NOUN
admet-2901	140	4	13c	13c	NOUN
admet-2901	140	5	-	-	ADJ
admet-2901	140	6	nmr	nmr	ADJ
admet-2901	140	7	spectrum	spectrum	NOUN
admet-2901	140	8	of	of	ADP
admet-2901	140	9	compound	compound	NOUN
admet-2901	140	10	1	1	NUM
admet-2901	140	11	(	(	PUNCT
admet-2901	140	12	table	table	NOUN
admet-2901	140	13	1	1	NUM
admet-2901	140	14	)	)	PUNCT
admet-2901	140	15	showed	show	VERB
admet-2901	140	16	twenty	twenty	NUM
admet-2901	140	17	-	-	PUNCT
admet-2901	140	18	four	four	NUM
admet-2901	140	19	signals	signal	NOUN
admet-2901	140	20	corresponding	correspond	VERB
admet-2901	140	21	to	to	ADP
admet-2901	140	22	twenty	twenty	NUM
admet-2901	140	23	-	-	PUNCT
admet-2901	140	24	four	four	NUM
admet-2901	140	25	carbons	carbon	NOUN
admet-2901	140	26	.	.	PUNCT
admet-2901	141	1	in	in	ADP
admet-2901	141	2	combination	combination	NOUN
admet-2901	141	3	with	with	ADP
admet-2901	141	4	dept-135	dept-135	NOUN
admet-2901	141	5	spectrum	spectrum	VERB
admet-2901	141	6	,	,	PUNCT
admet-2901	141	7	it	it	PRON
admet-2901	141	8	was	be	AUX
admet-2901	141	9	suggested	suggest	VERB
admet-2901	141	10	to	to	PART
admet-2901	141	11	possess	possess	VERB
admet-2901	141	12	four	four	NUM
admet-2901	141	13	methine	methine	ADJ
admet-2901	141	14	carbons	carbon	NOUN
admet-2901	141	15	(	(	PUNCT
admet-2901	141	16			NUM
admet-2901	141	17	125.2	125.2	NUM
admet-2901	141	18	,	,	PUNCT
admet-2901	141	19	123.9	123.9	NUM
admet-2901	141	20	,	,	PUNCT
admet-2901	141	21	102.8	102.8	NUM
admet-2901	141	22	and	and	CCONJ
admet-2901	141	23	93.2	93.2	NUM
admet-2901	141	24	ppm	ppm	NOUN
admet-2901	141	25	)	)	PUNCT
admet-2901	141	26	,	,	PUNCT
admet-2901	141	27	two	two	NUM
admet-2901	141	28	methylene	methylene	NOUN
admet-2901	141	29	carbons	carbon	NOUN
admet-2901	141	30	(	(	PUNCT
admet-2901	141	31			NUM
admet-2901	141	32	27.1	27.1	NUM
admet-2901	141	33	and	and	CCONJ
admet-2901	141	34	22.2	22.2	NUM
admet-2901	141	35	ppm	ppm	NOUN
admet-2901	141	36	)	)	PUNCT
admet-2901	141	37	,	,	PUNCT
admet-2901	141	38	two	two	NUM
admet-2901	141	39	methyl	methyl	NOUN
admet-2901	141	40	signals	signal	NOUN
admet-2901	141	41	for	for	ADP
admet-2901	141	42	c-4′	c-4′	NOUN
admet-2901	141	43	,	,	PUNCT
admet-2901	141	44	4′′	4′′	NUM
admet-2901	142	1	(	(	PUNCT
admet-2901	142	2			NUM
admet-2901	142	3	26.0	26.0	NUM
admet-2901	142	4	(	(	PUNCT
admet-2901	142	5	ch3	ch3	PROPN
admet-2901	142	6	)	)	PUNCT
admet-2901	142	7	,	,	PUNCT
admet-2901	142	8	25.9	25.9	NUM
admet-2901	142	9	(	(	PUNCT
admet-2901	142	10	ch3	ch3	PROPN
admet-2901	142	11	)	)	PUNCT
admet-2901	142	12	ppm	ppm	NOUN
admet-2901	142	13	)	)	PUNCT
admet-2901	142	14	,	,	PUNCT
admet-2901	142	15	two	two	NUM
admet-2901	142	16	methyl	methyl	NOUN
admet-2901	142	17	signals	signal	NOUN
admet-2901	142	18	for	for	ADP
admet-2901	142	19	c-5′	c-5′	NOUN
admet-2901	142	20	,	,	PUNCT
admet-2901	142	21	5′′	5′′	NUM
admet-2901	142	22	(	(	PUNCT
admet-2901	142	23			NUM
admet-2901	142	24	18.3	18.3	NUM
admet-2901	142	25	(	(	PUNCT
admet-2901	142	26	ch3	ch3	PROPN
admet-2901	142	27	)	)	PUNCT
admet-2901	142	28	,	,	PUNCT
admet-2901	142	29	18.0	18.0	NUM
admet-2901	142	30	(	(	PUNCT
admet-2901	142	31	ch3	ch3	PROPN
admet-2901	142	32	)	)	PUNCT
admet-2901	142	33	ppm	ppm	NOUN
admet-2901	142	34	)	)	PUNCT
admet-2901	142	35	and	and	CCONJ
admet-2901	142	36	twelve	twelve	NUM
admet-2901	142	37	quaternary	quaternary	ADJ
admet-2901	142	38	carbons	carbon	NOUN
admet-2901	142	39	(	(	PUNCT
admet-2901	142	40			NUM
admet-2901	142	41	163.5	163.5	NUM
admet-2901	142	42	,	,	PUNCT
admet-2901	142	43	161.5	161.5	NUM
admet-2901	142	44	,	,	PUNCT
admet-2901	142	45	157.7	157.7	NUM
admet-2901	142	46	,	,	PUNCT
admet-2901	142	47	156.6	156.6	NUM
admet-2901	142	48	,	,	PUNCT
admet-2901	142	49	156.1	156.1	NUM
admet-2901	142	50	,	,	PUNCT
admet-2901	142	51	144.7	144.7	NUM
admet-2901	142	52	,	,	PUNCT
admet-2901	142	53	138.4	138.4	NUM
admet-2901	142	54	,	,	PUNCT
admet-2901	142	55	131.7	131.7	NUM
admet-2901	142	56	,	,	PUNCT
admet-2901	142	57	131.6	131.6	NUM
admet-2901	142	58	,	,	PUNCT
admet-2901	142	59	112.3	112.3	NUM
admet-2901	142	60	,	,	PUNCT
admet-2901	142	61	111.4	111.4	NUM
admet-2901	142	62	and	and	CCONJ
admet-2901	142	63	103.8	103.8	NUM
admet-2901	142	64	ppm	ppm	NOUN
admet-2901	142	65	)	)	PUNCT
admet-2901	142	66	table	table	NOUN
admet-2901	142	67	1	1	NUM
admet-2901	142	68	.	.	PUNCT
admet-2901	142	69	nmr	nmr	NOUN
admet-2901	142	70	data	datum	NOUN
admet-2901	142	71	of	of	ADP
admet-2901	142	72	compound	compound	NOUN
admet-2901	142	73	1	1	NUM
admet-2901	142	74	in	in	ADP
admet-2901	142	75	meod	meod	ADJ
admet-2901	142	76	-	-	PUNCT
admet-2901	142	77	d4	d4	PROPN
admet-2901	142	78	position	position	NOUN
admet-2901	142	79	h	h	NOUN
admet-2901	142	80	,	,	PUNCT
admet-2901	142	81	/	/	SYM
admet-2901	142	82	ppm	ppm	NOUN
admet-2901	142	83	c	c	PUNCT
admet-2901	142	84	/	/	SYM
admet-2901	142	85	ppm	ppm	NOUN
admet-2901	142	86	cosy	cosy	NOUN
admet-2901	142	87	correlated	correlate	VERB
admet-2901	142	88	h	h	PROPN
admet-2901	142	89	hmbc	hmbc	PROPN
admet-2901	142	90	correlated	correlated	AUX
admet-2901	142	91	c	c	PROPN
admet-2901	142	92	noesy	noesy	PROPN
admet-2901	142	93	correlated	correlate	VERB
admet-2901	142	94	h	h	NOUN
admet-2901	142	95	1	1	NUM
admet-2901	142	96	6.52	6.52	NUM
admet-2901	142	97	(	(	PUNCT
admet-2901	142	98	1h	1h	NUM
admet-2901	142	99	,	,	PUNCT
admet-2901	142	100	s	s	NOUN
admet-2901	142	101	)	)	PUNCT
admet-2901	142	102	102.8	102.8	NUM
admet-2901	142	103	,	,	PUNCT
admet-2901	142	104	ch	ch	NOUN
admet-2901	142	105	8	8	NUM
admet-2901	142	106	1a	1a	PROPN
admet-2901	142	107	144.7	144.7	NUM
admet-2901	142	108	,	,	PUNCT
admet-2901	142	109	c	c	NOUN
admet-2901	142	110	1	1	NUM
admet-2901	142	111	,	,	PUNCT
admet-2901	142	112	1′	1′	NUM
admet-2901	142	113	2	2	NUM
admet-2901	142	114	112.3	112.3	NUM
admet-2901	142	115	,	,	PUNCT
admet-2901	142	116	c	c	PROPN
admet-2901	142	117	1	1	NUM
admet-2901	142	118	,	,	PUNCT
admet-2901	142	119	1′	1′	NUM
admet-2901	142	120	3	3	NUM
admet-2901	142	121	157.7	157.7	NUM
admet-2901	142	122	,	,	PUNCT
admet-2901	142	123	c	c	NOUN
admet-2901	142	124	1	1	NUM
admet-2901	142	125	4	4	NUM
admet-2901	142	126	138.4	138.4	NUM
admet-2901	142	127	,	,	PUNCT
admet-2901	142	128	c	c	PROPN
admet-2901	142	129	1′	1′	NUM
admet-2901	142	130	4a	4a	NOUN
admet-2901	142	131	156.6	156.6	NUM
admet-2901	142	132	,	,	PUNCT
admet-2901	142	133	c	c	NOUN
admet-2901	142	134	1	1	NUM
admet-2901	142	135	5	5	NUM
admet-2901	142	136	161.5	161.5	NUM
admet-2901	142	137	,	,	PUNCT
admet-2901	142	138	c	c	PROPN
admet-2901	142	139	1′′	1′′	NUM
admet-2901	142	140	5a	5a	NUM
admet-2901	142	141	156.1	156.1	NUM
admet-2901	142	142	,	,	PUNCT
admet-2901	142	143	c	c	PROPN
admet-2901	142	144	8	8	NUM
admet-2901	142	145	6	6	NUM
admet-2901	142	146	103.8	103.8	NUM
admet-2901	142	147	,	,	PUNCT
admet-2901	142	148	c	c	PROPN
admet-2901	142	149	8	8	NUM
admet-2901	142	150	7	7	NUM
admet-2901	142	151	163.5	163.5	NUM
admet-2901	142	152	,	,	PUNCT
admet-2901	142	153	c	c	NOUN
admet-2901	142	154	8	8	NUM
admet-2901	142	155	,	,	PUNCT
admet-2901	142	156	1′′	1′′	NUM
admet-2901	142	157	8	8	NUM
admet-2901	142	158	6.07	6.07	NUM
admet-2901	142	159	(	(	PUNCT
admet-2901	142	160	1h	1h	NUM
admet-2901	142	161	,	,	PUNCT
admet-2901	142	162	s	s	NOUN
admet-2901	142	163	)	)	PUNCT
admet-2901	142	164	93.2	93.2	NUM
admet-2901	142	165	,	,	PUNCT
admet-2901	142	166	ch	ch	NOUN
admet-2901	142	167	8a	8a	NUM
admet-2901	142	168	111.4	111.4	NUM
admet-2901	142	169	,	,	PUNCT
admet-2901	142	170	c	c	NOUN
admet-2901	142	171	8	8	NUM
admet-2901	142	172	,	,	PUNCT
admet-2901	142	173	1′′	1′′	NUM
admet-2901	142	174	9	9	NUM
admet-2901	142	175	183.1	183.1	NUM
admet-2901	142	176	,	,	PUNCT
admet-2901	142	177	c	c	PROPN
admet-2901	142	178	=	=	NOUN
admet-2901	142	179	o	o	NOUN
admet-2901	142	180	1′	1′	NUM
admet-2901	142	181	3.91	3.91	NUM
admet-2901	142	182	(	(	PUNCT
admet-2901	142	183	1h	1h	NUM
admet-2901	142	184	,	,	PUNCT
admet-2901	142	185	d	d	PROPN
admet-2901	142	186	,	,	PUNCT
admet-2901	142	187	j	j	PROPN
admet-2901	142	188	=	=	SYM
admet-2901	142	189	6.5	6.5	NUM
admet-2901	142	190	hz	hz	NOUN
admet-2901	142	191	)	)	PUNCT
admet-2901	142	192	27.1	27.1	NUM
admet-2901	142	193	,	,	PUNCT
admet-2901	142	194	ch2	ch2	PROPN
admet-2901	142	195	2′	2′	NUM
admet-2901	142	196	,	,	PUNCT
admet-2901	142	197	4′	4′	NUM
admet-2901	142	198	,	,	PUNCT
admet-2901	142	199	5′	5′	PROPN
admet-2901	142	200	2′	2′	NUM
admet-2901	142	201	,	,	PUNCT
admet-2901	142	202	5′	5′	NUM
admet-2901	142	203	2′	2′	NUM
admet-2901	142	204	5.12	5.12	NUM
admet-2901	142	205	-	-	SYM
admet-2901	142	206	5.09	5.09	NUM
admet-2901	142	207	(	(	PUNCT
admet-2901	142	208	1h	1h	NUM
admet-2901	142	209	,	,	PUNCT
admet-2901	142	210	m	m	NOUN
admet-2901	142	211	)	)	PUNCT
admet-2901	142	212	125.2	125.2	NUM
admet-2901	142	213	,	,	PUNCT
admet-2901	142	214	ch	ch	PROPN
admet-2901	142	215	1′	1′	NUM
admet-2901	142	216	,	,	PUNCT
admet-2901	142	217	4′	4′	NUM
admet-2901	142	218	,	,	PUNCT
admet-2901	142	219	5′	5′	PROPN
admet-2901	142	220	1′	1′	NUM
admet-2901	142	221	,	,	PUNCT
admet-2901	142	222	4′	4′	NUM
admet-2901	142	223	,	,	PUNCT
admet-2901	142	224	5′	5′	PROPN
admet-2901	142	225	4′	4′	NUM
admet-2901	142	226	,	,	PUNCT
admet-2901	142	227	5′	5′	PROPN
admet-2901	142	228	3′	3′	NUM
admet-2901	142	229	131.7	131.7	NUM
admet-2901	142	230	,	,	PUNCT
admet-2901	142	231	c	c	PROPN
admet-2901	142	232	1′	1′	NUM
admet-2901	142	233	,	,	PUNCT
admet-2901	142	234	4′	4′	NUM
admet-2901	142	235	,	,	PUNCT
admet-2901	142	236	5′	5′	NUM
admet-2901	142	237	4′	4′	NUM
admet-2901	142	238	1.55	1.55	NUM
admet-2901	142	239	(	(	PUNCT
admet-2901	142	240	3h	3h	NUM
admet-2901	142	241	,	,	PUNCT
admet-2901	142	242	d	d	PROPN
admet-2901	142	243	,	,	PUNCT
admet-2901	142	244	j	j	PROPN
admet-2901	143	1	=	=	SYM
admet-2901	143	2	0.9	0.9	NUM
admet-2901	143	3	hz	hz	VERB
admet-2901	143	4	)	)	PUNCT
admet-2901	143	5	26.0	26.0	NUM
admet-2901	143	6	,	,	PUNCT
admet-2901	143	7	ch3	ch3	PROPN
admet-2901	143	8	1′	1′	NUM
admet-2901	143	9	,	,	PUNCT
admet-2901	143	10	2′	2′	NUM
admet-2901	143	11	,	,	PUNCT
admet-2901	143	12	5′	5′	PROPN
admet-2901	143	13	2′	2′	NUM
admet-2901	143	14	,	,	PUNCT
admet-2901	143	15	5′	5′	NUM
admet-2901	143	16	5′	5′	NUM
admet-2901	143	17	1.70	1.70	NUM
admet-2901	143	18	(	(	PUNCT
admet-2901	143	19	3h	3h	NUM
admet-2901	143	20	,	,	PUNCT
admet-2901	143	21	d	d	PROPN
admet-2901	143	22	,	,	PUNCT
admet-2901	143	23	j	j	PROPN
admet-2901	144	1	=	=	NOUN
admet-2901	144	2	0.7	0.7	NUM
admet-2901	144	3	hz	hz	ADJ
admet-2901	144	4	)	)	PUNCT
admet-2901	144	5	18.3	18.3	NUM
admet-2901	144	6	,	,	PUNCT
admet-2901	144	7	ch3	ch3	PROPN
admet-2901	144	8	1′	1′	NUM
admet-2901	144	9	,	,	PUNCT
admet-2901	144	10	2′	2′	NUM
admet-2901	144	11	,	,	PUNCT
admet-2901	144	12	4′	4′	PRON
admet-2901	144	13	2′	2′	NUM
admet-2901	144	14	,	,	PUNCT
admet-2901	144	15	4′	4′	NUM
admet-2901	144	16	1′′	1′′	NUM
admet-2901	144	17	3.14	3.14	NUM
admet-2901	144	18	(	(	PUNCT
admet-2901	144	19	1h	1h	NUM
admet-2901	144	20	,	,	PUNCT
admet-2901	144	21	d	d	PROPN
admet-2901	144	22	,	,	PUNCT
admet-2901	144	23	j	j	PROPN
admet-2901	144	24	=	=	SYM
admet-2901	144	25	7.2	7.2	NUM
admet-2901	144	26	hz	hz	VERB
admet-2901	144	27	)	)	PUNCT
admet-2901	144	28	22.2	22.2	NUM
admet-2901	144	29	,	,	PUNCT
admet-2901	144	30	ch2	ch2	PROPN
admet-2901	144	31	2′′	2′′	NUM
admet-2901	144	32	,	,	PUNCT
admet-2901	144	33	4′′	4′′	NUM
admet-2901	144	34	,	,	PUNCT
admet-2901	144	35	5′′	5′′	NUM
admet-2901	144	36	2′′	2′′	NUM
admet-2901	144	37	,	,	PUNCT
admet-2901	144	38	5′′	5′′	PROPN
admet-2901	144	39	2′′	2′′	NUM
admet-2901	144	40	5.12	5.12	NUM
admet-2901	144	41	-	-	SYM
admet-2901	144	42	5.09	5.09	NUM
admet-2901	144	43	(	(	PUNCT
admet-2901	144	44	1h	1h	NUM
admet-2901	144	45	,	,	PUNCT
admet-2901	144	46	m	m	NOUN
admet-2901	144	47	)	)	PUNCT
admet-2901	144	48	123.9	123.9	NUM
admet-2901	144	49	,	,	PUNCT
admet-2901	144	50	ch	ch	NOUN
admet-2901	144	51	1′′	1′′	NUM
admet-2901	144	52	,	,	PUNCT
admet-2901	144	53	4′′	4′′	NUM
admet-2901	144	54	,	,	PUNCT
admet-2901	144	55	5′′	5′′	NUM
admet-2901	144	56	1′′	1′′	NUM
admet-2901	144	57	,	,	PUNCT
admet-2901	144	58	4′′	4′′	NUM
admet-2901	144	59	,	,	PUNCT
admet-2901	144	60	5′′	5′′	NUM
admet-2901	144	61	6	6	NUM
admet-2901	144	62	,	,	PUNCT
admet-2901	144	63	4′′	4′′	NUM
admet-2901	144	64	,	,	PUNCT
admet-2901	144	65	5′′	5′′	NUM
admet-2901	144	66	3′′	3′′	NUM
admet-2901	144	67	131.6	131.6	NUM
admet-2901	144	68	,	,	PUNCT
admet-2901	144	69	c	c	NOUN
admet-2901	144	70	1′′	1′′	NUM
admet-2901	144	71	,	,	PUNCT
admet-2901	144	72	4′′	4′′	NUM
admet-2901	144	73	,	,	PUNCT
admet-2901	144	74	5′′	5′′	NUM
admet-2901	144	75	4′′	4′′	NOUN
admet-2901	144	76	1.54	1.54	NUM
admet-2901	144	77	(	(	PUNCT
admet-2901	144	78	3h	3h	NUM
admet-2901	144	79	,	,	PUNCT
admet-2901	144	80	br	br	NOUN
admet-2901	144	81	d	d	NOUN
admet-2901	144	82	)	)	PUNCT
admet-2901	144	83	25.9	25.9	NUM
admet-2901	144	84	,	,	PUNCT
admet-2901	144	85	ch3	ch3	PROPN
admet-2901	144	86	1′′	1′′	NUM
admet-2901	144	87	,	,	PUNCT
admet-2901	144	88	2′′	2′′	NUM
admet-2901	144	89	,	,	PUNCT
admet-2901	144	90	5′′	5′′	NUM
admet-2901	144	91	2′′	2′′	NUM
admet-2901	144	92	,	,	PUNCT
admet-2901	144	93	5′′	5′′	PROPN
admet-2901	144	94	5′′	5′′	NUM
admet-2901	145	1	5′′	5′′	NUM
admet-2901	145	2	1.66	1.66	NUM
admet-2901	145	3	(	(	PUNCT
admet-2901	145	4	3h	3h	NUM
admet-2901	145	5	,	,	PUNCT
admet-2901	145	6	br	br	NOUN
admet-2901	145	7	d	d	NOUN
admet-2901	145	8	)	)	PUNCT
admet-2901	146	1	18.0	18.0	NUM
admet-2901	146	2	,	,	PUNCT
admet-2901	146	3	ch3	ch3	PROPN
admet-2901	146	4	1′′	1′′	NUM
admet-2901	146	5	,	,	PUNCT
admet-2901	146	6	4′′	4′′	NUM
admet-2901	146	7	,	,	PUNCT
admet-2901	146	8	4′′	4′′	NOUN
admet-2901	146	9	2′′	2′′	NUM
admet-2901	146	10	,	,	PUNCT
admet-2901	146	11	4′′	4′′	ADJ
admet-2901	146	12	6	6	NUM
admet-2901	146	13	-	-	PUNCT
admet-2901	146	14	och3	och3	ADJ
admet-2901	146	15	3.62	3.62	NUM
admet-2901	146	16	(	(	PUNCT
admet-2901	146	17	3h	3h	NUM
admet-2901	146	18	,	,	PUNCT
admet-2901	146	19	s	s	PART
admet-2901	146	20	)	)	PUNCT
admet-2901	146	21	61.3	61.3	NUM
admet-2901	146	22	,	,	PUNCT
admet-2901	146	23	och3	och3	ADJ
admet-2901	146	24	admet	admet	PROPN
admet-2901	146	25	&	&	CCONJ
admet-2901	146	26	dmpk	dmpk	PROPN
admet-2901	146	27	13(5	13(5	NUM
admet-2901	146	28	)	)	PUNCT
admet-2901	146	29	(	(	PUNCT
admet-2901	146	30	2025	2025	NUM
admet-2901	146	31	)	)	PUNCT
admet-2901	146	32	2901	2901	NUM
admet-2901	146	33	new	new	ADJ
admet-2901	146	34	xanthone	xanthone	PROPN
admet-2901	146	35	and	and	CCONJ
admet-2901	146	36	chemical	chemical	NOUN
admet-2901	146	37	constituents	constituent	NOUN
admet-2901	146	38	from	from	ADP
admet-2901	146	39	mallotus	mallotus	ADJ
admet-2901	146	40	glomerulatus	glomerulatus	NOUN
admet-2901	146	41	doi	doi	PROPN
admet-2901	146	42	:	:	PUNCT
admet-2901	146	43	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	NOUN
admet-2901	146	44	7	7	NUM
admet-2901	146	45	the	the	DET
admet-2901	146	46	skeleton	skeleton	NOUN
admet-2901	146	47	of	of	ADP
admet-2901	146	48	side	side	NOUN
admet-2901	146	49	chain	chain	NOUN
admet-2901	146	50	was	be	AUX
admet-2901	146	51	confirmed	confirm	VERB
admet-2901	146	52	by	by	ADP
admet-2901	146	53	the	the	DET
admet-2901	146	54	observed	observe	VERB
admet-2901	146	55	cosy	cosy	NOUN
admet-2901	146	56	correlations	correlation	NOUN
admet-2901	146	57	of	of	ADP
admet-2901	146	58	h-1′/h-2′	h-1′/h-2′	NOUN
admet-2901	146	59	,	,	PUNCT
admet-2901	146	60	h-4′	h-4′	NOUN
admet-2901	146	61	,	,	PUNCT
admet-2901	146	62	h-5′	h-5′	PRON
admet-2901	146	63	;	;	PUNCT
admet-2901	146	64	h-2′/	h-2′/	VERB
admet-2901	146	65	h-1′	h-1′	NOUN
admet-2901	146	66	,	,	PUNCT
admet-2901	146	67	h-4′	h-4′	NOUN
admet-2901	146	68	,	,	PUNCT
admet-2901	146	69	h-5′	h-5′	NOUN
admet-2901	146	70	;	;	PUNCT
admet-2901	146	71	h-4′/h-1′	h-4′/h-1′	PROPN
admet-2901	146	72	,	,	PUNCT
admet-2901	146	73	h-2′	h-2′	PROPN
admet-2901	146	74	,	,	PUNCT
admet-2901	146	75	h-5′	h-5′	NOUN
admet-2901	146	76	;	;	PUNCT
admet-2901	146	77	h-5′/h-1′	h-5′/h-1′	PROPN
admet-2901	146	78	,	,	PUNCT
admet-2901	146	79	h-2′	h-2′	PROPN
admet-2901	146	80	,	,	PUNCT
admet-2901	146	81	h-4′	h-4′	NOUN
admet-2901	146	82	;	;	PUNCT
admet-2901	146	83	h-1′′/	h-1′′/	PROPN
admet-2901	146	84	h-2′′	h-2′′	PROPN
admet-2901	146	85	,	,	PUNCT
admet-2901	146	86	h-4′′	h-4′′	PROPN
admet-2901	146	87	,	,	PUNCT
admet-2901	146	88	h-5′′	h-5′′	NUM
admet-2901	146	89	;	;	PUNCT
admet-2901	146	90	h-2′′/	h-2′′/	NOUN
admet-2901	146	91	h-1′′	h-1′′	PROPN
admet-2901	146	92	,	,	PUNCT
admet-2901	146	93	h-4′′	h-4′′	PROPN
admet-2901	146	94	,	,	PUNCT
admet-2901	146	95	h-5′′	h-5′′	NUM
admet-2901	146	96	;	;	PUNCT
admet-2901	146	97	h-4′′/	h-4′′/	PROPN
admet-2901	146	98	h-1′′	h-1′′	PROPN
admet-2901	146	99	,	,	PUNCT
admet-2901	146	100	h-2′′	h-2′′	PROPN
admet-2901	146	101	,	,	PUNCT
admet-2901	146	102	h-5′′	h-5′′	X
admet-2901	146	103	;	;	PUNCT
admet-2901	146	104	h-5′′/	h-5′′/	NOUN
admet-2901	146	105	h-1′′	h-1′′	PROPN
admet-2901	146	106	,	,	PUNCT
admet-2901	146	107	h-2′′	h-2′′	PROPN
admet-2901	146	108	,	,	PUNCT
admet-2901	146	109	h-4′′	h-4′′	ADP
admet-2901	146	110	;	;	PUNCT
admet-2901	146	111	as	as	ADV
admet-2901	146	112	well	well	ADV
admet-2901	146	113	as	as	ADP
admet-2901	146	114	the	the	DET
admet-2901	146	115	noesy	noesy	ADJ
admet-2901	146	116	correlations	correlation	NOUN
admet-2901	146	117	of	of	ADP
admet-2901	146	118	h-1/	h-1/	NOUN
admet-2901	146	119	h-8	h-8	NOUN
admet-2901	146	120	;	;	PUNCT
admet-2901	146	121	h-2′′/	h-2′′/	NOUN
admet-2901	146	122	h-6	h-6	NOUN
admet-2901	146	123	,	,	PUNCT
admet-2901	146	124	h-4′′	h-4′′	PROPN
admet-2901	146	125	,	,	PUNCT
admet-2901	146	126	h5′′	h5′′	PROPN
admet-2901	146	127	(	(	PUNCT
admet-2901	146	128	figure	figure	NOUN
admet-2901	146	129	2	2	NUM
admet-2901	146	130	)	)	PUNCT
admet-2901	146	131	.	.	PUNCT
admet-2901	147	1	full	full	ADJ
admet-2901	147	2	assignments	assignment	NOUN
admet-2901	147	3	of	of	ADP
admet-2901	147	4	1h	1h	NUM
admet-2901	147	5	and	and	CCONJ
admet-2901	147	6	13c	13c	NOUN
admet-2901	147	7	nmr	nmr	NOUN
admet-2901	147	8	signals	signal	NOUN
admet-2901	147	9	were	be	AUX
admet-2901	147	10	carried	carry	VERB
admet-2901	147	11	out	out	ADP
admet-2901	147	12	based	base	VERB
admet-2901	147	13	on	on	ADP
admet-2901	147	14	2d	2d	NUM
admet-2901	147	15	nmr	nmr	NOUN
admet-2901	147	16	analyses	analysis	NOUN
admet-2901	147	17	(	(	PUNCT
admet-2901	147	18	table	table	NOUN
admet-2901	147	19	1	1	NUM
admet-2901	147	20	)	)	PUNCT
admet-2901	147	21	.	.	PUNCT
admet-2901	148	1	figure	figure	NOUN
admet-2901	148	2	2	2	NUM
admet-2901	148	3	.	.	PUNCT
admet-2901	149	1	noesy	noesy	ADJ
admet-2901	149	2	correlations	correlation	NOUN
admet-2901	149	3	observed	observe	VERB
admet-2901	149	4	of	of	ADP
admet-2901	149	5	1	1	NUM
admet-2901	149	6	the	the	DET
admet-2901	149	7	500	500	NUM
admet-2901	149	8	mhz	mhz	NOUN
admet-2901	149	9	1h	1h	NUM
admet-2901	149	10	-	-	PUNCT
admet-2901	149	11	nmr	nmr	NOUN
admet-2901	149	12	spectrum	spectrum	NOUN
admet-2901	149	13	of	of	ADP
admet-2901	149	14	glomerulatusin	glomerulatusin	NOUN
admet-2901	149	15	(	(	PUNCT
admet-2901	149	16	2	2	NUM
admet-2901	149	17	)	)	PUNCT
admet-2901	149	18	in	in	ADP
admet-2901	149	19	cdcl3	cdcl3	NOUN
admet-2901	149	20	exhibited	exhibit	VERB
admet-2901	149	21	four	four	NUM
admet-2901	149	22	tertiary	tertiary	ADJ
admet-2901	149	23	methyl	methyl	NOUN
admet-2901	149	24	groups	group	NOUN
admet-2901	149	25	at	at	ADP
admet-2901	149	26			NUM
admet-2901	149	27	1.32	1.32	NUM
admet-2901	149	28	(	(	PUNCT
admet-2901	149	29	s	s	PROPN
admet-2901	149	30	,	,	PUNCT
admet-2901	149	31	ch3	ch3	PROPN
admet-2901	149	32	-	-	PUNCT
admet-2901	149	33	17	17	NUM
admet-2901	149	34	)	)	PUNCT
admet-2901	149	35	,	,	PUNCT
admet-2901	149	36	1.26	1.26	NUM
admet-2901	149	37	(	(	PUNCT
admet-2901	149	38	s	s	PROPN
admet-2901	149	39	,	,	PUNCT
admet-2901	149	40	ch3	ch3	PROPN
admet-2901	149	41	-	-	PUNCT
admet-2901	149	42	18	18	NUM
admet-2901	149	43	)	)	PUNCT
admet-2901	149	44	,	,	PUNCT
admet-2901	149	45	1.02	1.02	NUM
admet-2901	149	46	(	(	PUNCT
admet-2901	149	47	s	s	PROPN
admet-2901	149	48	,	,	PUNCT
admet-2901	149	49	ch3	ch3	PROPN
admet-2901	149	50	-	-	PUNCT
admet-2901	149	51	19	19	NUM
admet-2901	149	52	)	)	PUNCT
admet-2901	149	53	,	,	PUNCT
admet-2901	149	54	and	and	CCONJ
admet-2901	149	55	0.70	0.70	NUM
admet-2901	149	56	(	(	PUNCT
admet-2901	149	57	s	s	PROPN
admet-2901	149	58	,	,	PUNCT
admet-2901	149	59	ch3	ch3	PROPN
admet-2901	149	60	-	-	PUNCT
admet-2901	149	61	20	20	NUM
admet-2901	149	62	)	)	PUNCT
admet-2901	149	63	.	.	PUNCT
admet-2901	150	1	the	the	DET
admet-2901	150	2	signals	signal	NOUN
admet-2901	150	3	at	at	ADP
admet-2901	150	4			NUM
admet-2901	150	5	6.16	6.16	NUM
admet-2901	150	6	(	(	PUNCT
admet-2901	150	7	dd	dd	NOUN
admet-2901	150	8	,	,	PUNCT
admet-2901	150	9	17.7	17.7	NUM
admet-2901	150	10	,	,	PUNCT
admet-2901	150	11	10.9	10.9	NUM
admet-2901	150	12	hz	hz	NOUN
admet-2901	150	13	,	,	PUNCT
admet-2901	150	14	h-15	h-15	PROPN
admet-2901	150	15	)	)	PUNCT
admet-2901	150	16	,	,	PUNCT
admet-2901	150	17	5.04	5.04	NUM
admet-2901	150	18	(	(	PUNCT
admet-2901	150	19	d	d	PROPN
admet-2901	150	20	,	,	PUNCT
admet-2901	150	21	17.7	17.7	NUM
admet-2901	150	22	hz	hz	NOUN
admet-2901	150	23	,	,	PUNCT
admet-2901	150	24	h-16trans	h-16tran	NOUN
admet-2901	150	25	)	)	PUNCT
admet-2901	150	26	,	,	PUNCT
admet-2901	150	27	and	and	CCONJ
admet-2901	150	28			NUM
admet-2901	150	29	5.13	5.13	NUM
admet-2901	150	30	(	(	PUNCT
admet-2901	150	31	d	d	NOUN
admet-2901	150	32	,	,	PUNCT
admet-2901	150	33	10.9	10.9	NUM
admet-2901	150	34	hz	hz	NOUN
admet-2901	150	35	,	,	PUNCT
admet-2901	150	36	h-16cis	h-16cis	PRON
admet-2901	150	37	)	)	PUNCT
admet-2901	150	38	were	be	AUX
admet-2901	150	39	assigned	assign	VERB
admet-2901	150	40	to	to	ADP
admet-2901	150	41	the	the	DET
admet-2901	150	42	olefinic	olefinic	ADJ
admet-2901	150	43	protons	proton	NOUN
admet-2901	150	44	at	at	ADP
admet-2901	150	45	c-15	c-15	NOUN
admet-2901	150	46	and	and	CCONJ
admet-2901	150	47	c-16	c-16	PROPN
admet-2901	150	48	,	,	PUNCT
admet-2901	150	49	respectively	respectively	ADV
admet-2901	150	50	.	.	PUNCT
admet-2901	151	1	a	a	DET
admet-2901	151	2	pair	pair	NOUN
admet-2901	151	3	of	of	ADP
admet-2901	151	4	rather	rather	ADV
admet-2901	151	5	deshielded	deshielde	VERB
admet-2901	151	6	methylene	methylene	ADJ
admet-2901	151	7	protons	proton	NOUN
admet-2901	151	8			NUM
admet-2901	151	9	2.39	2.39	NUM
admet-2901	151	10	(	(	PUNCT
admet-2901	151	11	d	d	NOUN
admet-2901	151	12	,	,	PUNCT
admet-2901	151	13	13.9	13.9	NUM
admet-2901	151	14	hz	hz	NOUN
admet-2901	151	15	,	,	PUNCT
admet-2901	151	16	h-11e	h-11e	PRON
admet-2901	151	17	)	)	PUNCT
admet-2901	151	18	and	and	CCONJ
admet-2901	151	19	2.18	2.18	NUM
admet-2901	151	20	(	(	PUNCT
admet-2901	151	21	d	d	PROPN
admet-2901	151	22	,	,	PUNCT
admet-2901	151	23	13.9	13.9	NUM
admet-2901	151	24	hz	hz	NOUN
admet-2901	151	25	,	,	PUNCT
admet-2901	151	26	h-11a	h-11a	PRON
admet-2901	151	27	)	)	PUNCT
admet-2901	151	28	,	,	PUNCT
admet-2901	151	29	indicated	indicate	VERB
admet-2901	151	30	that	that	SCONJ
admet-2901	151	31	these	these	DET
admet-2901	151	32	two	two	NUM
admet-2901	151	33	hydrogen	hydrogen	NOUN
admet-2901	151	34	protons	proton	NOUN
admet-2901	151	35	were	be	AUX
admet-2901	151	36	in	in	ADP
admet-2901	151	37	the	the	DET
admet-2901	151	38	para	para	NOUN
admet-2901	151	39	-	-	PUNCT
admet-2901	151	40	position	position	NOUN
admet-2901	151	41	of	of	ADP
admet-2901	151	42	a	a	DET
admet-2901	151	43	carbonyl	carbonyl	NOUN
admet-2901	151	44	group	group	NOUN
admet-2901	151	45	.	.	PUNCT
admet-2901	152	1	the	the	DET
admet-2901	152	2	signal	signal	NOUN
admet-2901	152	3	at	at	ADP
admet-2901	152	4			NUM
admet-2901	152	5	3.80	3.80	NUM
admet-2901	152	6	(	(	PUNCT
admet-2901	152	7	dd	dd	NOUN
admet-2901	152	8	,	,	PUNCT
admet-2901	152	9	11.8	11.8	NUM
admet-2901	152	10	,	,	PUNCT
admet-2901	152	11	4.6	4.6	NUM
admet-2901	152	12	hz	hz	NOUN
admet-2901	152	13	,	,	PUNCT
admet-2901	152	14	h-6	h-6	NUM
admet-2901	152	15	)	)	PUNCT
admet-2901	152	16	was	be	AUX
admet-2901	152	17	assigned	assign	VERB
admet-2901	152	18	to	to	ADP
admet-2901	152	19	the	the	DET
admet-2901	152	20	proton	proton	NOUN
admet-2901	152	21	at	at	ADP
admet-2901	152	22	carbon	carbon	NOUN
admet-2901	152	23	(	(	PUNCT
admet-2901	152	24	c-6	c-6	X
admet-2901	152	25	)	)	PUNCT
admet-2901	152	26	carrying	carry	VERB
admet-2901	152	27	a	a	DET
admet-2901	152	28	hydroxyl	hydroxyl	NOUN
admet-2901	152	29	group	group	NOUN
admet-2901	152	30	,	,	PUNCT
admet-2901	152	31	the	the	DET
admet-2901	152	32	assignments	assignment	NOUN
admet-2901	152	33	of	of	ADP
admet-2901	152	34	protons	proton	NOUN
admet-2901	152	35	in	in	ADP
admet-2901	152	36	structure	structure	NOUN
admet-2901	152	37	2	2	NUM
admet-2901	152	38	,	,	PUNCT
admet-2901	152	39	except	except	SCONJ
admet-2901	152	40	the	the	DET
admet-2901	152	41	chemical	chemical	ADJ
admet-2901	152	42	shifts	shift	NOUN
admet-2901	152	43	for	for	ADP
admet-2901	152	44	h-17	h-17	NOUN
admet-2901	152	45	,	,	PUNCT
admet-2901	152	46	h-18	h-18	PROPN
admet-2901	152	47	and	and	CCONJ
admet-2901	152	48	h-19	h-19	PROPN
admet-2901	152	49	,	,	PUNCT
admet-2901	152	50	were	be	AUX
admet-2901	152	51	found	find	VERB
admet-2901	152	52	closely	closely	ADV
admet-2901	152	53	similar	similar	ADJ
admet-2901	152	54	to	to	ADP
admet-2901	152	55	those	those	PRON
admet-2901	152	56	of	of	ADP
admet-2901	152	57	anomallotusinin	anomallotusinin	ADV
admet-2901	152	58	previously	previously	ADV
admet-2901	152	59	reported	report	VERB
admet-2901	152	60	by	by	ADP
admet-2901	152	61	yang	yang	PROPN
admet-2901	152	62	yiping	yip	VERB
admet-2901	152	63	et	et	PROPN
admet-2901	152	64	al	al	PROPN
admet-2901	152	65	.	.	PUNCT
admet-2901	153	1	[	[	X
admet-2901	153	2	34	34	NUM
admet-2901	153	3	]	]	PUNCT
admet-2901	153	4	.	.	PUNCT
admet-2901	154	1	the	the	DET
admet-2901	154	2	isolated	isolate	VERB
admet-2901	154	3	compounds	compound	NOUN
admet-2901	154	4	,	,	PUNCT
admet-2901	154	5	along	along	ADP
admet-2901	154	6	with	with	ADP
admet-2901	154	7	the	the	DET
admet-2901	154	8	known	know	VERB
admet-2901	154	9	constituents	constituent	NOUN
admet-2901	154	10	,	,	PUNCT
admet-2901	154	11	were	be	AUX
admet-2901	154	12	further	far	ADV
admet-2901	154	13	evaluated	evaluate	VERB
admet-2901	154	14	for	for	SCONJ
admet-2901	154	15	their	their	PRON
admet-2901	154	16	activity	activity	NOUN
admet-2901	154	17	against	against	ADP
admet-2901	154	18	human	human	ADJ
admet-2901	154	19	breast	breast	NOUN
admet-2901	154	20	cancer	cancer	NOUN
admet-2901	154	21	cell	cell	NOUN
admet-2901	154	22	lines	line	NOUN
admet-2901	154	23	to	to	PART
admet-2901	154	24	explore	explore	VERB
admet-2901	154	25	their	their	PRON
admet-2901	154	26	potential	potential	NOUN
admet-2901	154	27	as	as	ADP
admet-2901	154	28	anticancer	anticancer	NOUN
admet-2901	154	29	agents	agent	NOUN
admet-2901	154	30	.	.	PUNCT
admet-2901	155	1	two	two	NUM
admet-2901	155	2	m.	m.	NOUN
admet-2901	155	3	glomerulatus	glomerulatus	NOUN
admet-2901	155	4	-	-	PUNCT
admet-2901	155	5	derived	derive	VERB
admet-2901	155	6	compounds	compound	NOUN
admet-2901	155	7	are	be	AUX
admet-2901	155	8	effective	effective	ADJ
admet-2901	155	9	against	against	ADP
admet-2901	155	10	breast	breast	NOUN
admet-2901	155	11	cancer	cancer	NOUN
admet-2901	155	12	cells	cell	NOUN
admet-2901	155	13	mcf-7	mcf-7	PUNCT
admet-2901	155	14	and	and	CCONJ
admet-2901	155	15	mda	mda	PROPN
admet-2901	155	16	-	-	PUNCT
admet-2901	155	17	mb-231	mb-231	PROPN
admet-2901	155	18	.	.	PUNCT
admet-2901	156	1	the	the	DET
admet-2901	156	2	phytochemical	phytochemical	ADJ
admet-2901	156	3	properties	property	NOUN
admet-2901	156	4	and	and	CCONJ
admet-2901	156	5	biological	biological	ADJ
admet-2901	156	6	effects	effect	NOUN
admet-2901	156	7	of	of	ADP
admet-2901	156	8	m.	m.	NOUN
admet-2901	156	9	glomerulatus	glomerulatus	NOUN
admet-2901	156	10	,	,	PUNCT
admet-2901	156	11	a	a	DET
admet-2901	156	12	natural	natural	ADJ
admet-2901	156	13	resource	resource	NOUN
admet-2901	156	14	primarily	primarily	ADV
admet-2901	156	15	found	find	VERB
admet-2901	156	16	in	in	ADP
admet-2901	156	17	tropical	tropical	ADJ
admet-2901	156	18	regions	region	NOUN
admet-2901	156	19	,	,	PUNCT
admet-2901	156	20	including	include	VERB
admet-2901	156	21	thailand	thailand	PROPN
admet-2901	156	22	,	,	PUNCT
admet-2901	156	23	have	have	AUX
admet-2901	156	24	not	not	PART
admet-2901	156	25	yet	yet	ADV
admet-2901	156	26	been	be	AUX
admet-2901	156	27	thoroughly	thoroughly	ADV
admet-2901	156	28	investigated	investigate	VERB
admet-2901	156	29	.	.	PUNCT
admet-2901	157	1	therefore	therefore	ADV
admet-2901	157	2	,	,	PUNCT
admet-2901	157	3	exploring	explore	VERB
admet-2901	157	4	local	local	ADJ
admet-2901	157	5	natural	natural	ADJ
admet-2901	157	6	resources	resource	NOUN
admet-2901	157	7	presents	present	VERB
admet-2901	157	8	a	a	DET
admet-2901	157	9	promising	promising	ADJ
admet-2901	157	10	and	and	CCONJ
admet-2901	157	11	urgent	urgent	ADJ
admet-2901	157	12	opportunity	opportunity	NOUN
admet-2901	157	13	for	for	ADP
admet-2901	157	14	developing	develop	VERB
admet-2901	157	15	new	new	ADJ
admet-2901	157	16	therapeutic	therapeutic	ADJ
admet-2901	157	17	agents	agent	NOUN
admet-2901	157	18	for	for	ADP
admet-2901	157	19	breast	breast	NOUN
admet-2901	157	20	cancer	cancer	NOUN
admet-2901	157	21	patients	patient	NOUN
admet-2901	157	22	within	within	ADP
admet-2901	157	23	the	the	DET
admet-2901	157	24	country	country	NOUN
admet-2901	157	25	.	.	PUNCT
admet-2901	158	1	in	in	ADP
admet-2901	158	2	this	this	DET
admet-2901	158	3	study	study	NOUN
admet-2901	158	4	,	,	PUNCT
admet-2901	158	5	11	11	NUM
admet-2901	158	6	compounds	compound	NOUN
admet-2901	158	7	isolated	isolate	VERB
admet-2901	158	8	from	from	ADP
admet-2901	158	9	m.	m.	NOUN
admet-2901	158	10	glomerulatus	glomerulatus	NOUN
admet-2901	158	11	were	be	AUX
admet-2901	158	12	screened	screen	VERB
admet-2901	158	13	for	for	ADP
admet-2901	158	14	their	their	PRON
admet-2901	158	15	effects	effect	NOUN
admet-2901	158	16	on	on	ADP
admet-2901	158	17	breast	breast	NOUN
admet-2901	158	18	cancer	cancer	NOUN
admet-2901	158	19	cell	cell	NOUN
admet-2901	158	20	viability	viability	NOUN
admet-2901	158	21	using	use	VERB
admet-2901	158	22	the	the	DET
admet-2901	158	23	mtt	mtt	NOUN
admet-2901	158	24	assay	assay	VERB
admet-2901	158	25	.	.	PUNCT
admet-2901	159	1	in	in	ADP
admet-2901	159	2	the	the	DET
admet-2901	159	3	initial	initial	ADJ
admet-2901	159	4	singleconcentration	singleconcentration	NOUN
admet-2901	159	5	screening	screen	VERB
admet-2901	159	6	(	(	PUNCT
admet-2901	159	7	primary	primary	ADJ
admet-2901	159	8	screening	screening	NOUN
admet-2901	159	9	)	)	PUNCT
admet-2901	159	10	,	,	PUNCT
admet-2901	159	11	two	two	NUM
admet-2901	159	12	compounds	compound	NOUN
admet-2901	159	13	,	,	PUNCT
admet-2901	159	14	compound	compound	NOUN
admet-2901	159	15	1	1	NUM
admet-2901	159	16	and	and	CCONJ
admet-2901	159	17	10	10	NUM
admet-2901	159	18	,	,	PUNCT
admet-2901	159	19	significantly	significantly	ADV
admet-2901	159	20	inhibited	inhibit	VERB
admet-2901	159	21	the	the	DET
admet-2901	159	22	viability	viability	NOUN
admet-2901	159	23	of	of	ADP
admet-2901	159	24	mcf-7	mcf-7	DET
admet-2901	159	25	(	(	PUNCT
admet-2901	159	26	low	low	ADJ
admet-2901	159	27	-	-	PUNCT
admet-2901	159	28	aggressiveness	aggressiveness	NOUN
admet-2901	159	29	)	)	PUNCT
admet-2901	159	30	cells	cell	NOUN
admet-2901	159	31	by	by	ADP
admet-2901	159	32	more	more	ADJ
admet-2901	159	33	than	than	ADP
admet-2901	159	34	80	80	NUM
admet-2901	159	35	%	%	NOUN
admet-2901	159	36	,	,	PUNCT
admet-2901	159	37	while	while	SCONJ
admet-2901	159	38	only	only	ADV
admet-2901	159	39	compound	compound	NOUN
admet-2901	159	40	10	10	NUM
admet-2901	159	41	achieved	achieve	VERB
admet-2901	159	42	a	a	DET
admet-2901	159	43	similar	similar	ADJ
admet-2901	159	44	inhibition	inhibition	NOUN
admet-2901	159	45	in	in	ADP
admet-2901	159	46	mda	mda	PROPN
admet-2901	159	47	-	-	PUNCT
admet-2901	159	48	mb-231	mb-231	PROPN
admet-2901	159	49	(	(	PUNCT
admet-2901	159	50	high	high	ADJ
admet-2901	159	51	-	-	PUNCT
admet-2901	159	52	aggressiveness	aggressiveness	NOUN
admet-2901	159	53	)	)	PUNCT
admet-2901	159	54	cells	cell	NOUN
admet-2901	159	55	(	(	PUNCT
admet-2901	159	56	figures	figure	NOUN
admet-2901	159	57	3a	3a	NUM
admet-2901	159	58	and	and	CCONJ
admet-2901	159	59	3b	3b	NUM
admet-2901	159	60	)	)	PUNCT
admet-2901	159	61	.	.	PUNCT
admet-2901	160	1	compound	compound	NOUN
admet-2901	160	2	1	1	NUM
admet-2901	160	3	,	,	PUNCT
admet-2901	160	4	which	which	PRON
admet-2901	160	5	is	be	AUX
admet-2901	160	6	a	a	DET
admet-2901	160	7	new	new	ADJ
admet-2901	160	8	xanthone	xanthone	NOUN
admet-2901	160	9	and	and	CCONJ
admet-2901	160	10	has	have	AUX
admet-2901	160	11	been	be	AUX
admet-2901	160	12	identified	identify	VERB
admet-2901	160	13	as	as	ADP
admet-2901	160	14	(	(	PUNCT
admet-2901	160	15	3,4,5)-trihydroxy-6	3,4,5)-trihydroxy-6	NUM
admet-2901	160	16	-	-	PUNCT
admet-2901	160	17	methoxy-2,7	methoxy-2,7	NOUN
admet-2901	160	18	-	-	PUNCT
admet-2901	160	19	bis(3	bis(3	NOUN
admet-2901	160	20	-	-	PUNCT
admet-2901	160	21	methylbut-2	methylbut-2	NUM
admet-2901	160	22	-	-	PUNCT
admet-2901	160	23	en-1	en-1	NOUN
admet-2901	160	24	-	-	PUNCT
admet-2901	160	25	yl)-9h	yl)-9h	NUM
admet-2901	160	26	-xanthen-9	-xanthen-9	ADJ
admet-2901	160	27	-	-	PUNCT
admet-2901	160	28	one	one	NUM
admet-2901	160	29	,	,	PUNCT
admet-2901	160	30	showed	show	VERB
admet-2901	160	31	strong	strong	ADJ
admet-2901	160	32	selectivity	selectivity	NOUN
admet-2901	160	33	toward	toward	ADP
admet-2901	160	34	mcf-7	mcf-7	NOUN
admet-2901	160	35	cells	cell	NOUN
admet-2901	160	36	,	,	PUNCT
admet-2901	160	37	reducing	reduce	VERB
admet-2901	160	38	viability	viability	NOUN
admet-2901	160	39	to	to	ADP
admet-2901	160	40	1.60	1.60	NUM
admet-2901	160	41	±	±	NUM
admet-2901	160	42	0.10	0.10	NUM
admet-2901	160	43	%	%	NOUN
admet-2901	160	44	.	.	PUNCT
admet-2901	161	1	in	in	ADP
admet-2901	161	2	contrast	contrast	NOUN
admet-2901	161	3	,	,	PUNCT
admet-2901	161	4	compound	compound	NOUN
admet-2901	161	5	1	1	NUM
admet-2901	161	6	-	-	PUNCT
admet-2901	161	7	treated	treat	VERB
admet-2901	161	8	mda	mda	PROPN
admet-2901	161	9	-	-	PUNCT
admet-2901	161	10	mb-231	mb-231	PROPN
admet-2901	161	11	cells	cell	NOUN
admet-2901	161	12	exhibited	exhibit	VERB
admet-2901	161	13	a	a	DET
admet-2901	161	14	viability	viability	NOUN
admet-2901	161	15	of	of	ADP
admet-2901	161	16	59.00	59.00	NUM
admet-2901	161	17	±	±	NUM
admet-2901	161	18	3.33	3.33	NUM
admet-2901	161	19	%	%	NOUN
admet-2901	161	20	.	.	PUNCT
admet-2901	162	1	notably	notably	ADV
admet-2901	162	2	,	,	PUNCT
admet-2901	162	3	compound	compound	NOUN
admet-2901	162	4	10	10	NUM
admet-2901	162	5	,	,	PUNCT
admet-2901	162	6	which	which	PRON
admet-2901	162	7	has	have	AUX
admet-2901	162	8	been	be	AUX
admet-2901	162	9	identified	identify	VERB
admet-2901	162	10	as	as	ADP
admet-2901	162	11	cleistanthin	cleistanthin	PROPN
admet-2901	162	12	a	a	PROPN
admet-2901	162	13	,	,	PUNCT
admet-2901	162	14	suppressed	suppress	VERB
admet-2901	162	15	the	the	DET
admet-2901	162	16	viability	viability	NOUN
admet-2901	162	17	of	of	ADP
admet-2901	162	18	both	both	PRON
admet-2901	162	19	mcf-7	mcf-7	PRON
admet-2901	162	20	and	and	CCONJ
admet-2901	162	21	mda	mda	PROPN
admet-2901	162	22	-	-	PUNCT
admet-2901	162	23	mb-231	mb-231	PROPN
admet-2901	162	24	cells	cell	NOUN
admet-2901	162	25	by	by	ADP
admet-2901	162	26	over	over	ADP
admet-2901	162	27	80	80	NUM
admet-2901	162	28	%	%	NOUN
admet-2901	162	29	.	.	PUNCT
admet-2901	163	1	the	the	DET
admet-2901	163	2	efficacy	efficacy	NOUN
admet-2901	163	3	of	of	ADP
admet-2901	163	4	both	both	DET
admet-2901	163	5	hit	hit	VERB
admet-2901	163	6	compounds	compound	NOUN
admet-2901	163	7	was	be	AUX
admet-2901	163	8	comparable	comparable	ADJ
admet-2901	163	9	to	to	ADP
admet-2901	163	10	that	that	PRON
admet-2901	163	11	of	of	ADP
admet-2901	163	12	the	the	DET
admet-2901	163	13	chemotherapeutic	chemotherapeutic	ADJ
admet-2901	163	14	drug	drug	NOUN
admet-2901	163	15	doxorubicin	doxorubicin	PROPN
admet-2901	163	16	,	,	PUNCT
admet-2901	163	17	4.02	4.02	NUM
admet-2901	163	18	±	±	NUM
admet-2901	163	19	0.24	0.24	NUM
admet-2901	163	20	%	%	NOUN
admet-2901	163	21	(	(	PUNCT
admet-2901	163	22	mcf-7	mcf-7	NOUN
admet-2901	163	23	)	)	PUNCT
admet-2901	163	24	and	and	CCONJ
admet-2901	163	25	4.72	4.72	NUM
admet-2901	163	26	±	±	NUM
admet-2901	163	27	1.07	1.07	NUM
admet-2901	163	28	%	%	NOUN
admet-2901	163	29	(	(	PUNCT
admet-2901	163	30	mda	mda	PROPN
admet-2901	163	31	-	-	PUNCT
admet-2901	163	32	mb-231	mb-231	PROPN
admet-2901	163	33	)	)	PUNCT
admet-2901	163	34	.	.	PUNCT
admet-2901	164	1	these	these	DET
admet-2901	164	2	findings	finding	NOUN
admet-2901	164	3	suggest	suggest	VERB
admet-2901	164	4	that	that	SCONJ
admet-2901	164	5	the	the	DET
admet-2901	164	6	two	two	NUM
admet-2901	164	7	m.	m.	NOUN
admet-2901	164	8	glomerulatus	glomerulatus	NOUN
admet-2901	164	9	-	-	PUNCT
admet-2901	164	10	derived	derive	VERB
admet-2901	164	11	compounds	compound	NOUN
admet-2901	164	12	,	,	PUNCT
admet-2901	164	13	3,4,5	3,4,5	NUM
admet-2901	164	14	-	-	PUNCT
admet-2901	164	15	trihydroxy-6	trihydroxy-6	NUM
admet-2901	164	16	-	-	PUNCT
admet-2901	164	17	methoxy-2,7	methoxy-2,7	NOUN
admet-2901	164	18	-	-	PUNCT
admet-2901	164	19	bis(3	bis(3	NOUN
admet-2901	164	20	-	-	PUNCT
admet-2901	164	21	methylbut-2	methylbut-2	NUM
admet-2901	164	22	-	-	PUNCT
admet-2901	164	23	en-1	en-1	NOUN
admet-2901	164	24	-	-	PUNCT
admet-2901	164	25	yl	yl	NOUN
admet-2901	164	26	)	)	PUNCT
admet-2901	164	27	and	and	CCONJ
admet-2901	164	28	cleistanthin	cleistanthin	NOUN
admet-2901	164	29	a	a	PRON
admet-2901	164	30	,	,	PUNCT
admet-2901	164	31	hold	hold	VERB
admet-2901	164	32	promise	promise	NOUN
admet-2901	164	33	as	as	ADP
admet-2901	164	34	potential	potential	ADJ
admet-2901	164	35	anti	anti	ADJ
admet-2901	164	36	-	-	ADJ
admet-2901	164	37	breast	breast	ADJ
admet-2901	164	38	cancer	cancer	NOUN
admet-2901	164	39	agents	agent	NOUN
admet-2901	164	40	.	.	PUNCT
admet-2901	165	1	therefore	therefore	ADV
admet-2901	165	2	,	,	PUNCT
admet-2901	165	3	both	both	DET
admet-2901	165	4	candidates	candidate	NOUN
admet-2901	165	5	will	will	AUX
admet-2901	165	6	be	be	AUX
admet-2901	165	7	further	far	ADV
admet-2901	165	8	evaluated	evaluate	VERB
admet-2901	165	9	in	in	ADP
admet-2901	165	10	secondary	secondary	ADJ
admet-2901	165	11	screening	screening	NOUN
admet-2901	165	12	using	use	VERB
admet-2901	165	13	dose	dose	NOUN
admet-2901	165	14	-	-	PUNCT
admet-2901	165	15	dependent	dependent	ADJ
admet-2901	165	16	assays	assay	NOUN
admet-2901	165	17	to	to	PART
admet-2901	165	18	determine	determine	VERB
admet-2901	165	19	their	their	PRON
admet-2901	165	20	ic₅₀	ic₅₀	PROPN
admet-2901	165	21	values	value	NOUN
admet-2901	165	22	.	.	PUNCT
admet-2901	166	1	from	from	ADP
admet-2901	166	2	the	the	DET
admet-2901	166	3	primary	primary	ADJ
admet-2901	166	4	screening	screening	NOUN
admet-2901	166	5	,	,	PUNCT
admet-2901	166	6	two	two	NUM
admet-2901	166	7	compounds	compound	NOUN
admet-2901	166	8	isolated	isolate	VERB
admet-2901	166	9	from	from	ADP
admet-2901	166	10	m.	m.	NOUN
admet-2901	166	11	glomerulatus	glomerulatus	NOUN
admet-2901	166	12	were	be	AUX
admet-2901	166	13	evaluated	evaluate	VERB
admet-2901	166	14	for	for	ADP
admet-2901	166	15	their	their	PRON
admet-2901	166	16	potential	potential	NOUN
admet-2901	166	17	as	as	ADP
admet-2901	166	18	anti	anti	ADJ
admet-2901	166	19	-	-	ADJ
admet-2901	166	20	breast	breast	ADJ
admet-2901	166	21	cancer	cancer	NOUN
admet-2901	166	22	agents	agent	NOUN
admet-2901	166	23	in	in	ADP
admet-2901	166	24	a	a	DET
admet-2901	166	25	dose	dose	NOUN
admet-2901	166	26	-	-	PUNCT
admet-2901	166	27	dependent	dependent	ADJ
admet-2901	166	28	manner	manner	NOUN
admet-2901	166	29	,	,	PUNCT
admet-2901	166	30	and	and	CCONJ
admet-2901	166	31	ic₅₀	ic₅₀	PROPN
admet-2901	166	32	values	value	NOUN
admet-2901	166	33	were	be	AUX
admet-2901	166	34	calculated	calculate	VERB
admet-2901	166	35	to	to	PART
admet-2901	166	36	determine	determine	VERB
admet-2901	166	37	their	their	PRON
admet-2901	166	38	potency	potency	NOUN
admet-2901	166	39	.	.	PUNCT
admet-2901	167	1	compound	compound	NOUN
admet-2901	167	2	1	1	NUM
admet-2901	167	3	exhibited	exhibit	VERB
admet-2901	167	4	moderate	moderate	ADJ
admet-2901	167	5	activity	activity	NOUN
admet-2901	167	6	,	,	PUNCT
admet-2901	167	7	with	with	ADP
admet-2901	167	8	ic₅₀	ic₅₀	PROPN
admet-2901	167	9	values	value	NOUN
admet-2901	167	10	of	of	ADP
admet-2901	167	11	28.28	28.28	NUM
admet-2901	167	12	±	±	NUM
admet-2901	167	13	0.83	0.83	NUM
admet-2901	167	14	μm	μm	NOUN
admet-2901	167	15	for	for	ADP
admet-2901	167	16	mcf-7	mcf-7	NOUN
admet-2901	167	17	cells	cell	NOUN
admet-2901	167	18	and	and	CCONJ
admet-2901	167	19	34.19	34.19	NUM
admet-2901	167	20	±	±	NUM
admet-2901	167	21	1.54	1.54	NUM
admet-2901	167	22	μm	μm	NOUN
admet-2901	167	23	for	for	ADP
admet-2901	167	24	mda	mda	PROPN
admet-2901	167	25	-	-	PUNCT
admet-2901	167	26	mb-231	mb-231	PROPN
admet-2901	167	27	cells	cell	NOUN
admet-2901	167	28	(	(	PUNCT
admet-2901	167	29	figures	figure	NOUN
admet-2901	167	30	4a	4a	NOUN
admet-2901	167	31	and	and	CCONJ
admet-2901	167	32	4d	4d	NUM
admet-2901	167	33	)	)	PUNCT
admet-2901	167	34	.	.	PUNCT
admet-2901	168	1	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	PROPN
admet-2901	168	2	n.	n.	PROPN
admet-2901	168	3	chabang	chabang	PROPN
admet-2901	168	4	et	et	PROPN
admet-2901	168	5	al	al	PROPN
admet-2901	168	6	.	.	PROPN
admet-2901	168	7	admet	admet	PROPN
admet-2901	168	8	&	&	CCONJ
admet-2901	168	9	dmpk	dmpk	PROPN
admet-2901	168	10	13(5	13(5	NUM
admet-2901	168	11	)	)	PUNCT
admet-2901	168	12	(	(	PUNCT
admet-2901	168	13	2025	2025	NUM
admet-2901	168	14	)	)	PUNCT
admet-2901	168	15	2901	2901	NUM
admet-2901	168	16	8	8	NUM
admet-2901	168	17	figure	figure	NOUN
admet-2901	168	18	3	3	NUM
admet-2901	168	19	.	.	PUNCT
admet-2901	169	1	the	the	DET
admet-2901	169	2	primary	primary	ADJ
admet-2901	169	3	screening	screening	NOUN
admet-2901	169	4	,	,	PUNCT
admet-2901	169	5	containing	contain	VERB
admet-2901	169	6	11	11	NUM
admet-2901	169	7	compounds	compound	NOUN
admet-2901	169	8	,	,	PUNCT
admet-2901	169	9	was	be	AUX
admet-2901	169	10	conducted	conduct	VERB
admet-2901	169	11	in	in	ADP
admet-2901	169	12	both	both	PRON
admet-2901	169	13	mcf-7	mcf-7	NOUN
admet-2901	169	14	(	(	PUNCT
admet-2901	169	15	a	a	X
admet-2901	169	16	)	)	PUNCT
admet-2901	169	17	and	and	CCONJ
admet-2901	169	18	mda	mda	PROPN
admet-2901	169	19	-	-	PUNCT
admet-2901	169	20	mb-231	mb-231	PROPN
admet-2901	169	21	(	(	PUNCT
admet-2901	169	22	b	b	NOUN
admet-2901	169	23	)	)	PUNCT
admet-2901	169	24	breast	breast	NOUN
admet-2901	169	25	cancer	cancer	NOUN
admet-2901	169	26	cell	cell	NOUN
admet-2901	169	27	lines	line	NOUN
admet-2901	169	28	.	.	PUNCT
admet-2901	170	1	the	the	DET
admet-2901	170	2	red	red	ADJ
admet-2901	170	3	color	color	NOUN
admet-2901	170	4	represents	represent	VERB
admet-2901	170	5	doxorubicin	doxorubicin	PROPN
admet-2901	170	6	,	,	PUNCT
admet-2901	170	7	a	a	DET
admet-2901	170	8	positive	positive	ADJ
admet-2901	170	9	control	control	NOUN
admet-2901	170	10	,	,	PUNCT
admet-2901	170	11	while	while	SCONJ
admet-2901	170	12	the	the	DET
admet-2901	170	13	green	green	ADJ
admet-2901	170	14	color	color	NOUN
admet-2901	170	15	represents	represent	VERB
admet-2901	170	16	dmso	dmso	NOUN
admet-2901	170	17	,	,	PUNCT
admet-2901	170	18	a	a	DET
admet-2901	170	19	negative	negative	ADJ
admet-2901	170	20	control	control	NOUN
admet-2901	170	21	.	.	PUNCT
admet-2901	171	1	the	the	DET
admet-2901	171	2	grey	grey	PROPN
admet-2901	171	3	colors	color	NOUN
admet-2901	171	4	are	be	AUX
admet-2901	171	5	considered	consider	VERB
admet-2901	171	6	as	as	ADP
admet-2901	171	7	the	the	DET
admet-2901	171	8	compounds	compound	NOUN
admet-2901	171	9	extracted	extract	VERB
admet-2901	171	10	from	from	ADP
admet-2901	171	11	m.	m.	NOUN
admet-2901	171	12	glomerulatus	glomerulatus	NOUN
admet-2901	171	13	including	include	VERB
admet-2901	171	14	(	(	PUNCT
admet-2901	171	15	3,4,5)-trihydroxy-6	3,4,5)-trihydroxy-6	NUM
admet-2901	171	16	-	-	PUNCT
admet-2901	171	17	methoxy-2,7	methoxy-2,7	NOUN
admet-2901	171	18	-	-	PUNCT
admet-2901	171	19	bis(3	bis(3	NOUN
admet-2901	171	20	-	-	PUNCT
admet-2901	171	21	methylbut-2	methylbut-2	NUM
admet-2901	171	22	-	-	PUNCT
admet-2901	171	23	en-1	en-1	NOUN
admet-2901	171	24	-	-	PUNCT
admet-2901	171	25	yl)-9h	yl)-9h	NOUN
admet-2901	171	26	-	-	PUNCT
admet-2901	171	27	xanthen-9	xanthen-9	NUM
admet-2901	171	28	-	-	PUNCT
admet-2901	171	29	one	one	NUM
admet-2901	171	30	(	(	PUNCT
admet-2901	171	31	compound	compound	NOUN
admet-2901	171	32	1	1	NUM
admet-2901	171	33	)	)	PUNCT
admet-2901	171	34	,	,	PUNCT
admet-2901	171	35	glomerulatusin	glomerulatusin	NOUN
admet-2901	171	36	(	(	PUNCT
admet-2901	171	37	compound	compound	NOUN
admet-2901	171	38	2	2	NUM
admet-2901	171	39	)	)	PUNCT
admet-2901	171	40	,	,	PUNCT
admet-2901	171	41	friedelin	friedelin	PROPN
admet-2901	171	42	(	(	PUNCT
admet-2901	171	43	compound	compound	NOUN
admet-2901	171	44	3	3	NUM
admet-2901	171	45	)	)	PUNCT
admet-2901	171	46	,	,	PUNCT
admet-2901	171	47	anomaluone	anomaluone	NOUN
admet-2901	171	48	(	(	PUNCT
admet-2901	171	49	compound	compound	NOUN
admet-2901	171	50	4	4	NUM
admet-2901	171	51	)	)	PUNCT
admet-2901	171	52	,	,	PUNCT
admet-2901	171	53	3,6	3,6	NUM
admet-2901	171	54	-	-	PUNCT
admet-2901	171	55	phenanthrenedione	phenanthrenedione	NOUN
admet-2901	171	56	(	(	PUNCT
admet-2901	171	57	compound	compound	NOUN
admet-2901	171	58	5	5	NUM
admet-2901	171	59	)	)	PUNCT
admet-2901	171	60	,	,	PUNCT
admet-2901	171	61	pinocembrin	pinocembrin	NOUN
admet-2901	171	62	(	(	PUNCT
admet-2901	171	63	compound	compound	NOUN
admet-2901	171	64	6	6	NUM
admet-2901	171	65	)	)	PUNCT
admet-2901	171	66	,	,	PUNCT
admet-2901	171	67	pinostrobin	pinostrobin	NOUN
admet-2901	171	68	(	(	PUNCT
admet-2901	171	69	compound	compound	NOUN
admet-2901	171	70	7	7	NUM
admet-2901	171	71	)	)	PUNCT
admet-2901	171	72	,	,	PUNCT
admet-2901	171	73	5	5	NUM
admet-2901	171	74	-	-	PUNCT
admet-2901	171	75	hydroxy-6,7,3',4',5′-pentametho	hydroxy-6,7,3',4',5′-pentametho	PROPN
admet-2901	171	76	-	-	PUNCT
admet-2901	171	77	xyflavone	xyflavone	NOUN
admet-2901	171	78	(	(	PUNCT
admet-2901	171	79	compound	compound	NOUN
admet-2901	171	80	8)	8)	NUM
admet-2901	171	81	,	,	PUNCT
admet-2901	171	82	chrysin	chrysin	NOUN
admet-2901	171	83	(	(	PUNCT
admet-2901	171	84	compound	compound	NOUN
admet-2901	171	85	9	9	NUM
admet-2901	171	86	)	)	PUNCT
admet-2901	171	87	,	,	PUNCT
admet-2901	171	88	cleistanthin	cleistanthin	VERB
admet-2901	171	89	a	a	DET
admet-2901	171	90	(	(	PUNCT
admet-2901	171	91	compound	compound	NOUN
admet-2901	171	92	10	10	NUM
admet-2901	171	93	)	)	PUNCT
admet-2901	171	94	,	,	PUNCT
admet-2901	171	95	4	4	NUM
admet-2901	171	96	-	-	NOUN
admet-2901	171	97	hydroxyacetophenone	hydroxyacetophenone	NOUN
admet-2901	171	98	(	(	PUNCT
admet-2901	171	99	compound	compound	NOUN
admet-2901	171	100	11	11	NUM
admet-2901	171	101	)	)	PUNCT
admet-2901	171	102	.	.	PUNCT
admet-2901	172	1	cancer	cancer	NOUN
admet-2901	172	2	cells	cell	NOUN
admet-2901	172	3	were	be	AUX
admet-2901	172	4	treated	treat	VERB
admet-2901	172	5	with	with	ADP
admet-2901	172	6	11	11	NUM
admet-2901	172	7	compounds	compound	NOUN
admet-2901	172	8	for	for	ADP
admet-2901	172	9	72	72	NUM
admet-2901	172	10	hours	hour	NOUN
admet-2901	172	11	.	.	PUNCT
admet-2901	173	1	then	then	ADV
admet-2901	173	2	,	,	PUNCT
admet-2901	173	3	they	they	PRON
admet-2901	173	4	measured	measure	VERB
admet-2901	173	5	the	the	DET
admet-2901	173	6	cell	cell	NOUN
admet-2901	173	7	viability	viability	NOUN
admet-2901	173	8	with	with	ADP
admet-2901	173	9	the	the	DET
admet-2901	173	10	mtt	mtt	NOUN
admet-2901	173	11	assay	assay	VERB
admet-2901	173	12	.	.	PUNCT
admet-2901	174	1	the	the	DET
admet-2901	174	2	percent	percent	NOUN
admet-2901	174	3	cell	cell	NOUN
admet-2901	174	4	viability	viability	NOUN
admet-2901	174	5	was	be	AUX
admet-2901	174	6	then	then	ADV
admet-2901	174	7	analyzed	analyze	VERB
admet-2901	174	8	and	and	CCONJ
admet-2901	174	9	measured	measure	VERB
admet-2901	174	10	as	as	ADP
admet-2901	174	11	a	a	DET
admet-2901	174	12	percentage	percentage	NOUN
admet-2901	174	13	.	.	PUNCT
admet-2901	175	1	data	datum	NOUN
admet-2901	175	2	are	be	AUX
admet-2901	175	3	shown	show	VERB
admet-2901	175	4	as	as	ADP
admet-2901	175	5	mean	mean	NOUN
admet-2901	175	6	 	 	SPACE
admet-2901	175	7	±	±	NOUN
admet-2901	175	8	 	 	SPACE
admet-2901	175	9	sem	sem	NOUN
admet-2901	175	10	from	from	ADP
admet-2901	175	11	at	at	ADV
admet-2901	175	12	least	least	ADV
admet-2901	175	13	three	three	NUM
admet-2901	175	14	bioreplicate	bioreplicate	ADJ
admet-2901	175	15	independent	independent	ADJ
admet-2901	175	16	experiments	experiment	NOUN
admet-2901	175	17	ccomponnd	ccomponnd	VERB
admet-2901	175	18	1	1	NUM
admet-2901	175	19	/	/	SYM
admet-2901	175	20	m	m	PROPN
admet-2901	175	21	ccomponnd	ccomponnd	VERB
admet-2901	175	22	10	10	NUM
admet-2901	175	23	/	/	SYM
admet-2901	175	24	m	m	PROPN
admet-2901	175	25	cdoxorubicin	cdoxorubicin	PROPN
admet-2901	175	26	/	/	SYM
admet-2901	175	27	m	m	PROPN
admet-2901	175	28	ccomponnd	ccomponnd	VERB
admet-2901	175	29	1	1	NUM
admet-2901	175	30	/	/	SYM
admet-2901	175	31	m	m	PROPN
admet-2901	175	32	ccomponnd	ccomponnd	VERB
admet-2901	175	33	10	10	NUM
admet-2901	175	34	/	/	SYM
admet-2901	175	35	m	m	PROPN
admet-2901	175	36	cdoxorubicin	cdoxorubicin	PROPN
admet-2901	175	37	/	/	SYM
admet-2901	175	38	m	m	PROPN
admet-2901	175	39	figure	figure	NOUN
admet-2901	175	40	4	4	NUM
admet-2901	175	41	.	.	PUNCT
admet-2901	175	42	dose	dose	NOUN
admet-2901	175	43	-	-	PUNCT
admet-2901	175	44	response	response	NOUN
admet-2901	175	45	effects	effect	NOUN
admet-2901	175	46	(	(	PUNCT
admet-2901	175	47	ic50	ic50	PROPN
admet-2901	175	48	values	value	NOUN
admet-2901	175	49	)	)	PUNCT
admet-2901	175	50	of	of	ADP
admet-2901	175	51	hit	hit	VERB
admet-2901	175	52	compounds	compound	NOUN
admet-2901	175	53	on	on	ADP
admet-2901	175	54	breast	breast	NOUN
admet-2901	175	55	cancer	cancer	NOUN
admet-2901	175	56	cells	cell	NOUN
admet-2901	175	57	.	.	PUNCT
admet-2901	176	1	(	(	PUNCT
admet-2901	176	2	a	a	DET
admet-2901	176	3	-	-	PUNCT
admet-2901	176	4	c	c	NOUN
admet-2901	176	5	)	)	PUNCT
admet-2901	176	6	dose	dose	NOUN
admet-2901	176	7	-	-	PUNCT
admet-2901	176	8	response	response	NOUN
admet-2901	176	9	effects	effect	NOUN
admet-2901	176	10	on	on	ADP
admet-2901	176	11	mcf-7	mcf-7	NOUN
admet-2901	176	12	cell	cell	NOUN
admet-2901	176	13	viability	viability	NOUN
admet-2901	176	14	for	for	ADP
admet-2901	176	15	compound	compound	NOUN
admet-2901	176	16	1	1	NUM
admet-2901	176	17	(	(	PUNCT
admet-2901	176	18	a	a	NOUN
admet-2901	176	19	)	)	PUNCT
admet-2901	176	20	,	,	PUNCT
admet-2901	176	21	compound	compound	NOUN
admet-2901	176	22	10	10	NUM
admet-2901	176	23	(	(	PUNCT
admet-2901	176	24	b	b	NOUN
admet-2901	176	25	)	)	PUNCT
admet-2901	176	26	,	,	PUNCT
admet-2901	176	27	and	and	CCONJ
admet-2901	176	28	doxorubicin	doxorubicin	PROPN
admet-2901	176	29	as	as	ADP
admet-2901	176	30	a	a	DET
admet-2901	176	31	control	control	NOUN
admet-2901	176	32	(	(	PUNCT
admet-2901	176	33	c	c	NOUN
admet-2901	176	34	)	)	PUNCT
admet-2901	176	35	.	.	PUNCT
admet-2901	177	1	(	(	PUNCT
admet-2901	177	2	d	d	X
admet-2901	177	3	-	-	PUNCT
admet-2901	177	4	f	f	ADJ
admet-2901	177	5	)	)	PUNCT
admet-2901	177	6	dose	dose	NOUN
admet-2901	177	7	-	-	PUNCT
admet-2901	177	8	response	response	NOUN
admet-2901	177	9	effects	effect	NOUN
admet-2901	177	10	on	on	ADP
admet-2901	177	11	mda	mda	PROPN
admet-2901	177	12	-	-	PUNCT
admet-2901	177	13	mb-231	mb-231	PROPN
admet-2901	177	14	cell	cell	NOUN
admet-2901	177	15	viability	viability	NOUN
admet-2901	177	16	for	for	ADP
admet-2901	177	17	compound	compound	NOUN
admet-2901	177	18	1	1	NUM
admet-2901	177	19	(	(	PUNCT
admet-2901	177	20	d	d	NOUN
admet-2901	177	21	)	)	PUNCT
admet-2901	177	22	,	,	PUNCT
admet-2901	177	23	compound	compound	NOUN
admet-2901	177	24	10	10	NUM
admet-2901	177	25	(	(	PUNCT
admet-2901	177	26	e	e	NOUN
admet-2901	177	27	)	)	PUNCT
admet-2901	177	28	,	,	PUNCT
admet-2901	177	29	and	and	CCONJ
admet-2901	177	30	doxorubicin	doxorubicin	PROPN
admet-2901	177	31	(	(	PUNCT
admet-2901	177	32	f	f	X
admet-2901	177	33	)	)	PUNCT
admet-2901	177	34	.	.	PUNCT
admet-2901	178	1	data	datum	NOUN
admet-2901	178	2	are	be	AUX
admet-2901	178	3	shown	show	VERB
admet-2901	178	4	as	as	ADP
admet-2901	178	5	mean	mean	PROPN
admet-2901	178	6	±	±	NUM
admet-2901	178	7	sd	sd	NOUN
admet-2901	178	8	.	.	PUNCT
admet-2901	179	1	notice	notice	VERB
admet-2901	179	2	that	that	SCONJ
admet-2901	179	3	all	all	PRON
admet-2901	179	4	of	of	ADP
admet-2901	179	5	these	these	DET
admet-2901	179	6	statistical	statistical	ADJ
admet-2901	179	7	analyses	analysis	NOUN
admet-2901	179	8	were	be	AUX
admet-2901	179	9	from	from	ADP
admet-2901	179	10	at	at	ADV
admet-2901	179	11	least	least	ADV
admet-2901	179	12	three	three	NUM
admet-2901	179	13	bioreplicate	bioreplicate	ADJ
admet-2901	179	14	independent	independent	ADJ
admet-2901	179	15	experiments	experiment	NOUN
admet-2901	179	16	however	however	ADV
admet-2901	179	17	,	,	PUNCT
admet-2901	179	18	its	its	PRON
admet-2901	179	19	effectiveness	effectiveness	NOUN
admet-2901	179	20	was	be	AUX
admet-2901	179	21	lower	low	ADJ
admet-2901	179	22	than	than	ADP
admet-2901	179	23	that	that	PRON
admet-2901	179	24	of	of	ADP
admet-2901	179	25	doxorubicin	doxorubicin	PROPN
admet-2901	179	26	,	,	PUNCT
admet-2901	179	27	which	which	PRON
admet-2901	179	28	showed	show	VERB
admet-2901	179	29	ic₅₀	ic₅₀	PROPN
admet-2901	179	30	values	value	NOUN
admet-2901	179	31	of	of	ADP
admet-2901	179	32	0.66	0.66	NUM
admet-2901	179	33	±	±	NUM
admet-2901	179	34	0.09	0.09	NUM
admet-2901	179	35	μm	μm	NOUN
admet-2901	179	36	and	and	CCONJ
admet-2901	179	37	0.98	0.98	NUM
admet-2901	179	38	±	±	NUM
admet-2901	179	39	0.09	0.09	NUM
admet-2901	179	40	μm	μm	NOUN
admet-2901	179	41	for	for	ADP
admet-2901	179	42	mcf-7	mcf-7	PRON
admet-2901	179	43	and	and	CCONJ
admet-2901	179	44	mda	mda	PROPN
admet-2901	179	45	-	-	PUNCT
admet-2901	179	46	mb-231	mb-231	PROPN
admet-2901	179	47	cells	cell	NOUN
admet-2901	179	48	,	,	PUNCT
admet-2901	179	49	respectively	respectively	ADV
admet-2901	179	50	(	(	PUNCT
admet-2901	179	51	figures	figure	NOUN
admet-2901	179	52	4c	4c	NOUN
admet-2901	179	53	and	and	CCONJ
admet-2901	179	54	4f	4f	NUM
admet-2901	179	55	)	)	PUNCT
admet-2901	179	56	.	.	PUNCT
admet-2901	180	1	interestingly	interestingly	ADV
admet-2901	180	2	,	,	PUNCT
admet-2901	180	3	compound	compound	NOUN
admet-2901	180	4	10	10	NUM
admet-2901	180	5	demonstrated	demonstrate	VERB
admet-2901	180	6	greater	great	ADJ
admet-2901	180	7	efficacy	efficacy	NOUN
admet-2901	180	8	than	than	ADP
admet-2901	180	9	doxorubicin	doxorubicin	PROPN
admet-2901	180	10	,	,	PUNCT
admet-2901	180	11	with	with	ADP
admet-2901	180	12	significantly	significantly	ADV
admet-2901	180	13	lower	low	ADJ
admet-2901	180	14	ic₅₀	ic₅₀	PROPN
admet-2901	180	15	values	value	NOUN
admet-2901	180	16	of	of	ADP
admet-2901	180	17	0.54	0.54	NUM
admet-2901	180	18	±	±	NUM
admet-2901	180	19	0.07	0.07	NUM
admet-2901	180	20	μm	μm	NOUN
admet-2901	180	21	and	and	CCONJ
admet-2901	180	22	admet	admet	PROPN
admet-2901	180	23	&	&	CCONJ
admet-2901	180	24	dmpk	dmpk	PROPN
admet-2901	180	25	13(5	13(5	NOUN
admet-2901	180	26	)	)	PUNCT
admet-2901	180	27	(	(	PUNCT
admet-2901	180	28	2025	2025	NUM
admet-2901	180	29	)	)	PUNCT
admet-2901	180	30	2901	2901	NUM
admet-2901	180	31	new	new	ADJ
admet-2901	180	32	xanthone	xanthone	PROPN
admet-2901	180	33	and	and	CCONJ
admet-2901	180	34	chemical	chemical	NOUN
admet-2901	180	35	constituents	constituent	NOUN
admet-2901	180	36	from	from	ADP
admet-2901	180	37	mallotus	mallotus	ADJ
admet-2901	180	38	glomerulatus	glomerulatus	NOUN
admet-2901	180	39	doi	doi	PROPN
admet-2901	180	40	:	:	PUNCT
admet-2901	180	41	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	NOUN
admet-2901	180	42	9	9	NUM
admet-2901	180	43	0.02	0.02	NUM
admet-2901	180	44	±	±	NUM
admet-2901	180	45	0.01	0.01	NUM
admet-2901	180	46	μm	μm	NOUN
admet-2901	180	47	for	for	ADP
admet-2901	180	48	mcf-7	mcf-7	PRON
admet-2901	180	49	and	and	CCONJ
admet-2901	180	50	mda	mda	PROPN
admet-2901	180	51	-	-	PUNCT
admet-2901	180	52	mb-231	mb-231	PROPN
admet-2901	180	53	cells	cell	NOUN
admet-2901	180	54	,	,	PUNCT
admet-2901	180	55	respectively	respectively	ADV
admet-2901	180	56	(	(	PUNCT
admet-2901	180	57	figures	figure	VERB
admet-2901	180	58	4b	4b	PROPN
admet-2901	180	59	and	and	CCONJ
admet-2901	180	60	4e	4e	PROPN
admet-2901	180	61	)	)	PUNCT
admet-2901	180	62	.	.	PUNCT
admet-2901	181	1	these	these	DET
admet-2901	181	2	findings	finding	NOUN
admet-2901	181	3	suggest	suggest	VERB
admet-2901	181	4	that	that	SCONJ
admet-2901	181	5	cleistanthin	cleistanthin	VERB
admet-2901	181	6	a	a	PRON
admet-2901	181	7	holds	hold	VERB
admet-2901	181	8	strong	strong	ADJ
admet-2901	181	9	potential	potential	NOUN
admet-2901	181	10	as	as	ADP
admet-2901	181	11	an	an	DET
admet-2901	181	12	anti	anti	ADJ
admet-2901	181	13	-	-	ADJ
admet-2901	181	14	breast	breast	ADJ
admet-2901	181	15	cancer	cancer	NOUN
admet-2901	181	16	agent	agent	NOUN
admet-2901	181	17	.	.	PUNCT
admet-2901	182	1	cleistanthin	cleistanthin	VERB
admet-2901	182	2	a	a	DET
admet-2901	182	3	acts	act	NOUN
admet-2901	182	4	as	as	ADP
admet-2901	182	5	an	an	DET
admet-2901	182	6	anti	anti	ADJ
admet-2901	182	7	-	-	ADJ
admet-2901	182	8	breast	breast	ADJ
admet-2901	182	9	cancer	cancer	NOUN
admet-2901	182	10	agent	agent	NOUN
admet-2901	182	11	without	without	ADP
admet-2901	182	12	inducing	induce	VERB
admet-2901	182	13	cytotoxicity	cytotoxicity	NOUN
admet-2901	182	14	in	in	ADP
admet-2901	182	15	liver	liver	NOUN
admet-2901	182	16	cells	cell	NOUN
admet-2901	182	17	the	the	DET
admet-2901	182	18	ic50	ic50	PROPN
admet-2901	182	19	value	value	NOUN
admet-2901	182	20	of	of	ADP
admet-2901	182	21	cleistanthin	cleistanthin	NOUN
admet-2901	182	22	a	a	DET
admet-2901	182	23	plays	play	VERB
admet-2901	182	24	a	a	DET
admet-2901	182	25	crucial	crucial	ADJ
admet-2901	182	26	role	role	NOUN
admet-2901	182	27	in	in	ADP
admet-2901	182	28	evaluating	evaluate	VERB
admet-2901	182	29	its	its	PRON
admet-2901	182	30	effectiveness	effectiveness	NOUN
admet-2901	182	31	as	as	ADP
admet-2901	182	32	an	an	DET
admet-2901	182	33	anti	anti	ADJ
admet-2901	182	34	-	-	ADJ
admet-2901	182	35	cancer	cancer	ADJ
admet-2901	182	36	agent	agent	NOUN
admet-2901	182	37	,	,	PUNCT
admet-2901	182	38	specifically	specifically	ADV
admet-2901	182	39	in	in	ADP
admet-2901	182	40	the	the	DET
admet-2901	182	41	treatment	treatment	NOUN
admet-2901	182	42	of	of	ADP
admet-2901	182	43	breast	breast	NOUN
admet-2901	182	44	cancer	cancer	NOUN
admet-2901	182	45	.	.	PUNCT
admet-2901	183	1	equally	equally	ADV
admet-2901	183	2	important	important	ADJ
admet-2901	183	3	,	,	PUNCT
admet-2901	183	4	however	however	ADV
admet-2901	183	5	,	,	PUNCT
admet-2901	183	6	is	be	AUX
admet-2901	183	7	the	the	DET
admet-2901	183	8	assessment	assessment	NOUN
admet-2901	183	9	of	of	ADP
admet-2901	183	10	its	its	PRON
admet-2901	183	11	cytotoxic	cytotoxic	ADJ
admet-2901	183	12	concentration	concentration	NOUN
admet-2901	183	13	(	(	PUNCT
admet-2901	183	14	cc50	cc50	PROPN
admet-2901	183	15	)	)	PUNCT
admet-2901	183	16	in	in	ADP
admet-2901	183	17	liver	liver	NOUN
admet-2901	183	18	cells	cell	NOUN
admet-2901	183	19	,	,	PUNCT
admet-2901	183	20	which	which	PRON
admet-2901	183	21	are	be	AUX
admet-2901	183	22	the	the	DET
admet-2901	183	23	first	first	ADJ
admet-2901	183	24	cells	cell	NOUN
admet-2901	183	25	to	to	PART
admet-2901	183	26	encounter	encounter	VERB
admet-2901	183	27	and	and	CCONJ
admet-2901	183	28	metabolize	metabolize	VERB
admet-2901	183	29	the	the	DET
admet-2901	183	30	compound	compound	NOUN
admet-2901	183	31	.	.	PUNCT
admet-2901	184	1	this	this	DET
admet-2901	184	2	evaluation	evaluation	NOUN
admet-2901	184	3	helps	help	VERB
admet-2901	184	4	define	define	VERB
admet-2901	184	5	the	the	DET
admet-2901	184	6	therapeutic	therapeutic	ADJ
admet-2901	184	7	window	window	NOUN
admet-2901	184	8	of	of	ADP
admet-2901	184	9	hit	hit	VERB
admet-2901	184	10	compounds	compound	NOUN
admet-2901	184	11	,	,	PUNCT
admet-2901	184	12	commonly	commonly	ADV
admet-2901	184	13	expressed	express	VERB
admet-2901	184	14	as	as	ADP
admet-2901	184	15	the	the	DET
admet-2901	184	16	selectivity	selectivity	NOUN
admet-2901	184	17	index	index	NOUN
admet-2901	184	18	(	(	PUNCT
admet-2901	184	19	si	si	NOUN
admet-2901	184	20	)	)	PUNCT
admet-2901	184	21	,	,	PUNCT
admet-2901	184	22	which	which	PRON
admet-2901	184	23	is	be	AUX
admet-2901	184	24	the	the	DET
admet-2901	184	25	ratio	ratio	NOUN
admet-2901	184	26	of	of	ADP
admet-2901	184	27	cc50	cc50	PROPN
admet-2901	184	28	to	to	ADP
admet-2901	184	29	ic50	ic50	PROPN
admet-2901	184	30	.	.	PUNCT
admet-2901	185	1	a	a	DET
admet-2901	185	2	higher	high	ADJ
admet-2901	185	3	si	si	NOUN
admet-2901	185	4	,	,	PUNCT
admet-2901	185	5	which	which	PRON
admet-2901	185	6	shows	show	VERB
admet-2901	185	7	as	as	ADP
admet-2901	185	8	10	10	NUM
admet-2901	185	9	or	or	CCONJ
admet-2901	185	10	higher	high	ADJ
admet-2901	185	11	,	,	PUNCT
admet-2901	185	12	is	be	AUX
admet-2901	185	13	preferable	preferable	ADJ
admet-2901	185	14	and	and	CCONJ
admet-2901	185	15	indicates	indicate	VERB
admet-2901	185	16	a	a	DET
admet-2901	185	17	greater	great	ADJ
admet-2901	185	18	margin	margin	NOUN
admet-2901	185	19	of	of	ADP
admet-2901	185	20	safety	safety	NOUN
admet-2901	185	21	between	between	ADP
admet-2901	185	22	the	the	DET
admet-2901	185	23	effective	effective	ADJ
admet-2901	185	24	and	and	CCONJ
admet-2901	185	25	toxic	toxic	ADJ
admet-2901	185	26	doses	dose	NOUN
admet-2901	185	27	[	[	X
admet-2901	185	28	47	47	NUM
admet-2901	185	29	]	]	PUNCT
admet-2901	185	30	.	.	PUNCT
admet-2901	186	1	in	in	ADP
admet-2901	186	2	this	this	DET
admet-2901	186	3	study	study	NOUN
admet-2901	186	4	,	,	PUNCT
admet-2901	186	5	compound	compound	NOUN
admet-2901	186	6	1	1	NUM
admet-2901	186	7	was	be	AUX
admet-2901	186	8	found	find	VERB
admet-2901	186	9	to	to	PART
admet-2901	186	10	have	have	VERB
admet-2901	186	11	a	a	DET
admet-2901	186	12	concentration	concentration	NOUN
admet-2901	186	13	that	that	PRON
admet-2901	186	14	causes	cause	VERB
admet-2901	186	15	toxicity	toxicity	NOUN
admet-2901	186	16	close	close	ADJ
admet-2901	186	17	to	to	ADP
admet-2901	186	18	the	the	DET
admet-2901	186	19	concentration	concentration	NOUN
admet-2901	186	20	that	that	PRON
admet-2901	186	21	is	be	AUX
admet-2901	186	22	active	active	ADJ
admet-2901	186	23	against	against	ADP
admet-2901	186	24	breast	breast	NOUN
admet-2901	186	25	cancer	cancer	NOUN
admet-2901	186	26	cells	cell	NOUN
admet-2901	186	27	,	,	PUNCT
admet-2901	186	28	with	with	ADP
admet-2901	186	29	a	a	DET
admet-2901	186	30	cc50	cc50	PROPN
admet-2901	186	31	of	of	ADP
admet-2901	186	32	32.76	32.76	NUM
admet-2901	186	33	±	±	NUM
admet-2901	186	34	1.00	1.00	NUM
admet-2901	186	35	μm	μm	NOUN
admet-2901	186	36	(	(	PUNCT
admet-2901	186	37	figure	figure	NOUN
admet-2901	186	38	5a	5a	NUM
admet-2901	186	39	)	)	PUNCT
admet-2901	186	40	.	.	PUNCT
admet-2901	187	1	furthermore	furthermore	ADV
admet-2901	187	2	,	,	PUNCT
admet-2901	187	3	this	this	DET
admet-2901	187	4	new	new	ADJ
admet-2901	187	5	xanthone	xanthone	PROPN
admet-2901	187	6	compound	compound	NOUN
admet-2901	187	7	exhibits	exhibit	VERB
admet-2901	187	8	a	a	DET
admet-2901	187	9	lower	low	ADJ
admet-2901	187	10	therapeutic	therapeutic	ADJ
admet-2901	187	11	window	window	NOUN
admet-2901	187	12	,	,	PUNCT
admet-2901	187	13	with	with	ADP
admet-2901	187	14	an	an	DET
admet-2901	187	15	si	si	NOUN
admet-2901	187	16	value	value	NOUN
admet-2901	187	17	of	of	ADP
admet-2901	187	18	less	less	ADJ
admet-2901	187	19	than	than	ADP
admet-2901	187	20	10	10	NUM
admet-2901	187	21	(	(	PUNCT
admet-2901	187	22	table	table	NOUN
admet-2901	187	23	2	2	NUM
admet-2901	187	24	)	)	PUNCT
admet-2901	187	25	.	.	PUNCT
admet-2901	188	1	thus	thus	ADV
admet-2901	188	2	,	,	PUNCT
admet-2901	188	3	compound	compound	NOUN
admet-2901	188	4	1	1	NUM
admet-2901	188	5	was	be	AUX
admet-2901	188	6	not	not	PART
admet-2901	188	7	studied	study	VERB
admet-2901	188	8	further	far	ADV
admet-2901	188	9	;	;	PUNCT
admet-2901	188	10	however	however	ADV
admet-2901	188	11	,	,	PUNCT
admet-2901	188	12	it	it	PRON
admet-2901	188	13	could	could	AUX
admet-2901	188	14	be	be	AUX
admet-2901	188	15	modified	modify	VERB
admet-2901	188	16	in	in	ADP
admet-2901	188	17	the	the	DET
admet-2901	188	18	future	future	NOUN
admet-2901	188	19	to	to	PART
admet-2901	188	20	increase	increase	VERB
admet-2901	188	21	its	its	PRON
admet-2901	188	22	efficacy	efficacy	NOUN
admet-2901	188	23	and	and	CCONJ
admet-2901	188	24	reduce	reduce	VERB
admet-2901	188	25	its	its	PRON
admet-2901	188	26	cytotoxicity	cytotoxicity	NOUN
admet-2901	188	27	.	.	PUNCT
admet-2901	189	1	meanwhile	meanwhile	ADV
admet-2901	189	2	,	,	PUNCT
admet-2901	189	3	compound	compound	NOUN
admet-2901	189	4	10	10	NUM
admet-2901	189	5	exhibited	exhibit	VERB
admet-2901	189	6	a	a	DET
admet-2901	189	7	cc50	cc50	PROPN
admet-2901	189	8	of	of	ADP
admet-2901	189	9	5.37	5.37	NUM
admet-2901	189	10	±	±	NUM
admet-2901	189	11	1.45	1.45	NUM
admet-2901	189	12	μm	μm	NOUN
admet-2901	189	13	in	in	ADP
admet-2901	189	14	liver	liver	NOUN
admet-2901	189	15	cells	cell	NOUN
admet-2901	189	16	(	(	PUNCT
admet-2901	189	17	figure	figure	NOUN
admet-2901	189	18	5b	5b	NUM
admet-2901	189	19	)	)	PUNCT
admet-2901	189	20	,	,	PUNCT
admet-2901	189	21	which	which	PRON
admet-2901	189	22	is	be	AUX
admet-2901	189	23	over	over	ADP
admet-2901	189	24	two	two	NUM
admet-2901	189	25	orders	order	NOUN
admet-2901	189	26	of	of	ADP
admet-2901	189	27	magnitude	magnitude	NOUN
admet-2901	189	28	higher	high	ADJ
admet-2901	189	29	than	than	ADP
admet-2901	189	30	its	its	PRON
admet-2901	189	31	ic50	ic50	PROPN
admet-2901	189	32	values	value	NOUN
admet-2901	189	33	against	against	ADP
admet-2901	189	34	breast	breast	NOUN
admet-2901	189	35	cancer	cancer	NOUN
admet-2901	189	36	cells	cell	NOUN
admet-2901	189	37	.	.	PUNCT
admet-2901	190	1	this	this	PRON
admet-2901	190	2	suggests	suggest	VERB
admet-2901	190	3	a	a	DET
admet-2901	190	4	favorable	favorable	ADJ
admet-2901	190	5	safety	safety	NOUN
admet-2901	190	6	profile	profile	NOUN
admet-2901	190	7	.	.	PUNCT
admet-2901	191	1	in	in	ADP
admet-2901	191	2	comparison	comparison	NOUN
admet-2901	191	3	,	,	PUNCT
admet-2901	191	4	doxorubicin	doxorubicin	PROPN
admet-2901	191	5	,	,	PUNCT
admet-2901	191	6	a	a	DET
admet-2901	191	7	standard	standard	ADJ
admet-2901	191	8	chemotherapeutic	chemotherapeutic	ADJ
admet-2901	191	9	drug	drug	NOUN
admet-2901	191	10	,	,	PUNCT
admet-2901	191	11	showed	show	VERB
admet-2901	191	12	a	a	DET
admet-2901	191	13	cc50	cc50	PROPN
admet-2901	191	14	of	of	ADP
admet-2901	191	15	0.55	0.55	NUM
admet-2901	191	16	±	±	NUM
admet-2901	191	17	0.01	0.01	NUM
admet-2901	191	18	μm	μm	NOUN
admet-2901	191	19	in	in	ADP
admet-2901	191	20	liver	liver	NOUN
admet-2901	191	21	cells	cell	NOUN
admet-2901	191	22	(	(	PUNCT
admet-2901	191	23	figure	figure	NOUN
admet-2901	191	24	5c	5c	NUM
admet-2901	191	25	)	)	PUNCT
admet-2901	191	26	,	,	PUNCT
admet-2901	191	27	indicating	indicate	VERB
admet-2901	191	28	significantly	significantly	ADV
admet-2901	191	29	higher	high	ADJ
admet-2901	191	30	toxicity	toxicity	NOUN
admet-2901	191	31	.	.	PUNCT
admet-2901	192	1	these	these	DET
admet-2901	192	2	results	result	NOUN
admet-2901	192	3	suggest	suggest	VERB
admet-2901	192	4	that	that	SCONJ
admet-2901	192	5	cleistanthin	cleistanthin	NOUN
admet-2901	192	6	a	a	PRON
admet-2901	192	7	is	be	AUX
admet-2901	192	8	relatively	relatively	ADV
admet-2901	192	9	safe	safe	ADJ
admet-2901	192	10	for	for	ADP
admet-2901	192	11	liver	liver	NOUN
admet-2901	192	12	cells	cell	NOUN
admet-2901	192	13	,	,	PUNCT
admet-2901	192	14	which	which	PRON
admet-2901	192	15	are	be	AUX
admet-2901	192	16	likely	likely	ADJ
admet-2901	192	17	to	to	PART
admet-2901	192	18	process	process	VERB
admet-2901	192	19	the	the	DET
admet-2901	192	20	compound	compound	NOUN
admet-2901	192	21	before	before	SCONJ
admet-2901	192	22	it	it	PRON
admet-2901	192	23	reaches	reach	VERB
admet-2901	192	24	its	its	PRON
admet-2901	192	25	target	target	NOUN
admet-2901	192	26	tissues	tissue	NOUN
admet-2901	192	27	.	.	PUNCT
admet-2901	193	1	the	the	DET
admet-2901	193	2	si	si	PROPN
admet-2901	193	3	values	value	NOUN
admet-2901	193	4	of	of	ADP
admet-2901	193	5	the	the	DET
admet-2901	193	6	tested	test	VERB
admet-2901	193	7	compounds	compound	NOUN
admet-2901	193	8	were	be	AUX
admet-2901	193	9	summarized	summarize	VERB
admet-2901	193	10	in	in	ADP
admet-2901	193	11	table	table	NOUN
admet-2901	193	12	2	2	NUM
admet-2901	193	13	.	.	PUNCT
admet-2901	194	1	compound	compound	NOUN
admet-2901	194	2	10	10	NUM
admet-2901	194	3	exhibited	exhibit	VERB
admet-2901	194	4	si	si	PROPN
admet-2901	194	5	values	value	NOUN
admet-2901	194	6	of	of	ADP
admet-2901	194	7	approximately	approximately	ADV
admet-2901	194	8	10	10	NUM
admet-2901	194	9	for	for	ADP
admet-2901	194	10	mcf-7	mcf-7	NOUN
admet-2901	194	11	cells	cell	NOUN
admet-2901	194	12	and	and	CCONJ
admet-2901	194	13	over	over	ADP
admet-2901	194	14	100	100	NUM
admet-2901	194	15	for	for	ADP
admet-2901	194	16	mda	mda	PROPN
admet-2901	194	17	-	-	PUNCT
admet-2901	194	18	mb-231	mb-231	PROPN
admet-2901	194	19	cells	cell	NOUN
admet-2901	194	20	,	,	PUNCT
admet-2901	194	21	indicating	indicate	VERB
admet-2901	194	22	a	a	DET
admet-2901	194	23	wide	wide	ADJ
admet-2901	194	24	therapeutic	therapeutic	ADJ
admet-2901	194	25	window	window	NOUN
admet-2901	194	26	and	and	CCONJ
admet-2901	194	27	strong	strong	ADJ
admet-2901	194	28	selectivity	selectivity	NOUN
admet-2901	194	29	toward	toward	ADP
admet-2901	194	30	breast	breast	NOUN
admet-2901	194	31	cancer	cancer	NOUN
admet-2901	194	32	cells	cell	NOUN
admet-2901	194	33	with	with	ADP
admet-2901	194	34	minimal	minimal	ADJ
admet-2901	194	35	toxicity	toxicity	NOUN
admet-2901	194	36	to	to	ADP
admet-2901	194	37	liver	liver	NOUN
admet-2901	194	38	cells	cell	NOUN
admet-2901	194	39	.	.	PUNCT
admet-2901	195	1	in	in	ADP
admet-2901	195	2	contrast	contrast	NOUN
admet-2901	195	3	,	,	PUNCT
admet-2901	195	4	doxorubicin	doxorubicin	PROPN
admet-2901	195	5	showed	show	VERB
admet-2901	195	6	si	si	PROPN
admet-2901	195	7	values	value	NOUN
admet-2901	195	8	below	below	ADP
admet-2901	195	9	1	1	NUM
admet-2901	195	10	for	for	ADP
admet-2901	195	11	both	both	DET
admet-2901	195	12	cell	cell	NOUN
admet-2901	195	13	types	type	NOUN
admet-2901	195	14	,	,	PUNCT
admet-2901	195	15	reflecting	reflect	VERB
admet-2901	195	16	a	a	DET
admet-2901	195	17	very	very	ADV
admet-2901	195	18	narrow	narrow	ADJ
admet-2901	195	19	therapeutic	therapeutic	ADJ
admet-2901	195	20	window	window	NOUN
admet-2901	195	21	and	and	CCONJ
admet-2901	195	22	high	high	ADJ
admet-2901	195	23	liver	liver	NOUN
admet-2901	195	24	cell	cell	NOUN
admet-2901	195	25	toxicity	toxicity	NOUN
admet-2901	195	26	.	.	PUNCT
admet-2901	196	1	these	these	DET
admet-2901	196	2	findings	finding	NOUN
admet-2901	196	3	emphasize	emphasize	VERB
admet-2901	196	4	the	the	DET
admet-2901	196	5	potential	potential	NOUN
admet-2901	196	6	of	of	ADP
admet-2901	196	7	cleistanthin	cleistanthin	NOUN
admet-2901	196	8	a	a	PRON
admet-2901	196	9	as	as	ADP
admet-2901	196	10	a	a	DET
admet-2901	196	11	safer	safe	ADJ
admet-2901	196	12	and	and	CCONJ
admet-2901	196	13	more	more	ADV
admet-2901	196	14	selective	selective	ADJ
admet-2901	196	15	anti	anti	ADJ
admet-2901	196	16	-	-	ADJ
admet-2901	196	17	breast	breast	ADJ
admet-2901	196	18	cancer	cancer	NOUN
admet-2901	196	19	agent	agent	NOUN
admet-2901	196	20	compared	compare	VERB
admet-2901	196	21	to	to	ADP
admet-2901	196	22	conventional	conventional	ADJ
admet-2901	196	23	chemotherapy	chemotherapy	NOUN
admet-2901	196	24	.	.	PUNCT
admet-2901	197	1	its	its	PRON
admet-2901	197	2	ability	ability	NOUN
admet-2901	197	3	to	to	PART
admet-2901	197	4	selectively	selectively	VERB
admet-2901	197	5	target	target	VERB
admet-2901	197	6	cancer	cancer	NOUN
admet-2901	197	7	cells	cell	NOUN
admet-2901	197	8	while	while	SCONJ
admet-2901	197	9	sparing	spare	VERB
admet-2901	197	10	normal	normal	ADJ
admet-2901	197	11	liver	liver	NOUN
admet-2901	197	12	cells	cell	NOUN
admet-2901	197	13	makes	make	VERB
admet-2901	197	14	it	it	PRON
admet-2901	197	15	a	a	DET
admet-2901	197	16	promising	promising	ADJ
admet-2901	197	17	candidate	candidate	NOUN
admet-2901	197	18	for	for	ADP
admet-2901	197	19	further	further	ADJ
admet-2901	197	20	preclinical	preclinical	ADJ
admet-2901	197	21	and	and	CCONJ
admet-2901	197	22	clinical	clinical	ADJ
admet-2901	197	23	development	development	NOUN
admet-2901	197	24	,	,	PUNCT
admet-2901	197	25	particularly	particularly	ADV
admet-2901	197	26	for	for	ADP
admet-2901	197	27	treating	treat	VERB
admet-2901	197	28	advanced	advanced	ADJ
admet-2901	197	29	stages	stage	NOUN
admet-2901	197	30	of	of	ADP
admet-2901	197	31	breast	breast	NOUN
admet-2901	197	32	cancer	cancer	NOUN
admet-2901	197	33	.	.	PUNCT
admet-2901	198	1	ccomponnd	ccomponnd	VERB
admet-2901	198	2	1	1	NUM
admet-2901	198	3	/	/	SYM
admet-2901	198	4	m	m	PROPN
admet-2901	198	5	ccomponnd	ccomponnd	VERB
admet-2901	198	6	10	10	NUM
admet-2901	198	7	/	/	SYM
admet-2901	198	8	m	m	PROPN
admet-2901	199	1	cdoxorubicin	cdoxorubicin	PROPN
admet-2901	199	2	/	/	SYM
admet-2901	199	3	m	m	PROPN
admet-2901	199	4	figure	figure	NOUN
admet-2901	199	5	5	5	NUM
admet-2901	199	6	.	.	NOUN
admet-2901	199	7	cytotoxicity	cytotoxicity	NOUN
admet-2901	199	8	testing	testing	NOUN
admet-2901	199	9	(	(	PUNCT
admet-2901	199	10	cc50	cc50	PROPN
admet-2901	199	11	)	)	PUNCT
admet-2901	199	12	of	of	ADP
admet-2901	199	13	the	the	DET
admet-2901	199	14	hit	hit	NOUN
admet-2901	199	15	compounds	compound	NOUN
admet-2901	199	16	against	against	ADP
admet-2901	199	17	the	the	DET
admet-2901	199	18	human	human	ADJ
admet-2901	199	19	liver	liver	NOUN
admet-2901	199	20	cells	cell	NOUN
admet-2901	199	21	.	.	PUNCT
admet-2901	200	1	dose	dose	NOUN
admet-2901	200	2	-	-	PUNCT
admet-2901	200	3	dependent	dependent	ADJ
admet-2901	200	4	cytotoxicity	cytotoxicity	NOUN
admet-2901	200	5	effects	effect	NOUN
admet-2901	200	6	of	of	ADP
admet-2901	200	7	compound	compound	NOUN
admet-2901	200	8	1	1	NUM
admet-2901	200	9	(	(	PUNCT
admet-2901	200	10	a	a	NOUN
admet-2901	200	11	)	)	PUNCT
admet-2901	200	12	,	,	PUNCT
admet-2901	200	13	compound	compound	NOUN
admet-2901	200	14	10	10	NUM
admet-2901	200	15	(	(	PUNCT
admet-2901	200	16	b	b	NOUN
admet-2901	200	17	)	)	PUNCT
admet-2901	200	18	,	,	PUNCT
admet-2901	200	19	and	and	CCONJ
admet-2901	200	20	doxorubicin	doxorubicin	PROPN
admet-2901	200	21	(	(	PUNCT
admet-2901	200	22	c	c	NOUN
admet-2901	200	23	)	)	PUNCT
admet-2901	200	24	on	on	ADP
admet-2901	200	25	the	the	DET
admet-2901	200	26	viability	viability	NOUN
admet-2901	200	27	of	of	ADP
admet-2901	200	28	human	human	ADJ
admet-2901	200	29	liver	liver	NOUN
admet-2901	200	30	cells	cell	NOUN
admet-2901	200	31	(	(	PUNCT
admet-2901	200	32	hepg2	hepg2	NOUN
admet-2901	200	33	cells	cell	NOUN
admet-2901	200	34	)	)	PUNCT
admet-2901	200	35	table	table	NOUN
admet-2901	200	36	2	2	NUM
admet-2901	200	37	.	.	PUNCT
admet-2901	200	38	selectivity	selectivity	NOUN
admet-2901	200	39	index	index	NOUN
admet-2901	200	40	(	(	PUNCT
admet-2901	200	41	si	si	NOUN
admet-2901	200	42	)	)	PUNCT
admet-2901	200	43	of	of	ADP
admet-2901	200	44	hit	hit	VERB
admet-2901	200	45	compounds	compound	NOUN
admet-2901	200	46	in	in	ADP
admet-2901	200	47	human	human	ADJ
admet-2901	200	48	liver	liver	NOUN
admet-2901	200	49	cells	cell	NOUN
admet-2901	200	50	compounds	compound	NOUN
admet-2901	200	51	ic5	ic5	VERB
admet-2901	200	52	/	/	PUNCT
admet-2901	200	53	m	m	PROPN
admet-2901	200	54	cc50	cc50	PROPN
admet-2901	200	55	/	/	SYM
admet-2901	200	56	m	m	PROPN
admet-2901	200	57	hepg2	hepg2	NOUN
admet-2901	201	1	si	si	X
admet-2901	201	2	(	(	PUNCT
admet-2901	201	3	cc50	cc50	PROPN
admet-2901	201	4	/	/	SYM
admet-2901	201	5	ic50	ic50	PROPN
admet-2901	201	6	)	)	PUNCT
admet-2901	201	7	mcf-7	mcf-7	PUNCT
admet-2901	201	8	mda	mda	PROPN
admet-2901	201	9	-	-	PUNCT
admet-2901	201	10	mb-231	mb-231	PROPN
admet-2901	201	11	hepg2	hepg2	NOUN
admet-2901	201	12	:	:	PUNCT
admet-2901	201	13	mcf-7	mcf-7	PRON
admet-2901	201	14	hepg2	hepg2	NOUN
admet-2901	201	15	:	:	PUNCT
admet-2901	201	16	mda	mda	PROPN
admet-2901	201	17	-	-	PUNCT
admet-2901	201	18	mb-231	mb-231	PROPN
admet-2901	201	19	1	1	NUM
admet-2901	201	20	28.28	28.28	NUM
admet-2901	201	21	34.19	34.19	NUM
admet-2901	201	22	32.76	32.76	NUM
admet-2901	201	23	1.16	1.16	NUM
admet-2901	201	24	0.96	0.96	NUM
admet-2901	201	25	10	10	NUM
admet-2901	201	26	0.54	0.54	NUM
admet-2901	201	27	0.02	0.02	NUM
admet-2901	201	28	5.37	5.37	NUM
admet-2901	201	29	9.94	9.94	NUM
admet-2901	201	30	268.50	268.50	NUM
admet-2901	201	31	doxorubicin	doxorubicin	NOUN
admet-2901	202	1	0.66	0.66	NUM
admet-2901	202	2	0.98	0.98	NUM
admet-2901	202	3	0.55	0.55	NUM
admet-2901	202	4	0.83	0.83	NUM
admet-2901	202	5	0.56	0.56	NUM
admet-2901	202	6	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	NOUN
admet-2901	202	7	n.	n.	NOUN
admet-2901	202	8	chabang	chabang	PROPN
admet-2901	202	9	et	et	PROPN
admet-2901	202	10	al	al	PROPN
admet-2901	202	11	.	.	PROPN
admet-2901	202	12	admet	admet	PROPN
admet-2901	202	13	&	&	CCONJ
admet-2901	202	14	dmpk	dmpk	PROPN
admet-2901	202	15	13(5	13(5	NUM
admet-2901	202	16	)	)	PUNCT
admet-2901	202	17	(	(	PUNCT
admet-2901	202	18	2025	2025	NUM
admet-2901	202	19	)	)	PUNCT
admet-2901	202	20	2901	2901	NUM
admet-2901	202	21	10	10	NUM
admet-2901	202	22	molecular	molecular	ADJ
admet-2901	202	23	docking	docking	NOUN
admet-2901	202	24	and	and	CCONJ
admet-2901	202	25	structural	structural	ADJ
admet-2901	202	26	analysis	analysis	NOUN
admet-2901	202	27	of	of	ADP
admet-2901	202	28	cleistanthin	cleistanthin	NOUN
admet-2901	202	29	a	a	PRON
admet-2901	202	30	and	and	CCONJ
admet-2901	202	31	a	a	DET
admet-2901	202	32	new	new	ADJ
admet-2901	202	33	xanthone	xanthone	NOUN
admet-2901	202	34	as	as	ADP
admet-2901	202	35	potential	potential	ADJ
admet-2901	202	36	v	v	NOUN
admet-2901	202	37	-	-	PUNCT
admet-2901	202	38	atpase	atpase	ADJ
admet-2901	202	39	inhibitors	inhibitor	NOUN
admet-2901	202	40	cleistanthin	cleistanthin	VERB
admet-2901	202	41	a	a	PRON
admet-2901	202	42	has	have	AUX
admet-2901	202	43	been	be	AUX
admet-2901	202	44	previously	previously	ADV
admet-2901	202	45	reported	report	VERB
admet-2901	202	46	to	to	PART
admet-2901	202	47	exhibit	exhibit	VERB
admet-2901	202	48	anticancer	anticancer	NOUN
admet-2901	202	49	activity	activity	NOUN
admet-2901	202	50	through	through	ADP
admet-2901	202	51	inhibition	inhibition	NOUN
admet-2901	202	52	of	of	ADP
admet-2901	202	53	v	v	NOUN
admet-2901	202	54	-	-	PUNCT
admet-2901	202	55	atpase	atpase	NOUN
admet-2901	202	56	,	,	PUNCT
admet-2901	202	57	leading	lead	VERB
admet-2901	202	58	to	to	ADP
admet-2901	202	59	lysosomal	lysosomal	ADJ
admet-2901	202	60	dysfunction	dysfunction	NOUN
admet-2901	202	61	and	and	CCONJ
admet-2901	202	62	subsequent	subsequent	ADJ
admet-2901	202	63	cancer	cancer	NOUN
admet-2901	202	64	cell	cell	NOUN
admet-2901	202	65	death	death	NOUN
admet-2901	203	1	[	[	X
admet-2901	203	2	29,48,49	29,48,49	NOUN
admet-2901	203	3	]	]	X
admet-2901	203	4	.	.	PUNCT
admet-2901	204	1	however	however	ADV
admet-2901	204	2	,	,	PUNCT
admet-2901	204	3	there	there	PRON
admet-2901	204	4	have	have	AUX
admet-2901	204	5	been	be	AUX
admet-2901	204	6	no	no	DET
admet-2901	204	7	reports	report	NOUN
admet-2901	204	8	of	of	ADP
admet-2901	204	9	such	such	ADJ
admet-2901	204	10	applications	application	NOUN
admet-2901	204	11	for	for	ADP
admet-2901	204	12	breast	breast	NOUN
admet-2901	204	13	cancer	cancer	NOUN
admet-2901	204	14	.	.	PUNCT
admet-2901	205	1	in	in	ADP
admet-2901	205	2	parallel	parallel	NOUN
admet-2901	205	3	,	,	PUNCT
admet-2901	205	4	xanthones	xanthone	NOUN
admet-2901	205	5	represent	represent	VERB
admet-2901	205	6	a	a	DET
admet-2901	205	7	diverse	diverse	ADJ
admet-2901	205	8	class	class	NOUN
admet-2901	205	9	of	of	ADP
admet-2901	205	10	polyphenolic	polyphenolic	ADJ
admet-2901	205	11	compounds	compound	NOUN
admet-2901	205	12	commonly	commonly	ADV
admet-2901	205	13	found	find	VERB
admet-2901	205	14	in	in	ADP
admet-2901	205	15	garcinia	garcinia	PROPN
admet-2901	205	16	species	specie	NOUN
admet-2901	205	17	,	,	PUNCT
admet-2901	205	18	many	many	ADJ
admet-2901	205	19	of	of	ADP
admet-2901	205	20	which	which	PRON
admet-2901	205	21	exhibit	exhibit	NOUN
admet-2901	205	22	anticancer	anticancer	NOUN
admet-2901	205	23	,	,	PUNCT
admet-2901	205	24	antioxidant	antioxidant	NOUN
admet-2901	205	25	,	,	PUNCT
admet-2901	205	26	and	and	CCONJ
admet-2901	205	27	antiinflammatory	antiinflammatory	NOUN
admet-2901	205	28	properties	property	NOUN
admet-2901	205	29	[	[	X
admet-2901	205	30	50	50	NUM
admet-2901	205	31	-	-	SYM
admet-2901	205	32	53	53	NUM
admet-2901	205	33	]	]	PUNCT
admet-2901	205	34	.	.	PUNCT
admet-2901	206	1	moreover	moreover	ADV
admet-2901	206	2	,	,	PUNCT
admet-2901	206	3	xanthone	xanthone	PROPN
admet-2901	206	4	derivatives	derivative	NOUN
admet-2901	206	5	,	,	PUNCT
admet-2901	206	6	particularly	particularly	ADV
admet-2901	206	7	garcinone	garcinone	NOUN
admet-2901	206	8	e	e	NOUN
admet-2901	206	9	,	,	PUNCT
admet-2901	206	10	have	have	AUX
admet-2901	206	11	been	be	AUX
admet-2901	206	12	previously	previously	ADV
admet-2901	206	13	shown	show	VERB
admet-2901	206	14	to	to	PART
admet-2901	206	15	have	have	VERB
admet-2901	206	16	promise	promise	NOUN
admet-2901	206	17	as	as	ADP
admet-2901	206	18	anticancer	anticancer	NOUN
admet-2901	206	19	agents	agent	NOUN
admet-2901	206	20	due	due	ADP
admet-2901	206	21	to	to	ADP
admet-2901	206	22	their	their	PRON
admet-2901	206	23	ability	ability	NOUN
admet-2901	206	24	to	to	PART
admet-2901	206	25	bind	bind	VERB
admet-2901	206	26	to	to	ADP
admet-2901	206	27	and	and	CCONJ
admet-2901	206	28	potentially	potentially	ADV
admet-2901	206	29	inhibit	inhibit	VERB
admet-2901	206	30	v	v	NOUN
admet-2901	206	31	-	-	PUNCT
admet-2901	206	32	atpase[54	atpase[54	NOUN
admet-2901	206	33	]	]	PUNCT
admet-2901	206	34	.	.	PUNCT
admet-2901	207	1	based	base	VERB
admet-2901	207	2	on	on	ADP
admet-2901	207	3	this	this	DET
admet-2901	207	4	evidence	evidence	NOUN
admet-2901	207	5	,	,	PUNCT
admet-2901	207	6	it	it	PRON
admet-2901	207	7	is	be	AUX
admet-2901	207	8	hypothesized	hypothesize	VERB
admet-2901	207	9	that	that	SCONJ
admet-2901	207	10	m.	m.	NOUN
admet-2901	207	11	glomerulatus	glomerulatus	NOUN
admet-2901	207	12	-	-	PUNCT
admet-2901	207	13	isolated	isolate	VERB
admet-2901	207	14	xanthone	xanthone	PROPN
admet-2901	207	15	(	(	PUNCT
admet-2901	207	16	1	1	X
admet-2901	207	17	)	)	PUNCT
admet-2901	207	18	might	might	AUX
admet-2901	207	19	also	also	ADV
admet-2901	207	20	interact	interact	VERB
admet-2901	207	21	with	with	ADP
admet-2901	207	22	and	and	CCONJ
admet-2901	207	23	inhibit	inhibit	VERB
admet-2901	207	24	v	v	NOUN
admet-2901	207	25	-	-	PUNCT
admet-2901	207	26	atpase	atpase	NOUN
admet-2901	207	27	.	.	PUNCT
admet-2901	208	1	this	this	DET
admet-2901	208	2	study	study	NOUN
admet-2901	208	3	aimed	aim	VERB
admet-2901	208	4	to	to	PART
admet-2901	208	5	investigate	investigate	VERB
admet-2901	208	6	whether	whether	SCONJ
admet-2901	208	7	m.	m.	NOUN
admet-2901	208	8	glomerulatus	glomerulatus	NOUN
admet-2901	208	9	-	-	PUNCT
admet-2901	208	10	isolated	isolate	VERB
admet-2901	208	11	xanthone	xanthone	PROPN
admet-2901	208	12	(	(	PUNCT
admet-2901	208	13	1	1	X
admet-2901	208	14	)	)	PUNCT
admet-2901	208	15	could	could	AUX
admet-2901	208	16	serve	serve	VERB
admet-2901	208	17	as	as	ADP
admet-2901	208	18	a	a	DET
admet-2901	208	19	novel	novel	NOUN
admet-2901	208	20	scaffold	scaffold	NOUN
admet-2901	208	21	for	for	ADP
admet-2901	208	22	v	v	NOUN
admet-2901	208	23	-	-	PUNCT
admet-2901	208	24	atpase	atpase	NOUN
admet-2901	208	25	inhibition	inhibition	NOUN
admet-2901	208	26	,	,	PUNCT
admet-2901	208	27	offering	offer	VERB
admet-2901	208	28	potential	potential	NOUN
admet-2901	208	29	for	for	ADP
admet-2901	208	30	future	future	ADJ
admet-2901	208	31	therapeutic	therapeutic	ADJ
admet-2901	208	32	development	development	NOUN
admet-2901	208	33	.	.	PUNCT
admet-2901	209	1	to	to	PART
admet-2901	209	2	investigate	investigate	VERB
admet-2901	209	3	the	the	DET
admet-2901	209	4	binding	bind	VERB
admet-2901	209	5	modes	mode	NOUN
admet-2901	209	6	and	and	CCONJ
admet-2901	209	7	affinities	affinity	NOUN
admet-2901	209	8	of	of	ADP
admet-2901	209	9	cleistanthin	cleistanthin	PROPN
admet-2901	209	10	a	a	DET
admet-2901	209	11	(	(	PUNCT
admet-2901	209	12	10	10	NUM
admet-2901	209	13	)	)	PUNCT
admet-2901	209	14	and	and	CCONJ
admet-2901	209	15	m.	m.	NOUN
admet-2901	209	16	glomerulatusisolated	glomerulatusisolate	VERB
admet-2901	209	17	xanthone	xanthone	PROPN
admet-2901	209	18	(	(	PUNCT
admet-2901	209	19	1	1	NUM
admet-2901	209	20	)	)	PUNCT
admet-2901	209	21	toward	toward	ADP
admet-2901	209	22	vacuolar	vacuolar	ADJ
admet-2901	209	23	v	v	NOUN
admet-2901	209	24	-	-	PUNCT
admet-2901	209	25	atpase	atpase	NOUN
admet-2901	209	26	,	,	PUNCT
admet-2901	209	27	a	a	DET
admet-2901	209	28	molecular	molecular	ADJ
admet-2901	209	29	docking	docking	NOUN
admet-2901	209	30	study	study	NOUN
admet-2901	209	31	was	be	AUX
admet-2901	209	32	conducted	conduct	VERB
admet-2901	209	33	.	.	PUNCT
admet-2901	210	1	both	both	DET
admet-2901	210	2	compounds	compound	NOUN
admet-2901	210	3	were	be	AUX
admet-2901	210	4	docked	dock	VERB
admet-2901	210	5	into	into	ADP
admet-2901	210	6	the	the	DET
admet-2901	210	7	interface	interface	NOUN
admet-2901	210	8	between	between	ADP
admet-2901	210	9	subunit	subunit	NOUN
admet-2901	210	10	a	a	X
admet-2901	210	11	(	(	PUNCT
admet-2901	210	12	shown	show	VERB
admet-2901	210	13	in	in	ADP
admet-2901	210	14	green	green	ADJ
admet-2901	210	15	in	in	ADP
admet-2901	210	16	figure	figure	NOUN
admet-2901	210	17	6	6	NUM
admet-2901	210	18	)	)	PUNCT
admet-2901	210	19	and	and	CCONJ
admet-2901	210	20	two	two	NUM
admet-2901	210	21	adjacent	adjacent	ADJ
admet-2901	210	22	c	c	NOUN
admet-2901	210	23	subunits	subunit	NOUN
admet-2901	210	24	(	(	PUNCT
admet-2901	210	25	shown	show	VERB
admet-2901	210	26	in	in	ADP
admet-2901	210	27	grey	grey	PROPN
admet-2901	210	28	in	in	ADP
admet-2901	210	29	figure	figure	NOUN
admet-2901	210	30	6	6	NUM
admet-2901	210	31	)	)	PUNCT
admet-2901	210	32	,	,	PUNCT
admet-2901	210	33	targeting	target	VERB
admet-2901	210	34	the	the	DET
admet-2901	210	35	same	same	ADJ
admet-2901	210	36	binding	bind	VERB
admet-2901	210	37	site	site	NOUN
admet-2901	210	38	previously	previously	ADV
admet-2901	210	39	used	use	VERB
admet-2901	210	40	for	for	ADP
admet-2901	210	41	docking	dock	VERB
admet-2901	210	42	the	the	DET
admet-2901	210	43	cleistanthin	cleistanthin	NOUN
admet-2901	210	44	a	a	DET
admet-2901	210	45	derivative	derivative	ADJ
admet-2901	210	46	,	,	PUNCT
admet-2901	210	47	ecdd	ecdd	NOUN
admet-2901	210	48	-	-	PUNCT
admet-2901	210	49	s18[29	s18[29	NOUN
admet-2901	210	50	]	]	X
admet-2901	210	51	.	.	PUNCT
admet-2901	211	1	figure	figure	NOUN
admet-2901	211	2	6	6	NUM
admet-2901	211	3	.	.	X
admet-2901	212	1	3d	3d	NUM
admet-2901	212	2	binding	bind	VERB
admet-2901	212	3	modes	mode	NOUN
admet-2901	212	4	of	of	ADP
admet-2901	212	5	cleistanthin	cleistanthin	PROPN
admet-2901	212	6	a	a	PRON
admet-2901	212	7	and	and	CCONJ
admet-2901	212	8	xanthone	xanthone	PROPN
admet-2901	212	9	at	at	ADP
admet-2901	212	10	the	the	DET
admet-2901	212	11	interface	interface	NOUN
admet-2901	212	12	between	between	ADP
admet-2901	212	13	subunit	subunit	NOUN
admet-2901	212	14	a	a	PRON
admet-2901	212	15	and	and	CCONJ
admet-2901	212	16	two	two	NUM
admet-2901	212	17	adjacent	adjacent	ADJ
admet-2901	212	18	c	c	NOUN
admet-2901	212	19	subunits	subunit	NOUN
admet-2901	212	20	of	of	ADP
admet-2901	212	21	vo	vo	PROPN
admet-2901	212	22	v	v	PROPN
admet-2901	212	23	-	-	PUNCT
admet-2901	212	24	atpase	atpase	NOUN
admet-2901	212	25	,	,	PUNCT
admet-2901	212	26	along	along	ADP
admet-2901	212	27	with	with	ADP
admet-2901	212	28	close	close	ADJ
admet-2901	212	29	-	-	PUNCT
admet-2901	212	30	up	up	ADP
admet-2901	212	31	views	view	NOUN
admet-2901	212	32	of	of	ADP
admet-2901	212	33	the	the	DET
admet-2901	212	34	binding	bind	VERB
admet-2901	212	35	residues	residue	NOUN
admet-2901	212	36	surrounding	surround	VERB
admet-2901	212	37	each	each	DET
admet-2901	212	38	compound	compound	NOUN
admet-2901	212	39	,	,	PUNCT
admet-2901	212	40	obtained	obtain	VERB
admet-2901	212	41	from	from	ADP
admet-2901	212	42	molecular	molecular	ADJ
admet-2901	212	43	docking	docking	NOUN
admet-2901	212	44	(	(	PUNCT
admet-2901	212	45	left	leave	VERB
admet-2901	212	46	panel	panel	NOUN
admet-2901	212	47	)	)	PUNCT
admet-2901	212	48	.	.	PUNCT
admet-2901	213	1	the	the	DET
admet-2901	213	2	binding	bind	VERB
admet-2901	213	3	interactions	interaction	NOUN
admet-2901	213	4	of	of	ADP
admet-2901	213	5	cleistanthin	cleistanthin	NOUN
admet-2901	213	6	a	a	PRON
admet-2901	213	7	and	and	CCONJ
admet-2901	213	8	xanthone	xanthone	NOUN
admet-2901	213	9	with	with	ADP
admet-2901	213	10	v	v	NOUN
admet-2901	213	11	-	-	PUNCT
admet-2901	213	12	atpase	atpase	PROPN
admet-2901	213	13	are	be	AUX
admet-2901	213	14	further	far	ADV
admet-2901	213	15	illustrated	illustrate	VERB
admet-2901	213	16	by	by	ADP
admet-2901	213	17	2d	2d	NUM
admet-2901	213	18	interaction	interaction	NOUN
admet-2901	213	19	diagrams	diagram	NOUN
admet-2901	213	20	(	(	PUNCT
admet-2901	213	21	right	right	ADJ
admet-2901	213	22	panel	panel	NOUN
admet-2901	213	23	)	)	PUNCT
admet-2901	213	24	.	.	PUNCT
admet-2901	214	1	*	*	PUNCT
admet-2901	214	2	residues	residue	NOUN
admet-2901	214	3	from	from	ADP
admet-2901	214	4	the	the	DET
admet-2901	214	5	second	second	ADJ
admet-2901	214	6	(	(	PUNCT
admet-2901	214	7	adjacent	adjacent	ADJ
admet-2901	214	8	)	)	PUNCT
admet-2901	214	9	c	c	NOUN
admet-2901	214	10	subunit	subunit	NOUN
admet-2901	214	11	the	the	DET
admet-2901	214	12	docking	docking	NOUN
admet-2901	214	13	results	result	NOUN
admet-2901	214	14	revealed	reveal	VERB
admet-2901	214	15	that	that	SCONJ
admet-2901	214	16	cleistanthin	cleistanthin	VERB
admet-2901	214	17	a	a	DET
admet-2901	214	18	(	(	PUNCT
admet-2901	214	19	10	10	NUM
admet-2901	214	20	)	)	PUNCT
admet-2901	214	21	bound	bind	VERB
admet-2901	214	22	to	to	ADP
admet-2901	214	23	v	v	NOUN
admet-2901	214	24	-	-	PUNCT
admet-2901	214	25	atpase	atpase	NOUN
admet-2901	214	26	with	with	ADP
admet-2901	214	27	a	a	DET
admet-2901	214	28	binding	bind	VERB
admet-2901	214	29	energy	energy	NOUN
admet-2901	214	30	of	of	ADP
admet-2901	214	31	-29.3	-29.3	PROPN
admet-2901	214	32	kj·mol⁻¹	kj·mol⁻¹	PROPN
admet-2901	214	33	(	(	PUNCT
admet-2901	214	34	-70	-70	PROPN
admet-2901	214	35	kcal·mol⁻¹	kcal·mol⁻¹	PROPN
admet-2901	214	36	)	)	PUNCT
admet-2901	214	37	,	,	PUNCT
admet-2901	214	38	while	while	SCONJ
admet-2901	214	39	m.	m.	NOUN
admet-2901	214	40	glomerulatus	glomerulatus	NOUN
admet-2901	214	41	-	-	PUNCT
admet-2901	214	42	isolated	isolate	VERB
admet-2901	214	43	xanthone	xanthone	PROPN
admet-2901	214	44	(	(	PUNCT
admet-2901	214	45	1	1	X
admet-2901	214	46	)	)	PUNCT
admet-2901	214	47	exhibited	exhibit	VERB
admet-2901	214	48	a	a	DET
admet-2901	214	49	slightly	slightly	ADV
admet-2901	214	50	stronger	strong	ADJ
admet-2901	214	51	binding	bind	VERB
admet-2901	214	52	energy	energy	NOUN
admet-2901	214	53	of	of	ADP
admet-2901	214	54	-31.4	-31.4	PRON
admet-2901	214	55	kj·mol-1	kj·mol-1	PROPN
admet-2901	214	56	(	(	PUNCT
admet-2901	214	57	-75	-75	PROPN
admet-2901	214	58	kcal·mol⁻1	kcal·mol⁻1	NUM
admet-2901	214	59	)	)	PUNCT
admet-2901	214	60	.	.	PUNCT
admet-2901	215	1	these	these	DET
admet-2901	215	2	findings	finding	NOUN
admet-2901	215	3	suggest	suggest	VERB
admet-2901	215	4	that	that	SCONJ
admet-2901	215	5	both	both	DET
admet-2901	215	6	compounds	compound	NOUN
admet-2901	215	7	have	have	VERB
admet-2901	215	8	a	a	DET
admet-2901	215	9	comparable	comparable	ADJ
admet-2901	215	10	ability	ability	NOUN
admet-2901	215	11	to	to	PART
admet-2901	215	12	bind	bind	VERB
admet-2901	215	13	v	v	NOUN
admet-2901	215	14	-	-	PUNCT
admet-2901	215	15	atpase	atpase	NOUN
admet-2901	215	16	,	,	PUNCT
admet-2901	215	17	potentially	potentially	ADV
admet-2901	215	18	disrupting	disrupt	VERB
admet-2901	215	19	the	the	DET
admet-2901	215	20	rotation	rotation	NOUN
admet-2901	215	21	of	of	ADP
admet-2901	215	22	the	the	DET
admet-2901	215	23	c	c	PROPN
admet-2901	215	24	ring	ring	NOUN
admet-2901	215	25	at	at	ADP
admet-2901	215	26	the	the	DET
admet-2901	215	27	a	a	NOUN
admet-2901	215	28	–	–	PUNCT
admet-2901	215	29	c	c	NOUN
admet-2901	215	30	interface	interface	NOUN
admet-2901	215	31	and	and	CCONJ
admet-2901	215	32	thereby	thereby	ADV
admet-2901	215	33	inhibiting	inhibit	VERB
admet-2901	215	34	v	v	NOUN
admet-2901	215	35	-	-	PUNCT
admet-2901	215	36	atpase	atpase	ADJ
admet-2901	215	37	activity	activity	NOUN
admet-2901	215	38	.	.	PUNCT
admet-2901	216	1	further	further	ADJ
admet-2901	216	2	analysis	analysis	NOUN
admet-2901	216	3	of	of	ADP
admet-2901	216	4	the	the	DET
admet-2901	216	5	2d	2d	NOUN
admet-2901	216	6	interaction	interaction	NOUN
admet-2901	216	7	diagrams	diagram	NOUN
admet-2901	216	8	revealed	reveal	VERB
admet-2901	216	9	that	that	SCONJ
admet-2901	216	10	cleistanthin	cleistanthin	VERB
admet-2901	216	11	a	a	DET
admet-2901	216	12	(	(	PUNCT
admet-2901	216	13	10	10	NUM
admet-2901	216	14	)	)	PUNCT
admet-2901	216	15	primarily	primarily	ADV
admet-2901	216	16	engaged	engage	VERB
admet-2901	216	17	in	in	ADP
admet-2901	216	18	π	π	PROPN
admet-2901	216	19	-	-	ADJ
admet-2901	216	20	alkyl	alkyl	ADJ
admet-2901	216	21	interactions	interaction	NOUN
admet-2901	216	22	with	with	ADP
admet-2901	216	23	val783	val783	NOUN
admet-2901	216	24	and	and	CCONJ
admet-2901	216	25	val784	val784	PROPN
admet-2901	216	26	(	(	PUNCT
admet-2901	216	27	subunit	subunit	NOUN
admet-2901	216	28	a	a	NOUN
admet-2901	216	29	)	)	PUNCT
admet-2901	216	30	and	and	CCONJ
admet-2901	216	31	ile58	ile58	PROPN
admet-2901	216	32	(	(	PUNCT
admet-2901	216	33	subunit	subunit	NOUN
admet-2901	216	34	c	c	PROPN
admet-2901	216	35	)	)	PUNCT
admet-2901	216	36	,	,	PUNCT
admet-2901	216	37	a	a	DET
admet-2901	216	38	π	π	PROPN
admet-2901	216	39	–	–	PUNCT
admet-2901	216	40	π	π	NOUN
admet-2901	216	41	tshaped	tshape	VERB
admet-2901	216	42	interaction	interaction	NOUN
admet-2901	216	43	with	with	ADP
admet-2901	216	44	phe135	phe135	PROPN
admet-2901	216	45	(	(	PUNCT
admet-2901	216	46	adjacent	adjacent	ADJ
admet-2901	216	47	c	c	NOUN
admet-2901	216	48	subunit	subunit	NOUN
admet-2901	216	49	)	)	PUNCT
admet-2901	216	50	,	,	PUNCT
admet-2901	216	51	and	and	CCONJ
admet-2901	216	52	non	non	ADJ
admet-2901	216	53	-	-	ADJ
admet-2901	216	54	classical	classical	ADJ
admet-2901	216	55	carbon	carbon	NOUN
admet-2901	216	56	–	–	PUNCT
admet-2901	216	57	hydrogen	hydrogen	NOUN
admet-2901	216	58	bonding	bonding	NOUN
admet-2901	216	59	with	with	ADP
admet-2901	216	60	gly61	gly61	PROPN
admet-2901	216	61	admet	admet	PROPN
admet-2901	216	62	&	&	CCONJ
admet-2901	216	63	dmpk	dmpk	PROPN
admet-2901	216	64	13(5	13(5	NOUN
admet-2901	216	65	)	)	PUNCT
admet-2901	216	66	(	(	PUNCT
admet-2901	216	67	2025	2025	NUM
admet-2901	216	68	)	)	PUNCT
admet-2901	216	69	2901	2901	NUM
admet-2901	216	70	new	new	ADJ
admet-2901	216	71	xanthone	xanthone	PROPN
admet-2901	216	72	and	and	CCONJ
admet-2901	216	73	chemical	chemical	NOUN
admet-2901	216	74	constituents	constituent	NOUN
admet-2901	216	75	from	from	ADP
admet-2901	216	76	mallotus	mallotus	ADJ
admet-2901	216	77	glomerulatus	glomerulatus	NOUN
admet-2901	216	78	doi	doi	PROPN
admet-2901	216	79	:	:	PUNCT
admet-2901	216	80	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	NOUN
admet-2901	216	81	11	11	NUM
admet-2901	216	82	(	(	PUNCT
admet-2901	216	83	subunit	subunit	NOUN
admet-2901	216	84	c	c	NOUN
admet-2901	216	85	)	)	PUNCT
admet-2901	216	86	.	.	PUNCT
admet-2901	217	1	similarly	similarly	ADV
admet-2901	217	2	,	,	PUNCT
admet-2901	217	3	m.	m.	NOUN
admet-2901	217	4	glomerulatus	glomerulatus	NOUN
admet-2901	217	5	-	-	PUNCT
admet-2901	217	6	isolated	isolate	VERB
admet-2901	217	7	xanthone	xanthone	PROPN
admet-2901	217	8	(	(	PUNCT
admet-2901	217	9	1	1	X
admet-2901	217	10	)	)	PUNCT
admet-2901	217	11	formed	form	VERB
admet-2901	217	12	multiple	multiple	ADJ
admet-2901	217	13	interactions	interaction	NOUN
admet-2901	217	14	with	with	ADP
admet-2901	217	15	residues	residue	NOUN
admet-2901	217	16	from	from	ADP
admet-2901	217	17	subunits	subunit	NOUN
admet-2901	217	18	a	a	PRON
admet-2901	217	19	and	and	CCONJ
admet-2901	217	20	c.	c.	NOUN
admet-2901	217	21	the	the	DET
admet-2901	217	22	m.	m.	NOUN
admet-2901	217	23	glomerulatus	glomerulatus	NOUN
admet-2901	217	24	-	-	PUNCT
admet-2901	217	25	isolated	isolate	VERB
admet-2901	217	26	xanthone	xanthone	PROPN
admet-2901	217	27	(	(	PUNCT
admet-2901	217	28	1	1	X
admet-2901	217	29	)	)	PUNCT
admet-2901	217	30	moiety	moiety	NOUN
admet-2901	217	31	established	establish	VERB
admet-2901	217	32	π	π	PROPN
admet-2901	217	33	-	-	ADJ
admet-2901	217	34	alkyl	alkyl	ADJ
admet-2901	217	35	interactions	interaction	NOUN
admet-2901	217	36	with	with	ADP
admet-2901	217	37	ile58	ile58	PROPN
admet-2901	217	38	(	(	PUNCT
admet-2901	217	39	subunit	subunit	NOUN
admet-2901	217	40	c	c	NOUN
admet-2901	217	41	)	)	PUNCT
admet-2901	217	42	,	,	PUNCT
admet-2901	217	43	ala783	ala783	PROPN
admet-2901	217	44	,	,	PUNCT
admet-2901	217	45	and	and	CCONJ
admet-2901	217	46	leu787	leu787	NOUN
admet-2901	217	47	(	(	PUNCT
admet-2901	217	48	subunit	subunit	NOUN
admet-2901	217	49	a	a	NOUN
admet-2901	217	50	)	)	PUNCT
admet-2901	217	51	,	,	PUNCT
admet-2901	217	52	as	as	ADV
admet-2901	217	53	well	well	ADV
admet-2901	217	54	as	as	ADP
admet-2901	217	55	π	π	NOUN
admet-2901	217	56	-	-	NOUN
admet-2901	217	57	sulphur	sulphur	ADJ
admet-2901	217	58	and	and	CCONJ
admet-2901	217	59	sulphur	sulphur	NOUN
admet-2901	217	60	-	-	PUNCT
admet-2901	217	61	x	x	NOUN
admet-2901	217	62	interactions	interaction	NOUN
admet-2901	217	63	with	with	ADP
admet-2901	217	64	met788	met788	PROPN
admet-2901	217	65	(	(	PUNCT
admet-2901	217	66	subunit	subunit	NOUN
admet-2901	217	67	a	a	NOUN
admet-2901	217	68	)	)	PUNCT
admet-2901	217	69	.	.	PUNCT
admet-2901	218	1	additionally	additionally	ADV
admet-2901	218	2	,	,	PUNCT
admet-2901	218	3	the	the	DET
admet-2901	218	4	methylbutene	methylbutene	NOUN
admet-2901	218	5	groups	group	NOUN
admet-2901	218	6	located	locate	VERB
admet-2901	218	7	on	on	ADP
admet-2901	218	8	both	both	DET
admet-2901	218	9	sides	side	NOUN
admet-2901	218	10	of	of	ADP
admet-2901	218	11	the	the	DET
admet-2901	218	12	m.	m.	NOUN
admet-2901	218	13	glomerulatus	glomerulatus	NOUN
admet-2901	218	14	-	-	PUNCT
admet-2901	218	15	isolated	isolate	VERB
admet-2901	218	16	xanthone	xanthone	PROPN
admet-2901	218	17	(	(	PUNCT
admet-2901	218	18	1	1	X
admet-2901	218	19	)	)	PUNCT
admet-2901	218	20	structure	structure	NOUN
admet-2901	218	21	engaged	engage	VERB
admet-2901	218	22	in	in	ADP
admet-2901	218	23	π	π	PROPN
admet-2901	218	24	-	-	ADJ
admet-2901	218	25	alkyl	alkyl	ADJ
admet-2901	218	26	interactions	interaction	NOUN
admet-2901	218	27	with	with	ADP
admet-2901	218	28	phe126	phe126	PROPN
admet-2901	218	29	and	and	CCONJ
admet-2901	218	30	phe135	phe135	NOUN
admet-2901	218	31	,	,	PUNCT
admet-2901	218	32	and	and	CCONJ
admet-2901	218	33	alkyl	alkyl	ADJ
admet-2901	218	34	interactions	interaction	NOUN
admet-2901	218	35	with	with	ADP
admet-2901	218	36	val55	val55	NOUN
admet-2901	218	37	,	,	PUNCT
admet-2901	218	38	ile62	ile62	NOUN
admet-2901	218	39	,	,	PUNCT
admet-2901	218	40	ile65	ile65	NOUN
admet-2901	218	41	,	,	PUNCT
admet-2901	218	42	and	and	CCONJ
admet-2901	218	43	ile130	ile130	PROPN
admet-2901	218	44	.	.	PUNCT
admet-2901	219	1	discussion	discussion	NOUN
admet-2901	219	2	the	the	DET
admet-2901	219	3	phytochemical	phytochemical	ADJ
admet-2901	219	4	analysis	analysis	NOUN
admet-2901	219	5	of	of	ADP
admet-2901	219	6	mallotus	mallotus	ADJ
admet-2901	219	7	glomerulatus	glomerulatus	NOUN
admet-2901	219	8	,	,	PUNCT
admet-2901	219	9	an	an	DET
admet-2901	219	10	underexplored	underexplored	ADJ
admet-2901	219	11	member	member	NOUN
admet-2901	219	12	of	of	ADP
admet-2901	219	13	the	the	DET
admet-2901	219	14	euphorbiaceae	euphorbiaceae	PROPN
admet-2901	219	15	family	family	NOUN
admet-2901	219	16	,	,	PUNCT
admet-2901	219	17	resulted	result	VERB
admet-2901	219	18	in	in	ADP
admet-2901	219	19	the	the	DET
admet-2901	219	20	successful	successful	ADJ
admet-2901	219	21	isolation	isolation	NOUN
admet-2901	219	22	and	and	CCONJ
admet-2901	219	23	structural	structural	ADJ
admet-2901	219	24	elucidation	elucidation	NOUN
admet-2901	219	25	of	of	ADP
admet-2901	219	26	a	a	DET
admet-2901	219	27	novel	novel	NOUN
admet-2901	219	28	xanthone	xanthone	PROPN
admet-2901	219	29	,	,	PUNCT
admet-2901	219	30	(	(	PUNCT
admet-2901	219	31	3,4,5)-trihydroxy	3,4,5)-trihydroxy	NUM
admet-2901	219	32	-6	-6	ADV
admet-2901	219	33	-	-	PUNCT
admet-2901	219	34	methoxy-2,7	methoxy-2,7	NOUN
admet-2901	219	35	-	-	PUNCT
admet-2901	219	36	bis(3	bis(3	NOUN
admet-2901	219	37	-	-	PUNCT
admet-2901	219	38	methylbut-2	methylbut-2	NUM
admet-2901	219	39	-	-	PUNCT
admet-2901	219	40	en-1	en-1	NOUN
admet-2901	219	41	-	-	PUNCT
admet-2901	219	42	yl)-9h	yl)-9h	NOUN
admet-2901	219	43	-	-	PUNCT
admet-2901	219	44	xanthen-9	xanthen-9	NUM
admet-2901	219	45	-	-	PUNCT
admet-2901	219	46	one	one	NUM
admet-2901	219	47	.	.	PUNCT
admet-2901	220	1	this	this	DET
admet-2901	220	2	compound	compound	NOUN
admet-2901	220	3	represents	represent	VERB
admet-2901	220	4	the	the	DET
admet-2901	220	5	first	first	ADJ
admet-2901	220	6	xanthone	xanthone	PROPN
admet-2901	220	7	reported	report	VERB
admet-2901	220	8	from	from	ADP
admet-2901	220	9	m.	m.	NOUN
admet-2901	220	10	glomerulatus	glomerulatus	NOUN
admet-2901	220	11	,	,	PUNCT
admet-2901	220	12	thereby	thereby	ADV
admet-2901	220	13	contributing	contribute	VERB
admet-2901	220	14	new	new	ADJ
admet-2901	220	15	structural	structural	ADJ
admet-2901	220	16	data	datum	NOUN
admet-2901	220	17	to	to	ADP
admet-2901	220	18	the	the	DET
admet-2901	220	19	limited	limited	ADJ
admet-2901	220	20	phytochemical	phytochemical	ADJ
admet-2901	220	21	record	record	NOUN
admet-2901	220	22	of	of	ADP
admet-2901	220	23	this	this	DET
admet-2901	220	24	endemic	endemic	ADJ
admet-2901	220	25	thai	thai	NOUN
admet-2901	220	26	species	specie	NOUN
admet-2901	220	27	[	[	X
admet-2901	220	28	9,12,33	9,12,33	NUM
admet-2901	220	29	]	]	PUNCT
admet-2901	220	30	.	.	PUNCT
admet-2901	221	1	the	the	DET
admet-2901	221	2	presence	presence	NOUN
admet-2901	221	3	of	of	ADP
admet-2901	221	4	a	a	DET
admet-2901	221	5	xanthone	xanthone	NOUN
admet-2901	221	6	framework	framework	NOUN
admet-2901	221	7	within	within	ADP
admet-2901	221	8	this	this	DET
admet-2901	221	9	plant	plant	NOUN
admet-2901	221	10	genus	genus	NOUN
admet-2901	221	11	is	be	AUX
admet-2901	221	12	of	of	ADP
admet-2901	221	13	particular	particular	ADJ
admet-2901	221	14	interest	interest	NOUN
admet-2901	221	15	,	,	PUNCT
admet-2901	221	16	as	as	SCONJ
admet-2901	221	17	such	such	ADJ
admet-2901	221	18	structures	structure	NOUN
admet-2901	221	19	have	have	AUX
admet-2901	221	20	been	be	AUX
admet-2901	221	21	predominantly	predominantly	ADV
admet-2901	221	22	reported	report	VERB
admet-2901	221	23	in	in	ADP
admet-2901	221	24	unrelated	unrelated	ADJ
admet-2901	221	25	genera	genera	NOUN
admet-2901	221	26	such	such	ADJ
admet-2901	221	27	as	as	ADP
admet-2901	221	28	garcinia	garcinia	PROPN
admet-2901	221	29	,	,	PUNCT
admet-2901	221	30	swertia	swertia	PROPN
admet-2901	221	31	,	,	PUNCT
admet-2901	221	32	and	and	CCONJ
admet-2901	221	33	calophyllum	calophyllum	PROPN
admet-2901	221	34	,	,	PUNCT
admet-2901	221	35	where	where	SCONJ
admet-2901	221	36	they	they	PRON
admet-2901	221	37	exhibit	exhibit	VERB
admet-2901	221	38	significant	significant	ADJ
admet-2901	221	39	biological	biological	ADJ
admet-2901	221	40	activities	activity	NOUN
admet-2901	221	41	[	[	X
admet-2901	221	42	50,52	50,52	NUM
admet-2901	221	43	]	]	PUNCT
admet-2901	221	44	.	.	PUNCT
admet-2901	222	1	the	the	DET
admet-2901	222	2	structural	structural	ADJ
admet-2901	222	3	features	feature	NOUN
admet-2901	222	4	of	of	ADP
admet-2901	222	5	the	the	DET
admet-2901	222	6	new	new	ADJ
admet-2901	222	7	compound	compound	NOUN
admet-2901	222	8	were	be	AUX
admet-2901	222	9	thoroughly	thoroughly	ADV
admet-2901	222	10	confirmed	confirm	VERB
admet-2901	222	11	using	use	VERB
admet-2901	222	12	modern	modern	ADJ
admet-2901	222	13	spectroscopic	spectroscopic	ADJ
admet-2901	222	14	techniques	technique	NOUN
admet-2901	222	15	,	,	PUNCT
admet-2901	222	16	including	include	VERB
admet-2901	222	17	uv	uv	NOUN
admet-2901	222	18	,	,	PUNCT
admet-2901	222	19	ir	ir	PROPN
admet-2901	222	20	,	,	PUNCT
admet-2901	222	21	1d	1d	NUM
admet-2901	222	22	and	and	CCONJ
admet-2901	222	23	2d	2d	NUM
admet-2901	222	24	nmr	nmr	NOUN
admet-2901	222	25	,	,	PUNCT
admet-2901	222	26	and	and	CCONJ
admet-2901	222	27	high	high	ADJ
admet-2901	222	28	-	-	PUNCT
admet-2901	222	29	resolution	resolution	NOUN
admet-2901	222	30	mass	mass	NOUN
admet-2901	222	31	spectrometry	spectrometry	NOUN
admet-2901	222	32	.	.	PUNCT
admet-2901	223	1	the	the	DET
admet-2901	223	2	ir	ir	PROPN
admet-2901	223	3	spectrum	spectrum	NOUN
admet-2901	223	4	showed	show	VERB
admet-2901	223	5	characteristic	characteristic	ADJ
admet-2901	223	6	signals	signal	NOUN
admet-2901	223	7	for	for	ADP
admet-2901	223	8	phenolic	phenolic	ADJ
admet-2901	223	9	hydroxyl	hydroxyl	NOUN
admet-2901	223	10	(	(	PUNCT
admet-2901	223	11	3420	3420	NUM
admet-2901	223	12	cm⁻¹	cm⁻¹	NOUN
admet-2901	223	13	)	)	PUNCT
admet-2901	223	14	,	,	PUNCT
admet-2901	223	15	aromatic	aromatic	NOUN
admet-2901	223	16	and	and	CCONJ
admet-2901	223	17	aliphatic	aliphatic	ADJ
admet-2901	223	18	c	c	NOUN
admet-2901	223	19	–	–	PUNCT
admet-2901	223	20	h	h	NOUN
admet-2901	223	21	stretching	stretching	NOUN
admet-2901	223	22	,	,	PUNCT
admet-2901	223	23	and	and	CCONJ
admet-2901	223	24	conjugated	conjugate	VERB
admet-2901	223	25	c	c	X
admet-2901	223	26	=	=	X
admet-2901	223	27	o	o	X
admet-2901	223	28	(	(	PUNCT
admet-2901	223	29	1609	1609	NUM
admet-2901	223	30	cm⁻¹	cm⁻¹	NOUN
admet-2901	223	31	)	)	PUNCT
admet-2901	223	32	,	,	PUNCT
admet-2901	223	33	consistent	consistent	ADJ
admet-2901	223	34	with	with	ADP
admet-2901	223	35	xanthonoid	xanthonoid	PROPN
admet-2901	223	36	structures	structure	NOUN
admet-2901	223	37	previously	previously	ADV
admet-2901	223	38	isolated	isolate	VERB
admet-2901	223	39	from	from	ADP
admet-2901	223	40	medicinal	medicinal	ADJ
admet-2901	223	41	plants[53	plants[53	NOUN
admet-2901	223	42	]	]	PUNCT
admet-2901	223	43	.	.	PUNCT
admet-2901	224	1	uv	uv	NOUN
admet-2901	224	2	absorption	absorption	NOUN
admet-2901	224	3	maxima	maxima	NOUN
admet-2901	224	4	at	at	ADP
admet-2901	224	5	243	243	NUM
admet-2901	224	6	,	,	PUNCT
admet-2901	224	7	258	258	NUM
admet-2901	224	8	,	,	PUNCT
admet-2901	224	9	316	316	NUM
admet-2901	224	10	and	and	CCONJ
admet-2901	224	11	354	354	NUM
admet-2901	224	12	nm	nm	NOUN
admet-2901	224	13	further	far	ADV
admet-2901	224	14	supported	support	VERB
admet-2901	224	15	the	the	DET
admet-2901	224	16	existence	existence	NOUN
admet-2901	224	17	of	of	ADP
admet-2901	224	18	a	a	DET
admet-2901	224	19	highly	highly	ADV
admet-2901	224	20	conjugated	conjugate	VERB
admet-2901	224	21	aromatic	aromatic	ADJ
admet-2901	224	22	system	system	NOUN
admet-2901	224	23	typical	typical	ADJ
admet-2901	224	24	of	of	ADP
admet-2901	224	25	polyhydroxylated	polyhydroxylate	VERB
admet-2901	224	26	xanthones[52	xanthones[52	NOUN
admet-2901	224	27	]	]	PUNCT
admet-2901	224	28	.	.	PUNCT
admet-2901	225	1	the	the	DET
admet-2901	225	2	¹h	¹h	NOUN
admet-2901	225	3	and	and	CCONJ
admet-2901	225	4	¹³c	¹³c	NOUN
admet-2901	225	5	nmr	nmr	NOUN
admet-2901	225	6	spectra	spectra	PROPN
admet-2901	225	7	revealed	reveal	VERB
admet-2901	225	8	a	a	DET
admet-2901	225	9	symmetric	symmetric	ADJ
admet-2901	225	10	substitution	substitution	NOUN
admet-2901	225	11	pattern	pattern	NOUN
admet-2901	225	12	:	:	PUNCT
admet-2901	225	13	hydroxyl	hydroxyl	NOUN
admet-2901	225	14	groups	group	NOUN
admet-2901	225	15	at	at	ADP
admet-2901	225	16	positions	position	NOUN
admet-2901	225	17	c-3	c-3	PROPN
admet-2901	225	18	,	,	PUNCT
admet-2901	225	19	c-4	c-4	NOUN
admet-2901	225	20	,	,	PUNCT
admet-2901	225	21	and	and	CCONJ
admet-2901	225	22	c-5	c-5	NOUN
admet-2901	225	23	,	,	PUNCT
admet-2901	225	24	and	and	CCONJ
admet-2901	225	25	a	a	DET
admet-2901	225	26	methoxy	methoxy	ADJ
admet-2901	225	27	group	group	NOUN
admet-2901	225	28	at	at	ADP
admet-2901	225	29	c-6	c-6	NOUN
admet-2901	225	30	on	on	ADP
admet-2901	225	31	ring	ring	NOUN
admet-2901	225	32	a	a	PRON
admet-2901	225	33	,	,	PUNCT
admet-2901	225	34	with	with	ADP
admet-2901	225	35	two	two	NUM
admet-2901	225	36	prenyl	prenyl	NOUN
admet-2901	225	37	(	(	PUNCT
admet-2901	225	38	3	3	NUM
admet-2901	225	39	-	-	PUNCT
admet-2901	225	40	methylbut-2	methylbut-2	NUM
admet-2901	225	41	-	-	PUNCT
admet-2901	225	42	en-1	en-1	NOUN
admet-2901	225	43	-	-	PUNCT
admet-2901	225	44	yl	yl	NOUN
admet-2901	225	45	)	)	PUNCT
admet-2901	225	46	side	side	NOUN
admet-2901	225	47	chains	chain	NOUN
admet-2901	225	48	symmetrically	symmetrically	ADV
admet-2901	225	49	located	locate	VERB
admet-2901	225	50	at	at	ADP
admet-2901	225	51	c-2	c-2	NOUN
admet-2901	225	52	and	and	CCONJ
admet-2901	225	53	c-7	c-7	PROPN
admet-2901	225	54	.	.	PUNCT
admet-2901	226	1	this	this	DET
admet-2901	226	2	arrangement	arrangement	NOUN
admet-2901	226	3	closely	closely	ADV
admet-2901	226	4	resembles	resemble	VERB
admet-2901	226	5	the	the	DET
admet-2901	226	6	substitution	substitution	NOUN
admet-2901	226	7	patterns	pattern	NOUN
admet-2901	226	8	found	find	VERB
admet-2901	226	9	in	in	ADP
admet-2901	226	10	cytotoxic	cytotoxic	ADJ
admet-2901	226	11	xanthones	xanthone	NOUN
admet-2901	226	12	,	,	PUNCT
admet-2901	226	13	such	such	ADJ
admet-2901	226	14	as	as	ADP
admet-2901	226	15	α	α	NOUN
admet-2901	226	16	-	-	PUNCT
admet-2901	226	17	mangostin	mangostin	NOUN
admet-2901	226	18	and	and	CCONJ
admet-2901	226	19	garcinone	garcinone	NOUN
admet-2901	226	20	e	e	NOUN
admet-2901	226	21	,	,	PUNCT
admet-2901	226	22	both	both	PRON
admet-2901	226	23	of	of	ADP
admet-2901	226	24	which	which	PRON
admet-2901	226	25	demonstrate	demonstrate	VERB
admet-2901	226	26	high	high	ADJ
admet-2901	226	27	selectivity	selectivity	NOUN
admet-2901	226	28	toward	toward	ADP
admet-2901	226	29	tumour	tumour	ADJ
admet-2901	226	30	cells[51,54	cells[51,54	NOUN
admet-2901	226	31	]	]	PUNCT
admet-2901	226	32	.	.	PUNCT
admet-2901	227	1	the	the	DET
admet-2901	227	2	novel	novel	NOUN
admet-2901	227	3	prenylated	prenylate	VERB
admet-2901	227	4	xanthone	xanthone	PROPN
admet-2901	227	5	(	(	PUNCT
admet-2901	227	6	compound	compound	NOUN
admet-2901	227	7	 	 	SPACE
admet-2901	227	8	1	1	NUM
admet-2901	227	9	)	)	PUNCT
admet-2901	227	10	and	and	CCONJ
admet-2901	227	11	cleistanthin	cleistanthin	NOUN
admet-2901	227	12	 	 	SPACE
admet-2901	227	13	a	a	DET
admet-2901	227	14	(	(	PUNCT
admet-2901	227	15	compound	compound	NOUN
admet-2901	227	16	 	 	SPACE
admet-2901	227	17	10	10	NUM
admet-2901	227	18	)	)	PUNCT
admet-2901	227	19	exhibited	exhibit	VERB
admet-2901	227	20	significant	significant	ADJ
admet-2901	227	21	cytotoxicity	cytotoxicity	NOUN
admet-2901	227	22	against	against	ADP
admet-2901	227	23	breast	breast	NOUN
admet-2901	227	24	cancer	cancer	NOUN
admet-2901	227	25	cell	cell	NOUN
admet-2901	227	26	lines	line	NOUN
admet-2901	227	27	.	.	PUNCT
admet-2901	228	1	compound	compound	NOUN
admet-2901	228	2	1	1	NUM
admet-2901	228	3	showed	show	VERB
admet-2901	228	4	pronounced	pronounce	VERB
admet-2901	228	5	activity	activity	NOUN
admet-2901	228	6	against	against	ADP
admet-2901	228	7	mcf-7	mcf-7	NOUN
admet-2901	228	8	cells	cell	NOUN
admet-2901	228	9	,	,	PUNCT
admet-2901	228	10	consistent	consistent	ADJ
admet-2901	228	11	with	with	ADP
admet-2901	228	12	the	the	DET
admet-2901	228	13	literature	literature	NOUN
admet-2901	228	14	,	,	PUNCT
admet-2901	228	15	which	which	PRON
admet-2901	228	16	demonstrates	demonstrate	VERB
admet-2901	228	17	that	that	SCONJ
admet-2901	228	18	prenylated	prenylate	VERB
admet-2901	228	19	xanthones	xanthone	NOUN
admet-2901	228	20	,	,	PUNCT
admet-2901	228	21	especially	especially	ADV
admet-2901	228	22	those	those	PRON
admet-2901	228	23	with	with	ADP
admet-2901	228	24	c-2	c-2	NOUN
admet-2901	228	25	prenylation	prenylation	NOUN
admet-2901	228	26	,	,	PUNCT
admet-2901	228	27	possess	possess	VERB
admet-2901	228	28	enhanced	enhanced	ADJ
admet-2901	228	29	efficacy	efficacy	NOUN
admet-2901	228	30	against	against	ADP
admet-2901	228	31	er	er	ADJ
admet-2901	228	32	-	-	PUNCT
admet-2901	228	33	positive	positive	ADJ
admet-2901	228	34	tumors	tumor	NOUN
admet-2901	228	35	by	by	ADP
admet-2901	228	36	increasing	increase	VERB
admet-2901	228	37	lipophilicity	lipophilicity	NOUN
admet-2901	228	38	,	,	PUNCT
admet-2901	228	39	membrane	membrane	NOUN
admet-2901	228	40	permeability	permeability	NOUN
admet-2901	228	41	,	,	PUNCT
admet-2901	228	42	and	and	CCONJ
admet-2901	228	43	possibly	possibly	ADV
admet-2901	228	44	modulating	modulate	VERB
admet-2901	228	45	the	the	DET
admet-2901	228	46	estrogen	estrogen	NOUN
admet-2901	228	47	receptor	receptor	NOUN
admet-2901	228	48	.	.	PUNCT
admet-2901	229	1	for	for	ADP
admet-2901	229	2	instance	instance	NOUN
admet-2901	229	3	,	,	PUNCT
admet-2901	229	4	prenylated	prenylate	VERB
admet-2901	229	5	xanthones	xanthone	NOUN
admet-2901	229	6	such	such	ADJ
admet-2901	229	7	as	as	ADP
admet-2901	229	8	those	those	PRON
admet-2901	229	9	from	from	ADP
admet-2901	229	10	garcinia	garcinia	PROPN
admet-2901	229	11	mangostana	mangostana	PROPN
admet-2901	229	12	and	and	CCONJ
admet-2901	229	13	garcinia	garcinia	PROPN
admet-2901	229	14	mckeaniana	mckeaniana	PROPN
admet-2901	229	15	have	have	AUX
admet-2901	229	16	demonstrated	demonstrate	VERB
admet-2901	229	17	nm	nm	ADJ
admet-2901	229	18	-	-	ADJ
admet-2901	229	19	range	range	ADJ
admet-2901	229	20	ic50	ic50	PROPN
admet-2901	229	21	values	value	NOUN
admet-2901	229	22	in	in	ADP
admet-2901	229	23	both	both	PRON
admet-2901	229	24	er	er	INTJ
admet-2901	229	25	-	-	PUNCT
admet-2901	229	26	positive	positive	ADJ
admet-2901	229	27	(	(	PUNCT
admet-2901	229	28	mcf‑7	mcf‑7	NUM
admet-2901	229	29	)	)	PUNCT
admet-2901	229	30	and	and	CCONJ
admet-2901	229	31	triple	triple	ADJ
admet-2901	229	32	-	-	PUNCT
admet-2901	229	33	negative	negative	ADJ
admet-2901	229	34	(	(	PUNCT
admet-2901	229	35	mda	mda	PROPN
admet-2901	229	36	-	-	PUNCT
admet-2901	229	37	mb-231	mb-231	PROPN
admet-2901	229	38	)	)	PUNCT
admet-2901	229	39	breast	breast	NOUN
admet-2901	229	40	cancer	cancer	NOUN
admet-2901	229	41	lines	line	NOUN
admet-2901	230	1	[	[	X
admet-2901	230	2	55	55	NUM
admet-2901	230	3	-	-	SYM
admet-2901	230	4	59	59	NUM
admet-2901	230	5	]	]	PUNCT
admet-2901	230	6	.	.	PUNCT
admet-2901	231	1	cleistanthin	cleistanthin	PROPN
admet-2901	231	2	 	 	SPACE
admet-2901	231	3	a	a	DET
admet-2901	231	4	exhibited	exhibit	VERB
admet-2901	231	5	broad	broad	ADJ
admet-2901	231	6	-	-	PUNCT
admet-2901	231	7	spectrum	spectrum	NOUN
admet-2901	231	8	cytotoxicity	cytotoxicity	NOUN
admet-2901	231	9	against	against	ADP
admet-2901	231	10	both	both	CCONJ
admet-2901	231	11	mcf‑7	mcf‑7	PROPN
admet-2901	231	12	and	and	CCONJ
admet-2901	231	13	mda‑mb‑231	mda‑mb‑231	PROPN
admet-2901	231	14	,	,	PUNCT
admet-2901	231	15	in	in	ADP
admet-2901	231	16	line	line	NOUN
admet-2901	231	17	with	with	ADP
admet-2901	231	18	previous	previous	ADJ
admet-2901	231	19	observations	observation	NOUN
admet-2901	231	20	from	from	ADP
admet-2901	231	21	colorectal	colorectal	ADJ
admet-2901	231	22	,	,	PUNCT
admet-2901	231	23	cervical	cervical	ADJ
admet-2901	231	24	,	,	PUNCT
admet-2901	231	25	melanoma	melanoma	ADJ
admet-2901	231	26	,	,	PUNCT
admet-2901	231	27	and	and	CCONJ
admet-2901	231	28	head	head	NOUN
admet-2901	231	29	-	-	PUNCT
admet-2901	231	30	and	and	CCONJ
admet-2901	231	31	-	-	PUNCT
admet-2901	231	32	neck	neck	NOUN
admet-2901	231	33	cancer	cancer	NOUN
admet-2901	231	34	cell	cell	NOUN
admet-2901	231	35	lines	line	NOUN
admet-2901	231	36	,	,	PUNCT
admet-2901	231	37	where	where	SCONJ
admet-2901	231	38	apoptosis	apoptosis	NOUN
admet-2901	231	39	,	,	PUNCT
admet-2901	231	40	mitochondrial	mitochondrial	ADJ
admet-2901	231	41	dysfunction	dysfunction	NOUN
admet-2901	231	42	,	,	PUNCT
admet-2901	231	43	and	and	CCONJ
admet-2901	231	44	v‑atpase	v‑atpase	VERB
admet-2901	231	45	inhibition	inhibition	NOUN
admet-2901	231	46	were	be	AUX
admet-2901	231	47	key	key	ADJ
admet-2901	231	48	mechanisms	mechanism	NOUN
admet-2901	231	49	[	[	X
admet-2901	231	50	48,49,60	48,49,60	NUM
admet-2901	231	51	]	]	PUNCT
admet-2901	231	52	.	.	PUNCT
admet-2901	232	1	the	the	DET
admet-2901	232	2	dose	dose	NOUN
admet-2901	232	3	-	-	PUNCT
admet-2901	232	4	response	response	NOUN
admet-2901	232	5	experiments	experiment	NOUN
admet-2901	232	6	demonstrated	demonstrate	VERB
admet-2901	232	7	that	that	SCONJ
admet-2901	232	8	cleistanthin	cleistanthin	NOUN
admet-2901	232	9	a	a	PRON
admet-2901	232	10	has	have	VERB
admet-2901	232	11	ic50	ic50	PROPN
admet-2901	232	12	values	value	NOUN
admet-2901	232	13	in	in	ADP
admet-2901	232	14	the	the	DET
admet-2901	232	15	low	low	ADJ
admet-2901	232	16	-	-	PUNCT
admet-2901	232	17	nanomolar	nanomolar	ADJ
admet-2901	232	18	range	range	NOUN
admet-2901	232	19	,	,	PUNCT
admet-2901	232	20	surpassing	surpass	VERB
admet-2901	232	21	the	the	DET
admet-2901	232	22	efficacy	efficacy	NOUN
admet-2901	232	23	of	of	ADP
admet-2901	232	24	the	the	DET
admet-2901	232	25	xanthone	xanthone	PROPN
admet-2901	232	26	and	and	CCONJ
admet-2901	232	27	doxorubicin	doxorubicin	PROPN
admet-2901	232	28	.	.	PUNCT
admet-2901	233	1	this	this	DET
admet-2901	233	2	finding	finding	NOUN
admet-2901	233	3	is	be	AUX
admet-2901	233	4	consistent	consistent	ADJ
admet-2901	233	5	with	with	ADP
admet-2901	233	6	wongpan	wongpan	PROPN
admet-2901	233	7	et	et	PROPN
admet-2901	233	8	 	 	SPACE
admet-2901	233	9	al	al	PROPN
admet-2901	233	10	.	.	PUNCT
admet-2901	234	1	[	[	X
admet-2901	234	2	60	60	NUM
admet-2901	234	3	]	]	PUNCT
admet-2901	234	4	,	,	PUNCT
admet-2901	234	5	who	who	PRON
admet-2901	234	6	reported	report	VERB
admet-2901	234	7	a	a	DET
admet-2901	234	8	similar	similar	ADJ
admet-2901	234	9	nanomolar	nanomolar	ADJ
admet-2901	234	10	potency	potency	NOUN
admet-2901	234	11	for	for	ADP
admet-2901	234	12	cleistanthin	cleistanthin	ADJ
admet-2901	234	13	derivatives	derivative	NOUN
admet-2901	234	14	in	in	ADP
admet-2901	234	15	head	head	NOUN
admet-2901	234	16	and	and	CCONJ
admet-2901	234	17	neck	neck	NOUN
admet-2901	234	18	cancer	cancer	NOUN
admet-2901	234	19	cells	cell	NOUN
admet-2901	234	20	via	via	ADP
admet-2901	234	21	v‑atpase	v‑atpase	AUX
admet-2901	234	22	targeting	target	VERB
admet-2901	234	23	.	.	PUNCT
admet-2901	235	1	by	by	ADP
admet-2901	235	2	contrast	contrast	NOUN
admet-2901	235	3	,	,	PUNCT
admet-2901	235	4	the	the	DET
admet-2901	235	5	novel	novel	NOUN
admet-2901	235	6	xanthone	xanthone	PROPN
admet-2901	235	7	had	have	VERB
admet-2901	235	8	mid	mid	ADJ
admet-2901	235	9	-	-	ADJ
admet-2901	235	10	micromolar	micromolar	ADJ
admet-2901	235	11	ic50	ic50	PROPN
admet-2901	235	12	values	value	NOUN
admet-2901	235	13	;	;	PUNCT
admet-2901	235	14	this	this	PRON
admet-2901	235	15	aligns	align	VERB
admet-2901	235	16	with	with	ADP
admet-2901	235	17	established	establish	VERB
admet-2901	235	18	trends	trend	NOUN
admet-2901	235	19	in	in	ADP
admet-2901	235	20	xanthone	xanthone	PROPN
admet-2901	235	21	research	research	NOUN
admet-2901	235	22	,	,	PUNCT
admet-2901	235	23	where	where	SCONJ
admet-2901	235	24	non	non	ADJ
admet-2901	235	25	-	-	ADJ
admet-2901	235	26	optimized	optimized	ADJ
admet-2901	235	27	derivatives	derivative	NOUN
admet-2901	235	28	typically	typically	ADV
admet-2901	235	29	display	display	VERB
admet-2901	235	30	moderate	moderate	ADJ
admet-2901	235	31	cytotoxicity	cytotoxicity	NOUN
admet-2901	235	32	unless	unless	SCONJ
admet-2901	235	33	modified	modify	VERB
admet-2901	235	34	for	for	ADP
admet-2901	235	35	improved	improved	ADJ
admet-2901	235	36	pharmacological	pharmacological	ADJ
admet-2901	235	37	performance	performance	NOUN
admet-2901	235	38	[	[	X
admet-2901	235	39	57,59,61	57,59,61	NUM
admet-2901	235	40	-	-	SYM
admet-2901	235	41	64	64	NUM
admet-2901	235	42	]	]	PUNCT
admet-2901	235	43	.	.	PUNCT
admet-2901	236	1	the	the	DET
admet-2901	236	2	biological	biological	ADJ
admet-2901	236	3	evaluation	evaluation	NOUN
admet-2901	236	4	of	of	ADP
admet-2901	236	5	compound	compound	NOUN
admet-2901	236	6	1	1	NUM
admet-2901	236	7	and	and	CCONJ
admet-2901	236	8	compound	compound	VERB
admet-2901	236	9	10	10	NUM
admet-2901	236	10	against	against	ADP
admet-2901	236	11	two	two	NUM
admet-2901	236	12	phenotypically	phenotypically	ADV
admet-2901	236	13	distinct	distinct	ADJ
admet-2901	236	14	breast	breast	NOUN
admet-2901	236	15	cancer	cancer	NOUN
admet-2901	236	16	cell	cell	NOUN
admet-2901	236	17	lines	line	NOUN
admet-2901	236	18	,	,	PUNCT
admet-2901	236	19	mcf-7	mcf-7	PUNCT
admet-2901	236	20	and	and	CCONJ
admet-2901	236	21	mda	mda	PROPN
admet-2901	236	22	-	-	PUNCT
admet-2901	236	23	mb-231	mb-231	PROPN
admet-2901	236	24	,	,	PUNCT
admet-2901	236	25	demonstrates	demonstrate	VERB
admet-2901	236	26	their	their	PRON
admet-2901	236	27	differential	differential	NOUN
admet-2901	236	28	but	but	CCONJ
admet-2901	236	29	promising	promising	ADJ
admet-2901	236	30	anticancer	anticancer	NOUN
admet-2901	236	31	potential	potential	NOUN
admet-2901	236	32	.	.	PUNCT
admet-2901	237	1	mcf-7	mcf-7	PUNCT
admet-2901	237	2	is	be	AUX
admet-2901	237	3	a	a	DET
admet-2901	237	4	luminal	luminal	ADJ
admet-2901	237	5	a	a	DET
admet-2901	237	6	subtype	subtype	NOUN
admet-2901	237	7	,	,	PUNCT
admet-2901	237	8	estrogen	estrogen	NOUN
admet-2901	237	9	receptor	receptor	NOUN
admet-2901	237	10	-	-	PUNCT
admet-2901	237	11	positive	positive	ADJ
admet-2901	237	12	(	(	PUNCT
admet-2901	237	13	er⁺	er⁺	PROPN
admet-2901	237	14	)	)	PUNCT
admet-2901	237	15	,	,	PUNCT
admet-2901	237	16	and	and	CCONJ
admet-2901	237	17	considered	consider	VERB
admet-2901	237	18	less	less	ADV
admet-2901	237	19	aggressive	aggressive	ADJ
admet-2901	237	20	,	,	PUNCT
admet-2901	237	21	while	while	SCONJ
admet-2901	237	22	mda	mda	PROPN
admet-2901	237	23	-	-	PUNCT
admet-2901	237	24	mb-231	mb-231	PROPN
admet-2901	237	25	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	NOUN
admet-2901	237	26	n.	n.	NOUN
admet-2901	237	27	chabang	chabang	PROPN
admet-2901	237	28	et	et	PROPN
admet-2901	237	29	al	al	PROPN
admet-2901	237	30	.	.	PROPN
admet-2901	237	31	admet	admet	PROPN
admet-2901	237	32	&	&	CCONJ
admet-2901	237	33	dmpk	dmpk	PROPN
admet-2901	237	34	13(5	13(5	NUM
admet-2901	237	35	)	)	PUNCT
admet-2901	237	36	(	(	PUNCT
admet-2901	237	37	2025	2025	NUM
admet-2901	237	38	)	)	PUNCT
admet-2901	237	39	2901	2901	NUM
admet-2901	237	40	12	12	NUM
admet-2901	237	41	represents	represent	VERB
admet-2901	237	42	the	the	DET
admet-2901	237	43	triple	triple	ADJ
admet-2901	237	44	-	-	PUNCT
admet-2901	237	45	negative	negative	ADJ
admet-2901	237	46	breast	breast	NOUN
admet-2901	237	47	cancer	cancer	NOUN
admet-2901	237	48	(	(	PUNCT
admet-2901	237	49	tnbc	tnbc	ADJ
admet-2901	237	50	)	)	PUNCT
admet-2901	237	51	subtype	subtype	NOUN
admet-2901	237	52	,	,	PUNCT
admet-2901	237	53	characterized	characterize	VERB
admet-2901	237	54	by	by	ADP
admet-2901	237	55	the	the	DET
admet-2901	237	56	absence	absence	NOUN
admet-2901	237	57	of	of	ADP
admet-2901	237	58	er	er	INTJ
admet-2901	237	59	,	,	PUNCT
admet-2901	237	60	pr	pr	NOUN
admet-2901	237	61	,	,	PUNCT
admet-2901	237	62	and	and	CCONJ
admet-2901	237	63	her2	her2	VERB
admet-2901	237	64	expression	expression	NOUN
admet-2901	237	65	,	,	PUNCT
admet-2901	237	66	and	and	CCONJ
admet-2901	237	67	is	be	AUX
admet-2901	237	68	associated	associate	VERB
admet-2901	237	69	with	with	ADP
admet-2901	237	70	higher	high	ADJ
admet-2901	237	71	aggressiveness	aggressiveness	NOUN
admet-2901	237	72	,	,	PUNCT
admet-2901	237	73	invasiveness	invasiveness	ADJ
admet-2901	237	74	,	,	PUNCT
admet-2901	237	75	and	and	CCONJ
admet-2901	237	76	poor	poor	ADJ
admet-2901	237	77	prognosis	prognosis	NOUN
admet-2901	237	78	[	[	X
admet-2901	237	79	65,66	65,66	NOUN
admet-2901	237	80	]	]	PUNCT
admet-2901	237	81	.	.	PUNCT
admet-2901	238	1	compound	compound	NOUN
admet-2901	238	2	1	1	NUM
admet-2901	238	3	,	,	PUNCT
admet-2901	238	4	a	a	DET
admet-2901	238	5	newly	newly	ADV
admet-2901	238	6	identified	identify	VERB
admet-2901	238	7	prenylated	prenylate	VERB
admet-2901	238	8	xanthone	xanthone	PROPN
admet-2901	238	9	,	,	PUNCT
admet-2901	238	10	exhibited	exhibit	VERB
admet-2901	238	11	selective	selective	ADJ
admet-2901	238	12	cytotoxicity	cytotoxicity	NOUN
admet-2901	238	13	against	against	ADP
admet-2901	238	14	mcf-7	mcf-7	NOUN
admet-2901	238	15	cells	cell	NOUN
admet-2901	238	16	.	.	PUNCT
admet-2901	239	1	this	this	DET
admet-2901	239	2	result	result	NOUN
admet-2901	239	3	is	be	AUX
admet-2901	239	4	consistent	consistent	ADJ
admet-2901	239	5	with	with	ADP
admet-2901	239	6	previous	previous	ADJ
admet-2901	239	7	studies	study	NOUN
admet-2901	239	8	,	,	PUNCT
admet-2901	239	9	which	which	PRON
admet-2901	239	10	have	have	AUX
admet-2901	239	11	shown	show	VERB
admet-2901	239	12	that	that	SCONJ
admet-2901	239	13	xanthones	xanthone	NOUN
admet-2901	239	14	,	,	PUNCT
admet-2901	239	15	particularly	particularly	ADV
admet-2901	239	16	those	those	PRON
admet-2901	239	17	with	with	ADP
admet-2901	239	18	prenyl	prenyl	NOUN
admet-2901	239	19	or	or	CCONJ
admet-2901	239	20	hydroxyl	hydroxyl	NOUN
admet-2901	239	21	substitutions	substitution	NOUN
admet-2901	239	22	,	,	PUNCT
admet-2901	239	23	demonstrate	demonstrate	VERB
admet-2901	239	24	enhanced	enhanced	ADJ
admet-2901	239	25	activity	activity	NOUN
admet-2901	239	26	in	in	ADP
admet-2901	239	27	er⁺	er⁺	PROPN
admet-2901	239	28	breast	breast	NOUN
admet-2901	239	29	cancer	cancer	NOUN
admet-2901	239	30	cells	cell	NOUN
admet-2901	239	31	by	by	ADP
admet-2901	239	32	modulating	modulate	VERB
admet-2901	239	33	oestrogen	oestrogen	NOUN
admet-2901	239	34	signalling	signal	VERB
admet-2901	239	35	,	,	PUNCT
admet-2901	239	36	mitochondrial	mitochondrial	ADJ
admet-2901	239	37	function	function	NOUN
admet-2901	239	38	,	,	PUNCT
admet-2901	239	39	or	or	CCONJ
admet-2901	239	40	inducing	induce	VERB
admet-2901	239	41	oxidative	oxidative	ADJ
admet-2901	239	42	stress	stress	NOUN
admet-2901	239	43	[	[	X
admet-2901	239	44	50,54	50,54	NUM
admet-2901	239	45	]	]	X
admet-2901	239	46	.	.	PUNCT
admet-2901	240	1	the	the	DET
admet-2901	240	2	selective	selective	ADJ
admet-2901	240	3	activity	activity	NOUN
admet-2901	240	4	of	of	ADP
admet-2901	240	5	compound	compound	NOUN
admet-2901	240	6	1	1	NUM
admet-2901	240	7	suggests	suggest	VERB
admet-2901	240	8	its	its	PRON
admet-2901	240	9	potential	potential	NOUN
admet-2901	240	10	as	as	ADP
admet-2901	240	11	a	a	DET
admet-2901	240	12	therapeutic	therapeutic	ADJ
admet-2901	240	13	candidate	candidate	NOUN
admet-2901	240	14	for	for	ADP
admet-2901	240	15	hormone	hormone	NOUN
admet-2901	240	16	-	-	PUNCT
admet-2901	240	17	responsive	responsive	ADJ
admet-2901	240	18	,	,	PUNCT
admet-2901	240	19	low	low	ADJ
admet-2901	240	20	-	-	PUNCT
admet-2901	240	21	aggressiveness	aggressiveness	NOUN
admet-2901	240	22	breast	breast	NOUN
admet-2901	240	23	cancers	cancer	NOUN
admet-2901	240	24	,	,	PUNCT
admet-2901	240	25	where	where	SCONJ
admet-2901	240	26	treatment	treatment	NOUN
admet-2901	240	27	options	option	NOUN
admet-2901	240	28	are	be	AUX
admet-2901	240	29	often	often	ADV
admet-2901	240	30	successful	successful	ADJ
admet-2901	240	31	but	but	CCONJ
admet-2901	240	32	long	long	ADJ
admet-2901	240	33	-	-	PUNCT
admet-2901	240	34	term	term	NOUN
admet-2901	240	35	resistance	resistance	NOUN
admet-2901	240	36	remains	remain	VERB
admet-2901	240	37	a	a	DET
admet-2901	240	38	challenge	challenge	NOUN
admet-2901	240	39	.	.	PUNCT
admet-2901	241	1	its	its	PRON
admet-2901	241	2	distinct	distinct	ADJ
admet-2901	241	3	structural	structural	ADJ
admet-2901	241	4	features	feature	NOUN
admet-2901	241	5	,	,	PUNCT
admet-2901	241	6	especially	especially	ADV
admet-2901	241	7	the	the	DET
admet-2901	241	8	bis	bis	ADJ
admet-2901	241	9	-	-	ADJ
admet-2901	241	10	prenylated	prenylate	VERB
admet-2901	241	11	aromatic	aromatic	ADJ
admet-2901	241	12	core	core	NOUN
admet-2901	241	13	,	,	PUNCT
admet-2901	241	14	may	may	AUX
admet-2901	241	15	allow	allow	VERB
admet-2901	241	16	further	further	ADJ
admet-2901	241	17	chemical	chemical	ADJ
admet-2901	241	18	optimization	optimization	NOUN
admet-2901	241	19	to	to	PART
admet-2901	241	20	broaden	broaden	VERB
admet-2901	241	21	its	its	PRON
admet-2901	241	22	activity	activity	NOUN
admet-2901	241	23	spectrum	spectrum	NOUN
admet-2901	241	24	or	or	CCONJ
admet-2901	241	25	increase	increase	VERB
admet-2901	241	26	potency	potency	NOUN
admet-2901	241	27	.	.	PUNCT
admet-2901	242	1	in	in	ADP
admet-2901	242	2	contrast	contrast	NOUN
admet-2901	242	3	,	,	PUNCT
admet-2901	242	4	compound	compound	NOUN
admet-2901	242	5	10	10	NUM
admet-2901	242	6	(	(	PUNCT
admet-2901	242	7	cleistanthin	cleistanthin	NOUN
admet-2901	242	8	a	a	PRON
admet-2901	242	9	)	)	PUNCT
admet-2901	242	10	demonstrated	demonstrate	VERB
admet-2901	242	11	broad	broad	ADJ
admet-2901	242	12	-	-	PUNCT
admet-2901	242	13	spectrum	spectrum	NOUN
admet-2901	242	14	cytotoxicity	cytotoxicity	NOUN
admet-2901	242	15	,	,	PUNCT
admet-2901	242	16	with	with	ADP
admet-2901	242	17	strong	strong	ADJ
admet-2901	242	18	efficacy	efficacy	NOUN
admet-2901	242	19	in	in	ADP
admet-2901	242	20	both	both	PRON
admet-2901	242	21	mcf-7	mcf-7	PUNCT
admet-2901	242	22	and	and	CCONJ
admet-2901	242	23	mda	mda	PROPN
admet-2901	242	24	-	-	PUNCT
admet-2901	242	25	mb-231	mb-231	PROPN
admet-2901	242	26	cells	cell	NOUN
admet-2901	242	27	.	.	PUNCT
admet-2901	243	1	this	this	DET
admet-2901	243	2	finding	finding	NOUN
admet-2901	243	3	is	be	AUX
admet-2901	243	4	significant	significant	ADJ
admet-2901	243	5	,	,	PUNCT
admet-2901	243	6	as	as	SCONJ
admet-2901	243	7	tnbc	tnbc	NOUN
admet-2901	243	8	remains	remain	VERB
admet-2901	243	9	one	one	NUM
admet-2901	243	10	of	of	ADP
admet-2901	243	11	the	the	DET
admet-2901	243	12	most	most	ADV
admet-2901	243	13	difficult	difficult	ADJ
admet-2901	243	14	subtypes	subtype	NOUN
admet-2901	243	15	to	to	PART
admet-2901	243	16	treat	treat	VERB
admet-2901	243	17	due	due	ADP
admet-2901	243	18	to	to	ADP
admet-2901	243	19	its	its	PRON
admet-2901	243	20	heterogeneity	heterogeneity	NOUN
admet-2901	243	21	,	,	PUNCT
admet-2901	243	22	lack	lack	NOUN
admet-2901	243	23	of	of	ADP
admet-2901	243	24	hormonal	hormonal	ADJ
admet-2901	243	25	targets	target	NOUN
admet-2901	243	26	,	,	PUNCT
admet-2901	243	27	and	and	CCONJ
admet-2901	243	28	resistance	resistance	NOUN
admet-2901	243	29	to	to	ADP
admet-2901	243	30	conventional	conventional	ADJ
admet-2901	243	31	chemotherapy[66,67	chemotherapy[66,67	PROPN
admet-2901	243	32	]	]	PUNCT
admet-2901	243	33	.	.	PUNCT
admet-2901	244	1	the	the	DET
admet-2901	244	2	ability	ability	NOUN
admet-2901	244	3	of	of	ADP
admet-2901	244	4	cleistanthin	cleistanthin	NOUN
admet-2901	244	5	a	a	PRON
admet-2901	244	6	to	to	PART
admet-2901	244	7	inhibit	inhibit	VERB
admet-2901	244	8	proliferation	proliferation	NOUN
admet-2901	244	9	in	in	ADP
admet-2901	244	10	both	both	DET
admet-2901	244	11	cell	cell	NOUN
admet-2901	244	12	types	type	NOUN
admet-2901	244	13	implies	imply	VERB
admet-2901	244	14	a	a	DET
admet-2901	244	15	mechanism	mechanism	NOUN
admet-2901	244	16	that	that	PRON
admet-2901	244	17	bypasses	bypass	VERB
admet-2901	244	18	receptor	receptor	NOUN
admet-2901	244	19	dependency	dependency	NOUN
admet-2901	244	20	.	.	PUNCT
admet-2901	245	1	indeed	indeed	ADV
admet-2901	245	2	,	,	PUNCT
admet-2901	245	3	prior	prior	ADJ
admet-2901	245	4	studies	study	NOUN
admet-2901	245	5	have	have	AUX
admet-2901	245	6	confirmed	confirm	VERB
admet-2901	245	7	that	that	SCONJ
admet-2901	245	8	cleistanthin	cleistanthin	NOUN
admet-2901	245	9	a	a	DET
admet-2901	245	10	and	and	CCONJ
admet-2901	245	11	related	related	ADJ
admet-2901	245	12	diphyllin	diphyllin	NOUN
admet-2901	245	13	-	-	PUNCT
admet-2901	245	14	type	type	NOUN
admet-2901	245	15	lignans	lignan	NOUN
admet-2901	245	16	inhibit	inhibit	VERB
admet-2901	245	17	the	the	DET
admet-2901	245	18	v	v	NOUN
admet-2901	245	19	-	-	PUNCT
admet-2901	245	20	atpase	atpase	ADJ
admet-2901	245	21	,	,	PUNCT
admet-2901	245	22	disrupt	disrupt	ADJ
admet-2901	245	23	lysosomal	lysosomal	ADJ
admet-2901	245	24	acidification	acidification	NOUN
admet-2901	245	25	,	,	PUNCT
admet-2901	245	26	and	and	CCONJ
admet-2901	245	27	impair	impair	VERB
admet-2901	245	28	autophagy	autophagy	NOUN
admet-2901	245	29	,	,	PUNCT
admet-2901	245	30	a	a	DET
admet-2901	245	31	pathway	pathway	NOUN
admet-2901	245	32	commonly	commonly	ADV
admet-2901	245	33	upregulated	upregulate	VERB
admet-2901	245	34	in	in	ADP
admet-2901	245	35	tnbc	tnbc	NOUN
admet-2901	245	36	to	to	PART
admet-2901	245	37	sustain	sustain	VERB
admet-2901	245	38	survival	survival	NOUN
admet-2901	245	39	under	under	ADP
admet-2901	245	40	metabolic	metabolic	NOUN
admet-2901	245	41	stress	stress	NOUN
admet-2901	245	42	[	[	X
admet-2901	245	43	60,68	60,68	NUM
admet-2901	245	44	]	]	PUNCT
admet-2901	245	45	.	.	PUNCT
admet-2901	246	1	thus	thus	ADV
admet-2901	246	2	,	,	PUNCT
admet-2901	246	3	cleistanthin	cleistanthin	VERB
admet-2901	246	4	a	a	PRON
admet-2901	246	5	holds	hold	VERB
admet-2901	246	6	therapeutic	therapeutic	ADJ
admet-2901	246	7	potential	potential	NOUN
admet-2901	246	8	as	as	ADP
admet-2901	246	9	a	a	DET
admet-2901	246	10	non	non	ADJ
admet-2901	246	11	-	-	ADJ
admet-2901	246	12	receptor	receptor	NOUN
admet-2901	246	13	-	-	PUNCT
admet-2901	246	14	targeted	target	VERB
admet-2901	246	15	agent	agent	NOUN
admet-2901	246	16	capable	capable	ADJ
admet-2901	246	17	of	of	ADP
admet-2901	246	18	suppressing	suppress	VERB
admet-2901	246	19	both	both	CCONJ
admet-2901	246	20	indolent	indolent	ADJ
admet-2901	246	21	and	and	CCONJ
admet-2901	246	22	aggressive	aggressive	ADJ
admet-2901	246	23	breast	breast	NOUN
admet-2901	246	24	cancer	cancer	NOUN
admet-2901	246	25	phenotypes	phenotype	NOUN
admet-2901	246	26	.	.	PUNCT
admet-2901	247	1	although	although	SCONJ
admet-2901	247	2	the	the	DET
admet-2901	247	3	exact	exact	ADJ
admet-2901	247	4	mechanism	mechanism	NOUN
admet-2901	247	5	of	of	ADP
admet-2901	247	6	action	action	NOUN
admet-2901	247	7	in	in	ADP
admet-2901	247	8	breast	breast	NOUN
admet-2901	247	9	cancer	cancer	NOUN
admet-2901	247	10	cells	cell	NOUN
admet-2901	247	11	remains	remain	VERB
admet-2901	247	12	unclear	unclear	ADJ
admet-2901	247	13	,	,	PUNCT
admet-2901	247	14	emerging	emerge	VERB
admet-2901	247	15	evidence	evidence	NOUN
admet-2901	247	16	suggests	suggest	VERB
admet-2901	247	17	that	that	SCONJ
admet-2901	247	18	the	the	DET
admet-2901	247	19	compound	compound	NOUN
admet-2901	247	20	may	may	AUX
admet-2901	247	21	exert	exert	VERB
admet-2901	247	22	its	its	PRON
admet-2901	247	23	anticancer	anticancer	NOUN
admet-2901	247	24	effects	effect	NOUN
admet-2901	247	25	by	by	ADP
admet-2901	247	26	targeting	target	VERB
admet-2901	247	27	vacuolar	vacuolar	ADJ
admet-2901	247	28	h+-atpase	h+-atpase	PROPN
admet-2901	247	29	(	(	PUNCT
admet-2901	247	30	v	v	NOUN
admet-2901	247	31	-	-	PUNCT
admet-2901	247	32	atpase	atpase	NOUN
admet-2901	247	33	)	)	PUNCT
admet-2901	247	34	.	.	PUNCT
admet-2901	248	1	vatpase	vatpase	PROPN
admet-2901	248	2	is	be	AUX
admet-2901	248	3	a	a	DET
admet-2901	248	4	proton	proton	NOUN
admet-2901	248	5	pump	pump	NOUN
admet-2901	248	6	involved	involve	VERB
admet-2901	248	7	in	in	ADP
admet-2901	248	8	maintaining	maintain	VERB
admet-2901	248	9	intracellular	intracellular	ADJ
admet-2901	248	10	ph	ph	ADJ
admet-2901	248	11	and	and	CCONJ
admet-2901	248	12	lysosomal	lysosomal	ADJ
admet-2901	248	13	acidification	acidification	NOUN
admet-2901	248	14	,	,	PUNCT
admet-2901	248	15	processes	process	NOUN
admet-2901	248	16	that	that	PRON
admet-2901	248	17	are	be	AUX
admet-2901	248	18	critical	critical	ADJ
admet-2901	248	19	for	for	ADP
admet-2901	248	20	cancer	cancer	NOUN
admet-2901	248	21	cell	cell	NOUN
admet-2901	248	22	survival	survival	NOUN
admet-2901	248	23	and	and	CCONJ
admet-2901	248	24	progression	progression	NOUN
admet-2901	248	25	[	[	X
admet-2901	248	26	24,69	24,69	NUM
admet-2901	248	27	]	]	PUNCT
admet-2901	248	28	.	.	PUNCT
admet-2901	249	1	in	in	ADP
admet-2901	249	2	cancer	cancer	NOUN
admet-2901	249	3	,	,	PUNCT
admet-2901	249	4	v	v	NOUN
admet-2901	249	5	-	-	PUNCT
admet-2901	249	6	atpase	atpase	ADJ
admet-2901	249	7	activity	activity	NOUN
admet-2901	249	8	is	be	AUX
admet-2901	249	9	frequently	frequently	ADV
admet-2901	249	10	upregulated	upregulate	VERB
admet-2901	249	11	,	,	PUNCT
admet-2901	249	12	contributing	contribute	VERB
admet-2901	249	13	to	to	ADP
admet-2901	249	14	tumour	tumour	NOUN
admet-2901	249	15	invasiveness	invasiveness	NOUN
admet-2901	249	16	,	,	PUNCT
admet-2901	249	17	metastasis	metastasis	NOUN
admet-2901	249	18	,	,	PUNCT
admet-2901	249	19	and	and	CCONJ
admet-2901	249	20	chemoresistance	chemoresistance	NOUN
admet-2901	249	21	by	by	ADP
admet-2901	249	22	acidifying	acidify	VERB
admet-2901	249	23	the	the	DET
admet-2901	249	24	tumour	tumour	NOUN
admet-2901	249	25	microenvironment	microenvironment	NOUN
admet-2901	249	26	and	and	CCONJ
admet-2901	249	27	facilitating	facilitate	VERB
admet-2901	249	28	the	the	DET
admet-2901	249	29	sequestration	sequestration	NOUN
admet-2901	249	30	of	of	ADP
admet-2901	249	31	lysosomal	lysosomal	ADJ
admet-2901	249	32	drugs	drug	NOUN
admet-2901	249	33	[	[	X
admet-2901	249	34	25	25	NUM
admet-2901	249	35	]	]	PUNCT
admet-2901	249	36	.	.	PUNCT
admet-2901	250	1	consequently	consequently	ADV
admet-2901	250	2	,	,	PUNCT
admet-2901	250	3	v	v	X
admet-2901	250	4	-	-	PUNCT
admet-2901	250	5	atpase	atpase	PROPN
admet-2901	250	6	has	have	AUX
admet-2901	250	7	emerged	emerge	VERB
admet-2901	250	8	as	as	ADP
admet-2901	250	9	a	a	DET
admet-2901	250	10	promising	promising	ADJ
admet-2901	250	11	therapeutic	therapeutic	ADJ
admet-2901	250	12	target	target	NOUN
admet-2901	250	13	in	in	ADP
admet-2901	250	14	oncology	oncology	NOUN
admet-2901	250	15	.	.	PUNCT
admet-2901	251	1	v	v	X
admet-2901	251	2	-	-	PUNCT
admet-2901	251	3	atpase	atpase	PROPN
admet-2901	251	4	plays	play	VERB
admet-2901	251	5	a	a	DET
admet-2901	251	6	central	central	ADJ
admet-2901	251	7	role	role	NOUN
admet-2901	251	8	in	in	ADP
admet-2901	251	9	the	the	DET
admet-2901	251	10	autophagic	autophagic	ADJ
admet-2901	251	11	pathway	pathway	NOUN
admet-2901	251	12	,	,	PUNCT
admet-2901	251	13	particularly	particularly	ADV
admet-2901	251	14	in	in	ADP
admet-2901	251	15	the	the	DET
admet-2901	251	16	fusion	fusion	NOUN
admet-2901	251	17	of	of	ADP
admet-2901	251	18	autophagosomes	autophagosome	NOUN
admet-2901	251	19	with	with	ADP
admet-2901	251	20	lysosomes	lysosome	NOUN
admet-2901	251	21	and	and	CCONJ
admet-2901	251	22	the	the	DET
admet-2901	251	23	subsequent	subsequent	ADJ
admet-2901	251	24	degradation	degradation	NOUN
admet-2901	251	25	of	of	ADP
admet-2901	251	26	cellular	cellular	ADJ
admet-2901	251	27	components	component	NOUN
admet-2901	251	28	[	[	X
admet-2901	251	29	70,71	70,71	NUM
admet-2901	251	30	]	]	PUNCT
admet-2901	251	31	.	.	PUNCT
admet-2901	252	1	inhibition	inhibition	NOUN
admet-2901	252	2	of	of	ADP
admet-2901	252	3	v	v	NOUN
admet-2901	252	4	-	-	PUNCT
admet-2901	252	5	atpase	atpase	PROPN
admet-2901	252	6	can	can	AUX
admet-2901	252	7	block	block	VERB
admet-2901	252	8	autophagic	autophagic	PROPN
admet-2901	252	9	flux	flux	NOUN
admet-2901	252	10	,	,	PUNCT
admet-2901	252	11	leading	lead	VERB
admet-2901	252	12	to	to	ADP
admet-2901	252	13	the	the	DET
admet-2901	252	14	accumulation	accumulation	NOUN
admet-2901	252	15	of	of	ADP
admet-2901	252	16	autophagosomes	autophagosome	NOUN
admet-2901	252	17	and	and	CCONJ
admet-2901	252	18	impaired	impaired	ADJ
admet-2901	252	19	cellular	cellular	ADJ
admet-2901	252	20	clearance	clearance	NOUN
admet-2901	252	21	.	.	PUNCT
admet-2901	253	1	this	this	DET
admet-2901	253	2	autophagy	autophagy	ADJ
admet-2901	253	3	flux	flux	NOUN
admet-2901	253	4	inhibition	inhibition	NOUN
admet-2901	253	5	can	can	AUX
admet-2901	253	6	promote	promote	VERB
admet-2901	253	7	stressinduced	stressinduced	ADJ
admet-2901	253	8	cell	cell	NOUN
admet-2901	253	9	death	death	NOUN
admet-2901	253	10	,	,	PUNCT
admet-2901	253	11	especially	especially	ADV
admet-2901	253	12	in	in	ADP
admet-2901	253	13	cancer	cancer	NOUN
admet-2901	253	14	cells	cell	NOUN
admet-2901	253	15	that	that	PRON
admet-2901	253	16	rely	rely	VERB
admet-2901	253	17	on	on	ADP
admet-2901	253	18	autophagy	autophagy	NOUN
admet-2901	253	19	for	for	ADP
admet-2901	253	20	survival	survival	NOUN
admet-2901	253	21	under	under	ADP
admet-2901	253	22	harsh	harsh	ADJ
admet-2901	253	23	microenvironments	microenvironment	NOUN
admet-2901	253	24	[	[	X
admet-2901	253	25	49	49	NUM
admet-2901	253	26	]	]	PUNCT
admet-2901	253	27	.	.	PUNCT
admet-2901	254	1	therefore	therefore	ADV
admet-2901	254	2	,	,	PUNCT
admet-2901	254	3	the	the	DET
admet-2901	254	4	m.	m.	NOUN
admet-2901	254	5	glomerulotus	glomerulotus	NOUN
admet-2901	254	6	-	-	PUNCT
admet-2901	254	7	isolated	isolate	VERB
admet-2901	254	8	compounds	compound	NOUN
admet-2901	254	9	may	may	AUX
admet-2901	254	10	exert	exert	VERB
admet-2901	254	11	their	their	PRON
admet-2901	254	12	cytotoxic	cytotoxic	ADJ
admet-2901	254	13	effects	effect	NOUN
admet-2901	254	14	in	in	ADP
admet-2901	254	15	breast	breast	NOUN
admet-2901	254	16	cancer	cancer	NOUN
admet-2901	254	17	cells	cell	NOUN
admet-2901	254	18	by	by	ADP
admet-2901	254	19	inhibiting	inhibit	VERB
admet-2901	254	20	both	both	DET
admet-2901	254	21	v	v	NOUN
admet-2901	254	22	-	-	PUNCT
admet-2901	254	23	atpase	atpase	ADJ
admet-2901	254	24	activity	activity	NOUN
admet-2901	254	25	and	and	CCONJ
admet-2901	254	26	autophagic	autophagic	PROPN
admet-2901	254	27	flux	flux	NOUN
admet-2901	254	28	,	,	PUNCT
admet-2901	254	29	ultimately	ultimately	ADV
admet-2901	254	30	leading	lead	VERB
admet-2901	254	31	to	to	ADP
admet-2901	254	32	reduced	reduce	VERB
admet-2901	254	33	cell	cell	NOUN
admet-2901	254	34	viability	viability	NOUN
admet-2901	254	35	and	and	CCONJ
admet-2901	254	36	cancer	cancer	NOUN
admet-2901	254	37	cell	cell	NOUN
admet-2901	254	38	death	death	NOUN
admet-2901	254	39	.	.	PUNCT
admet-2901	255	1	the	the	DET
admet-2901	255	2	molecular	molecular	ADJ
admet-2901	255	3	docking	docking	NOUN
admet-2901	255	4	analysis	analysis	NOUN
admet-2901	255	5	revealed	reveal	VERB
admet-2901	255	6	that	that	SCONJ
admet-2901	255	7	both	both	PRON
admet-2901	255	8	cleistanthin	cleistanthin	VERB
admet-2901	255	9	a	a	PRON
admet-2901	255	10	and	and	CCONJ
admet-2901	255	11	the	the	DET
admet-2901	255	12	novel	novel	NOUN
admet-2901	255	13	xanthone	xanthone	PROPN
admet-2901	255	14	exhibited	exhibit	VERB
admet-2901	255	15	favourable	favourable	ADJ
admet-2901	255	16	binding	bind	VERB
admet-2901	255	17	affinities	affinity	NOUN
admet-2901	255	18	toward	toward	ADP
admet-2901	255	19	the	the	DET
admet-2901	255	20	v	v	NOUN
admet-2901	255	21	-	-	PUNCT
admet-2901	255	22	atpase	atpase	NOUN
admet-2901	255	23	enzyme	enzyme	NOUN
admet-2901	255	24	,	,	PUNCT
admet-2901	255	25	particularly	particularly	ADV
admet-2901	255	26	at	at	ADP
admet-2901	255	27	the	the	DET
admet-2901	255	28	interface	interface	NOUN
admet-2901	255	29	between	between	ADP
admet-2901	255	30	subunit	subunit	NOUN
admet-2901	255	31	a	a	PRON
admet-2901	255	32	and	and	CCONJ
admet-2901	255	33	the	the	DET
admet-2901	255	34	adjacent	adjacent	ADJ
admet-2901	255	35	c	c	PROPN
admet-2901	255	36	subunits	subunit	NOUN
admet-2901	255	37	.	.	PUNCT
admet-2901	256	1	cleistanthin	cleistanthin	PROPN
admet-2901	256	2	a	a	PRON
admet-2901	256	3	showed	show	VERB
admet-2901	256	4	a	a	DET
admet-2901	256	5	docking	docking	NOUN
admet-2901	256	6	score	score	NOUN
admet-2901	256	7	of	of	ADP
admet-2901	256	8	-29.3	-29.3	PROPN
admet-2901	256	9	kj·mol⁻¹	kj·mol⁻¹	PROPN
admet-2901	256	10	(	(	PUNCT
admet-2901	256	11	-70	-70	PROPN
admet-2901	256	12	kcal·mol⁻¹	kcal·mol⁻¹	PROPN
admet-2901	256	13	)	)	PUNCT
admet-2901	256	14	,	,	PUNCT
admet-2901	256	15	which	which	PRON
admet-2901	256	16	is	be	AUX
admet-2901	256	17	consistent	consistent	ADJ
admet-2901	256	18	with	with	ADP
admet-2901	256	19	previous	previous	ADJ
admet-2901	256	20	studies	study	NOUN
admet-2901	256	21	demonstrating	demonstrate	VERB
admet-2901	256	22	that	that	SCONJ
admet-2901	256	23	diphyllin	diphyllin	NOUN
admet-2901	256	24	-	-	PUNCT
admet-2901	256	25	type	type	NOUN
admet-2901	256	26	lignans	lignan	NOUN
admet-2901	256	27	exert	exert	VERB
admet-2901	256	28	anticancer	anticancer	NOUN
admet-2901	256	29	effects	effect	NOUN
admet-2901	256	30	through	through	ADP
admet-2901	256	31	inhibition	inhibition	NOUN
admet-2901	256	32	of	of	ADP
admet-2901	256	33	v	v	NOUN
admet-2901	256	34	-	-	PUNCT
admet-2901	256	35	atpase	atpase	NOUN
admet-2901	256	36	,	,	PUNCT
admet-2901	256	37	a	a	DET
admet-2901	256	38	proton	proton	NOUN
admet-2901	256	39	pump	pump	NOUN
admet-2901	256	40	critical	critical	ADJ
admet-2901	256	41	for	for	ADP
admet-2901	256	42	maintaining	maintain	VERB
admet-2901	256	43	the	the	DET
admet-2901	256	44	acidic	acidic	ADJ
admet-2901	256	45	environment	environment	NOUN
admet-2901	256	46	of	of	ADP
admet-2901	256	47	intracellular	intracellular	ADJ
admet-2901	256	48	organelles	organelle	NOUN
admet-2901	256	49	such	such	ADJ
admet-2901	256	50	as	as	ADP
admet-2901	256	51	lysosomes	lysosome	NOUN
admet-2901	256	52	and	and	CCONJ
admet-2901	256	53	endosomes	endosome	VERB
admet-2901	257	1	[	[	X
admet-2901	257	2	48,60	48,60	NOUN
admet-2901	257	3	]	]	X
admet-2901	257	4	the	the	DET
admet-2901	257	5	ability	ability	NOUN
admet-2901	257	6	of	of	ADP
admet-2901	257	7	cleistanthin	cleistanthin	NOUN
admet-2901	257	8	a	a	PRON
admet-2901	257	9	to	to	PART
admet-2901	257	10	interact	interact	VERB
admet-2901	257	11	with	with	ADP
admet-2901	257	12	key	key	ADJ
admet-2901	257	13	residues	residue	NOUN
admet-2901	257	14	such	such	ADJ
admet-2901	257	15	as	as	ADP
admet-2901	257	16	val783	val783	PROPN
admet-2901	257	17	,	,	PUNCT
admet-2901	257	18	val784	val784	PROPN
admet-2901	257	19	,	,	PUNCT
admet-2901	257	20	and	and	CCONJ
admet-2901	257	21	ile58	ile58	NOUN
admet-2901	257	22	suggests	suggest	VERB
admet-2901	257	23	that	that	SCONJ
admet-2901	257	24	the	the	DET
admet-2901	257	25	compound	compound	NOUN
admet-2901	257	26	may	may	AUX
admet-2901	257	27	disrupt	disrupt	VERB
admet-2901	257	28	proton	proton	NOUN
admet-2901	257	29	translocation	translocation	NOUN
admet-2901	257	30	and	and	CCONJ
admet-2901	257	31	interfere	interfere	VERB
admet-2901	257	32	with	with	ADP
admet-2901	257	33	organelle	organelle	NOUN
admet-2901	257	34	acidification	acidification	NOUN
admet-2901	257	35	,	,	PUNCT
admet-2901	257	36	mechanisms	mechanism	NOUN
admet-2901	257	37	that	that	PRON
admet-2901	257	38	have	have	AUX
admet-2901	257	39	been	be	AUX
admet-2901	257	40	shown	show	VERB
admet-2901	257	41	to	to	PART
admet-2901	257	42	lead	lead	VERB
admet-2901	257	43	to	to	ADP
admet-2901	257	44	cancer	cancer	NOUN
admet-2901	257	45	cell	cell	NOUN
admet-2901	257	46	apoptosis	apoptosis	NOUN
admet-2901	257	47	and	and	CCONJ
admet-2901	257	48	autophagy	autophagy	ADJ
admet-2901	257	49	inhibition	inhibition	NOUN
admet-2901	257	50	[	[	X
admet-2901	257	51	49,60	49,60	NOUN
admet-2901	257	52	]	]	PUNCT
admet-2901	257	53	.	.	PUNCT
admet-2901	258	1	the	the	DET
admet-2901	258	2	xanthone	xanthone	PROPN
admet-2901	258	3	compound	compound	NOUN
admet-2901	258	4	also	also	ADV
admet-2901	258	5	demonstrated	demonstrate	VERB
admet-2901	258	6	a	a	DET
admet-2901	258	7	strong	strong	ADJ
admet-2901	258	8	binding	binding	ADJ
admet-2901	258	9	affinity	affinity	NOUN
admet-2901	258	10	,	,	PUNCT
admet-2901	258	11	with	with	ADP
admet-2901	258	12	a	a	DET
admet-2901	258	13	docking	docking	NOUN
admet-2901	258	14	score	score	NOUN
admet-2901	258	15	of	of	ADP
admet-2901	258	16	-31.4	-31.4	PROPN
admet-2901	258	17	kj·mol⁻¹	kj·mol⁻¹	PROPN
admet-2901	258	18	(	(	PUNCT
admet-2901	258	19	-75	-75	PROPN
admet-2901	258	20	kcal·mol⁻¹	kcal·mol⁻¹	PROPN
admet-2901	258	21	)	)	PUNCT
admet-2901	258	22	,	,	PUNCT
admet-2901	258	23	indicating	indicate	VERB
admet-2901	258	24	a	a	DET
admet-2901	258	25	comparable	comparable	ADJ
admet-2901	258	26	potential	potential	NOUN
admet-2901	258	27	to	to	PART
admet-2901	258	28	inhibit	inhibit	VERB
admet-2901	258	29	v	v	NOUN
admet-2901	258	30	-	-	PUNCT
admet-2901	258	31	atpase	atpase	ADJ
admet-2901	258	32	activity	activity	NOUN
admet-2901	258	33	.	.	PUNCT
admet-2901	259	1	the	the	DET
admet-2901	259	2	structural	structural	ADJ
admet-2901	259	3	features	feature	NOUN
admet-2901	259	4	of	of	ADP
admet-2901	259	5	the	the	DET
admet-2901	259	6	xanthone	xanthone	PROPN
admet-2901	259	7	,	,	PUNCT
admet-2901	259	8	namely	namely	ADV
admet-2901	259	9	the	the	DET
admet-2901	259	10	hydroxylated	hydroxylated	ADJ
admet-2901	259	11	aromatic	aromatic	ADJ
admet-2901	259	12	rings	ring	NOUN
admet-2901	259	13	and	and	CCONJ
admet-2901	259	14	bis	bis	ADJ
admet-2901	259	15	-	-	ADJ
admet-2901	259	16	prenylated	prenylate	VERB
admet-2901	259	17	side	side	NOUN
admet-2901	259	18	chains	chain	NOUN
admet-2901	259	19	,	,	PUNCT
admet-2901	259	20	contributed	contribute	VERB
admet-2901	259	21	to	to	ADP
admet-2901	259	22	multiple	multiple	ADJ
admet-2901	259	23	interactions	interaction	NOUN
admet-2901	259	24	with	with	ADP
admet-2901	259	25	hydrophobic	hydrophobic	NOUN
admet-2901	259	26	residues	residue	NOUN
admet-2901	259	27	such	such	ADJ
admet-2901	259	28	as	as	ADP
admet-2901	259	29	ile62	ile62	NOUN
admet-2901	259	30	,	,	PUNCT
admet-2901	259	31	ile130	ile130	ADJ
admet-2901	259	32	,	,	PUNCT
admet-2901	259	33	and	and	CCONJ
admet-2901	259	34	leu787	leu787	PROPN
admet-2901	259	35	,	,	PUNCT
admet-2901	259	36	as	as	ADP
admet-2901	259	37	admet	admet	PROPN
admet-2901	259	38	&	&	CCONJ
admet-2901	259	39	dmpk	dmpk	PROPN
admet-2901	259	40	13(5	13(5	NOUN
admet-2901	259	41	)	)	PUNCT
admet-2901	259	42	(	(	PUNCT
admet-2901	259	43	2025	2025	NUM
admet-2901	259	44	)	)	PUNCT
admet-2901	259	45	2901	2901	NUM
admet-2901	259	46	new	new	ADJ
admet-2901	259	47	xanthone	xanthone	PROPN
admet-2901	259	48	and	and	CCONJ
admet-2901	259	49	chemical	chemical	NOUN
admet-2901	259	50	constituents	constituent	NOUN
admet-2901	259	51	from	from	ADP
admet-2901	259	52	mallotus	mallotus	ADJ
admet-2901	259	53	glomerulatus	glomerulatus	NOUN
admet-2901	259	54	doi	doi	PROPN
admet-2901	259	55	:	:	PUNCT
admet-2901	259	56	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	NOUN
admet-2901	259	57	13	13	NUM
admet-2901	259	58	well	well	ADV
admet-2901	259	59	as	as	ADP
admet-2901	259	60	π	π	NOUN
admet-2901	259	61	-	-	VERB
admet-2901	259	62	alkyl	alkyl	ADJ
admet-2901	259	63	and	and	CCONJ
admet-2901	259	64	π	π	ADJ
admet-2901	259	65	-	-	PUNCT
admet-2901	259	66	sulphur	sulphur	ADJ
admet-2901	259	67	interactions	interaction	NOUN
admet-2901	259	68	with	with	ADP
admet-2901	259	69	met788	met788	PROPN
admet-2901	259	70	.	.	PUNCT
admet-2901	260	1	these	these	DET
admet-2901	260	2	interactions	interaction	NOUN
admet-2901	260	3	are	be	AUX
admet-2901	260	4	indicative	indicative	ADJ
admet-2901	260	5	of	of	ADP
admet-2901	260	6	stable	stable	ADJ
admet-2901	260	7	ligand	ligand	NOUN
admet-2901	260	8	–	–	PUNCT
admet-2901	260	9	protein	protein	NOUN
admet-2901	260	10	complexes	complex	NOUN
admet-2901	260	11	,	,	PUNCT
admet-2901	260	12	which	which	PRON
admet-2901	260	13	are	be	AUX
admet-2901	260	14	essential	essential	ADJ
admet-2901	260	15	for	for	ADP
admet-2901	260	16	effective	effective	ADJ
admet-2901	260	17	enzyme	enzyme	NOUN
admet-2901	260	18	inhibition	inhibition	NOUN
admet-2901	260	19	.	.	PUNCT
admet-2901	261	1	previous	previous	ADJ
admet-2901	261	2	reports	report	NOUN
admet-2901	261	3	have	have	AUX
admet-2901	261	4	shown	show	VERB
admet-2901	261	5	that	that	SCONJ
admet-2901	261	6	polyphenolic	polyphenolic	ADJ
admet-2901	261	7	scaffolds	scaffold	NOUN
admet-2901	261	8	,	,	PUNCT
admet-2901	261	9	particularly	particularly	ADV
admet-2901	261	10	xanthones	xanthone	NOUN
admet-2901	261	11	,	,	PUNCT
admet-2901	261	12	can	can	AUX
admet-2901	261	13	interfere	interfere	VERB
admet-2901	261	14	with	with	ADP
admet-2901	261	15	v	v	NOUN
admet-2901	261	16	-	-	PUNCT
admet-2901	261	17	atpase	atpase	ADJ
admet-2901	261	18	function	function	NOUN
admet-2901	261	19	and	and	CCONJ
admet-2901	261	20	induce	induce	VERB
admet-2901	261	21	lysosomal	lysosomal	ADJ
admet-2901	261	22	dysfunction	dysfunction	NOUN
admet-2901	261	23	in	in	ADP
admet-2901	261	24	cancer	cancer	NOUN
admet-2901	261	25	cells	cell	NOUN
admet-2901	261	26	[	[	X
admet-2901	261	27	50,54	50,54	NUM
admet-2901	261	28	]	]	X
admet-2901	261	29	.	.	PUNCT
admet-2901	262	1	the	the	DET
admet-2901	262	2	docking	docking	NOUN
admet-2901	262	3	results	result	VERB
admet-2901	262	4	support	support	VERB
admet-2901	262	5	this	this	DET
admet-2901	262	6	mechanism	mechanism	NOUN
admet-2901	262	7	,	,	PUNCT
admet-2901	262	8	suggesting	suggest	VERB
admet-2901	262	9	that	that	SCONJ
admet-2901	262	10	the	the	DET
admet-2901	262	11	novel	novel	NOUN
admet-2901	262	12	xanthone	xanthone	PROPN
admet-2901	262	13	may	may	AUX
admet-2901	262	14	act	act	VERB
admet-2901	262	15	through	through	ADP
admet-2901	262	16	a	a	DET
admet-2901	262	17	similar	similar	ADJ
admet-2901	262	18	inhibitory	inhibitory	ADJ
admet-2901	262	19	pathway	pathway	NOUN
admet-2901	262	20	.	.	PUNCT
admet-2901	263	1	the	the	DET
admet-2901	263	2	presence	presence	NOUN
admet-2901	263	3	of	of	ADP
admet-2901	263	4	π	π	PROPN
admet-2901	263	5	–	–	PUNCT
admet-2901	263	6	π	π	PROPN
admet-2901	263	7	t	t	NOUN
admet-2901	263	8	-	-	PUNCT
admet-2901	263	9	shaped	shape	VERB
admet-2901	263	10	interactions	interaction	NOUN
admet-2901	263	11	between	between	ADP
admet-2901	263	12	both	both	DET
admet-2901	263	13	compounds	compound	NOUN
admet-2901	263	14	and	and	CCONJ
admet-2901	263	15	residues	residue	NOUN
admet-2901	263	16	such	such	ADJ
admet-2901	263	17	as	as	ADP
admet-2901	263	18	phe126	phe126	NOUN
admet-2901	263	19	and	and	CCONJ
admet-2901	263	20	phe135	phe135	NOUN
admet-2901	263	21	further	far	ADV
admet-2901	263	22	supports	support	VERB
admet-2901	263	23	their	their	PRON
admet-2901	263	24	potential	potential	NOUN
admet-2901	263	25	to	to	PART
admet-2901	263	26	anchor	anchor	VERB
admet-2901	263	27	at	at	ADP
admet-2901	263	28	the	the	DET
admet-2901	263	29	a	a	NOUN
admet-2901	263	30	–	–	PUNCT
admet-2901	263	31	c	c	NOUN
admet-2901	263	32	subunit	subunit	NOUN
admet-2901	263	33	interface	interface	NOUN
admet-2901	263	34	of	of	ADP
admet-2901	263	35	the	the	DET
admet-2901	263	36	enzyme	enzyme	NOUN
admet-2901	263	37	.	.	PUNCT
admet-2901	264	1	this	this	DET
admet-2901	264	2	region	region	NOUN
admet-2901	264	3	has	have	AUX
admet-2901	264	4	been	be	AUX
admet-2901	264	5	identified	identify	VERB
admet-2901	264	6	as	as	ADP
admet-2901	264	7	a	a	DET
admet-2901	264	8	critical	critical	ADJ
admet-2901	264	9	target	target	NOUN
admet-2901	264	10	site	site	NOUN
admet-2901	264	11	for	for	ADP
admet-2901	264	12	v	v	NOUN
admet-2901	264	13	-	-	PUNCT
admet-2901	264	14	atpase	atpase	ADJ
admet-2901	264	15	modulation	modulation	NOUN
admet-2901	264	16	,	,	PUNCT
admet-2901	264	17	as	as	SCONJ
admet-2901	264	18	previously	previously	ADV
admet-2901	264	19	described	describe	VERB
admet-2901	264	20	in	in	ADP
admet-2901	264	21	structural	structural	ADJ
admet-2901	264	22	studies	study	NOUN
admet-2901	264	23	using	use	VERB
admet-2901	264	24	cryo	cryo	NOUN
admet-2901	264	25	-	-	PUNCT
admet-2901	264	26	em	em	PRON
admet-2901	264	27	and	and	CCONJ
admet-2901	264	28	small	small	ADJ
admet-2901	264	29	-	-	PUNCT
admet-2901	264	30	molecule	molecule	NOUN
admet-2901	264	31	inhibitors[28	inhibitors[28	NOUN
admet-2901	264	32	]	]	X
admet-2901	264	33	.	.	PUNCT
admet-2901	265	1	the	the	DET
admet-2901	265	2	ability	ability	NOUN
admet-2901	265	3	of	of	ADP
admet-2901	265	4	both	both	PRON
admet-2901	265	5	cleistanthin	cleistanthin	ADJ
admet-2901	265	6	a	a	PRON
admet-2901	265	7	and	and	CCONJ
admet-2901	265	8	the	the	DET
admet-2901	265	9	xanthone	xanthone	PROPN
admet-2901	265	10	to	to	PART
admet-2901	265	11	occupy	occupy	VERB
admet-2901	265	12	this	this	DET
admet-2901	265	13	region	region	NOUN
admet-2901	265	14	reinforces	reinforce	VERB
admet-2901	265	15	their	their	PRON
admet-2901	265	16	candidacy	candidacy	NOUN
admet-2901	265	17	as	as	ADP
admet-2901	265	18	vatpase	vatpase	NOUN
admet-2901	265	19	-	-	PUNCT
admet-2901	265	20	targeting	target	VERB
admet-2901	265	21	agents	agent	NOUN
admet-2901	265	22	.	.	PUNCT
admet-2901	266	1	while	while	SCONJ
admet-2901	266	2	cleistanthin	cleistanthin	ADJ
admet-2901	266	3	a	a	PRON
admet-2901	266	4	has	have	AUX
admet-2901	266	5	been	be	AUX
admet-2901	266	6	experimentally	experimentally	ADV
admet-2901	266	7	validated	validate	VERB
admet-2901	266	8	in	in	ADP
admet-2901	266	9	multiple	multiple	ADJ
admet-2901	266	10	cancer	cancer	NOUN
admet-2901	266	11	models	model	NOUN
admet-2901	266	12	for	for	ADP
admet-2901	266	13	its	its	PRON
admet-2901	266	14	v	v	NOUN
admet-2901	266	15	-	-	PUNCT
admet-2901	266	16	atpase	atpase	ADJ
admet-2901	266	17	-	-	PUNCT
admet-2901	266	18	dependent	dependent	ADJ
admet-2901	266	19	cytotoxicity	cytotoxicity	NOUN
admet-2901	266	20	,	,	PUNCT
admet-2901	266	21	the	the	DET
admet-2901	266	22	xanthone	xanthone	PROPN
admet-2901	266	23	’s	’s	PART
admet-2901	266	24	predicted	predict	VERB
admet-2901	266	25	binding	bind	VERB
admet-2901	266	26	profile	profile	NOUN
admet-2901	266	27	provides	provide	VERB
admet-2901	266	28	a	a	DET
admet-2901	266	29	strong	strong	ADJ
admet-2901	266	30	rationale	rationale	NOUN
admet-2901	266	31	for	for	ADP
admet-2901	266	32	further	far	ADV
admet-2901	266	33	in	in	ADP
admet-2901	266	34	vitro	vitro	X
admet-2901	266	35	and	and	CCONJ
admet-2901	266	36	in	in	ADP
admet-2901	266	37	vivo	vivo	ADJ
admet-2901	266	38	evaluation	evaluation	NOUN
admet-2901	266	39	.	.	PUNCT
admet-2901	267	1	the	the	DET
admet-2901	267	2	presence	presence	NOUN
admet-2901	267	3	of	of	ADP
admet-2901	267	4	bis	bis	ADJ
admet-2901	267	5	-	-	ADJ
admet-2901	267	6	prenylated	prenylate	VERB
admet-2901	267	7	moieties	moiety	NOUN
admet-2901	267	8	in	in	ADP
admet-2901	267	9	xanthones	xanthone	NOUN
admet-2901	267	10	has	have	AUX
admet-2901	267	11	been	be	AUX
admet-2901	267	12	associated	associate	VERB
admet-2901	267	13	with	with	ADP
admet-2901	267	14	enhanced	enhanced	ADJ
admet-2901	267	15	anticancer	anticancer	NOUN
admet-2901	267	16	potency	potency	NOUN
admet-2901	267	17	,	,	PUNCT
admet-2901	267	18	attributed	attribute	VERB
admet-2901	267	19	to	to	ADP
admet-2901	267	20	increased	increase	VERB
admet-2901	267	21	lipophilicity	lipophilicity	NOUN
admet-2901	267	22	,	,	PUNCT
admet-2901	267	23	cell	cell	NOUN
admet-2901	267	24	permeability	permeability	NOUN
admet-2901	267	25	,	,	PUNCT
admet-2901	267	26	and	and	CCONJ
admet-2901	267	27	binding	bind	VERB
admet-2901	267	28	to	to	ADP
admet-2901	267	29	the	the	DET
admet-2901	267	30	hydrophobic	hydrophobic	NOUN
admet-2901	267	31	regions	region	NOUN
admet-2901	267	32	of	of	ADP
admet-2901	267	33	protein	protein	NOUN
admet-2901	267	34	targets	target	NOUN
admet-2901	267	35	[	[	X
admet-2901	267	36	50	50	NUM
admet-2901	267	37	]	]	PUNCT
admet-2901	267	38	.	.	PUNCT
admet-2901	268	1	for	for	ADP
admet-2901	268	2	instance	instance	NOUN
admet-2901	268	3	,	,	PUNCT
admet-2901	268	4	the	the	DET
admet-2901	268	5	prenylation	prenylation	NOUN
admet-2901	268	6	on	on	ADP
admet-2901	268	7	the	the	DET
admet-2901	268	8	xanthone	xanthone	PROPN
admet-2901	268	9	skeleton	skeleton	NOUN
admet-2901	268	10	significantly	significantly	ADV
admet-2901	268	11	improves	improve	VERB
admet-2901	268	12	anticancer	anticancer	NOUN
admet-2901	268	13	efficacy	efficacy	NOUN
admet-2901	268	14	by	by	ADP
admet-2901	268	15	facilitating	facilitate	VERB
admet-2901	268	16	membrane	membrane	NOUN
admet-2901	268	17	interaction	interaction	NOUN
admet-2901	268	18	and	and	CCONJ
admet-2901	268	19	target	target	NOUN
admet-2901	268	20	specificity[50	specificity[50	NOUN
admet-2901	268	21	]	]	PUNCT
admet-2901	268	22	.	.	PUNCT
admet-2901	269	1	furthermore	furthermore	ADV
admet-2901	269	2	,	,	PUNCT
admet-2901	269	3	the	the	DET
admet-2901	269	4	garcinone	garcinone	NOUN
admet-2901	269	5	e	e	NOUN
admet-2901	269	6	,	,	PUNCT
admet-2901	269	7	which	which	PRON
admet-2901	269	8	features	feature	VERB
admet-2901	269	9	a	a	DET
admet-2901	269	10	similar	similar	ADJ
admet-2901	269	11	substitution	substitution	NOUN
admet-2901	269	12	pattern	pattern	NOUN
admet-2901	269	13	,	,	PUNCT
admet-2901	269	14	could	could	AUX
admet-2901	269	15	inhibit	inhibit	VERB
admet-2901	269	16	autophagy	autophagy	ADV
admet-2901	269	17	in	in	ADP
admet-2901	269	18	ovarian	ovarian	ADJ
admet-2901	269	19	cancer	cancer	NOUN
admet-2901	269	20	cells	cell	NOUN
admet-2901	269	21	by	by	ADP
admet-2901	269	22	disrupting	disrupt	VERB
admet-2901	269	23	lysosomal	lysosomal	ADJ
admet-2901	269	24	function	function	NOUN
admet-2901	269	25	through	through	ADP
admet-2901	269	26	v	v	NOUN
admet-2901	269	27	-	-	PUNCT
admet-2901	269	28	atpase	atpase	NOUN
admet-2901	269	29	inhibition	inhibition	NOUN
admet-2901	269	30	[	[	X
admet-2901	269	31	54	54	NUM
admet-2901	269	32	]	]	PUNCT
admet-2901	269	33	.	.	PUNCT
admet-2901	270	1	these	these	DET
admet-2901	270	2	parallels	parallel	VERB
admet-2901	270	3	support	support	VERB
admet-2901	270	4	the	the	DET
admet-2901	270	5	hypothesis	hypothesis	NOUN
admet-2901	270	6	that	that	PRON
admet-2901	270	7	the	the	DET
admet-2901	270	8	novel	novel	NOUN
admet-2901	270	9	xanthone	xanthone	PROPN
admet-2901	270	10	from	from	ADP
admet-2901	270	11	m.	m.	NOUN
admet-2901	270	12	glomerulatus	glomerulatus	NOUN
admet-2901	270	13	may	may	AUX
admet-2901	270	14	share	share	VERB
admet-2901	270	15	a	a	DET
admet-2901	270	16	similar	similar	ADJ
admet-2901	270	17	mechanism	mechanism	NOUN
admet-2901	270	18	of	of	ADP
admet-2901	270	19	action	action	NOUN
admet-2901	270	20	.	.	PUNCT
admet-2901	271	1	cleistanthin	cleistanthin	PROPN
admet-2901	271	2	a	a	PRON
admet-2901	271	3	,	,	PUNCT
admet-2901	271	4	a	a	DET
admet-2901	271	5	diphyllin	diphyllin	NOUN
admet-2901	271	6	-	-	PUNCT
admet-2901	271	7	type	type	NOUN
admet-2901	271	8	arylnaphthalene	arylnaphthalene	ADJ
admet-2901	271	9	lignan	lignan	NOUN
admet-2901	271	10	,	,	PUNCT
admet-2901	271	11	possesses	possess	VERB
admet-2901	271	12	a	a	DET
admet-2901	271	13	structural	structural	ADJ
admet-2901	271	14	architecture	architecture	NOUN
admet-2901	271	15	that	that	PRON
admet-2901	271	16	supports	support	VERB
admet-2901	271	17	effective	effective	ADJ
admet-2901	271	18	intracellular	intracellular	ADJ
admet-2901	271	19	delivery	delivery	NOUN
admet-2901	271	20	and	and	CCONJ
admet-2901	271	21	target	target	NOUN
admet-2901	271	22	engagement	engagement	NOUN
admet-2901	271	23	,	,	PUNCT
admet-2901	271	24	particularly	particularly	ADV
admet-2901	271	25	relevant	relevant	ADJ
admet-2901	271	26	to	to	ADP
admet-2901	271	27	its	its	PRON
admet-2901	271	28	proposed	propose	VERB
admet-2901	271	29	mechanism	mechanism	NOUN
admet-2901	271	30	of	of	ADP
admet-2901	271	31	v	v	NOUN
admet-2901	271	32	-	-	PUNCT
admet-2901	271	33	atpase	atpase	NOUN
admet-2901	271	34	inhibition	inhibition	NOUN
admet-2901	271	35	.	.	PUNCT
admet-2901	272	1	its	its	PRON
admet-2901	272	2	molecular	molecular	ADJ
admet-2901	272	3	features	feature	NOUN
admet-2901	272	4	include	include	VERB
admet-2901	272	5	multiple	multiple	ADJ
admet-2901	272	6	methoxy	methoxy	ADJ
admet-2901	272	7	groups	group	NOUN
admet-2901	272	8	,	,	PUNCT
admet-2901	272	9	a	a	DET
admet-2901	272	10	methylenedioxy	methylenedioxy	ADJ
admet-2901	272	11	bridge	bridge	NOUN
admet-2901	272	12	,	,	PUNCT
admet-2901	272	13	and	and	CCONJ
admet-2901	272	14	a	a	DET
admet-2901	272	15	lactone	lactone	NOUN
admet-2901	272	16	ring	ring	NOUN
admet-2901	272	17	,	,	PUNCT
admet-2901	272	18	which	which	PRON
admet-2901	272	19	collectively	collectively	ADV
admet-2901	272	20	contribute	contribute	VERB
admet-2901	272	21	to	to	ADP
admet-2901	272	22	moderate	moderate	ADJ
admet-2901	272	23	lipophilicity	lipophilicity	NOUN
admet-2901	272	24	and	and	CCONJ
admet-2901	272	25	favourable	favourable	ADJ
admet-2901	272	26	passive	passive	ADJ
admet-2901	272	27	permeability	permeability	NOUN
admet-2901	272	28	[	[	X
admet-2901	272	29	72	72	NUM
admet-2901	272	30	-	-	SYM
admet-2901	272	31	75	75	NUM
admet-2901	272	32	]	]	PUNCT
admet-2901	272	33	.	.	PUNCT
admet-2901	273	1	additionally	additionally	ADV
admet-2901	273	2	,	,	PUNCT
admet-2901	273	3	its	its	PRON
admet-2901	273	4	molecular	molecular	ADJ
admet-2901	273	5	weight	weight	NOUN
admet-2901	273	6	,	,	PUNCT
admet-2901	273	7	approximately	approximately	ADV
admet-2901	273	8	540.5	540.5	NUM
admet-2901	273	9	g	g	NOUN
admet-2901	273	10	mol-1	mol-1	ADP
admet-2901	273	11	,	,	PUNCT
admet-2901	273	12	slightly	slightly	ADV
admet-2901	273	13	exceeds	exceed	VERB
admet-2901	273	14	the	the	DET
admet-2901	273	15	lipinski	lipinski	PROPN
admet-2901	273	16	rule	rule	NOUN
admet-2901	273	17	threshold	threshold	NOUN
admet-2901	273	18	(	(	PUNCT
admet-2901	273	19	500	500	NUM
admet-2901	273	20	da	da	NOUN
admet-2901	273	21	)	)	PUNCT
admet-2901	274	1	[	[	X
admet-2901	274	2	76,77	76,77	NOUN
admet-2901	274	3	]	]	X
admet-2901	274	4	,	,	PUNCT
admet-2901	274	5	but	but	CCONJ
admet-2901	274	6	remains	remain	VERB
admet-2901	274	7	within	within	ADP
admet-2901	274	8	the	the	DET
admet-2901	274	9	acceptable	acceptable	ADJ
admet-2901	274	10	range	range	NOUN
admet-2901	274	11	observed	observe	VERB
admet-2901	274	12	for	for	ADP
admet-2901	274	13	many	many	ADJ
admet-2901	274	14	bioactive	bioactive	ADJ
admet-2901	274	15	natural	natural	ADJ
admet-2901	274	16	products	product	NOUN
admet-2901	275	1	[	[	X
admet-2901	275	2	77,78	77,78	PROPN
admet-2901	275	3	]	]	PUNCT
admet-2901	275	4	.	.	PUNCT
admet-2901	276	1	several	several	ADJ
admet-2901	276	2	clinically	clinically	ADV
admet-2901	276	3	approved	approve	VERB
admet-2901	276	4	anticancer	anticancer	NOUN
admet-2901	276	5	drugs	drug	NOUN
admet-2901	276	6	,	,	PUNCT
admet-2901	276	7	including	include	VERB
admet-2901	276	8	taxanes	taxane	NOUN
admet-2901	276	9	and	and	CCONJ
admet-2901	276	10	epipodophyllotoxins	epipodophyllotoxin	NOUN
admet-2901	276	11	,	,	PUNCT
admet-2901	276	12	exceed	exceed	VERB
admet-2901	276	13	500	500	NUM
admet-2901	276	14	da	da	NOUN
admet-2901	276	15	but	but	CCONJ
admet-2901	276	16	retain	retain	VERB
admet-2901	276	17	oral	oral	ADJ
admet-2901	276	18	bioavailability	bioavailability	NOUN
admet-2901	276	19	due	due	ADP
admet-2901	276	20	to	to	ADP
admet-2901	276	21	structural	structural	ADJ
admet-2901	276	22	rigidity	rigidity	NOUN
admet-2901	276	23	and	and	CCONJ
admet-2901	276	24	efficient	efficient	ADJ
admet-2901	276	25	transporter	transporter	NOUN
admet-2901	276	26	engagement[79	engagement[79	ADV
admet-2901	276	27	]	]	PUNCT
admet-2901	276	28	.	.	PUNCT
admet-2901	277	1	molecular	molecular	ADJ
admet-2901	277	2	docking	docking	NOUN
admet-2901	277	3	results	result	NOUN
admet-2901	277	4	from	from	ADP
admet-2901	277	5	this	this	DET
admet-2901	277	6	study	study	NOUN
admet-2901	277	7	revealed	reveal	VERB
admet-2901	277	8	that	that	SCONJ
admet-2901	277	9	cleistanthin	cleistanthin	NOUN
admet-2901	277	10	a	a	DET
admet-2901	277	11	binds	bind	NOUN
admet-2901	277	12	favourably	favourably	ADV
admet-2901	277	13	to	to	ADP
admet-2901	277	14	the	the	DET
admet-2901	277	15	a	a	NOUN
admet-2901	277	16	–	–	PUNCT
admet-2901	277	17	c	c	NOUN
admet-2901	277	18	subunit	subunit	NOUN
admet-2901	277	19	interface	interface	NOUN
admet-2901	277	20	of	of	ADP
admet-2901	277	21	vacuolar	vacuolar	ADJ
admet-2901	277	22	h+-atpase	h+-atpase	PROPN
admet-2901	277	23	,	,	PUNCT
admet-2901	277	24	with	with	ADP
admet-2901	277	25	a	a	DET
admet-2901	277	26	docking	docking	NOUN
admet-2901	277	27	score	score	NOUN
admet-2901	277	28	of	of	ADP
admet-2901	277	29	-29.3	-29.3	PROPN
admet-2901	277	30	kj·mol⁻¹	kj·mol⁻¹	PROPN
admet-2901	277	31	(	(	PUNCT
admet-2901	277	32	-70	-70	PROPN
admet-2901	277	33	kcal·mol⁻¹	kcal·mol⁻¹	PROPN
admet-2901	277	34	)	)	PUNCT
admet-2901	277	35	.	.	PUNCT
admet-2901	278	1	the	the	DET
admet-2901	278	2	compound	compound	NOUN
admet-2901	278	3	forms	form	VERB
admet-2901	278	4	multiple	multiple	ADJ
admet-2901	278	5	π	π	NOUN
admet-2901	278	6	-	-	ADJ
admet-2901	278	7	alkyl	alkyl	ADJ
admet-2901	278	8	and	and	CCONJ
admet-2901	278	9	hydrophobic	hydrophobic	NOUN
admet-2901	278	10	interactions	interaction	NOUN
admet-2901	278	11	with	with	ADP
admet-2901	278	12	key	key	ADJ
admet-2901	278	13	transmembrane	transmembrane	NOUN
admet-2901	278	14	residues	residue	NOUN
admet-2901	278	15	,	,	PUNCT
admet-2901	278	16	including	include	VERB
admet-2901	278	17	val783	val783	PROPN
admet-2901	278	18	,	,	PUNCT
admet-2901	278	19	val784	val784	PROPN
admet-2901	278	20	,	,	PUNCT
admet-2901	278	21	ile58	ile58	PROPN
admet-2901	278	22	,	,	PUNCT
admet-2901	278	23	and	and	CCONJ
admet-2901	278	24	phe135	phe135	PROPN
admet-2901	278	25	,	,	PUNCT
admet-2901	278	26	regions	region	NOUN
admet-2901	278	27	associated	associate	VERB
admet-2901	278	28	with	with	ADP
admet-2901	278	29	proton	proton	NOUN
admet-2901	278	30	transport	transport	NOUN
admet-2901	278	31	and	and	CCONJ
admet-2901	278	32	enzyme	enzyme	NOUN
admet-2901	278	33	function	function	NOUN
admet-2901	278	34	[	[	X
admet-2901	278	35	49	49	NUM
admet-2901	278	36	]	]	PUNCT
admet-2901	278	37	.	.	PUNCT
admet-2901	279	1	these	these	DET
admet-2901	279	2	findings	finding	NOUN
admet-2901	279	3	are	be	AUX
admet-2901	279	4	consistent	consistent	ADJ
admet-2901	279	5	with	with	ADP
admet-2901	279	6	previous	previous	ADJ
admet-2901	279	7	studies	study	NOUN
admet-2901	279	8	reporting	report	VERB
admet-2901	279	9	that	that	SCONJ
admet-2901	279	10	lipophilic	lipophilic	ADJ
admet-2901	279	11	natural	natural	ADJ
admet-2901	279	12	products	product	NOUN
admet-2901	279	13	often	often	ADV
admet-2901	279	14	anchor	anchor	VERB
admet-2901	279	15	within	within	ADP
admet-2901	279	16	the	the	DET
admet-2901	279	17	hydrophobic	hydrophobic	ADJ
admet-2901	279	18	transmembrane	transmembrane	NOUN
admet-2901	279	19	domains	domain	NOUN
admet-2901	279	20	of	of	ADP
admet-2901	279	21	v	v	NOUN
admet-2901	279	22	-	-	PUNCT
admet-2901	279	23	atpase	atpase	ADJ
admet-2901	279	24	and	and	CCONJ
admet-2901	279	25	similar	similar	ADJ
admet-2901	279	26	proton	proton	NOUN
admet-2901	279	27	pumps	pump	NOUN
admet-2901	279	28	[	[	X
admet-2901	279	29	28,80,81	28,80,81	NUM
admet-2901	279	30	]	]	X
admet-2901	279	31	.	.	PUNCT
admet-2901	280	1	structurally	structurally	ADV
admet-2901	280	2	,	,	PUNCT
admet-2901	280	3	cleistanthin	cleistanthin	VERB
admet-2901	280	4	a	a	DET
admet-2901	280	5	's	's	PART
admet-2901	280	6	planar	planar	ADJ
admet-2901	280	7	aromatic	aromatic	ADJ
admet-2901	280	8	naphthalene	naphthalene	NOUN
admet-2901	280	9	core	core	NOUN
admet-2901	280	10	facilitates	facilitate	VERB
admet-2901	280	11	π	π	PROPN
admet-2901	280	12	–	–	PUNCT
admet-2901	280	13	π	π	NOUN
admet-2901	280	14	stacking	stacking	NOUN
admet-2901	280	15	,	,	PUNCT
admet-2901	280	16	while	while	SCONJ
admet-2901	280	17	the	the	DET
admet-2901	280	18	methylenedioxy	methylenedioxy	NOUN
admet-2901	280	19	and	and	CCONJ
admet-2901	280	20	methoxy	methoxy	ADJ
admet-2901	280	21	substituents	substituent	NOUN
admet-2901	280	22	enhance	enhance	VERB
admet-2901	280	23	its	its	PRON
admet-2901	280	24	compatibility	compatibility	NOUN
admet-2901	280	25	with	with	ADP
admet-2901	280	26	lipophilic	lipophilic	ADJ
admet-2901	280	27	protein	protein	NOUN
admet-2901	280	28	cavities	cavity	NOUN
admet-2901	281	1	[	[	X
admet-2901	281	2	52	52	NUM
admet-2901	281	3	]	]	PUNCT
admet-2901	281	4	.	.	PUNCT
admet-2901	282	1	the	the	DET
admet-2901	282	2	physicochemical	physicochemical	ADJ
admet-2901	282	3	profile	profile	NOUN
admet-2901	282	4	of	of	ADP
admet-2901	282	5	cleistanthin	cleistanthin	NOUN
admet-2901	282	6	a	a	PRON
admet-2901	282	7	supports	support	VERB
admet-2901	282	8	its	its	PRON
admet-2901	282	9	candidacy	candidacy	NOUN
admet-2901	282	10	as	as	ADP
admet-2901	282	11	a	a	DET
admet-2901	282	12	cell	cell	NOUN
admet-2901	282	13	-	-	PUNCT
admet-2901	282	14	permeable	permeable	ADJ
admet-2901	282	15	anticancer	anticancer	NOUN
admet-2901	282	16	agent	agent	NOUN
admet-2901	282	17	that	that	PRON
admet-2901	282	18	acts	act	VERB
admet-2901	282	19	by	by	ADP
admet-2901	282	20	v	v	NOUN
admet-2901	282	21	-	-	PUNCT
admet-2901	282	22	atpase	atpase	NOUN
admet-2901	282	23	inhibition	inhibition	NOUN
admet-2901	282	24	.	.	PUNCT
admet-2901	283	1	previous	previous	ADJ
admet-2901	283	2	work	work	NOUN
admet-2901	283	3	has	have	AUX
admet-2901	283	4	demonstrated	demonstrate	VERB
admet-2901	283	5	that	that	SCONJ
admet-2901	283	6	diphyllin	diphyllin	NOUN
admet-2901	283	7	-	-	PUNCT
admet-2901	283	8	based	base	VERB
admet-2901	283	9	lignans	lignan	NOUN
admet-2901	283	10	,	,	PUNCT
admet-2901	283	11	such	such	ADJ
admet-2901	283	12	as	as	ADP
admet-2901	283	13	cleistanthin	cleistanthin	NOUN
admet-2901	283	14	a	a	PRON
admet-2901	283	15	,	,	PUNCT
admet-2901	283	16	preferentially	preferentially	ADV
admet-2901	283	17	accumulate	accumulate	VERB
admet-2901	283	18	in	in	ADP
admet-2901	283	19	acidic	acidic	ADJ
admet-2901	283	20	intracellular	intracellular	ADJ
admet-2901	283	21	compartments	compartment	NOUN
admet-2901	283	22	,	,	PUNCT
admet-2901	283	23	such	such	ADJ
admet-2901	283	24	as	as	ADP
admet-2901	283	25	lysosomes	lysosome	NOUN
admet-2901	283	26	,	,	PUNCT
admet-2901	283	27	due	due	ADJ
admet-2901	283	28	to	to	ADP
admet-2901	283	29	passive	passive	ADJ
admet-2901	283	30	ph	ph	ADJ
admet-2901	283	31	-	-	ADJ
admet-2901	283	32	dependent	dependent	ADJ
admet-2901	283	33	diffusion	diffusion	NOUN
admet-2901	283	34	and	and	CCONJ
admet-2901	283	35	v	v	NOUN
admet-2901	283	36	-	-	PUNCT
admet-2901	283	37	atpase	atpase	ADJ
admet-2901	283	38	binding	binding	NOUN
admet-2901	283	39	,	,	PUNCT
admet-2901	283	40	leading	lead	VERB
admet-2901	283	41	to	to	ADP
admet-2901	283	42	autophagy	autophagy	ADJ
admet-2901	283	43	blockade	blockade	NOUN
admet-2901	283	44	and	and	CCONJ
admet-2901	283	45	cancer	cancer	NOUN
admet-2901	283	46	cell	cell	NOUN
admet-2901	283	47	apoptosis	apoptosis	NOUN
admet-2901	283	48	[	[	X
admet-2901	283	49	49,82	49,82	NOUN
admet-2901	283	50	]	]	PUNCT
admet-2901	283	51	.	.	PUNCT
admet-2901	284	1	importantly	importantly	ADV
admet-2901	284	2	,	,	PUNCT
admet-2901	284	3	these	these	DET
admet-2901	284	4	properties	property	NOUN
admet-2901	284	5	contribute	contribute	VERB
admet-2901	284	6	not	not	PART
admet-2901	284	7	only	only	ADV
admet-2901	284	8	to	to	ADP
admet-2901	284	9	its	its	PRON
admet-2901	284	10	cytotoxic	cytotoxic	ADJ
admet-2901	284	11	selectivity	selectivity	NOUN
admet-2901	284	12	against	against	ADP
admet-2901	284	13	cancer	cancer	NOUN
admet-2901	284	14	cells	cell	NOUN
admet-2901	284	15	but	but	CCONJ
admet-2901	284	16	also	also	ADV
admet-2901	284	17	to	to	ADP
admet-2901	284	18	its	its	PRON
admet-2901	284	19	low	low	ADJ
admet-2901	284	20	toxicity	toxicity	NOUN
admet-2901	284	21	in	in	ADP
admet-2901	284	22	non	non	ADJ
admet-2901	284	23	-	-	ADJ
admet-2901	284	24	malignant	malignant	ADJ
admet-2901	284	25	cells	cell	NOUN
admet-2901	284	26	,	,	PUNCT
admet-2901	284	27	including	include	VERB
admet-2901	284	28	hepatocytes	hepatocyte	NOUN
admet-2901	284	29	,	,	PUNCT
admet-2901	284	30	which	which	PRON
admet-2901	284	31	typically	typically	ADV
admet-2901	284	32	maintain	maintain	VERB
admet-2901	284	33	a	a	DET
admet-2901	284	34	neutral	neutral	ADJ
admet-2901	284	35	intracellular	intracellular	ADJ
admet-2901	284	36	ph	ph	NOUN
admet-2901	285	1	[	[	X
admet-2901	285	2	47	47	NUM
admet-2901	285	3	]	]	PUNCT
admet-2901	285	4	.	.	PUNCT
admet-2901	286	1	although	although	SCONJ
admet-2901	286	2	the	the	DET
admet-2901	286	3	hepg2	hepg2	NOUN
admet-2901	286	4	cells	cell	NOUN
admet-2901	286	5	are	be	AUX
admet-2901	286	6	a	a	DET
admet-2901	286	7	hepatoma	hepatoma	ADJ
admet-2901	286	8	cell	cell	NOUN
admet-2901	286	9	line	line	NOUN
admet-2901	286	10	,	,	PUNCT
admet-2901	286	11	they	they	PRON
admet-2901	286	12	are	be	AUX
admet-2901	286	13	commonly	commonly	ADV
admet-2901	286	14	used	use	VERB
admet-2901	286	15	for	for	ADP
admet-2901	286	16	pharmacotoxicological	pharmacotoxicological	ADJ
admet-2901	286	17	research	research	NOUN
admet-2901	286	18	.	.	PUNCT
admet-2901	287	1	it	it	PRON
admet-2901	287	2	is	be	AUX
admet-2901	287	3	not	not	PART
admet-2901	287	4	only	only	ADV
admet-2901	287	5	a	a	DET
admet-2901	287	6	nontumorigenic	nontumorigenic	ADJ
admet-2901	287	7	and	and	CCONJ
admet-2901	287	8	highly	highly	ADV
admet-2901	287	9	proliferative	proliferative	ADJ
admet-2901	287	10	cell	cell	NOUN
admet-2901	287	11	,	,	PUNCT
admet-2901	287	12	but	but	CCONJ
admet-2901	287	13	it	it	PRON
admet-2901	287	14	also	also	ADV
admet-2901	287	15	offers	offer	VERB
admet-2901	287	16	several	several	ADJ
admet-2901	287	17	benefits	benefit	NOUN
admet-2901	287	18	such	such	ADJ
admet-2901	287	19	as	as	ADP
admet-2901	287	20	high	high	ADJ
admet-2901	287	21	availability	availability	NOUN
admet-2901	287	22	,	,	PUNCT
admet-2901	287	23	easy	easy	ADJ
admet-2901	287	24	to	to	PART
admet-2901	287	25	handle	handle	VERB
admet-2901	287	26	,	,	PUNCT
admet-2901	287	27	almost	almost	ADV
admet-2901	287	28	unlimited	unlimited	ADJ
admet-2901	287	29	life	life	NOUN
admet-2901	287	30	-	-	PUNCT
admet-2901	287	31	span	span	NOUN
admet-2901	287	32	,	,	PUNCT
admet-2901	287	33	and	and	CCONJ
admet-2901	287	34	stability	stability	NOUN
admet-2901	287	35	[	[	X
admet-2901	287	36	83	83	NUM
admet-2901	287	37	]	]	PUNCT
admet-2901	287	38	in	in	ADP
admet-2901	287	39	hepg2	hepg2	NOUN
admet-2901	287	40	liver	liver	NOUN
admet-2901	287	41	models	model	NOUN
admet-2901	287	42	,	,	PUNCT
admet-2901	287	43	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	NOUN
admet-2901	287	44	n.	n.	NOUN
admet-2901	287	45	chabang	chabang	PROPN
admet-2901	287	46	et	et	PROPN
admet-2901	287	47	al	al	PROPN
admet-2901	287	48	.	.	PROPN
admet-2901	287	49	admet	admet	PROPN
admet-2901	287	50	&	&	CCONJ
admet-2901	287	51	dmpk	dmpk	PROPN
admet-2901	287	52	13(5	13(5	NUM
admet-2901	287	53	)	)	PUNCT
admet-2901	287	54	(	(	PUNCT
admet-2901	287	55	2025	2025	NUM
admet-2901	287	56	)	)	PUNCT
admet-2901	287	57	2901	2901	NUM
admet-2901	287	58	14	14	NUM
admet-2901	287	59	cleistanthin	cleistanthin	NOUN
admet-2901	287	60	 	 	SPACE
admet-2901	287	61	a	a	DET
admet-2901	287	62	showed	show	VERB
admet-2901	287	63	negligible	negligible	ADJ
admet-2901	287	64	cytotoxicity	cytotoxicity	NOUN
admet-2901	287	65	,	,	PUNCT
admet-2901	287	66	yielding	yield	VERB
admet-2901	287	67	a	a	DET
admet-2901	287	68	selectivity	selectivity	NOUN
admet-2901	287	69	index	index	NOUN
admet-2901	287	70	>	>	X
admet-2901	287	71	100	100	NUM
admet-2901	287	72	in	in	ADP
admet-2901	287	73	mda‑mb‑231	mda‑mb‑231	ADJ
admet-2901	287	74	cells	cell	NOUN
admet-2901	287	75	and	and	CCONJ
admet-2901	287	76	10	10	PROPN
admet-2901	287	77	in	in	ADP
admet-2901	287	78	mcf‑7	mcf‑7	NUM
admet-2901	287	79	,	,	PUNCT
admet-2901	287	80	mirroring	mirror	VERB
admet-2901	287	81	reports	report	NOUN
admet-2901	287	82	that	that	SCONJ
admet-2901	287	83	diphyllin	diphyllin	NOUN
admet-2901	287	84	-	-	PUNCT
admet-2901	287	85	type	type	NOUN
admet-2901	287	86	lignans	lignan	NOUN
admet-2901	287	87	preferentially	preferentially	ADV
admet-2901	287	88	accumulate	accumulate	VERB
admet-2901	287	89	in	in	ADP
admet-2901	287	90	acidic	acidic	ADJ
admet-2901	287	91	tumours	tumour	NOUN
admet-2901	287	92	and	and	CCONJ
admet-2901	287	93	spare	spare	ADJ
admet-2901	287	94	non	non	ADJ
admet-2901	287	95	-	-	ADJ
admet-2901	287	96	malignant	malignant	ADJ
admet-2901	287	97	tissues	tissue	NOUN
admet-2901	287	98	likewise	likewise	ADV
admet-2901	287	99	reported	report	VERB
admet-2901	287	100	low	low	ADJ
admet-2901	287	101	hepatocyte	hepatocyte	NOUN
admet-2901	287	102	toxicity	toxicity	NOUN
admet-2901	287	103	at	at	ADP
admet-2901	287	104	similar	similar	ADJ
admet-2901	287	105	concentrations	concentration	NOUN
admet-2901	287	106	[	[	X
admet-2901	287	107	68,84,85	68,84,85	NUM
admet-2901	287	108	]	]	PUNCT
admet-2901	287	109	.	.	PUNCT
admet-2901	288	1	by	by	ADP
admet-2901	288	2	contrast	contrast	NOUN
admet-2901	288	3	,	,	PUNCT
admet-2901	288	4	doxorubicin	doxorubicin	PROPN
admet-2901	288	5	induced	induce	VERB
admet-2901	288	6	notable	notable	ADJ
admet-2901	288	7	liver	liver	NOUN
admet-2901	288	8	cell	cell	NOUN
admet-2901	288	9	toxicity	toxicity	NOUN
admet-2901	288	10	,	,	PUNCT
admet-2901	288	11	consistent	consistent	ADJ
admet-2901	288	12	with	with	ADP
admet-2901	288	13	well	well	ADV
admet-2901	288	14	-	-	PUNCT
admet-2901	288	15	established	establish	VERB
admet-2901	288	16	dose	dose	NOUN
admet-2901	288	17	-	-	PUNCT
admet-2901	288	18	limiting	limit	VERB
admet-2901	288	19	hepatotoxicity	hepatotoxicity	NOUN
admet-2901	288	20	in	in	ADP
admet-2901	288	21	clinical	clinical	ADJ
admet-2901	288	22	use	use	NOUN
admet-2901	288	23	[	[	X
admet-2901	288	24	47	47	NUM
admet-2901	288	25	]	]	PUNCT
admet-2901	288	26	.	.	PUNCT
admet-2901	289	1	the	the	DET
admet-2901	289	2	novel	novel	NOUN
admet-2901	289	3	xanthone	xanthone	PROPN
admet-2901	289	4	displayed	display	VERB
admet-2901	289	5	limited	limited	ADJ
admet-2901	289	6	selectivity	selectivity	NOUN
admet-2901	289	7	(	(	PUNCT
admet-2901	289	8	si	si	X
admet-2901	289	9	<	<	X
admet-2901	289	10	10	10	NUM
admet-2901	289	11	)	)	PUNCT
admet-2901	289	12	,	,	PUNCT
admet-2901	289	13	suggesting	suggest	VERB
admet-2901	289	14	the	the	DET
admet-2901	289	15	need	need	NOUN
admet-2901	289	16	for	for	ADP
admet-2901	289	17	structural	structural	ADJ
admet-2901	289	18	modifications	modification	NOUN
admet-2901	289	19	such	such	ADJ
admet-2901	289	20	as	as	ADP
admet-2901	289	21	glycosylation	glycosylation	NOUN
admet-2901	289	22	to	to	PART
admet-2901	289	23	enhance	enhance	VERB
admet-2901	289	24	safety	safety	NOUN
admet-2901	289	25	and	and	CCONJ
admet-2901	289	26	pharmacokinetic	pharmacokinetic	ADJ
admet-2901	289	27	properties	property	NOUN
admet-2901	289	28	,	,	PUNCT
admet-2901	289	29	strategies	strategy	NOUN
admet-2901	289	30	previously	previously	ADV
admet-2901	289	31	shown	show	VERB
admet-2901	289	32	to	to	PART
admet-2901	289	33	improve	improve	VERB
admet-2901	289	34	xanthonoid	xanthonoid	PROPN
admet-2901	289	35	profiles	profile	NOUN
admet-2901	289	36	[	[	X
admet-2901	289	37	52,86	52,86	NOUN
admet-2901	289	38	]	]	PUNCT
admet-2901	289	39	.	.	PUNCT
admet-2901	290	1	the	the	DET
admet-2901	290	2	dual	dual	ADJ
admet-2901	290	3	effectiveness	effectiveness	NOUN
admet-2901	290	4	of	of	ADP
admet-2901	290	5	these	these	DET
admet-2901	290	6	two	two	NUM
admet-2901	290	7	structurally	structurally	ADV
admet-2901	290	8	unrelated	unrelated	ADJ
admet-2901	290	9	compounds	compound	NOUN
admet-2901	290	10	reflects	reflect	VERB
admet-2901	290	11	complementary	complementary	ADJ
admet-2901	290	12	benefits	benefit	NOUN
admet-2901	290	13	:	:	PUNCT
admet-2901	290	14	compound	compound	NOUN
admet-2901	290	15	1	1	NUM
admet-2901	290	16	may	may	AUX
admet-2901	290	17	serve	serve	VERB
admet-2901	290	18	as	as	ADP
admet-2901	290	19	a	a	DET
admet-2901	290	20	targeted	target	VERB
admet-2901	290	21	option	option	NOUN
admet-2901	290	22	for	for	ADP
admet-2901	290	23	early	early	ADJ
admet-2901	290	24	-	-	PUNCT
admet-2901	290	25	stage	stage	NOUN
admet-2901	290	26	,	,	PUNCT
admet-2901	290	27	hormone	hormone	NOUN
admet-2901	290	28	-	-	PUNCT
admet-2901	290	29	sensitive	sensitive	ADJ
admet-2901	290	30	tumours	tumour	NOUN
admet-2901	290	31	,	,	PUNCT
admet-2901	290	32	while	while	SCONJ
admet-2901	290	33	compound	compound	NOUN
admet-2901	290	34	10	10	NUM
admet-2901	290	35	offers	offer	VERB
admet-2901	290	36	broad	broad	ADJ
admet-2901	290	37	applicability	applicability	NOUN
admet-2901	290	38	across	across	ADP
admet-2901	290	39	subtypes	subtype	NOUN
admet-2901	290	40	,	,	PUNCT
admet-2901	290	41	including	include	VERB
admet-2901	290	42	aggressive	aggressive	ADJ
admet-2901	290	43	and	and	CCONJ
admet-2901	290	44	treatment	treatment	NOUN
admet-2901	290	45	-	-	PUNCT
admet-2901	290	46	resistant	resistant	ADJ
admet-2901	290	47	tnbc	tnbc	NOUN
admet-2901	290	48	.	.	PUNCT
admet-2901	291	1	moreover	moreover	ADV
admet-2901	291	2	,	,	PUNCT
admet-2901	291	3	the	the	DET
admet-2901	291	4	low	low	ADJ
admet-2901	291	5	hepatotoxicity	hepatotoxicity	NOUN
admet-2901	291	6	of	of	ADP
admet-2901	291	7	cleistanthin	cleistanthin	PROPN
admet-2901	291	8	a	a	DET
admet-2901	291	9	observed	observed	ADJ
admet-2901	291	10	in	in	ADP
admet-2901	291	11	hepg2	hepg2	NOUN
admet-2901	291	12	cells	cell	NOUN
admet-2901	291	13	further	far	ADV
admet-2901	291	14	supports	support	VERB
admet-2901	291	15	its	its	PRON
admet-2901	291	16	candidacy	candidacy	NOUN
admet-2901	291	17	as	as	ADP
admet-2901	291	18	a	a	DET
admet-2901	291	19	lead	lead	NOUN
admet-2901	291	20	compound	compound	NOUN
admet-2901	291	21	with	with	ADP
admet-2901	291	22	a	a	DET
admet-2901	291	23	favourable	favourable	ADJ
admet-2901	291	24	therapeutic	therapeutic	ADJ
admet-2901	291	25	index	index	NOUN
admet-2901	291	26	,	,	PUNCT
admet-2901	291	27	which	which	PRON
admet-2901	291	28	is	be	AUX
admet-2901	291	29	especially	especially	ADV
admet-2901	291	30	important	important	ADJ
admet-2901	291	31	in	in	ADP
admet-2901	291	32	advanced	advanced	ADJ
admet-2901	291	33	disease	disease	NOUN
admet-2901	291	34	settings	setting	NOUN
admet-2901	291	35	where	where	SCONJ
admet-2901	291	36	long	long	ADJ
admet-2901	291	37	-	-	PUNCT
admet-2901	291	38	term	term	NOUN
admet-2901	291	39	systemic	systemic	ADJ
admet-2901	291	40	toxicity	toxicity	NOUN
admet-2901	291	41	is	be	AUX
admet-2901	291	42	a	a	DET
admet-2901	291	43	concern	concern	NOUN
admet-2901	291	44	[	[	X
admet-2901	291	45	68,84	68,84	NOUN
admet-2901	291	46	]	]	PUNCT
admet-2901	291	47	.	.	PUNCT
admet-2901	292	1	together	together	ADV
admet-2901	292	2	,	,	PUNCT
admet-2901	292	3	these	these	DET
admet-2901	292	4	findings	finding	NOUN
admet-2901	292	5	underscore	underscore	VERB
admet-2901	292	6	the	the	DET
admet-2901	292	7	therapeutic	therapeutic	ADJ
admet-2901	292	8	value	value	NOUN
admet-2901	292	9	of	of	ADP
admet-2901	292	10	mallotus	mallotus	ADJ
admet-2901	292	11	glomerulatus	glomerulatus	NOUN
admet-2901	292	12	-	-	PUNCT
admet-2901	292	13	derived	derive	VERB
admet-2901	292	14	compounds	compound	NOUN
admet-2901	292	15	and	and	CCONJ
admet-2901	292	16	justify	justify	VERB
admet-2901	292	17	further	far	ADV
admet-2901	292	18	mechanistic	mechanistic	ADJ
admet-2901	292	19	and	and	CCONJ
admet-2901	292	20	in	in	ADP
admet-2901	292	21	vivo	vivo	ADJ
admet-2901	292	22	studies	study	NOUN
admet-2901	292	23	to	to	PART
admet-2901	292	24	validate	validate	VERB
admet-2901	292	25	their	their	PRON
admet-2901	292	26	efficacy	efficacy	NOUN
admet-2901	292	27	and	and	CCONJ
admet-2901	292	28	safety	safety	NOUN
admet-2901	292	29	.	.	PUNCT
admet-2901	293	1	conclusions	conclusion	NOUN
admet-2901	293	2	this	this	DET
admet-2901	293	3	study	study	NOUN
admet-2901	293	4	highlights	highlight	VERB
admet-2901	293	5	the	the	DET
admet-2901	293	6	therapeutic	therapeutic	ADJ
admet-2901	293	7	potential	potential	NOUN
admet-2901	293	8	of	of	ADP
admet-2901	293	9	two	two	NUM
admet-2901	293	10	phytochemicals	phytochemical	NOUN
admet-2901	293	11	isolated	isolate	VERB
admet-2901	293	12	from	from	ADP
admet-2901	293	13	mallotus	mallotus	ADJ
admet-2901	293	14	glomerulatus	glomerulatus	NOUN
admet-2901	293	15	,	,	PUNCT
admet-2901	293	16	a	a	DET
admet-2901	293	17	novel	novel	NOUN
admet-2901	293	18	xanthone	xanthone	PROPN
admet-2901	293	19	(	(	PUNCT
admet-2901	293	20	compound	compound	NOUN
admet-2901	293	21	1	1	NUM
admet-2901	293	22	)	)	PUNCT
admet-2901	293	23	and	and	CCONJ
admet-2901	293	24	cleistanthin	cleistanthin	VERB
admet-2901	293	25	a	a	PRON
admet-2901	293	26	(	(	PUNCT
admet-2901	293	27	compound	compound	NOUN
admet-2901	293	28	10	10	NUM
admet-2901	293	29	)	)	PUNCT
admet-2901	293	30	,	,	PUNCT
admet-2901	293	31	against	against	ADP
admet-2901	293	32	breast	breast	NOUN
admet-2901	293	33	cancer	cancer	NOUN
admet-2901	293	34	.	.	PUNCT
admet-2901	294	1	compound	compound	NOUN
admet-2901	294	2	1	1	NUM
admet-2901	294	3	exhibited	exhibit	VERB
admet-2901	294	4	selective	selective	ADJ
admet-2901	294	5	cytotoxicity	cytotoxicity	NOUN
admet-2901	294	6	toward	toward	ADP
admet-2901	294	7	the	the	DET
admet-2901	294	8	low	low	ADJ
admet-2901	294	9	-	-	PUNCT
admet-2901	294	10	aggressive	aggressive	ADJ
admet-2901	294	11	mcf-7	mcf-7	PUNCT
admet-2901	294	12	breast	breast	NOUN
admet-2901	294	13	cancer	cancer	NOUN
admet-2901	294	14	cells	cell	NOUN
admet-2901	294	15	,	,	PUNCT
admet-2901	294	16	whereas	whereas	SCONJ
admet-2901	294	17	cleistanthin	cleistanthin	VERB
admet-2901	294	18	a	a	DET
admet-2901	294	19	demonstrated	demonstrate	VERB
admet-2901	294	20	potent	potent	ADJ
admet-2901	294	21	,	,	PUNCT
admet-2901	294	22	broad	broad	ADJ
admet-2901	294	23	-	-	PUNCT
admet-2901	294	24	spectrum	spectrum	NOUN
admet-2901	294	25	cytotoxicity	cytotoxicity	NOUN
admet-2901	294	26	against	against	ADP
admet-2901	294	27	both	both	CCONJ
admet-2901	294	28	the	the	DET
admet-2901	294	29	low	low	ADJ
admet-2901	294	30	-	-	PUNCT
admet-2901	294	31	aggressive	aggressive	ADJ
admet-2901	294	32	mcf-7	mcf-7	NOUN
admet-2901	294	33	and	and	CCONJ
admet-2901	294	34	the	the	DET
admet-2901	294	35	highly	highly	ADV
admet-2901	294	36	aggressive	aggressive	ADJ
admet-2901	294	37	mda	mda	PROPN
admet-2901	294	38	-	-	PUNCT
admet-2901	294	39	mb-231	mb-231	PROPN
admet-2901	294	40	cells	cell	NOUN
admet-2901	294	41	.	.	PUNCT
admet-2901	295	1	dose	dose	NOUN
admet-2901	295	2	-	-	PUNCT
admet-2901	295	3	response	response	NOUN
admet-2901	295	4	studies	study	NOUN
admet-2901	295	5	confirmed	confirm	VERB
admet-2901	295	6	that	that	SCONJ
admet-2901	295	7	cleistanthin	cleistanthin	VERB
admet-2901	295	8	a	a	DET
admet-2901	295	9	possesses	possesse	NOUN
admet-2901	295	10	nanomolar	nanomolar	ADJ
admet-2901	295	11	-	-	PUNCT
admet-2901	295	12	range	range	NOUN
admet-2901	295	13	ic50	ic50	PROPN
admet-2901	295	14	values	value	NOUN
admet-2901	295	15	and	and	CCONJ
admet-2901	295	16	a	a	DET
admet-2901	295	17	high	high	ADJ
admet-2901	295	18	selectivity	selectivity	NOUN
admet-2901	295	19	index	index	NOUN
admet-2901	295	20	,	,	PUNCT
admet-2901	295	21	indicating	indicate	VERB
admet-2901	295	22	strong	strong	ADJ
admet-2901	295	23	efficacy	efficacy	NOUN
admet-2901	295	24	and	and	CCONJ
admet-2901	295	25	low	low	ADJ
admet-2901	295	26	toxicity	toxicity	NOUN
admet-2901	295	27	toward	toward	ADP
admet-2901	295	28	normal	normal	ADJ
admet-2901	295	29	liver	liver	NOUN
admet-2901	295	30	cells	cell	NOUN
admet-2901	295	31	.	.	PUNCT
admet-2901	296	1	molecular	molecular	ADJ
admet-2901	296	2	docking	docking	NOUN
admet-2901	296	3	further	far	ADV
admet-2901	296	4	revealed	reveal	VERB
admet-2901	296	5	that	that	SCONJ
admet-2901	296	6	both	both	DET
admet-2901	296	7	compounds	compound	VERB
admet-2901	296	8	interact	interact	VERB
admet-2901	296	9	with	with	ADP
admet-2901	296	10	critical	critical	ADJ
admet-2901	296	11	hydrophobic	hydrophobic	NOUN
admet-2901	296	12	residues	residue	NOUN
admet-2901	296	13	at	at	ADP
admet-2901	296	14	the	the	DET
admet-2901	296	15	a	a	NOUN
admet-2901	296	16	–	–	PUNCT
admet-2901	296	17	c	c	NOUN
admet-2901	296	18	subunit	subunit	NOUN
admet-2901	296	19	interface	interface	NOUN
admet-2901	296	20	of	of	ADP
admet-2901	296	21	v	v	NOUN
admet-2901	296	22	-	-	PUNCT
admet-2901	296	23	atpase	atpase	NOUN
admet-2901	296	24	,	,	PUNCT
admet-2901	296	25	suggesting	suggest	VERB
admet-2901	296	26	a	a	DET
admet-2901	296	27	shared	share	VERB
admet-2901	296	28	mechanism	mechanism	NOUN
admet-2901	296	29	of	of	ADP
admet-2901	296	30	action	action	NOUN
admet-2901	296	31	through	through	ADP
admet-2901	296	32	proton	proton	NOUN
admet-2901	296	33	pump	pump	NOUN
admet-2901	296	34	inhibition	inhibition	NOUN
admet-2901	296	35	,	,	PUNCT
admet-2901	296	36	which	which	PRON
admet-2901	296	37	is	be	AUX
admet-2901	296	38	known	know	VERB
admet-2901	296	39	to	to	PART
admet-2901	296	40	suppress	suppress	VERB
admet-2901	296	41	tumour	tumour	ADJ
admet-2901	296	42	survival	survival	NOUN
admet-2901	296	43	pathways	pathway	NOUN
admet-2901	296	44	such	such	ADJ
admet-2901	296	45	as	as	ADP
admet-2901	296	46	autophagy	autophagy	ADJ
admet-2901	296	47	.	.	PUNCT
admet-2901	297	1	despite	despite	SCONJ
admet-2901	297	2	these	these	DET
admet-2901	297	3	promising	promising	ADJ
admet-2901	297	4	results	result	NOUN
admet-2901	297	5	,	,	PUNCT
admet-2901	297	6	several	several	ADJ
admet-2901	297	7	limitations	limitation	NOUN
admet-2901	297	8	remain	remain	VERB
admet-2901	297	9	.	.	PUNCT
admet-2901	298	1	future	future	ADJ
admet-2901	298	2	research	research	NOUN
admet-2901	298	3	may	may	AUX
admet-2901	298	4	focus	focus	VERB
admet-2901	298	5	on	on	ADP
admet-2901	298	6	validating	validate	VERB
admet-2901	298	7	these	these	DET
admet-2901	298	8	hit	hit	VERB
admet-2901	298	9	compounds	compound	NOUN
admet-2901	298	10	,	,	PUNCT
admet-2901	298	11	performing	perform	VERB
admet-2901	298	12	mechanistic	mechanistic	ADJ
admet-2901	298	13	studies	study	NOUN
admet-2901	298	14	to	to	PART
admet-2901	298	15	confirm	confirm	VERB
admet-2901	298	16	v	v	NOUN
admet-2901	298	17	-	-	PUNCT
admet-2901	298	18	atpase	atpase	NOUN
admet-2901	298	19	inhibition	inhibition	NOUN
admet-2901	298	20	,	,	PUNCT
admet-2901	298	21	and	and	CCONJ
admet-2901	298	22	conducting	conduct	VERB
admet-2901	298	23	medicinal	medicinal	ADJ
admet-2901	298	24	chemistry	chemistry	NOUN
admet-2901	298	25	efforts	effort	NOUN
admet-2901	298	26	to	to	PART
admet-2901	298	27	enhance	enhance	VERB
admet-2901	298	28	the	the	DET
admet-2901	298	29	bioactivity	bioactivity	NOUN
admet-2901	298	30	and	and	CCONJ
admet-2901	298	31	safety	safety	NOUN
admet-2901	298	32	profile	profile	NOUN
admet-2901	298	33	of	of	ADP
admet-2901	298	34	the	the	DET
admet-2901	298	35	novel	novel	NOUN
admet-2901	298	36	xanthone	xanthone	PROPN
admet-2901	298	37	scaffold	scaffold	NOUN
admet-2901	298	38	.	.	PUNCT
admet-2901	299	1	overall	overall	ADJ
admet-2901	299	2	,	,	PUNCT
admet-2901	299	3	m.	m.	NOUN
admet-2901	299	4	glomerulatus	glomerulatus	NOUN
admet-2901	299	5	-	-	PUNCT
admet-2901	299	6	derived	derive	VERB
admet-2901	299	7	compounds	compound	NOUN
admet-2901	299	8	,	,	PUNCT
admet-2901	299	9	especially	especially	ADV
admet-2901	299	10	cleistanthin	cleistanthin	VERB
admet-2901	299	11	a	a	PRON
admet-2901	299	12	,	,	PUNCT
admet-2901	299	13	represent	represent	VERB
admet-2901	299	14	promising	promise	VERB
admet-2901	299	15	leads	lead	NOUN
admet-2901	299	16	for	for	ADP
admet-2901	299	17	the	the	DET
admet-2901	299	18	development	development	NOUN
admet-2901	299	19	of	of	ADP
admet-2901	299	20	affordable	affordable	ADJ
admet-2901	299	21	and	and	CCONJ
admet-2901	299	22	effective	effective	ADJ
admet-2901	299	23	anti	anti	ADJ
admet-2901	299	24	-	-	ADJ
admet-2901	299	25	breast	breast	ADJ
admet-2901	299	26	cancer	cancer	NOUN
admet-2901	299	27	therapies	therapy	NOUN
admet-2901	299	28	.	.	PUNCT
admet-2901	300	1	acknowledgements	acknowledgement	NOUN
admet-2901	300	2	:	:	PUNCT
admet-2901	300	3	this	this	DET
admet-2901	300	4	research	research	NOUN
admet-2901	300	5	was	be	AUX
admet-2901	300	6	partially	partially	ADV
admet-2901	300	7	supported	support	VERB
admet-2901	300	8	by	by	ADP
admet-2901	300	9	the	the	DET
admet-2901	300	10	ramathibodi	ramathibodi	PROPN
admet-2901	300	11	foundation	foundation	PROPN
admet-2901	300	12	and	and	CCONJ
admet-2901	300	13	thailand	thailand	PROPN
admet-2901	300	14	center	center	PROPN
admet-2901	300	15	of	of	ADP
admet-2901	300	16	excellence	excellence	PROPN
admet-2901	300	17	for	for	ADP
admet-2901	300	18	life	life	NOUN
admet-2901	300	19	sciences	science	NOUN
admet-2901	300	20	(	(	PUNCT
admet-2901	300	21	tcels	tcel	NOUN
admet-2901	300	22	)	)	PUNCT
admet-2901	300	23	,	,	PUNCT
admet-2901	300	24	and	and	CCONJ
admet-2901	300	25	also	also	ADV
admet-2901	300	26	by	by	ADP
admet-2901	300	27	the	the	DET
admet-2901	300	28	faculty	faculty	NOUN
admet-2901	300	29	of	of	ADP
admet-2901	300	30	science	science	NOUN
admet-2901	300	31	,	,	PUNCT
admet-2901	300	32	mahidol	mahidol	PROPN
admet-2901	300	33	university	university	PROPN
admet-2901	300	34	via	via	ADP
admet-2901	300	35	the	the	DET
admet-2901	300	36	reinventing	reinvent	VERB
admet-2901	300	37	university	university	NOUN
admet-2901	300	38	project	project	NOUN
admet-2901	300	39	.	.	PUNCT
admet-2901	301	1	conflict	conflict	NOUN
admet-2901	301	2	of	of	ADP
admet-2901	301	3	interest	interest	NOUN
admet-2901	301	4	:	:	PUNCT
admet-2901	301	5	there	there	PRON
admet-2901	301	6	are	be	VERB
admet-2901	301	7	no	no	DET
admet-2901	301	8	conflicts	conflict	NOUN
admet-2901	301	9	to	to	PART
admet-2901	301	10	declare	declare	VERB
admet-2901	301	11	.	.	PUNCT
admet-2901	302	1	authors	author	NOUN
admet-2901	302	2	contribution	contribution	VERB
admet-2901	302	3	:	:	PUNCT
admet-2901	302	4	napason	napason	PROPN
admet-2901	302	5	chabang	chabang	PROPN
admet-2901	302	6	and	and	CCONJ
admet-2901	302	7	chanikarn	chanikarn	ADJ
admet-2901	302	8	wongwitayasombat	wongwitayasombat	NOUN
admet-2901	302	9	contributed	contribute	VERB
admet-2901	302	10	equally	equally	ADV
admet-2901	302	11	references	reference	NOUN
admet-2901	302	12	[	[	X
admet-2901	302	13	1	1	NUM
admet-2901	302	14	]	]	PUNCT
admet-2901	302	15	f.	f.	PROPN
admet-2901	302	16	bray	bray	PROPN
admet-2901	302	17	,	,	PUNCT
admet-2901	302	18	m.	m.	NOUN
admet-2901	302	19	laversanne	laversanne	PROPN
admet-2901	302	20	,	,	PUNCT
admet-2901	302	21	h.	h.	PROPN
admet-2901	302	22	sung	sung	PROPN
admet-2901	302	23	,	,	PUNCT
admet-2901	302	24	j.	j.	PROPN
admet-2901	302	25	ferlay	ferlay	PROPN
admet-2901	302	26	,	,	PUNCT
admet-2901	302	27	r.l	r.l	PROPN
admet-2901	302	28	.	.	PROPN
admet-2901	302	29	siegel	siegel	PROPN
admet-2901	302	30	,	,	PUNCT
admet-2901	302	31	i.	i.	PROPN
admet-2901	302	32	soerjomataram	soerjomataram	PROPN
admet-2901	302	33	,	,	PUNCT
admet-2901	302	34	a.	a.	PROPN
admet-2901	302	35	jemal	jemal	PROPN
admet-2901	302	36	.	.	PUNCT
admet-2901	303	1	global	global	ADJ
admet-2901	303	2	cancer	cancer	NOUN
admet-2901	303	3	statistics	statistic	NOUN
admet-2901	303	4	2022	2022	NUM
admet-2901	303	5	:	:	PUNCT
admet-2901	303	6	globocan	globocan	PROPN
admet-2901	303	7	estimates	estimate	NOUN
admet-2901	303	8	of	of	ADP
admet-2901	303	9	incidence	incidence	NOUN
admet-2901	303	10	and	and	CCONJ
admet-2901	303	11	mortality	mortality	NOUN
admet-2901	303	12	worldwide	worldwide	ADV
admet-2901	303	13	for	for	ADP
admet-2901	303	14	36	36	NUM
admet-2901	303	15	cancers	cancer	NOUN
admet-2901	303	16	in	in	ADP
admet-2901	303	17	185	185	NUM
admet-2901	303	18	countries	country	NOUN
admet-2901	303	19	.	.	PUNCT
admet-2901	304	1	ca	can	AUX
admet-2901	304	2	:	:	PUNCT
admet-2901	304	3	a	a	DET
admet-2901	304	4	cancer	cancer	NOUN
admet-2901	304	5	journal	journal	NOUN
admet-2901	304	6	for	for	ADP
admet-2901	304	7	clinicians	clinician	NOUN
admet-2901	304	8	74	74	NUM
admet-2901	304	9	(	(	PUNCT
admet-2901	304	10	2024	2024	NUM
admet-2901	304	11	)	)	PUNCT
admet-2901	304	12	229	229	NUM
admet-2901	304	13	-	-	SYM
admet-2901	304	14	263	263	NUM
admet-2901	304	15	.	.	PUNCT
admet-2901	305	1	https://doi.org/10.3322/caac.21834	https://doi.org/10.3322/caac.21834	NOUN
admet-2901	306	1	[	[	X
admet-2901	306	2	2	2	NUM
admet-2901	306	3	]	]	PUNCT
admet-2901	306	4	j.	j.	PROPN
admet-2901	306	5	chen	chen	PROPN
admet-2901	306	6	,	,	PUNCT
admet-2901	306	7	f.d.v	f.d.v	PROPN
admet-2901	306	8	.	.	PUNCT
admet-2901	306	9	ho	ho	PROPN
admet-2901	306	10	,	,	PUNCT
admet-2901	306	11	e.j.g	e.j.g	PROPN
admet-2901	306	12	.	.	PUNCT
admet-2901	307	1	feliciano	feliciano	PROPN
admet-2901	307	2	,	,	PUNCT
admet-2901	307	3	j.f	j.f	PROPN
admet-2901	307	4	.	.	PROPN
admet-2901	307	5	wu	wu	PROPN
admet-2901	307	6	,	,	PUNCT
admet-2901	307	7	k.	k.	PROPN
admet-2901	307	8	magsanoc	magsanoc	PROPN
admet-2901	307	9	-	-	PUNCT
admet-2901	307	10	alikpala	alikpala	NOUN
admet-2901	307	11	,	,	PUNCT
admet-2901	307	12	e.c	e.c	PROPN
admet-2901	307	13	.	.	PROPN
admet-2901	307	14	dee	dee	PROPN
admet-2901	307	15	.	.	PROPN
admet-2901	307	16	trends	trend	NOUN
admet-2901	307	17	in	in	ADP
admet-2901	307	18	female	female	ADJ
admet-2901	307	19	breast	breast	NOUN
admet-2901	307	20	cancer	cancer	NOUN
admet-2901	307	21	among	among	ADP
admet-2901	307	22	adolescent	adolescent	ADJ
admet-2901	307	23	and	and	CCONJ
admet-2901	307	24	young	young	ADJ
admet-2901	307	25	adults	adult	NOUN
admet-2901	307	26	in	in	ADP
admet-2901	307	27	southeast	southeast	PROPN
admet-2901	307	28	asia	asia	PROPN
admet-2901	307	29	.	.	PUNCT
admet-2901	308	1	lancet	lancet	PROPN
admet-2901	308	2	regional	regional	PROPN
admet-2901	308	3	health	health	PROPN
admet-2901	308	4	southeast	southeast	PROPN
admet-2901	308	5	asia	asia	PROPN
admet-2901	308	6	34	34	NUM
admet-2901	308	7	(	(	PUNCT
admet-2901	308	8	2025	2025	NUM
admet-2901	308	9	)	)	PUNCT
admet-2901	308	10	100545	100545	NUM
admet-2901	308	11	.	.	PUNCT
admet-2901	309	1	https://doi.org/10.1016/j.lansea.2025.100545	https://doi.org/10.1016/j.lansea.2025.100545	ADJ
admet-2901	309	2	https://doi.org/10.3322/caac.21834	https://doi.org/10.3322/caac.21834	PROPN
admet-2901	309	3	https://doi.org/10.1016/j.lansea.2025.100545	https://doi.org/10.1016/j.lansea.2025.100545	PROPN
admet-2901	309	4	admet	admet	PROPN
admet-2901	309	5	&	&	CCONJ
admet-2901	309	6	dmpk	dmpk	PROPN
admet-2901	309	7	13(5	13(5	NUM
admet-2901	309	8	)	)	PUNCT
admet-2901	309	9	(	(	PUNCT
admet-2901	309	10	2025	2025	NUM
admet-2901	309	11	)	)	PUNCT
admet-2901	309	12	2901	2901	NUM
admet-2901	309	13	new	new	ADJ
admet-2901	309	14	xanthone	xanthone	PROPN
admet-2901	309	15	and	and	CCONJ
admet-2901	309	16	chemical	chemical	NOUN
admet-2901	309	17	constituents	constituent	NOUN
admet-2901	309	18	from	from	ADP
admet-2901	309	19	mallotus	mallotus	ADJ
admet-2901	309	20	glomerulatus	glomerulatus	NOUN
admet-2901	309	21	doi	doi	PROPN
admet-2901	309	22	:	:	PUNCT
admet-2901	309	23	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	NOUN
admet-2901	309	24	15	15	NUM
admet-2901	309	25	[	[	X
admet-2901	309	26	3	3	NUM
admet-2901	309	27	]	]	PUNCT
admet-2901	309	28	j.	j.	PROPN
admet-2901	309	29	wang	wang	PROPN
admet-2901	309	30	,	,	PUNCT
admet-2901	309	31	s.g	s.g	PROPN
admet-2901	309	32	.	.	PROPN
admet-2901	309	33	wu	wu	PROPN
admet-2901	309	34	.	.	PUNCT
admet-2901	310	1	breast	breast	NOUN
admet-2901	310	2	cancer	cancer	NOUN
admet-2901	310	3	:	:	PUNCT
admet-2901	310	4	an	an	DET
admet-2901	310	5	overview	overview	NOUN
admet-2901	310	6	of	of	ADP
admet-2901	310	7	current	current	ADJ
admet-2901	310	8	therapeutic	therapeutic	ADJ
admet-2901	310	9	strategies	strategy	NOUN
admet-2901	310	10	,	,	PUNCT
admet-2901	310	11	challenge	challenge	NOUN
admet-2901	310	12	,	,	PUNCT
admet-2901	310	13	and	and	CCONJ
admet-2901	310	14	perspectives	perspective	NOUN
admet-2901	310	15	.	.	PUNCT
admet-2901	311	1	breast	breast	NOUN
admet-2901	311	2	cancer	cancer	NOUN
admet-2901	311	3	:	:	PUNCT
admet-2901	311	4	targets	target	NOUN
admet-2901	311	5	and	and	CCONJ
admet-2901	311	6	therapy	therapy	NOUN
admet-2901	311	7	15	15	NUM
admet-2901	311	8	(	(	PUNCT
admet-2901	311	9	2023	2023	NUM
admet-2901	311	10	)	)	PUNCT
admet-2901	311	11	721	721	NUM
admet-2901	311	12	-	-	SYM
admet-2901	311	13	730	730	NUM
admet-2901	311	14	.	.	PUNCT
admet-2901	312	1	https://doi.org/10.2147/bctt.s432526	https://doi.org/10.2147/bctt.s432526	VERB
admet-2901	313	1	[	[	X
admet-2901	313	2	4	4	NUM
admet-2901	313	3	]	]	PUNCT
admet-2901	313	4	m.	m.	PROPN
admet-2901	313	5	gion	gion	PROPN
admet-2901	313	6	,	,	PUNCT
admet-2901	313	7	c.	c.	PROPN
admet-2901	313	8	saavedra	saavedra	PROPN
admet-2901	313	9	,	,	PUNCT
admet-2901	313	10	j.	j.	PROPN
admet-2901	313	11	perez	perez	PROPN
admet-2901	313	12	-	-	PUNCT
admet-2901	313	13	garcia	garcia	PROPN
admet-2901	313	14	,	,	PUNCT
admet-2901	313	15	j.	j.	PROPN
admet-2901	313	16	cortes	cortes	PROPN
admet-2901	313	17	.	.	PUNCT
admet-2901	314	1	oligometastatic	oligometastatic	ADJ
admet-2901	314	2	disease	disease	NOUN
admet-2901	314	3	:	:	PUNCT
admet-2901	314	4	when	when	SCONJ
admet-2901	314	5	stage	stage	NOUN
admet-2901	314	6	iv	iv	NUM
admet-2901	314	7	breast	breast	NOUN
admet-2901	314	8	cancer	cancer	NOUN
admet-2901	314	9	could	could	AUX
admet-2901	314	10	be	be	AUX
admet-2901	314	11	"	"	PUNCT
admet-2901	314	12	cured	cure	VERB
admet-2901	314	13	"	"	PUNCT
admet-2901	314	14	.	.	PUNCT
admet-2901	315	1	cancers	cancer	NOUN
admet-2901	315	2	(	(	PUNCT
admet-2901	315	3	basel	basel	PROPN
admet-2901	315	4	)	)	PUNCT
admet-2901	315	5	14	14	NUM
admet-2901	315	6	(	(	PUNCT
admet-2901	315	7	2022	2022	NUM
admet-2901	315	8	)	)	PUNCT
admet-2901	315	9	.	.	PUNCT
admet-2901	316	1	https://doi.org/10.3390/cancers14215229	https://doi.org/10.3390/cancers14215229	PROPN
admet-2901	317	1	[	[	X
admet-2901	317	2	5	5	NUM
admet-2901	317	3	]	]	X
admet-2901	317	4	t.u	t.u	PROPN
admet-2901	317	5	.	.	PROPN
admet-2901	317	6	barbie	barbie	PROPN
admet-2901	317	7	,	,	PUNCT
admet-2901	317	8	m.	m.	NOUN
admet-2901	317	9	golshan	golshan	NOUN
admet-2901	317	10	.	.	PUNCT
admet-2901	318	1	de	de	PROPN
admet-2901	318	2	novo	novo	PROPN
admet-2901	318	3	stage	stage	NOUN
admet-2901	318	4	4	4	NUM
admet-2901	318	5	metastatic	metastatic	ADJ
admet-2901	318	6	breast	breast	NOUN
admet-2901	318	7	cancer	cancer	NOUN
admet-2901	318	8	:	:	PUNCT
admet-2901	318	9	a	a	DET
admet-2901	318	10	surgical	surgical	ADJ
admet-2901	318	11	disease	disease	NOUN
admet-2901	318	12	?	?	PUNCT
admet-2901	319	1	annals	annal	NOUN
admet-2901	319	2	of	of	ADP
admet-2901	319	3	surgical	surgical	ADJ
admet-2901	319	4	oncology	oncology	NOUN
admet-2901	319	5	25	25	NUM
admet-2901	319	6	(	(	PUNCT
admet-2901	319	7	2018	2018	NUM
admet-2901	319	8	)	)	PUNCT
admet-2901	319	9	3109	3109	NUM
admet-2901	319	10	-	-	SYM
admet-2901	319	11	3111	3111	NUM
admet-2901	319	12	.	.	PUNCT
admet-2901	320	1	https://doi.org/10.1245/s10434-018-6664-6	https://doi.org/10.1245/s10434-018-6664-6	PUNCT
admet-2901	321	1	[	[	X
admet-2901	321	2	6	6	NUM
admet-2901	321	3	]	]	X
admet-2901	321	4	c.h	c.h	PROPN
admet-2901	321	5	.	.	PROPN
admet-2901	321	6	barrios	barrios	PROPN
admet-2901	321	7	,	,	PUNCT
admet-2901	321	8	t.	t.	NOUN
admet-2901	321	9	reinert	reinert	NOUN
admet-2901	321	10	,	,	PUNCT
admet-2901	321	11	g.	g.	PROPN
admet-2901	321	12	werutsky	werutsky	PROPN
admet-2901	321	13	.	.	PUNCT
admet-2901	322	1	access	access	NOUN
admet-2901	322	2	to	to	ADP
admet-2901	322	3	high	high	ADJ
admet-2901	322	4	-	-	PUNCT
admet-2901	322	5	cost	cost	NOUN
admet-2901	322	6	drugs	drug	NOUN
admet-2901	322	7	for	for	ADP
admet-2901	322	8	advanced	advanced	ADJ
admet-2901	322	9	breast	breast	NOUN
admet-2901	322	10	cancer	cancer	NOUN
admet-2901	322	11	in	in	ADP
admet-2901	322	12	latin	latin	PROPN
admet-2901	322	13	america	america	PROPN
admet-2901	322	14	,	,	PUNCT
admet-2901	322	15	particularly	particularly	ADV
admet-2901	322	16	trastuzumab	trastuzumab	NOUN
admet-2901	322	17	.	.	PUNCT
admet-2901	323	1	ecancermedicalscience	ecancermedicalscience	NOUN
admet-2901	323	2	13	13	NUM
admet-2901	323	3	(	(	PUNCT
admet-2901	323	4	2019	2019	NUM
admet-2901	323	5	)	)	PUNCT
admet-2901	323	6	898	898	NUM
admet-2901	323	7	.	.	PUNCT
admet-2901	324	1	https://doi.org/10.3332/ecancer.2019.898	https://doi.org/10.3332/ecancer.2019.898	PROPN
admet-2901	324	2	[	[	X
admet-2901	324	3	7	7	X
admet-2901	324	4	]	]	PUNCT
admet-2901	324	5	k.	k.	PROPN
admet-2901	324	6	daoprasert	daoprasert	PROPN
admet-2901	324	7	,	,	PUNCT
admet-2901	324	8	s.	s.	PROPN
admet-2901	324	9	sangkam	sangkam	PROPN
admet-2901	324	10	,	,	PUNCT
admet-2901	324	11	m.	m.	NOUN
admet-2901	324	12	praditkay	praditkay	PROPN
admet-2901	324	13	,	,	PUNCT
admet-2901	324	14	k.	k.	PROPN
admet-2901	324	15	khamkhod	khamkhod	PROPN
admet-2901	324	16	,	,	PUNCT
admet-2901	324	17	p.	p.	PROPN
admet-2901	324	18	suwannamuang	suwannamuang	PROPN
admet-2901	324	19	.	.	PUNCT
admet-2901	325	1	factors	factor	NOUN
admet-2901	325	2	related	relate	VERB
admet-2901	325	3	to	to	ADP
admet-2901	325	4	survival	survival	NOUN
admet-2901	325	5	rate	rate	NOUN
admet-2901	325	6	in	in	ADP
admet-2901	325	7	breast	breast	NOUN
admet-2901	325	8	cancer	cancer	NOUN
admet-2901	325	9	patients	patient	NOUN
admet-2901	325	10	undergoing	undergo	VERB
admet-2901	325	11	treatments	treatment	NOUN
admet-2901	325	12	at	at	ADP
admet-2901	325	13	lampang	lampang	PROPN
admet-2901	325	14	cancer	cancer	NOUN
admet-2901	325	15	hospital	hospital	NOUN
admet-2901	325	16	.	.	PUNCT
admet-2901	326	1	journal	journal	NOUN
admet-2901	326	2	of	of	ADP
admet-2901	326	3	the	the	DET
admet-2901	326	4	department	department	PROPN
admet-2901	326	5	of	of	ADP
admet-2901	326	6	medical	medical	ADJ
admet-2901	326	7	services	service	NOUN
admet-2901	326	8	49	49	NUM
admet-2901	326	9	(	(	PUNCT
admet-2901	326	10	2024	2024	NUM
admet-2901	326	11	)	)	PUNCT
admet-2901	326	12	60	60	NUM
admet-2901	326	13	-	-	SYM
admet-2901	326	14	68	68	NUM
admet-2901	326	15	.	.	PUNCT
admet-2901	327	1	https://he02.tcithaijo.org/index.php/jdms/article/view/265917	https://he02.tcithaijo.org/index.php/jdms/article/view/265917	PRON
admet-2901	327	2	[	[	X
admet-2901	327	3	8	8	NUM
admet-2901	327	4	]	]	PUNCT
admet-2901	327	5	p.	p.	NOUN
admet-2901	327	6	sukpan	sukpan	PROPN
admet-2901	327	7	,	,	PUNCT
admet-2901	327	8	k.	k.	PROPN
admet-2901	327	9	kanokwiroon	kanokwiroon	PROPN
admet-2901	327	10	,	,	PUNCT
admet-2901	327	11	h.	h.	PROPN
admet-2901	327	12	sriplung	sriplung	PROPN
admet-2901	327	13	,	,	PUNCT
admet-2901	327	14	p.	p.	PROPN
admet-2901	327	15	paisarn	paisarn	PROPN
admet-2901	327	16	,	,	PUNCT
admet-2901	327	17	s.	s.	PROPN
admet-2901	327	18	sangkhathat	sangkhathat	PROPN
admet-2901	327	19	.	.	PUNCT
admet-2901	328	1	survival	survival	NOUN
admet-2901	328	2	outcomes	outcome	NOUN
admet-2901	328	3	in	in	ADP
admet-2901	328	4	breast	breast	NOUN
admet-2901	328	5	cancer	cancer	NOUN
admet-2901	328	6	patients	patient	NOUN
admet-2901	328	7	and	and	CCONJ
admet-2901	328	8	associated	associated	ADJ
admet-2901	328	9	factors	factor	NOUN
admet-2901	328	10	in	in	ADP
admet-2901	328	11	a	a	DET
admet-2901	328	12	border	border	NOUN
admet-2901	328	13	province	province	NOUN
admet-2901	328	14	of	of	ADP
admet-2901	328	15	thailand	thailand	PROPN
admet-2901	328	16	:	:	PUNCT
admet-2901	328	17	a	a	DET
admet-2901	328	18	hospital	hospital	NOUN
admet-2901	328	19	-	-	PUNCT
admet-2901	328	20	based	base	VERB
admet-2901	328	21	review	review	NOUN
admet-2901	328	22	.	.	PUNCT
admet-2901	329	1	journal	journal	PROPN
admet-2901	329	2	of	of	ADP
admet-2901	329	3	health	health	PROPN
admet-2901	329	4	science	science	PROPN
admet-2901	329	5	and	and	CCONJ
admet-2901	329	6	medical	medical	ADJ
admet-2901	329	7	research	research	NOUN
admet-2901	329	8	41	41	NUM
admet-2901	329	9	(	(	PUNCT
admet-2901	329	10	2023	2023	NUM
admet-2901	329	11	)	)	PUNCT
admet-2901	329	12	1	1	NUM
admet-2901	329	13	-	-	SYM
admet-2901	329	14	9	9	NUM
admet-2901	329	15	.	.	PUNCT
admet-2901	330	1	https://doi.org/10.31584/jhsmr.2022911	https://doi.org/10.31584/jhsmr.2022911	NUM
admet-2901	331	1	[	[	X
admet-2901	331	2	9	9	NUM
admet-2901	331	3	]	]	X
admet-2901	331	4	p.c.v	p.c.v	X
admet-2901	331	5	.	.	PROPN
admet-2901	331	6	welzen	welzen	PROPN
admet-2901	331	7	,	,	PUNCT
admet-2901	331	8	r.w.j.m.v.d	r.w.j.m.v.d	PROPN
admet-2901	331	9	.	.	PROPN
admet-2901	331	10	ham	ham	PROPN
admet-2901	331	11	,	,	PUNCT
admet-2901	331	12	k.k.m	k.k.m	PROPN
admet-2901	331	13	.	.	PUNCT
admet-2901	332	1	kulju	kulju	PROPN
admet-2901	332	2	.	.	PUNCT
admet-2901	333	1	mallotusglomerulatus	mallotusglomerulatus	NOUN
admet-2901	333	2	(	(	PUNCT
admet-2901	333	3	euphorbiaceae	euphorbiaceae	ADJ
admet-2901	333	4	sensu	sensu	NOUN
admet-2901	333	5	stricto	stricto	X
admet-2901	333	6	)	)	PUNCT
admet-2901	333	7	,	,	PUNCT
admet-2901	333	8	a	a	DET
admet-2901	333	9	new	new	ADJ
admet-2901	333	10	species	specie	NOUN
admet-2901	333	11	:	:	PUNCT
admet-2901	333	12	description	description	NOUN
admet-2901	333	13	,	,	PUNCT
admet-2901	333	14	pollen	pollen	NOUN
admet-2901	333	15	and	and	CCONJ
admet-2901	333	16	phylogenetic	phylogenetic	ADJ
admet-2901	333	17	position	position	NOUN
admet-2901	333	18	.	.	PUNCT
admet-2901	334	1	thai	thai	PROPN
admet-2901	334	2	forest	forest	PROPN
admet-2901	334	3	bulletin	bulletin	NOUN
admet-2901	334	4	(	(	PUNCT
admet-2901	334	5	botany	botany	NOUN
admet-2901	334	6	)	)	PUNCT
admet-2901	334	7	0	0	NUM
admet-2901	334	8	(	(	PUNCT
admet-2901	334	9	2014	2014	NUM
admet-2901	334	10	)	)	PUNCT
admet-2901	334	11	173	173	NUM
admet-2901	334	12	-	-	SYM
admet-2901	334	13	178	178	NUM
admet-2901	334	14	.	.	PUNCT
admet-2901	335	1	https://li01.tci-thaijo.org/index.php/thaiforestbulletin/article/view/24387	https://li01.tci-thaijo.org/index.php/thaiforestbulletin/article/view/24387	PROPN
admet-2901	336	1	[	[	X
admet-2901	336	2	10	10	NUM
admet-2901	336	3	]	]	PUNCT
admet-2901	336	4	d.-l	d.-l	NOUN
admet-2901	336	5	.	.	PUNCT
admet-2901	337	1	chen	chen	PROPN
admet-2901	337	2	.	.	PUNCT
admet-2901	338	1	research	research	NOUN
admet-2901	338	2	progress	progress	NOUN
admet-2901	338	3	on	on	ADP
admet-2901	338	4	chemical	chemical	ADJ
admet-2901	338	5	constituents	constituent	NOUN
admet-2901	338	6	of	of	ADP
admet-2901	338	7	plants	plant	NOUN
admet-2901	338	8	from	from	ADP
admet-2901	338	9	mallotus	mallotus	NOUN
admet-2901	338	10	lour	lour	ADJ
admet-2901	338	11	.	.	PUNCT
admet-2901	339	1	and	and	CCONJ
admet-2901	339	2	their	their	PRON
admet-2901	339	3	pharmacological	pharmacological	ADJ
admet-2901	339	4	activities	activity	NOUN
admet-2901	339	5	.	.	PUNCT
admet-2901	340	1	zhongcaoyao	zhongcaoyao	NOUN
admet-2901	340	2	(	(	PUNCT
admet-2901	340	3	2014	2014	NUM
admet-2901	340	4	)	)	PUNCT
admet-2901	340	5	2248	2248	NUM
admet-2901	340	6	-	-	SYM
admet-2901	340	7	2264	2264	NUM
admet-2901	340	8	.	.	PUNCT
admet-2901	341	1	https://doi.org/10.7501/j.issn.02532670.2014.15.024	https://doi.org/10.7501/j.issn.02532670.2014.15.024	PUNCT
admet-2901	342	1	[	[	X
admet-2901	342	2	11	11	NUM
admet-2901	342	3	]	]	X
admet-2901	342	4	i.	i.	PROPN
admet-2901	342	5	tripathi	tripathi	PROPN
admet-2901	342	6	,	,	PUNCT
admet-2901	342	7	p.	p.	PROPN
admet-2901	342	8	chaudhary	chaudhary	PROPN
admet-2901	342	9	,	,	PUNCT
admet-2901	342	10	p.	p.	PROPN
admet-2901	342	11	pandey	pandey	PROPN
admet-2901	342	12	.	.	PROPN
admet-2901	342	13	mallotus	mallotus	PROPN
admet-2901	342	14	philippensis	philippensis	PROPN
admet-2901	342	15	:	:	PUNCT
admet-2901	342	16	a	a	DET
admet-2901	342	17	miracle	miracle	NOUN
admet-2901	342	18	stick	stick	NOUN
admet-2901	342	19	.	.	PUNCT
admet-2901	343	1	world	world	PROPN
admet-2901	343	2	journal	journal	PROPN
admet-2901	343	3	of	of	ADP
admet-2901	343	4	pharmacceutical	pharmacceutical	ADJ
admet-2901	343	5	research	research	NOUN
admet-2901	343	6	6	6	NUM
admet-2901	343	7	(	(	PUNCT
admet-2901	343	8	2017	2017	NUM
admet-2901	343	9	)	)	PUNCT
admet-2901	343	10	678	678	NUM
admet-2901	343	11	-	-	SYM
admet-2901	343	12	687	687	NUM
admet-2901	343	13	.	.	PUNCT
admet-2901	344	1	https://doi.org/10.20959/wjpr20177-8816	https://doi.org/10.20959/wjpr20177-8816	PRON
admet-2901	344	2	[	[	X
admet-2901	344	3	12	12	NUM
admet-2901	344	4	]	]	X
admet-2901	344	5	c.	c.	PROPN
admet-2901	344	6	rivière	rivière	PROPN
admet-2901	344	7	,	,	PUNCT
admet-2901	344	8	v.	v.	ADP
admet-2901	344	9	nguyen	nguyen	NOUN
admet-2901	344	10	thi	thi	PROPN
admet-2901	344	11	hong	hong	PROPN
admet-2901	344	12	,	,	PUNCT
admet-2901	344	13	q.	q.	PROPN
admet-2901	344	14	tran	tran	PROPN
admet-2901	344	15	hong	hong	PROPN
admet-2901	344	16	,	,	PUNCT
admet-2901	344	17	g.	g.	PROPN
admet-2901	344	18	chataigné	chataigné	PROPN
admet-2901	344	19	,	,	PUNCT
admet-2901	344	20	n.	n.	PROPN
admet-2901	344	21	nguyen	nguyen	PROPN
admet-2901	344	22	hoai	hoai	PROPN
admet-2901	344	23	,	,	PUNCT
admet-2901	344	24	b.	b.	PROPN
admet-2901	344	25	dejaegher	dejaegher	PROPN
admet-2901	344	26	,	,	PUNCT
admet-2901	344	27	c.	c.	PROPN
admet-2901	344	28	tistaert	tistaert	PROPN
admet-2901	344	29	,	,	PUNCT
admet-2901	344	30	t.	t.	PROPN
admet-2901	344	31	nguyen	nguyen	PROPN
admet-2901	344	32	thi	thi	PROPN
admet-2901	344	33	kim	kim	PROPN
admet-2901	344	34	,	,	PUNCT
admet-2901	344	35	y.	y.	PROPN
admet-2901	344	36	vander	vander	PROPN
admet-2901	344	37	heyden	heyden	PROPN
admet-2901	344	38	,	,	PUNCT
admet-2901	344	39	m.	m.	NOUN
admet-2901	344	40	chau	chau	PROPN
admet-2901	344	41	van	van	PROPN
admet-2901	344	42	,	,	PUNCT
admet-2901	344	43	j.	j.	PROPN
admet-2901	344	44	quetin	quetin	PROPN
admet-2901	344	45	-	-	PUNCT
admet-2901	344	46	leclercq	leclercq	NOUN
admet-2901	344	47	.	.	PUNCT
admet-2901	345	1	mallotus	mallotus	PROPN
admet-2901	345	2	species	specie	NOUN
admet-2901	345	3	from	from	ADP
admet-2901	345	4	vietnamese	vietnamese	ADJ
admet-2901	345	5	mountainous	mountainous	ADJ
admet-2901	345	6	areas	area	NOUN
admet-2901	345	7	:	:	PUNCT
admet-2901	345	8	phytochemistry	phytochemistry	NOUN
admet-2901	345	9	and	and	CCONJ
admet-2901	345	10	pharmacological	pharmacological	ADJ
admet-2901	345	11	activities	activity	NOUN
admet-2901	345	12	.	.	PUNCT
admet-2901	346	1	phytochemistry	phytochemistry	NOUN
admet-2901	346	2	reviews	review	NOUN
admet-2901	346	3	9	9	NUM
admet-2901	346	4	(	(	PUNCT
admet-2901	346	5	2010	2010	NUM
admet-2901	346	6	)	)	PUNCT
admet-2901	346	7	217	217	NUM
admet-2901	346	8	-	-	SYM
admet-2901	346	9	253	253	NUM
admet-2901	346	10	.	.	PUNCT
admet-2901	347	1	https://doi.org/10.1007/s11101-009-9152-6	https://doi.org/10.1007/s11101-009-9152-6	X
admet-2901	348	1	[	[	X
admet-2901	348	2	13	13	NUM
admet-2901	348	3	]	]	SYM
admet-2901	348	4	p.m.	p.m.	NOUN
admet-2901	348	5	giang	giang	PROPN
admet-2901	348	6	,	,	PUNCT
admet-2901	348	7	h.	h.	PROPN
admet-2901	348	8	otsuka	otsuka	PROPN
admet-2901	348	9	.	.	PUNCT
admet-2901	349	1	new	new	ADJ
admet-2901	349	2	compounds	compound	NOUN
admet-2901	349	3	and	and	CCONJ
admet-2901	349	4	potential	potential	ADJ
admet-2901	349	5	candidates	candidate	NOUN
admet-2901	349	6	for	for	ADP
admet-2901	349	7	drug	drug	NOUN
admet-2901	349	8	discovery	discovery	NOUN
admet-2901	349	9	from	from	ADP
admet-2901	349	10	medicinal	medicinal	ADJ
admet-2901	349	11	plants	plant	NOUN
admet-2901	349	12	of	of	ADP
admet-2901	349	13	vietnam	vietnam	PROPN
admet-2901	349	14	.	.	PUNCT
admet-2901	350	1	chemical	chemical	PROPN
admet-2901	350	2	and	and	CCONJ
admet-2901	350	3	pharmaceutical	pharmaceutical	ADJ
admet-2901	350	4	bulletin	bulletin	NOUN
admet-2901	350	5	66	66	NUM
admet-2901	350	6	(	(	PUNCT
admet-2901	350	7	2018	2018	NUM
admet-2901	350	8	)	)	PUNCT
admet-2901	350	9	493	493	NUM
admet-2901	350	10	-	-	SYM
admet-2901	350	11	505	505	NUM
admet-2901	350	12	.	.	PUNCT
admet-2901	351	1	https://doi.org/10.1248/cpb.c17-00628	https://doi.org/10.1248/cpb.c17-00628	PROPN
admet-2901	352	1	[	[	X
admet-2901	352	2	14	14	NUM
admet-2901	352	3	]	]	X
admet-2901	352	4	p.	p.	NOUN
admet-2901	352	5	bag	bag	NOUN
admet-2901	352	6	,	,	PUNCT
admet-2901	352	7	d.	d.	PROPN
admet-2901	352	8	chattopadhyay	chattopadhyay	PROPN
admet-2901	352	9	,	,	PUNCT
admet-2901	352	10	h.	h.	PROPN
admet-2901	352	11	mukherjee	mukherjee	PROPN
admet-2901	352	12	,	,	PUNCT
admet-2901	352	13	d.	d.	PROPN
admet-2901	352	14	ojha	ojha	PROPN
admet-2901	352	15	,	,	PUNCT
admet-2901	352	16	n.	n.	PROPN
admet-2901	352	17	mandal	mandal	PROPN
admet-2901	352	18	,	,	PUNCT
admet-2901	352	19	m.c	m.c	PROPN
admet-2901	352	20	.	.	PROPN
admet-2901	352	21	sarkar	sarkar	PROPN
admet-2901	352	22	,	,	PUNCT
admet-2901	352	23	t.	t.	PROPN
admet-2901	352	24	chatterjee	chatterjee	PROPN
admet-2901	352	25	,	,	PUNCT
admet-2901	352	26	g.	g.	PROPN
admet-2901	352	27	das	das	PROPN
admet-2901	352	28	,	,	PUNCT
admet-2901	352	29	s.	s.	PROPN
admet-2901	352	30	chakraborti	chakraborti	PROPN
admet-2901	352	31	.	.	PUNCT
admet-2901	353	1	anti	anti	ADJ
admet-2901	353	2	-	-	ADJ
admet-2901	353	3	herpes	herpes	ADJ
admet-2901	353	4	virus	virus	NOUN
admet-2901	353	5	activities	activity	NOUN
admet-2901	353	6	of	of	ADP
admet-2901	353	7	bioactive	bioactive	ADJ
admet-2901	353	8	fraction	fraction	NOUN
admet-2901	353	9	and	and	CCONJ
admet-2901	353	10	isolated	isolate	VERB
admet-2901	353	11	pure	pure	ADJ
admet-2901	353	12	constituent	constituent	NOUN
admet-2901	353	13	of	of	ADP
admet-2901	353	14	mallotus	mallotus	ADJ
admet-2901	353	15	peltatus	peltatus	NOUN
admet-2901	353	16	:	:	PUNCT
admet-2901	353	17	an	an	DET
admet-2901	353	18	ethnomedicine	ethnomedicine	NOUN
admet-2901	353	19	from	from	ADP
admet-2901	353	20	andaman	andaman	PROPN
admet-2901	353	21	islands	island	NOUN
admet-2901	353	22	.	.	PUNCT
admet-2901	354	1	virology	virology	NOUN
admet-2901	354	2	journal	journal	NOUN
admet-2901	354	3	9	9	NUM
admet-2901	354	4	(	(	PUNCT
admet-2901	354	5	2012	2012	NUM
admet-2901	354	6	)	)	PUNCT
admet-2901	354	7	98	98	NUM
admet-2901	354	8	.	.	PUNCT
admet-2901	355	1	https://doi.org/10.1186/1743-422x-9-98	https://doi.org/10.1186/1743-422x-9-98	NOUN
admet-2901	356	1	[	[	X
admet-2901	356	2	15	15	NUM
admet-2901	356	3	]	]	X
admet-2901	356	4	m.	m.	NOUN
admet-2901	356	5	adhav	adhav	PROPN
admet-2901	356	6	.	.	PUNCT
admet-2901	357	1	phytochemical	phytochemical	ADJ
admet-2901	357	2	screening	screening	NOUN
admet-2901	357	3	and	and	CCONJ
admet-2901	357	4	antimicrobial	antimicrobial	ADJ
admet-2901	357	5	activity	activity	NOUN
admet-2901	357	6	of	of	ADP
admet-2901	357	7	mallotus	mallotus	NOUN
admet-2901	357	8	philippensis	philippensis	NOUN
admet-2901	357	9	muell	muell	ADV
admet-2901	357	10	.	.	PUNCT
admet-2901	358	1	arg	arg	PROPN
admet-2901	358	2	.	.	PROPN
admet-2901	358	3	journal	journal	PROPN
admet-2901	358	4	of	of	ADP
admet-2901	358	5	pharmacognosy	pharmacognosy	NOUN
admet-2901	358	6	and	and	CCONJ
admet-2901	358	7	phytochemistry	phytochemistry	NOUN
admet-2901	358	8	3	3	NUM
admet-2901	358	9	(	(	PUNCT
admet-2901	358	10	2015	2015	NUM
admet-2901	358	11	)	)	PUNCT
admet-2901	358	12	188	188	NUM
admet-2901	358	13	-	-	SYM
admet-2901	358	14	191	191	NUM
admet-2901	358	15	.	.	PUNCT
admet-2901	359	1	https://www.phytojournal.com/archives/2015.v3.i5.484/phytochemical-screening-andantimicrobial-activity-of-mallotus-philippensis-muell-arg	https://www.phytojournal.com/archives/2015.v3.i5.484/phytochemical-screening-andantimicrobial-activity-of-mallotus-philippensis-muell-arg	ADJ
admet-2901	359	2	[	[	X
admet-2901	359	3	16	16	NUM
admet-2901	359	4	]	]	X
admet-2901	359	5	v.p	v.p	PROPN
admet-2901	359	6	.	.	PROPN
admet-2901	359	7	shelly	shelly	PROPN
admet-2901	359	8	rana	rana	PROPN
admet-2901	359	9	,	,	PUNCT
admet-2901	359	10	anand	anand	PROPN
admet-2901	359	11	sagar	sagar	PROPN
admet-2901	359	12	.	.	PUNCT
admet-2901	359	13	antibacterial	antibacterial	ADJ
admet-2901	359	14	activity	activity	NOUN
admet-2901	359	15	of	of	ADP
admet-2901	359	16	malotus	malotus	NOUN
admet-2901	359	17	philippensis	philippensis	NOUN
admet-2901	359	18	fruit	fruit	NOUN
admet-2901	359	19	extract	extract	NOUN
admet-2901	359	20	.	.	PUNCT
admet-2901	360	1	journal	journal	NOUN
admet-2901	360	2	of	of	ADP
admet-2901	360	3	medicinal	medicinal	ADJ
admet-2901	360	4	plants	plant	NOUN
admet-2901	360	5	studies	study	NOUN
admet-2901	360	6	4	4	NUM
admet-2901	360	7	(	(	PUNCT
admet-2901	360	8	2016	2016	NUM
admet-2901	360	9	)	)	PUNCT
admet-2901	360	10	104	104	NUM
admet-2901	360	11	-	-	SYM
admet-2901	360	12	106	106	NUM
admet-2901	360	13	.	.	PUNCT
admet-2901	361	1	https://www.plantsjournal.com/archives/?year=2016&vol=4&issue=3&part=b&articleid=343	https://www.plantsjournal.com/archives/?year=2016&vol=4&issue=3&part=b&articleid=343	NOUN
admet-2901	362	1	[	[	X
admet-2901	362	2	17	17	NUM
admet-2901	362	3	]	]	X
admet-2901	362	4	m.m	m.m	PROPN
admet-2901	362	5	.	.	PROPN
admet-2901	362	6	hasan	hasan	PROPN
admet-2901	362	7	,	,	PUNCT
admet-2901	362	8	n.	n.	PROPN
admet-2901	362	9	uddin	uddin	PROPN
admet-2901	362	10	,	,	PUNCT
admet-2901	362	11	m.r	m.r	PROPN
admet-2901	362	12	.	.	PROPN
admet-2901	362	13	hasan	hasan	PROPN
admet-2901	362	14	,	,	PUNCT
admet-2901	362	15	a.f	a.f	PROPN
admet-2901	362	16	.	.	PROPN
admet-2901	363	1	islam	islam	PROPN
admet-2901	363	2	,	,	PUNCT
admet-2901	363	3	m.m	m.m	PROPN
admet-2901	363	4	.	.	PROPN
admet-2901	363	5	hossain	hossain	PROPN
admet-2901	363	6	,	,	PUNCT
admet-2901	363	7	a.b	a.b	PROPN
admet-2901	363	8	.	.	PROPN
admet-2901	363	9	rahman	rahman	PROPN
admet-2901	363	10	,	,	PUNCT
admet-2901	363	11	m.s	m.s	PROPN
admet-2901	363	12	.	.	PROPN
admet-2901	363	13	hossain	hossain	PROPN
admet-2901	363	14	,	,	PUNCT
admet-2901	363	15	i.a	i.a	PROPN
admet-2901	363	16	.	.	PROPN
admet-2901	363	17	chowdhury	chowdhury	PROPN
admet-2901	363	18	,	,	PUNCT
admet-2901	363	19	m.s	m.s	PROPN
admet-2901	363	20	.	.	PROPN
admet-2901	363	21	rana	rana	PROPN
admet-2901	363	22	.	.	PUNCT
admet-2901	364	1	analgesic	analgesic	ADJ
admet-2901	364	2	and	and	CCONJ
admet-2901	364	3	anti	anti	ADJ
admet-2901	364	4	-	-	ADJ
admet-2901	364	5	inflammatory	inflammatory	ADJ
admet-2901	364	6	activities	activity	NOUN
admet-2901	364	7	of	of	ADP
admet-2901	364	8	leaf	leaf	NOUN
admet-2901	364	9	extract	extract	NOUN
admet-2901	364	10	of	of	ADP
admet-2901	364	11	mallotus	mallotus	NOUN
admet-2901	364	12	repandus	repandus	X
admet-2901	364	13	(	(	PUNCT
admet-2901	364	14	willd	willd	NOUN
admet-2901	364	15	.	.	PUNCT
admet-2901	364	16	)	)	PUNCT
admet-2901	365	1	muell	muell	INTJ
admet-2901	365	2	.	.	PUNCT
admet-2901	366	1	arg	arg	PROPN
admet-2901	366	2	.	.	PROPN
admet-2901	366	3	biomed	biome	VERB
admet-2901	366	4	research	research	NOUN
admet-2901	366	5	international	international	PROPN
admet-2901	366	6	2014	2014	NUM
admet-2901	366	7	(	(	PUNCT
admet-2901	366	8	2014	2014	NUM
admet-2901	366	9	)	)	PUNCT
admet-2901	366	10	539807	539807	NUM
admet-2901	366	11	.	.	PUNCT
admet-2901	367	1	https://doi.org/10.1155/2014/539807	https://doi.org/10.1155/2014/539807	PROPN
admet-2901	367	2	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	PROPN
admet-2901	367	3	https://doi.org/10.2147/bctt.s432526	https://doi.org/10.2147/bctt.s432526	PROPN
admet-2901	367	4	https://doi.org/10.3390/cancers14215229	https://doi.org/10.3390/cancers14215229	PROPN
admet-2901	367	5	https://doi.org/10.1245/s10434-018-6664-6	https://doi.org/10.1245/s10434-018-6664-6	NOUN
admet-2901	367	6	https://doi.org/10.3332/ecancer.2019.898	https://doi.org/10.3332/ecancer.2019.898	PROPN
admet-2901	367	7	https://he02.tci-thaijo.org/index.php/jdms/article/view/265917	https://he02.tci-thaijo.org/index.php/jdms/article/view/265917	PROPN
admet-2901	367	8	https://he02.tci-thaijo.org/index.php/jdms/article/view/265917	https://he02.tci-thaijo.org/index.php/jdms/article/view/265917	PROPN
admet-2901	367	9	https://doi.org/10.31584/jhsmr.2022911	https://doi.org/10.31584/jhsmr.2022911	NUM
admet-2901	367	10	https://li01.tci-thaijo.org/index.php/thaiforestbulletin/article/view/24387	https://li01.tci-thaijo.org/index.php/thaiforestbulletin/article/view/24387	PROPN
admet-2901	368	1	https://doi.org/10.7501/j.issn.0253-2670.2014.15.024	https://doi.org/10.7501/j.issn.0253-2670.2014.15.024	NOUN
admet-2901	368	2	https://doi.org/10.7501/j.issn.0253-2670.2014.15.024	https://doi.org/10.7501/j.issn.0253-2670.2014.15.024	NOUN
admet-2901	368	3	https://doi.org/10.20959/wjpr20177-8816	https://doi.org/10.20959/wjpr20177-8816	PRON
admet-2901	368	4	https://doi.org/10.1007/s11101-009-9152-6	https://doi.org/10.1007/s11101-009-9152-6	VERB
admet-2901	368	5	https://doi.org/10.1248/cpb.c17-00628	https://doi.org/10.1248/cpb.c17-00628	PROPN
admet-2901	368	6	https://doi.org/10.1186/1743-422x-9-98	https://doi.org/10.1186/1743-422x-9-98	ADV
admet-2901	369	1	https://www.phytojournal.com/archives/2015.v3.i5.484/phytochemical-screening-and-antimicrobial-activity-of-mallotus-philippensis-muell-arg	https://www.phytojournal.com/archives/2015.v3.i5.484/phytochemical-screening-and-antimicrobial-activity-of-mallotus-philippensis-muell-arg	NOUN
admet-2901	369	2	https://www.phytojournal.com/archives/2015.v3.i5.484/phytochemical-screening-and-antimicrobial-activity-of-mallotus-philippensis-muell-arg	https://www.phytojournal.com/archives/2015.v3.i5.484/phytochemical-screening-and-antimicrobial-activity-of-mallotus-philippensis-muell-arg	PROPN
admet-2901	369	3	https://www.plantsjournal.com/archives/?year=2016&vol=4&issue=3&part=b&articleid=343	https://www.plantsjournal.com/archives/?year=2016&vol=4&issue=3&part=b&articleid=343	PROPN
admet-2901	369	4	https://doi.org/10.1155/2014/539807	https://doi.org/10.1155/2014/539807	PROPN
admet-2901	369	5	n.	n.	PROPN
admet-2901	369	6	chabang	chabang	PROPN
admet-2901	369	7	et	et	PROPN
admet-2901	369	8	al	al	PROPN
admet-2901	369	9	.	.	PROPN
admet-2901	369	10	admet	admet	PROPN
admet-2901	369	11	&	&	CCONJ
admet-2901	369	12	dmpk	dmpk	PROPN
admet-2901	369	13	13(5	13(5	NUM
admet-2901	369	14	)	)	PUNCT
admet-2901	369	15	(	(	PUNCT
admet-2901	369	16	2025	2025	NUM
admet-2901	369	17	)	)	PUNCT
admet-2901	369	18	2901	2901	NUM
admet-2901	369	19	16	16	NUM
admet-2901	370	1	[	[	X
admet-2901	370	2	18	18	NUM
admet-2901	370	3	]	]	PUNCT
admet-2901	370	4	p.	p.	NOUN
admet-2901	370	5	sakthidhasan	sakthidhasan	NOUN
admet-2901	370	6	,	,	PUNCT
admet-2901	370	7	p.	p.	NOUN
admet-2901	370	8	sathish	sathish	PROPN
admet-2901	370	9	kumar	kumar	PROPN
admet-2901	370	10	,	,	PUNCT
admet-2901	370	11	m.b.g	m.b.g	PROPN
admet-2901	370	12	.	.	PUNCT
admet-2901	370	13	viswanathan	viswanathan	PROPN
admet-2901	370	14	.	.	PUNCT
admet-2901	371	1	cytotoxic	cytotoxic	ADJ
admet-2901	371	2	potential	potential	NOUN
admet-2901	371	3	of	of	ADP
admet-2901	371	4	bioactive	bioactive	ADJ
admet-2901	371	5	seed	seed	NOUN
admet-2901	371	6	proteins	protein	NOUN
admet-2901	371	7	from	from	ADP
admet-2901	371	8	mallotus	mallotus	ADJ
admet-2901	371	9	philippensis	philippensis	NOUN
admet-2901	371	10	against	against	ADP
admet-2901	371	11	various	various	ADJ
admet-2901	371	12	cancer	cancer	NOUN
admet-2901	371	13	cell	cell	NOUN
admet-2901	371	14	lines	line	NOUN
admet-2901	371	15	.	.	PUNCT
admet-2901	372	1	applied	apply	VERB
admet-2901	372	2	nanoscience	nanoscience	NOUN
admet-2901	372	3	13	13	NUM
admet-2901	372	4	(	(	PUNCT
admet-2901	372	5	2023	2023	NUM
admet-2901	372	6	)	)	PUNCT
admet-2901	372	7	1179	1179	NUM
admet-2901	372	8	-	-	SYM
admet-2901	372	9	1186	1186	NUM
admet-2901	372	10	.	.	PUNCT
admet-2901	373	1	https://doi.org/10.1007/s13204-021-01974-6	https://doi.org/10.1007/s13204-021-01974-6	X
admet-2901	374	1	[	[	X
admet-2901	374	2	19	19	NUM
admet-2901	374	3	]	]	PUNCT
admet-2901	374	4	p.	p.	PROPN
admet-2901	374	5	laupattarakasem	laupattarakasem	PROPN
admet-2901	374	6	,	,	PUNCT
admet-2901	374	7	b.	b.	PROPN
admet-2901	374	8	sripa	sripa	PROPN
admet-2901	374	9	,	,	PUNCT
admet-2901	374	10	c.	c.	PROPN
admet-2901	374	11	hahnvajanawong	hahnvajanawong	PROPN
admet-2901	374	12	.	.	PUNCT
admet-2901	375	1	effect	effect	NOUN
admet-2901	375	2	of	of	ADP
admet-2901	375	3	mallotus	mallotus	NOUN
admet-2901	375	4	repandus	repandus	VERB
admet-2901	375	5	onvascular	onvascular	ADJ
admet-2901	375	6	endothelial	endothelial	NOUN
admet-2901	375	7	and	and	CCONJ
admet-2901	375	8	cholangiocarcinoma	cholangiocarcinoma	ADJ
admet-2901	375	9	cells	cell	NOUN
admet-2901	375	10	migration	migration	NOUN
admet-2901	375	11	.	.	PUNCT
admet-2901	376	1	srinagarind	srinagarind	ADJ
admet-2901	376	2	medical	medical	ADJ
admet-2901	376	3	journal	journal	NOUN
admet-2901	376	4	25	25	NUM
admet-2901	376	5	(	(	PUNCT
admet-2901	376	6	2010	2010	NUM
admet-2901	376	7	)	)	PUNCT
admet-2901	376	8	201207	201207	NUM
admet-2901	376	9	.	.	PUNCT
admet-2901	377	1	https://li01.tci-thaijo.org/index.php/srimedj/article/view/12921	https://li01.tci-thaijo.org/index.php/srimedj/article/view/12921	PROPN
admet-2901	378	1	[	[	X
admet-2901	378	2	20	20	NUM
admet-2901	378	3	]	]	PUNCT
admet-2901	379	1	]	]	PUNCT
admet-2901	379	2	j.b	j.b	PROPN
admet-2901	379	3	.	.	PUNCT
admet-2901	380	1	kim	kim	PROPN
admet-2901	380	2	,	,	PUNCT
admet-2901	380	3	k.-m	k.-m	PROPN
admet-2901	380	4	.	.	PUNCT
admet-2901	381	1	lee	lee	PROPN
admet-2901	381	2	,	,	PUNCT
admet-2901	381	3	e.	e.	PROPN
admet-2901	381	4	ko	ko	PROPN
admet-2901	381	5	,	,	PUNCT
admet-2901	381	6	w.	w.	PROPN
admet-2901	381	7	han	han	PROPN
admet-2901	381	8	,	,	PUNCT
admet-2901	381	9	j.e	j.e	PROPN
admet-2901	381	10	.	.	PROPN
admet-2901	381	11	lee	lee	PROPN
admet-2901	381	12	,	,	PUNCT
admet-2901	381	13	i.	i.	PROPN
admet-2901	381	14	shin	shin	PROPN
admet-2901	381	15	,	,	PUNCT
admet-2901	381	16	j.-y	j.-y	PROPN
admet-2901	381	17	.	.	PUNCT
admet-2901	382	1	bae	bae	PROPN
admet-2901	382	2	,	,	PUNCT
admet-2901	382	3	s.	s.	PROPN
admet-2901	382	4	kim	kim	PROPN
admet-2901	382	5	,	,	PUNCT
admet-2901	382	6	d.-y	d.-y	PROPN
admet-2901	382	7	.	.	PUNCT
admet-2901	383	1	noh	noh	PROPN
admet-2901	383	2	.	.	PROPN
admet-2901	383	3	berberine	berberine	PROPN
admet-2901	383	4	inhibits	inhibit	VERB
admet-2901	383	5	growth	growth	NOUN
admet-2901	383	6	of	of	ADP
admet-2901	383	7	the	the	DET
admet-2901	383	8	breast	breast	NOUN
admet-2901	383	9	cancer	cancer	NOUN
admet-2901	383	10	cell	cell	NOUN
admet-2901	383	11	lines	line	NOUN
admet-2901	383	12	mcf-7	mcf-7	PUNCT
admet-2901	383	13	and	and	CCONJ
admet-2901	383	14	mda	mda	PROPN
admet-2901	383	15	-	-	PUNCT
admet-2901	383	16	mb-231	mb-231	PROPN
admet-2901	383	17	.	.	PUNCT
admet-2901	384	1	planta	planta	PROPN
admet-2901	384	2	medica	medica	PROPN
admet-2901	384	3	74	74	NUM
admet-2901	384	4	(	(	PUNCT
admet-2901	384	5	2008	2008	NUM
admet-2901	384	6	)	)	PUNCT
admet-2901	384	7	39	39	NUM
admet-2901	384	8	-	-	SYM
admet-2901	384	9	42	42	NUM
admet-2901	384	10	.	.	PUNCT
admet-2901	385	1	https://doi.org/10.1055/s-2007-993779	https://doi.org/10.1055/s-2007-993779	PROPN
admet-2901	385	2	[	[	X
admet-2901	385	3	21	21	NUM
admet-2901	385	4	]	]	PUNCT
admet-2901	385	5	p.	p.	NOUN
admet-2901	385	6	phannasil	phannasil	PROPN
admet-2901	385	7	,	,	PUNCT
admet-2901	385	8	c.	c.	PROPN
admet-2901	385	9	akekawatchai	akekawatchai	PROPN
admet-2901	385	10	,	,	PUNCT
admet-2901	385	11	s.	s.	PROPN
admet-2901	385	12	jitrapakdee	jitrapakdee	PROPN
admet-2901	385	13	.	.	PUNCT
admet-2901	386	1	microrna	microrna	PROPN
admet-2901	386	2	expression	expression	NOUN
admet-2901	386	3	profiles	profile	NOUN
admet-2901	386	4	associated	associate	VERB
admet-2901	386	5	with	with	ADP
admet-2901	386	6	the	the	DET
admet-2901	386	7	metastatic	metastatic	ADJ
admet-2901	386	8	ability	ability	NOUN
admet-2901	386	9	of	of	ADP
admet-2901	386	10	mda‑mb‑231	mda‑mb‑231	ADJ
admet-2901	386	11	breast	breast	NOUN
admet-2901	386	12	cancer	cancer	NOUN
admet-2901	386	13	cells	cell	NOUN
admet-2901	386	14	.	.	PUNCT
admet-2901	387	1	oncology	oncology	NOUN
admet-2901	387	2	letters	letter	NOUN
admet-2901	387	3	26	26	NUM
admet-2901	387	4	(	(	PUNCT
admet-2901	387	5	2023	2023	NUM
admet-2901	387	6	)	)	PUNCT
admet-2901	387	7	339	339	NUM
admet-2901	387	8	.	.	PUNCT
admet-2901	388	1	https://doi.org/10.3892/ol.2023.13926	https://doi.org/10.3892/ol.2023.13926	NOUN
admet-2901	389	1	[	[	X
admet-2901	389	2	22	22	NUM
admet-2901	389	3	]	]	X
admet-2901	389	4	a.r	a.r	PROPN
admet-2901	389	5	.	.	PROPN
admet-2901	389	6	estrada	estrada	PROPN
admet-2901	389	7	-	-	PUNCT
admet-2901	389	8	pérez	pérez	PROPN
admet-2901	389	9	,	,	PUNCT
admet-2901	389	10	n.	n.	NOUN
admet-2901	389	11	bakalara	bakalara	NOUN
admet-2901	389	12	,	,	PUNCT
admet-2901	389	13	j.b	j.b	PROPN
admet-2901	389	14	.	.	PUNCT
admet-2901	389	15	garcía	garcía	ADJ
admet-2901	389	16	-	-	PUNCT
admet-2901	389	17	vázquez	vázquez	NOUN
admet-2901	389	18	,	,	PUNCT
admet-2901	389	19	m.c	m.c	PROPN
admet-2901	389	20	.	.	PROPN
admet-2901	389	21	rosales	rosales	PROPN
admet-2901	389	22	-	-	PUNCT
admet-2901	389	23	hernández	hernández	PROPN
admet-2901	389	24	,	,	PUNCT
admet-2901	389	25	c.	c.	NOUN
admet-2901	389	26	fernándezpomares	fernándezpomare	NOUN
admet-2901	389	27	,	,	PUNCT
admet-2901	389	28	j.	j.	PROPN
admet-2901	389	29	correa	correa	PROPN
admet-2901	389	30	-	-	PUNCT
admet-2901	389	31	basurto	basurto	PROPN
admet-2901	389	32	.	.	PUNCT
admet-2901	390	1	lc	lc	PROPN
admet-2901	390	2	–	–	PUNCT
admet-2901	390	3	ms	ms	PROPN
admet-2901	390	4	based	base	VERB
admet-2901	390	5	lipidomics	lipidomic	NOUN
admet-2901	390	6	depict	depict	VERB
admet-2901	390	7	phosphatidylethanolamine	phosphatidylethanolamine	PROPN
admet-2901	390	8	as	as	ADP
admet-2901	390	9	biomarkers	biomarker	NOUN
admet-2901	390	10	of	of	ADP
admet-2901	390	11	tnbc	tnbc	ADJ
admet-2901	390	12	mda	mda	PROPN
admet-2901	390	13	-	-	PUNCT
admet-2901	390	14	mb-231	mb-231	PROPN
admet-2901	390	15	over	over	ADP
admet-2901	390	16	ntnbc	ntnbc	ADJ
admet-2901	390	17	mcf-7	mcf-7	NOUN
admet-2901	390	18	cells	cell	NOUN
admet-2901	390	19	.	.	PUNCT
admet-2901	391	1	international	international	ADJ
admet-2901	391	2	journal	journal	NOUN
admet-2901	391	3	of	of	ADP
admet-2901	391	4	molecular	molecular	ADJ
admet-2901	391	5	sciences	science	NOUN
admet-2901	391	6	23	23	NUM
admet-2901	391	7	(	(	PUNCT
admet-2901	391	8	2022	2022	NUM
admet-2901	391	9	)	)	PUNCT
admet-2901	391	10	12074	12074	NUM
admet-2901	391	11	.	.	PUNCT
admet-2901	392	1	https://doi.org/10.3390/ijms232012074	https://doi.org/10.3390/ijms232012074	PROPN
admet-2901	393	1	[	[	X
admet-2901	393	2	23	23	NUM
admet-2901	393	3	]	]	PUNCT
admet-2901	393	4	m.	m.	NOUN
admet-2901	393	5	franchi	franchi	PROPN
admet-2901	393	6	,	,	PUNCT
admet-2901	393	7	v.	v.	PROPN
admet-2901	393	8	masola	masola	PROPN
admet-2901	393	9	,	,	PUNCT
admet-2901	393	10	g.	g.	PROPN
admet-2901	393	11	bellin	bellin	PROPN
admet-2901	393	12	,	,	PUNCT
admet-2901	393	13	m.	m.	NOUN
admet-2901	393	14	onisto	onisto	NOUN
admet-2901	393	15	,	,	PUNCT
admet-2901	393	16	k.-a	k.-a	PROPN
admet-2901	393	17	.	.	PUNCT
admet-2901	394	1	karamanos	karamanos	PROPN
admet-2901	394	2	,	,	PUNCT
admet-2901	394	3	z.	z.	PROPN
admet-2901	394	4	piperigkou	piperigkou	PROPN
admet-2901	394	5	.	.	PUNCT
admet-2901	395	1	collagen	collagen	NOUN
admet-2901	395	2	fiber	fiber	PROPN
admet-2901	395	3	array	array	NOUN
admet-2901	395	4	of	of	ADP
admet-2901	395	5	peritumoral	peritumoral	ADJ
admet-2901	395	6	stroma	stroma	NOUN
admet-2901	395	7	influences	influence	VERB
admet-2901	395	8	epithelial	epithelial	NOUN
admet-2901	395	9	-	-	PUNCT
admet-2901	395	10	to	to	ADP
admet-2901	395	11	-	-	PUNCT
admet-2901	395	12	mesenchymal	mesenchymal	NOUN
admet-2901	395	13	transition	transition	NOUN
admet-2901	395	14	and	and	CCONJ
admet-2901	395	15	invasive	invasive	ADJ
admet-2901	395	16	potential	potential	NOUN
admet-2901	395	17	of	of	ADP
admet-2901	395	18	mammary	mammary	ADJ
admet-2901	395	19	cancer	cancer	NOUN
admet-2901	395	20	cells	cell	NOUN
admet-2901	395	21	.	.	PUNCT
admet-2901	396	1	journal	journal	NOUN
admet-2901	396	2	of	of	ADP
admet-2901	396	3	clinical	clinical	ADJ
admet-2901	396	4	medicine	medicine	NOUN
admet-2901	396	5	8	8	NUM
admet-2901	396	6	(	(	PUNCT
admet-2901	396	7	2019	2019	NUM
admet-2901	396	8	)	)	PUNCT
admet-2901	396	9	213	213	NUM
admet-2901	396	10	.	.	PUNCT
admet-2901	397	1	https://doi.org/10.3390/jcm8020213	https://doi.org/10.3390/jcm8020213	NOUN
admet-2901	397	2	[	[	X
admet-2901	397	3	24	24	NUM
admet-2901	397	4	]	]	PUNCT
admet-2901	397	5	m.	m.	NOUN
admet-2901	397	6	yang	yang	PROPN
admet-2901	397	7	,	,	PUNCT
admet-2901	397	8	w.j	w.j	PROPN
admet-2901	397	9	.	.	PROPN
admet-2901	397	10	brackenbury	brackenbury	PROPN
admet-2901	397	11	.	.	PUNCT
admet-2901	398	1	membrane	membrane	NOUN
admet-2901	398	2	potential	potential	NOUN
admet-2901	398	3	and	and	CCONJ
admet-2901	398	4	cancer	cancer	NOUN
admet-2901	398	5	progression	progression	NOUN
admet-2901	398	6	.	.	PUNCT
admet-2901	399	1	frontiers	frontier	NOUN
admet-2901	399	2	in	in	ADP
admet-2901	399	3	physiology	physiology	NOUN
admet-2901	399	4	4	4	NUM
admet-2901	399	5	(	(	PUNCT
admet-2901	399	6	2013	2013	NUM
admet-2901	399	7	)	)	PUNCT
admet-2901	399	8	185	185	NUM
admet-2901	399	9	.	.	PUNCT
admet-2901	400	1	https://doi.org/10.3389/fphys.2013.00185	https://doi.org/10.3389/fphys.2013.00185	PROPN
admet-2901	401	1	[	[	X
admet-2901	401	2	25	25	NUM
admet-2901	401	3	]	]	PUNCT
admet-2901	401	4	l.	l.	PROPN
admet-2901	401	5	stransky	stransky	PROPN
admet-2901	401	6	,	,	PUNCT
admet-2901	401	7	k.	k.	PROPN
admet-2901	401	8	cotter	cotter	PROPN
admet-2901	401	9	,	,	PUNCT
admet-2901	401	10	m.	m.	NOUN
admet-2901	401	11	forgac	forgac	PROPN
admet-2901	401	12	.	.	PUNCT
admet-2901	402	1	the	the	DET
admet-2901	402	2	function	function	NOUN
admet-2901	402	3	of	of	ADP
admet-2901	402	4	v	v	NOUN
admet-2901	402	5	-	-	PUNCT
admet-2901	402	6	atpases	atpase	NOUN
admet-2901	402	7	in	in	ADP
admet-2901	402	8	cancer	cancer	NOUN
admet-2901	402	9	.	.	PUNCT
admet-2901	403	1	physiological	physiological	ADJ
admet-2901	403	2	reviews	review	NOUN
admet-2901	403	3	96	96	NUM
admet-2901	403	4	(	(	PUNCT
admet-2901	403	5	2016	2016	NUM
admet-2901	403	6	)	)	PUNCT
admet-2901	403	7	1071	1071	NUM
admet-2901	403	8	-	-	SYM
admet-2901	403	9	1091	1091	NUM
admet-2901	403	10	.	.	PUNCT
admet-2901	404	1	https://doi.org/10.1152/physrev.00035.2015	https://doi.org/10.1152/physrev.00035.2015	PROPN
admet-2901	405	1	[	[	X
admet-2901	405	2	26	26	NUM
admet-2901	405	3	]	]	X
admet-2901	405	4	s.r	s.r	PROPN
admet-2901	405	5	.	.	PROPN
admet-2901	405	6	sennoune	sennoune	PROPN
admet-2901	405	7	,	,	PUNCT
admet-2901	405	8	k.	k.	PROPN
admet-2901	405	9	bakunts	bakunts	PROPN
admet-2901	405	10	,	,	PUNCT
admet-2901	405	11	g.m	g.m	PROPN
admet-2901	405	12	.	.	PROPN
admet-2901	405	13	martínez	martínez	PROPN
admet-2901	405	14	,	,	PUNCT
admet-2901	405	15	j.l	j.l	PROPN
admet-2901	405	16	.	.	PROPN
admet-2901	405	17	chua	chua	PROPN
admet-2901	405	18	-	-	PUNCT
admet-2901	405	19	tuan	tuan	PROPN
admet-2901	405	20	,	,	PUNCT
admet-2901	405	21	y.	y.	PROPN
admet-2901	405	22	kebir	kebir	PROPN
admet-2901	405	23	,	,	PUNCT
admet-2901	405	24	m.n	m.n	PROPN
admet-2901	405	25	.	.	PROPN
admet-2901	405	26	attaya	attaya	PROPN
admet-2901	405	27	,	,	PUNCT
admet-2901	405	28	r.	r.	NOUN
admet-2901	405	29	martínezzaguilán	martínezzaguilán	NOUN
admet-2901	405	30	.	.	PUNCT
admet-2901	406	1	vacuolar	vacuolar	ADJ
admet-2901	406	2	h+-atpase	h+-atpase	PROPN
admet-2901	406	3	in	in	ADP
admet-2901	406	4	human	human	ADJ
admet-2901	406	5	breast	breast	NOUN
admet-2901	406	6	cancer	cancer	NOUN
admet-2901	406	7	cells	cell	NOUN
admet-2901	406	8	with	with	ADP
admet-2901	406	9	distinct	distinct	ADJ
admet-2901	406	10	metastatic	metastatic	ADJ
admet-2901	406	11	potential	potential	NOUN
admet-2901	406	12	:	:	PUNCT
admet-2901	406	13	distribution	distribution	NOUN
admet-2901	406	14	and	and	CCONJ
admet-2901	406	15	functional	functional	ADJ
admet-2901	406	16	activity	activity	NOUN
admet-2901	406	17	.	.	PUNCT
admet-2901	407	1	american	american	PROPN
admet-2901	407	2	journal	journal	PROPN
admet-2901	407	3	of	of	ADP
admet-2901	407	4	physiology	physiology	NOUN
admet-2901	407	5	-	-	PUNCT
admet-2901	407	6	cell	cell	NOUN
admet-2901	407	7	physiology	physiology	NOUN
admet-2901	407	8	286	286	NUM
admet-2901	407	9	(	(	PUNCT
admet-2901	407	10	2004	2004	NUM
admet-2901	407	11	)	)	PUNCT
admet-2901	407	12	c1443	c1443	NOUN
admet-2901	407	13	-	-	PUNCT
admet-2901	407	14	c1452	c1452	NOUN
admet-2901	407	15	.	.	PUNCT
admet-2901	408	1	https://doi.org/10.1152/ajpcell.00407.2003	https://doi.org/10.1152/ajpcell.00407.2003	PROPN
admet-2901	409	1	[	[	X
admet-2901	409	2	27	27	NUM
admet-2901	409	3	]	]	PUNCT
admet-2901	409	4	a.	a.	NOUN
admet-2901	409	5	hendrix	hendrix	PROPN
admet-2901	409	6	,	,	PUNCT
admet-2901	409	7	r.	r.	PROPN
admet-2901	409	8	sormunen	sormunen	PROPN
admet-2901	409	9	,	,	PUNCT
admet-2901	409	10	w.	w.	PROPN
admet-2901	409	11	westbroek	westbroek	PROPN
admet-2901	409	12	,	,	PUNCT
admet-2901	409	13	k.	k.	PROPN
admet-2901	409	14	lambein	lambein	PROPN
admet-2901	409	15	,	,	PUNCT
admet-2901	409	16	h.	h.	PROPN
admet-2901	409	17	denys	denys	PROPN
admet-2901	409	18	,	,	PUNCT
admet-2901	409	19	g.	g.	PROPN
admet-2901	409	20	sys	sys	PROPN
admet-2901	409	21	,	,	PUNCT
admet-2901	409	22	g.	g.	PROPN
admet-2901	409	23	braems	braems	PROPN
admet-2901	409	24	,	,	PUNCT
admet-2901	409	25	r.	r.	PROPN
admet-2901	409	26	van	van	PROPN
admet-2901	409	27	den	den	PROPN
admet-2901	409	28	broecke	broecke	PROPN
admet-2901	409	29	,	,	PUNCT
admet-2901	409	30	v.	v.	PROPN
admet-2901	409	31	cocquyt	cocquyt	NOUN
admet-2901	409	32	,	,	PUNCT
admet-2901	409	33	c.	c.	PROPN
admet-2901	409	34	gespach	gespach	NOUN
admet-2901	409	35	.	.	PUNCT
admet-2901	410	1	vacuolar	vacuolar	ADJ
admet-2901	410	2	h+	h+	PUNCT
admet-2901	410	3	atpase	atpase	PROPN
admet-2901	410	4	expression	expression	NOUN
admet-2901	410	5	and	and	CCONJ
admet-2901	410	6	activity	activity	NOUN
admet-2901	410	7	is	be	AUX
admet-2901	410	8	required	require	VERB
admet-2901	410	9	for	for	ADP
admet-2901	410	10	rab27b	rab27b	NOUN
admet-2901	410	11	-	-	PUNCT
admet-2901	410	12	dependent	dependent	ADJ
admet-2901	410	13	invasive	invasive	ADJ
admet-2901	410	14	growth	growth	NOUN
admet-2901	410	15	and	and	CCONJ
admet-2901	410	16	metastasis	metastasis	NOUN
admet-2901	410	17	of	of	ADP
admet-2901	410	18	breast	breast	NOUN
admet-2901	410	19	cancer	cancer	NOUN
admet-2901	410	20	.	.	PUNCT
admet-2901	411	1	international	international	ADJ
admet-2901	411	2	journal	journal	PROPN
admet-2901	411	3	of	of	ADP
admet-2901	411	4	cancer	cancer	NOUN
admet-2901	411	5	133	133	NUM
admet-2901	411	6	(	(	PUNCT
admet-2901	411	7	2013	2013	NUM
admet-2901	411	8	)	)	PUNCT
admet-2901	411	9	843	843	NUM
admet-2901	411	10	-	-	SYM
admet-2901	411	11	854	854	NUM
admet-2901	411	12	.	.	PUNCT
admet-2901	412	1	https://doi.org/10.1002/ijc.28079	https://doi.org/10.1002/ijc.28079	PROPN
admet-2901	412	2	[	[	X
admet-2901	412	3	28	28	NUM
admet-2901	412	4	]	]	X
admet-2901	412	5	k.a	k.a	PROPN
admet-2901	412	6	.	.	PUNCT
admet-2901	412	7	keon	keon	PROPN
admet-2901	412	8	,	,	PUNCT
admet-2901	412	9	s.	s.	PROPN
admet-2901	412	10	benlekbir	benlekbir	PROPN
admet-2901	412	11	,	,	PUNCT
admet-2901	412	12	s.h	s.h	PROPN
admet-2901	412	13	.	.	PROPN
admet-2901	412	14	kirsch	kirsch	PROPN
admet-2901	412	15	,	,	PUNCT
admet-2901	412	16	r.	r.	PROPN
admet-2901	412	17	müller	müller	PROPN
admet-2901	412	18	,	,	PUNCT
admet-2901	412	19	j.l	j.l	PROPN
admet-2901	412	20	.	.	PROPN
admet-2901	412	21	rubinstein	rubinstein	PROPN
admet-2901	412	22	.	.	PUNCT
admet-2901	413	1	cryo	cryo	PROPN
admet-2901	413	2	-	-	PUNCT
admet-2901	413	3	em	em	PRON
admet-2901	413	4	of	of	ADP
admet-2901	413	5	the	the	DET
admet-2901	413	6	yeast	yeast	NOUN
admet-2901	413	7	vo	vo	NOUN
admet-2901	413	8	complex	complex	PROPN
admet-2901	413	9	reveals	reveal	VERB
admet-2901	413	10	distinct	distinct	ADJ
admet-2901	413	11	binding	bind	VERB
admet-2901	413	12	sites	site	NOUN
admet-2901	413	13	for	for	ADP
admet-2901	413	14	macrolide	macrolide	ADJ
admet-2901	413	15	v	v	NOUN
admet-2901	413	16	-	-	PUNCT
admet-2901	413	17	atpase	atpase	ADJ
admet-2901	413	18	inhibitors	inhibitor	NOUN
admet-2901	413	19	.	.	PUNCT
admet-2901	414	1	acs	acs	PROPN
admet-2901	414	2	chemical	chemical	PROPN
admet-2901	414	3	biology	biology	NOUN
admet-2901	414	4	17	17	NUM
admet-2901	414	5	(	(	PUNCT
admet-2901	414	6	2022	2022	NUM
admet-2901	414	7	)	)	PUNCT
admet-2901	414	8	619	619	NUM
admet-2901	414	9	-	-	SYM
admet-2901	414	10	628	628	NUM
admet-2901	414	11	.	.	PUNCT
admet-2901	415	1	https://doi.org/10.1021/acschembio.1c00894	https://doi.org/10.1021/acschembio.1c00894	PROPN
admet-2901	415	2	[	[	X
admet-2901	415	3	29	29	NUM
admet-2901	415	4	]	]	PUNCT
admet-2901	415	5	a.	a.	NOUN
admet-2901	415	6	wongpan	wongpan	PROPN
admet-2901	415	7	,	,	PUNCT
admet-2901	415	8	w.	w.	PROPN
admet-2901	415	9	panvongsa	panvongsa	PROPN
admet-2901	415	10	,	,	PUNCT
admet-2901	415	11	s.	s.	PROPN
admet-2901	415	12	krobthong	krobthong	PROPN
admet-2901	415	13	,	,	PUNCT
admet-2901	415	14	b.	b.	PROPN
admet-2901	415	15	nutho	nutho	PROPN
admet-2901	415	16	,	,	PUNCT
admet-2901	415	17	p.	p.	NOUN
admet-2901	415	18	kanjanasirirat	kanjanasirirat	PROPN
admet-2901	415	19	,	,	PUNCT
admet-2901	415	20	k.	k.	PROPN
admet-2901	415	21	jearawuttanakul	jearawuttanakul	PROPN
admet-2901	415	22	,	,	PUNCT
admet-2901	415	23	t.	t.	PROPN
admet-2901	415	24	khumpanied	khumpanied	PROPN
admet-2901	415	25	,	,	PUNCT
admet-2901	415	26	s.	s.	PROPN
admet-2901	415	27	phlaetita	phlaetita	PROPN
admet-2901	415	28	,	,	PUNCT
admet-2901	415	29	n.	n.	PROPN
admet-2901	415	30	chabang	chabang	PROPN
admet-2901	415	31	,	,	PUNCT
admet-2901	415	32	b.	b.	PROPN
admet-2901	415	33	munyoo	munyoo	PROPN
admet-2901	415	34	,	,	PUNCT
admet-2901	415	35	p.	p.	NOUN
admet-2901	415	36	tuchinda	tuchinda	PROPN
admet-2901	415	37	,	,	PUNCT
admet-2901	415	38	m.	m.	NOUN
admet-2901	415	39	ponpuak	ponpuak	NOUN
admet-2901	415	40	,	,	PUNCT
admet-2901	415	41	s.	s.	PROPN
admet-2901	415	42	borwornpinyo	borwornpinyo	PROPN
admet-2901	415	43	,	,	PUNCT
admet-2901	415	44	a.	a.	NOUN
admet-2901	415	45	chairoungdua	chairoungdua	PROPN
admet-2901	415	46	.	.	PUNCT
admet-2901	416	1	cleistanthin	cleistanthin	VERB
admet-2901	416	2	a	a	DET
admet-2901	416	3	derivative	derivative	ADJ
admet-2901	416	4	disrupts	disrupt	NOUN
admet-2901	416	5	autophagy	autophagy	NOUN
admet-2901	416	6	and	and	CCONJ
admet-2901	416	7	suppresses	suppress	VERB
admet-2901	416	8	head	head	NOUN
admet-2901	416	9	and	and	CCONJ
admet-2901	416	10	neck	neck	VERB
admet-2901	416	11	squamous	squamous	ADJ
admet-2901	416	12	cell	cell	NOUN
admet-2901	416	13	carcinoma	carcinoma	NOUN
admet-2901	416	14	progression	progression	NOUN
admet-2901	416	15	via	via	ADP
admet-2901	416	16	targeted	target	VERB
admet-2901	416	17	vacuolar	vacuolar	ADJ
admet-2901	416	18	atpase	atpase	NOUN
admet-2901	416	19	.	.	PUNCT
admet-2901	417	1	scientific	scientific	ADJ
admet-2901	417	2	reports	report	NOUN
admet-2901	417	3	14	14	NUM
admet-2901	417	4	(	(	PUNCT
admet-2901	417	5	2024	2024	NUM
admet-2901	417	6	)	)	PUNCT
admet-2901	417	7	22582	22582	NUM
admet-2901	417	8	.	.	PUNCT
admet-2901	417	9	https://doi.org/10.1038/s41598-024-73186-1	https://doi.org/10.1038/s41598-024-73186-1	NOUN
admet-2901	418	1	[	[	X
admet-2901	418	2	30	30	NUM
admet-2901	418	3	]	]	X
admet-2901	418	4	p.a	p.a	PROPN
admet-2901	418	5	.	.	PROPN
admet-2901	418	6	ravindranath	ravindranath	PROPN
admet-2901	418	7	,	,	PUNCT
admet-2901	418	8	s.	s.	PROPN
admet-2901	418	9	forli	forli	PROPN
admet-2901	418	10	,	,	PUNCT
admet-2901	418	11	d.s	d.s	PROPN
admet-2901	418	12	.	.	PROPN
admet-2901	418	13	goodsell	goodsell	PROPN
admet-2901	418	14	,	,	PUNCT
admet-2901	418	15	a.j	a.j	PROPN
admet-2901	418	16	.	.	PROPN
admet-2901	418	17	olson	olson	PROPN
admet-2901	418	18	,	,	PUNCT
admet-2901	418	19	m.f	m.f	PROPN
admet-2901	418	20	.	.	PROPN
admet-2901	418	21	sanner	sanner	NOUN
admet-2901	418	22	.	.	PUNCT
admet-2901	419	1	autodockfr	autodockfr	PROPN
admet-2901	419	2	:	:	PUNCT
admet-2901	419	3	advances	advance	NOUN
admet-2901	419	4	in	in	ADP
admet-2901	419	5	proteinligand	proteinligand	ADJ
admet-2901	419	6	docking	docking	NOUN
admet-2901	419	7	with	with	ADP
admet-2901	419	8	explicitly	explicitly	ADV
admet-2901	419	9	specified	specify	VERB
admet-2901	419	10	binding	bind	VERB
admet-2901	419	11	site	site	NOUN
admet-2901	419	12	flexibility	flexibility	NOUN
admet-2901	419	13	.	.	PUNCT
admet-2901	420	1	plos	plos	PROPN
admet-2901	420	2	computational	computational	ADJ
admet-2901	420	3	biology	biology	NOUN
admet-2901	420	4	11	11	NUM
admet-2901	420	5	(	(	PUNCT
admet-2901	420	6	2015	2015	NUM
admet-2901	420	7	)	)	PUNCT
admet-2901	420	8	e1004586	e1004586	PROPN
admet-2901	420	9	.	.	PUNCT
admet-2901	420	10	https://doi.org/10.1371/journal.pcbi.1004586	https://doi.org/10.1371/journal.pcbi.1004586	NOUN
admet-2901	421	1	[	[	X
admet-2901	421	2	31	31	NUM
admet-2901	421	3	]	]	PUNCT
admet-2901	421	4	j.	j.	PROPN
admet-2901	421	5	eberhardt	eberhardt	PROPN
admet-2901	421	6	,	,	PUNCT
admet-2901	421	7	d.	d.	PROPN
admet-2901	421	8	santos	santos	PROPN
admet-2901	421	9	-	-	PUNCT
admet-2901	421	10	martins	martins	PROPN
admet-2901	421	11	,	,	PUNCT
admet-2901	421	12	a.f	a.f	PROPN
admet-2901	421	13	.	.	PROPN
admet-2901	421	14	tillack	tillack	PROPN
admet-2901	421	15	,	,	PUNCT
admet-2901	421	16	s.	s.	PROPN
admet-2901	421	17	forli	forli	PROPN
admet-2901	421	18	.	.	PUNCT
admet-2901	422	1	autodock	autodock	PROPN
admet-2901	422	2	vina	vina	PROPN
admet-2901	422	3	1.2.0	1.2.0	NUM
admet-2901	422	4	:	:	PUNCT
admet-2901	422	5	new	new	ADJ
admet-2901	422	6	docking	docking	NOUN
admet-2901	422	7	methods	method	NOUN
admet-2901	422	8	,	,	PUNCT
admet-2901	422	9	expanded	expand	VERB
admet-2901	422	10	force	force	NOUN
admet-2901	422	11	field	field	NOUN
admet-2901	422	12	,	,	PUNCT
admet-2901	422	13	and	and	CCONJ
admet-2901	422	14	python	python	NOUN
admet-2901	422	15	bindings	binding	NOUN
admet-2901	422	16	.	.	PUNCT
admet-2901	423	1	journal	journal	PROPN
admet-2901	423	2	of	of	ADP
admet-2901	423	3	chemical	chemical	ADJ
admet-2901	423	4	information	information	NOUN
admet-2901	423	5	and	and	CCONJ
admet-2901	423	6	modeling	model	VERB
admet-2901	423	7	61	61	NUM
admet-2901	423	8	(	(	PUNCT
admet-2901	423	9	2021	2021	NUM
admet-2901	423	10	)	)	PUNCT
admet-2901	423	11	3891	3891	NUM
admet-2901	423	12	-	-	SYM
admet-2901	423	13	3898	3898	NUM
admet-2901	423	14	.	.	PUNCT
admet-2901	424	1	https://doi.org/10.1021/acs.jcim.1c00203	https://doi.org/10.1021/acs.jcim.1c00203	NOUN
admet-2901	424	2	[	[	X
admet-2901	424	3	32	32	NUM
admet-2901	424	4	]	]	X
admet-2901	424	5	e.f	e.f	PROPN
admet-2901	424	6	.	.	PROPN
admet-2901	424	7	pettersen	pettersen	PROPN
admet-2901	424	8	,	,	PUNCT
admet-2901	424	9	t.d	t.d	PROPN
admet-2901	424	10	.	.	PROPN
admet-2901	424	11	goddard	goddard	PROPN
admet-2901	424	12	,	,	PUNCT
admet-2901	424	13	c.c	c.c	PROPN
admet-2901	424	14	.	.	PROPN
admet-2901	424	15	huang	huang	PROPN
admet-2901	424	16	,	,	PUNCT
admet-2901	424	17	e.c	e.c	PROPN
admet-2901	424	18	.	.	PROPN
admet-2901	424	19	meng	meng	PROPN
admet-2901	424	20	,	,	PUNCT
admet-2901	424	21	g.s	g.s	PROPN
admet-2901	424	22	.	.	PROPN
admet-2901	424	23	couch	couch	PROPN
admet-2901	424	24	,	,	PUNCT
admet-2901	424	25	t.i	t.i	PROPN
admet-2901	424	26	.	.	PROPN
admet-2901	424	27	croll	croll	PROPN
admet-2901	424	28	,	,	PUNCT
admet-2901	424	29	j.h	j.h	PROPN
admet-2901	424	30	.	.	PROPN
admet-2901	424	31	morris	morris	PROPN
admet-2901	424	32	,	,	PUNCT
admet-2901	424	33	t.e	t.e	PROPN
admet-2901	424	34	.	.	PROPN
admet-2901	424	35	ferrin	ferrin	PROPN
admet-2901	424	36	.	.	PUNCT
admet-2901	425	1	ucsf	ucsf	PROPN
admet-2901	425	2	chimerax	chimerax	PROPN
admet-2901	425	3	:	:	PUNCT
admet-2901	425	4	structure	structure	NOUN
admet-2901	425	5	visualization	visualization	NOUN
admet-2901	425	6	for	for	ADP
admet-2901	425	7	researchers	researcher	NOUN
admet-2901	425	8	,	,	PUNCT
admet-2901	425	9	educators	educator	NOUN
admet-2901	425	10	,	,	PUNCT
admet-2901	425	11	and	and	CCONJ
admet-2901	425	12	developers	developer	NOUN
admet-2901	425	13	.	.	PUNCT
admet-2901	426	1	protein	protein	NOUN
admet-2901	426	2	science	science	NOUN
admet-2901	426	3	30	30	NUM
admet-2901	426	4	(	(	PUNCT
admet-2901	426	5	2021	2021	NUM
admet-2901	426	6	)	)	PUNCT
admet-2901	426	7	70	70	NUM
admet-2901	426	8	-	-	SYM
admet-2901	426	9	82	82	NUM
admet-2901	426	10	.	.	PUNCT
admet-2901	427	1	https://doi.org/https://doi.org/10.1002/pro.3943	https://doi.org/https://doi.org/10.1002/pro.3943	X
admet-2901	427	2	https://doi.org/10.1007/s13204-021-01974-6	https://doi.org/10.1007/s13204-021-01974-6	NUM
admet-2901	428	1	https://li01.tci-thaijo.org/index.php/srimedj/article/view/12921	https://li01.tci-thaijo.org/index.php/srimedj/article/view/12921	PROPN
admet-2901	428	2	https://doi.org/10.1055/s-2007-993779	https://doi.org/10.1055/s-2007-993779	PROPN
admet-2901	428	3	https://doi.org/10.3892/ol.2023.13926	https://doi.org/10.3892/ol.2023.13926	NOUN
admet-2901	428	4	https://doi.org/10.3390/ijms232012074	https://doi.org/10.3390/ijms232012074	PROPN
admet-2901	428	5	https://doi.org/10.3390/jcm8020213	https://doi.org/10.3390/jcm8020213	NOUN
admet-2901	428	6	https://doi.org/10.3389/fphys.2013.00185	https://doi.org/10.3389/fphys.2013.00185	PROPN
admet-2901	429	1	https://doi.org/10.1152/physrev.00035.2015	https://doi.org/10.1152/physrev.00035.2015	PROPN
admet-2901	429	2	https://doi.org/10.1152/ajpcell.00407.2003	https://doi.org/10.1152/ajpcell.00407.2003	PROPN
admet-2901	429	3	https://doi.org/10.1002/ijc.28079	https://doi.org/10.1002/ijc.28079	PROPN
admet-2901	429	4	https://doi.org/10.1021/acschembio.1c00894	https://doi.org/10.1021/acschembio.1c00894	PROPN
admet-2901	429	5	https://doi.org/10.1038/s41598-024-73186-1	https://doi.org/10.1038/s41598-024-73186-1	NUM
admet-2901	429	6	https://doi.org/10.1371/journal.pcbi.1004586	https://doi.org/10.1371/journal.pcbi.1004586	NOUN
admet-2901	429	7	https://doi.org/10.1021/acs.jcim.1c00203	https://doi.org/10.1021/acs.jcim.1c00203	PROPN
admet-2901	429	8	https://doi.org/https:/doi.org/10.1002/pro.3943	https://doi.org/https:/doi.org/10.1002/pro.3943	PUNCT
admet-2901	429	9	admet	admet	PROPN
admet-2901	429	10	&	&	CCONJ
admet-2901	429	11	dmpk	dmpk	PROPN
admet-2901	429	12	13(5	13(5	NOUN
admet-2901	429	13	)	)	PUNCT
admet-2901	429	14	(	(	PUNCT
admet-2901	429	15	2025	2025	NUM
admet-2901	429	16	)	)	PUNCT
admet-2901	429	17	2901	2901	NUM
admet-2901	429	18	new	new	ADJ
admet-2901	429	19	xanthone	xanthone	PROPN
admet-2901	429	20	and	and	CCONJ
admet-2901	429	21	chemical	chemical	NOUN
admet-2901	429	22	constituents	constituent	NOUN
admet-2901	429	23	from	from	ADP
admet-2901	429	24	mallotus	mallotus	ADJ
admet-2901	429	25	glomerulatus	glomerulatus	NOUN
admet-2901	429	26	doi	doi	PROPN
admet-2901	429	27	:	:	PUNCT
admet-2901	429	28	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	NOUN
admet-2901	429	29	17	17	NUM
admet-2901	430	1	[	[	SYM
admet-2901	430	2	33	33	NUM
admet-2901	430	3	]	]	PUNCT
admet-2901	430	4	g.	g.	PROPN
admet-2901	430	5	ni	ni	PROPN
admet-2901	430	6	,	,	PUNCT
admet-2901	430	7	s.	s.	PROPN
admet-2901	430	8	yang	yang	PROPN
admet-2901	430	9	,	,	PUNCT
admet-2901	430	10	j.	j.	PROPN
admet-2901	430	11	yue	yue	PROPN
admet-2901	430	12	.	.	PROPN
admet-2901	430	13	anomalusins	anomalusin	VERB
admet-2901	430	14	a	a	PRON
admet-2901	430	15	and	and	CCONJ
admet-2901	430	16	b	b	NOUN
admet-2901	430	17	,	,	PUNCT
admet-2901	430	18	two	two	NUM
admet-2901	430	19	new	new	ADJ
admet-2901	430	20	ent	ent	NOUN
admet-2901	430	21	-	-	PUNCT
admet-2901	430	22	rosane	rosane	PROPN
admet-2901	430	23	diterpenoids	diterpenoid	NOUN
admet-2901	430	24	from	from	ADP
admet-2901	430	25	mallotus	mallotus	PROPN
admet-2901	430	26	anomalus	anomalus	PROPN
admet-2901	430	27	.	.	PUNCT
admet-2901	431	1	journal	journal	PROPN
admet-2901	431	2	of	of	ADP
admet-2901	431	3	chinese	chinese	PROPN
admet-2901	431	4	pharmaceutical	pharmaceutical	ADJ
admet-2901	431	5	sciences	science	NOUN
admet-2901	431	6	21	21	NUM
admet-2901	431	7	(	(	PUNCT
admet-2901	431	8	2012	2012	NUM
admet-2901	431	9	)	)	PUNCT
admet-2901	431	10	421	421	NUM
admet-2901	431	11	.	.	PUNCT
admet-2901	432	1	https://doi.org/10.5246/jcps.2012.05.056	https://doi.org/10.5246/jcps.2012.05.056	PROPN
admet-2901	432	2	[	[	X
admet-2901	432	3	34	34	NUM
admet-2901	432	4	]	]	X
admet-2901	432	5	y.	y.	PROPN
admet-2901	432	6	yang	yang	PROPN
admet-2901	432	7	,	,	PUNCT
admet-2901	432	8	z.	z.	PROPN
admet-2901	432	9	tang	tang	PROPN
admet-2901	432	10	,	,	PUNCT
admet-2901	432	11	s.	s.	PROPN
admet-2901	432	12	feng	feng	PROPN
admet-2901	432	13	,	,	PUNCT
admet-2901	432	14	r.	r.	PROPN
admet-2901	432	15	xu	xu	PROPN
admet-2901	432	16	,	,	PUNCT
admet-2901	432	17	q.	q.	PROPN
admet-2901	432	18	zhong	zhong	PROPN
admet-2901	432	19	,	,	PUNCT
admet-2901	432	20	y.	y.	PROPN
admet-2901	432	21	zhong	zhong	PROPN
admet-2901	432	22	.	.	PUNCT
admet-2901	433	1	studies	study	NOUN
admet-2901	433	2	on	on	ADP
admet-2901	433	3	chemical	chemical	ADJ
admet-2901	433	4	constitutions	constitution	NOUN
admet-2901	433	5	of	of	ADP
admet-2901	433	6	mallotus	mallotus	PROPN
admet-2901	433	7	anomalus	anomalus	PROPN
admet-2901	433	8	iii	iii	PROPN
admet-2901	433	9	:	:	PUNCT
admet-2901	433	10	the	the	DET
admet-2901	433	11	structure	structure	NOUN
admet-2901	433	12	of	of	ADP
admet-2901	433	13	new	new	ADJ
admet-2901	433	14	rosane	rosane	PROPN
admet-2901	433	15	type	type	NOUN
admet-2901	433	16	diterpenoids	diterpenoids	PROPN
admet-2901	433	17	.	.	PUNCT
admet-2901	434	1	acta	acta	PROPN
admet-2901	434	2	chimica	chimica	PROPN
admet-2901	434	3	sinica	sinica	PROPN
admet-2901	434	4	50	50	NUM
admet-2901	434	5	(	(	PUNCT
admet-2901	434	6	1992	1992	NUM
admet-2901	434	7	)	)	PUNCT
admet-2901	434	8	200	200	NUM
admet-2901	434	9	.	.	PUNCT
admet-2901	435	1	https://sioc-journal.cn/jwk_hxxb/en/y1992/v50/i2/200	https://sioc-journal.cn/jwk_hxxb/en/y1992/v50/i2/200	PROPN
admet-2901	436	1	[	[	X
admet-2901	436	2	35	35	NUM
admet-2901	436	3	]	]	X
admet-2901	436	4	p.v	p.v	PROPN
admet-2901	436	5	.	.	PROPN
admet-2901	436	6	kiem	kiem	PROPN
admet-2901	436	7	,	,	PUNCT
admet-2901	436	8	c.v	c.v	PROPN
admet-2901	436	9	.	.	PROPN
admet-2901	436	10	minh	minh	PROPN
admet-2901	436	11	,	,	PUNCT
admet-2901	436	12	h.t	h.t	PROPN
admet-2901	436	13	.	.	PROPN
admet-2901	436	14	huong	huong	PROPN
admet-2901	436	15	,	,	PUNCT
admet-2901	436	16	n.h	n.h	PROPN
admet-2901	436	17	.	.	PROPN
admet-2901	436	18	nam	nam	PROPN
admet-2901	436	19	,	,	PUNCT
admet-2901	436	20	j.j	j.j	PROPN
admet-2901	436	21	.	.	PROPN
admet-2901	436	22	lee	lee	PROPN
admet-2901	436	23	,	,	PUNCT
admet-2901	436	24	y.h	y.h	PROPN
admet-2901	436	25	.	.	PROPN
admet-2901	436	26	kim	kim	PROPN
admet-2901	436	27	.	.	PUNCT
admet-2901	436	28	pentacyclic	pentacyclic	PROPN
admet-2901	436	29	triterpenoids	triterpenoids	PROPN
admet-2901	436	30	from	from	ADP
admet-2901	436	31	mallotus	mallotus	NOUN
admet-2901	436	32	apelta	apelta	NOUN
admet-2901	436	33	.	.	PUNCT
admet-2901	437	1	archives	archive	NOUN
admet-2901	437	2	of	of	ADP
admet-2901	437	3	pharmacal	pharmacal	ADJ
admet-2901	437	4	research	research	NOUN
admet-2901	437	5	27	27	NUM
admet-2901	437	6	(	(	PUNCT
admet-2901	437	7	2004	2004	NUM
admet-2901	437	8	)	)	PUNCT
admet-2901	437	9	1109	1109	NUM
admet-2901	437	10	-	-	SYM
admet-2901	437	11	1113	1113	NUM
admet-2901	437	12	.	.	PUNCT
admet-2901	438	1	https://doi.org/10.1007/bf02975113	https://doi.org/10.1007/bf02975113	PROPN
admet-2901	439	1	[	[	X
admet-2901	439	2	36	36	NUM
admet-2901	439	3	]	]	X
admet-2901	439	4	g.f	g.f	PROPN
admet-2901	439	5	.	.	PROPN
admet-2901	439	6	sousa	sousa	PROPN
admet-2901	439	7	,	,	PUNCT
admet-2901	439	8	l.p	l.p	PROPN
admet-2901	439	9	.	.	PROPN
admet-2901	439	10	duarte	duarte	PROPN
admet-2901	439	11	,	,	PUNCT
admet-2901	439	12	a.f	a.f	PROPN
admet-2901	439	13	.	.	PROPN
admet-2901	439	14	alcântara	alcântara	PROPN
admet-2901	439	15	,	,	PUNCT
admet-2901	439	16	g.d	g.d	PROPN
admet-2901	439	17	.	.	PROPN
admet-2901	439	18	silva	silva	PROPN
admet-2901	439	19	,	,	PUNCT
admet-2901	439	20	s.a	s.a	PROPN
admet-2901	439	21	.	.	PROPN
admet-2901	439	22	vieira	vieira	PROPN
admet-2901	439	23	-	-	PUNCT
admet-2901	439	24	filho	filho	PROPN
admet-2901	439	25	,	,	PUNCT
admet-2901	439	26	r.r	r.r	PROPN
admet-2901	439	27	.	.	PROPN
admet-2901	439	28	silva	silva	PROPN
admet-2901	439	29	,	,	PUNCT
admet-2901	439	30	d.m	d.m	PROPN
admet-2901	439	31	.	.	PROPN
admet-2901	439	32	oliveira	oliveira	PROPN
admet-2901	439	33	,	,	PUNCT
admet-2901	439	34	j.a	j.a	PROPN
admet-2901	439	35	.	.	PROPN
admet-2901	439	36	takahashi	takahashi	PROPN
admet-2901	439	37	.	.	PUNCT
admet-2901	440	1	new	new	ADJ
admet-2901	440	2	triterpenes	triterpene	NOUN
admet-2901	440	3	from	from	ADP
admet-2901	440	4	maytenus	maytenus	ADP
admet-2901	440	5	robusta	robusta	NOUN
admet-2901	440	6	:	:	PUNCT
admet-2901	440	7	structural	structural	ADJ
admet-2901	440	8	elucidation	elucidation	NOUN
admet-2901	440	9	based	base	VERB
admet-2901	440	10	on	on	ADP
admet-2901	440	11	nmr	nmr	NOUN
admet-2901	440	12	experimental	experimental	ADJ
admet-2901	440	13	data	datum	NOUN
admet-2901	440	14	and	and	CCONJ
admet-2901	440	15	theoretical	theoretical	ADJ
admet-2901	440	16	calculations	calculation	NOUN
admet-2901	440	17	.	.	PUNCT
admet-2901	441	1	molecules	molecule	NOUN
admet-2901	441	2	17	17	NUM
admet-2901	441	3	(	(	PUNCT
admet-2901	441	4	2012	2012	NUM
admet-2901	441	5	)	)	PUNCT
admet-2901	441	6	13439	13439	NUM
admet-2901	441	7	-	-	SYM
admet-2901	441	8	13456	13456	NUM
admet-2901	441	9	.	.	PUNCT
admet-2901	442	1	https://doi.org/10.3390/molecules171113439	https://doi.org/10.3390/molecules171113439	PROPN
admet-2901	443	1	[	[	X
admet-2901	443	2	37	37	NUM
admet-2901	443	3	]	]	X
admet-2901	443	4	w.f	w.f	PROPN
admet-2901	443	5	.	.	PROPN
admet-2901	443	6	tinto	tinto	PROPN
admet-2901	443	7	,	,	PUNCT
admet-2901	443	8	g.	g.	PROPN
admet-2901	443	9	blyden	blyden	PROPN
admet-2901	443	10	,	,	PUNCT
admet-2901	443	11	w.f	w.f	PROPN
admet-2901	443	12	.	.	PROPN
admet-2901	443	13	reynolds	reynolds	PROPN
admet-2901	443	14	,	,	PUNCT
admet-2901	443	15	s.	s.	PROPN
admet-2901	443	16	mclean	mclean	PROPN
admet-2901	443	17	.	.	PUNCT
admet-2901	444	1	diterpene	diterpene	PROPN
admet-2901	444	2	and	and	CCONJ
admet-2901	444	3	anthraquinone	anthraquinone	NOUN
admet-2901	444	4	constituents	constituent	NOUN
admet-2901	444	5	of	of	ADP
admet-2901	444	6	glycydendron	glycydendron	PROPN
admet-2901	444	7	amazonicum	amazonicum	PROPN
admet-2901	444	8	.	.	PUNCT
admet-2901	445	1	journal	journal	PROPN
admet-2901	445	2	of	of	ADP
admet-2901	445	3	natural	natural	ADJ
admet-2901	445	4	products	product	NOUN
admet-2901	445	5	54	54	NUM
admet-2901	445	6	(	(	PUNCT
admet-2901	445	7	1991	1991	NUM
admet-2901	445	8	)	)	PUNCT
admet-2901	445	9	1127	1127	NUM
admet-2901	445	10	-	-	SYM
admet-2901	445	11	1130	1130	NUM
admet-2901	445	12	.	.	PUNCT
admet-2901	446	1	https://doi.org/10.1021/np50076a037	https://doi.org/10.1021/np50076a037	NOUN
admet-2901	446	2	[	[	PUNCT
admet-2901	446	3	38	38	NUM
admet-2901	446	4	]	]	PUNCT
admet-2901	446	5	j.	j.	PROPN
admet-2901	446	6	mi	mi	PROPN
admet-2901	446	7	,	,	PUNCT
admet-2901	446	8	r.	r.	PROPN
admet-2901	446	9	xu	xu	PROPN
admet-2901	446	10	,	,	PUNCT
admet-2901	446	11	y.	y.	PROPN
admet-2901	446	12	yang	yang	PROPN
admet-2901	446	13	,	,	PUNCT
admet-2901	446	14	p.	p.	PROPN
admet-2901	446	15	yang	yang	PROPN
admet-2901	446	16	.	.	PUNCT
admet-2901	447	1	studies	study	NOUN
admet-2901	447	2	on	on	ADP
admet-2901	447	3	circular	circular	ADJ
admet-2901	447	4	dichroism	dichroism	NOUN
admet-2901	447	5	of	of	ADP
admet-2901	447	6	diterpenoids	diterpenoid	NOUN
admet-2901	447	7	from	from	ADP
admet-2901	447	8	mallotus	mallotus	NOUN
admet-2901	447	9	anomalus	anomalus	NOUN
admet-2901	447	10	and	and	CCONJ
admet-2901	447	11	sesquiterpenoid	sesquiterpenoid	VERB
admet-2901	447	12	tussilagone	tussilagone	NOUN
admet-2901	447	13	.	.	PUNCT
admet-2901	448	1	acta	acta	PROPN
admet-2901	448	2	pharmaceutica	pharmaceutica	PROPN
admet-2901	448	3	sinica	sinica	PROPN
admet-2901	448	4	28	28	NUM
admet-2901	448	5	(	(	PUNCT
admet-2901	448	6	1993	1993	NUM
admet-2901	448	7	)	)	PUNCT
admet-2901	448	8	105	105	NUM
admet-2901	448	9	-	-	SYM
admet-2901	448	10	109	109	NUM
admet-2901	448	11	.	.	PUNCT
admet-2901	448	12	https://europepmc.org/article/med/8328277	https://europepmc.org/article/med/8328277	NOUN
admet-2901	449	1	[	[	X
admet-2901	449	2	39	39	NUM
admet-2901	449	3	]	]	PUNCT
admet-2901	449	4	m.	m.	NOUN
admet-2901	449	5	tanjung	tanjung	PROPN
admet-2901	449	6	,	,	PUNCT
admet-2901	449	7	t.s	t.s	PROPN
admet-2901	449	8	.	.	PROPN
admet-2901	449	9	tjahjandarie	tjahjandarie	PROPN
admet-2901	449	10	,	,	PUNCT
admet-2901	449	11	m.h	m.h	PROPN
admet-2901	449	12	.	.	PROPN
admet-2901	449	13	sentosa	sentosa	PROPN
admet-2901	449	14	.	.	PROPN
admet-2901	449	15	antioxidant	antioxidant	PROPN
admet-2901	449	16	and	and	CCONJ
admet-2901	449	17	cytotoxic	cytotoxic	ADJ
admet-2901	449	18	agent	agent	NOUN
admet-2901	449	19	from	from	ADP
admet-2901	449	20	the	the	DET
admet-2901	449	21	rhizomes	rhizome	NOUN
admet-2901	449	22	of	of	ADP
admet-2901	449	23	kaempferia	kaempferia	PROPN
admet-2901	449	24	pandurata	pandurata	PROPN
admet-2901	449	25	.	.	PUNCT
admet-2901	450	1	asian	asian	PROPN
admet-2901	450	2	pacific	pacific	PROPN
admet-2901	450	3	journal	journal	PROPN
admet-2901	450	4	of	of	ADP
admet-2901	450	5	tropical	tropical	ADJ
admet-2901	450	6	disease	disease	NOUN
admet-2901	450	7	3	3	NUM
admet-2901	450	8	(	(	PUNCT
admet-2901	450	9	2013	2013	NUM
admet-2901	450	10	)	)	PUNCT
admet-2901	450	11	401	401	NUM
admet-2901	450	12	-	-	SYM
admet-2901	450	13	404	404	NUM
admet-2901	450	14	.	.	PUNCT
admet-2901	451	1	https://doi.org/10.1016/s2222-1808(13)60091-2	https://doi.org/10.1016/s2222-1808(13)60091-2	PROPN
admet-2901	452	1	[	[	X
admet-2901	452	2	40	40	NUM
admet-2901	452	3	]	]	PUNCT
admet-2901	452	4	b.-n	b.-n	PROPN
admet-2901	452	5	.	.	PUNCT
admet-2901	453	1	su	su	PROPN
admet-2901	453	2	,	,	PUNCT
admet-2901	453	3	e.j	e.j	PROPN
admet-2901	453	4	.	.	PROPN
admet-2901	453	5	park	park	PROPN
admet-2901	453	6	,	,	PUNCT
admet-2901	453	7	j.s	j.s	PROPN
admet-2901	453	8	.	.	PROPN
admet-2901	453	9	vigo	vigo	PROPN
admet-2901	453	10	,	,	PUNCT
admet-2901	453	11	j.g	j.g	PROPN
admet-2901	453	12	.	.	PROPN
admet-2901	453	13	graham	graham	PROPN
admet-2901	453	14	,	,	PUNCT
admet-2901	453	15	f.	f.	PROPN
admet-2901	453	16	cabieses	cabieses	PROPN
admet-2901	453	17	,	,	PUNCT
admet-2901	453	18	h.h	h.h	PROPN
admet-2901	453	19	.	.	PROPN
admet-2901	453	20	fong	fong	PROPN
admet-2901	453	21	,	,	PUNCT
admet-2901	453	22	j.m	j.m	PROPN
admet-2901	453	23	.	.	PROPN
admet-2901	453	24	pezzuto	pezzuto	PROPN
admet-2901	453	25	,	,	PUNCT
admet-2901	453	26	a.d	a.d	PROPN
admet-2901	453	27	.	.	PROPN
admet-2901	453	28	kinghorn	kinghorn	PROPN
admet-2901	453	29	.	.	PUNCT
admet-2901	454	1	activity	activity	NOUN
admet-2901	454	2	-	-	PUNCT
admet-2901	454	3	guided	guide	VERB
admet-2901	454	4	isolation	isolation	NOUN
admet-2901	454	5	of	of	ADP
admet-2901	454	6	the	the	DET
admet-2901	454	7	chemical	chemical	ADJ
admet-2901	454	8	constituents	constituent	NOUN
admet-2901	454	9	of	of	ADP
admet-2901	454	10	muntingia	muntingia	PROPN
admet-2901	454	11	calabura	calabura	PROPN
admet-2901	454	12	using	use	VERB
admet-2901	454	13	a	a	DET
admet-2901	454	14	quinone	quinone	NOUN
admet-2901	454	15	reductase	reductase	NOUN
admet-2901	454	16	induction	induction	NOUN
admet-2901	454	17	assay	assay	VERB
admet-2901	454	18	.	.	PUNCT
admet-2901	455	1	phytochemistry	phytochemistry	NOUN
admet-2901	455	2	63	63	NUM
admet-2901	455	3	(	(	PUNCT
admet-2901	455	4	2003	2003	NUM
admet-2901	455	5	)	)	PUNCT
admet-2901	455	6	335	335	NUM
admet-2901	455	7	-	-	SYM
admet-2901	455	8	341	341	NUM
admet-2901	455	9	.	.	PUNCT
admet-2901	455	10	https://doi.org/10.1016/s00319422(03)00112-2	https://doi.org/10.1016/s00319422(03)00112-2	NOUN
admet-2901	455	11	[	[	X
admet-2901	455	12	41	41	NUM
admet-2901	455	13	]	]	PUNCT
admet-2901	455	14	p.	p.	NOUN
admet-2901	455	15	rwangabo	rwangabo	NOUN
admet-2901	455	16	,	,	PUNCT
admet-2901	455	17	m.	m.	NOUN
admet-2901	455	18	claeys	claey	NOUN
admet-2901	455	19	,	,	PUNCT
admet-2901	455	20	l.	l.	PROPN
admet-2901	455	21	pieters	pieters	PROPN
admet-2901	455	22	,	,	PUNCT
admet-2901	455	23	j.	j.	PROPN
admet-2901	455	24	corthout	corthout	PROPN
admet-2901	455	25	,	,	PUNCT
admet-2901	455	26	d.	d.	PROPN
admet-2901	455	27	vanden	vanden	PROPN
admet-2901	455	28	berghe	berghe	PROPN
admet-2901	455	29	,	,	PUNCT
admet-2901	455	30	a.	a.	NOUN
admet-2901	455	31	vlietinck	vlietinck	NOUN
admet-2901	455	32	.	.	PUNCT
admet-2901	456	1	umuhengerin	umuhengerin	NOUN
admet-2901	456	2	,	,	PUNCT
admet-2901	456	3	a	a	DET
admet-2901	456	4	new	new	ADJ
admet-2901	456	5	antimicrobially	antimicrobially	ADV
admet-2901	456	6	active	active	ADJ
admet-2901	456	7	flavonoid	flavonoid	NOUN
admet-2901	456	8	from	from	ADP
admet-2901	456	9	lantana	lantana	NOUN
admet-2901	456	10	trifolia	trifolia	PROPN
admet-2901	456	11	.	.	PUNCT
admet-2901	457	1	journal	journal	PROPN
admet-2901	457	2	of	of	ADP
admet-2901	457	3	natural	natural	ADJ
admet-2901	457	4	products	product	NOUN
admet-2901	457	5	51	51	NUM
admet-2901	457	6	(	(	PUNCT
admet-2901	457	7	1988	1988	NUM
admet-2901	457	8	)	)	PUNCT
admet-2901	457	9	966	966	NUM
admet-2901	457	10	-	-	SYM
admet-2901	457	11	968	968	NUM
admet-2901	457	12	.	.	PUNCT
admet-2901	458	1	https://doi.org/10.1021/np50059a026	https://doi.org/10.1021/np50059a026	PROPN
admet-2901	458	2	[	[	X
admet-2901	458	3	42	42	NUM
admet-2901	458	4	]	]	PUNCT
admet-2901	458	5	d.	d.	PROPN
admet-2901	458	6	deka	deka	PROPN
admet-2901	458	7	,	,	PUNCT
admet-2901	458	8	v.	v.	PROPN
admet-2901	458	9	kumar	kumar	PROPN
admet-2901	458	10	,	,	PUNCT
admet-2901	458	11	c.	c.	PROPN
admet-2901	458	12	prasad	prasad	PROPN
admet-2901	458	13	,	,	PUNCT
admet-2901	458	14	r.	r.	PROPN
admet-2901	458	15	srivastava	srivastava	PROPN
admet-2901	458	16	.	.	PUNCT
admet-2901	459	1	isolation	isolation	NOUN
admet-2901	459	2	of	of	ADP
admet-2901	459	3	flavonoids	flavonoid	NOUN
admet-2901	459	4	from	from	ADP
admet-2901	459	5	oroxylum	oroxylum	PROPN
admet-2901	459	6	indicum	indicum	NOUN
admet-2901	459	7	(	(	PUNCT
admet-2901	459	8	vent	vent	NOUN
admet-2901	459	9	.	.	PUNCT
admet-2901	459	10	)	)	PUNCT
admet-2901	459	11	stem	stem	NOUN
admet-2901	459	12	bark	bark	NOUN
admet-2901	459	13	and	and	CCONJ
admet-2901	459	14	their	their	PRON
admet-2901	459	15	antioxidant	antioxidant	ADJ
admet-2901	459	16	activity	activity	NOUN
admet-2901	459	17	using	use	VERB
admet-2901	459	18	dpph	dpph	PROPN
admet-2901	459	19	assay	assay	PROPN
admet-2901	459	20	.	.	PUNCT
admet-2901	460	1	international	international	ADJ
admet-2901	460	2	journal	journal	PROPN
admet-2901	460	3	of	of	ADP
admet-2901	460	4	chemistry	chemistry	NOUN
admet-2901	460	5	and	and	CCONJ
admet-2901	460	6	pharmaceutical	pharmaceutical	NOUN
admet-2901	460	7	sciences	science	NOUN
admet-2901	460	8	2	2	NUM
admet-2901	460	9	(	(	PUNCT
admet-2901	460	10	2014	2014	NUM
admet-2901	460	11	)	)	PUNCT
admet-2901	460	12	783	783	NUM
admet-2901	460	13	-	-	SYM
admet-2901	460	14	787	787	NUM
admet-2901	460	15	.	.	PUNCT
admet-2901	460	16	https://www.researchgate.net/publication/280561916_isolation_of_flavonoids_from_oroxylum_in	https://www.researchgate.net/publication/280561916_isolation_of_flavonoids_from_oroxylum_in	PUNCT
admet-2901	461	1	dicum_stem_bark_and_their_antioxidant_activity_using_dpph_assay#fulltextfilecontent	dicum_stem_bark_and_their_antioxidant_activity_using_dpph_assay#fulltextfilecontent	PART
admet-2901	462	1	[	[	X
admet-2901	462	2	43	43	NUM
admet-2901	462	3	]	]	PUNCT
admet-2901	462	4	a.	a.	NOUN
admet-2901	462	5	anjaneyulu	anjaneyulu	PROPN
admet-2901	462	6	,	,	PUNCT
admet-2901	462	7	p.a	p.a	PROPN
admet-2901	462	8	.	.	PROPN
admet-2901	462	9	ramaiah	ramaiah	PROPN
admet-2901	462	10	,	,	PUNCT
admet-2901	462	11	l.r	l.r	PROPN
admet-2901	462	12	.	.	PROPN
admet-2901	462	13	row	row	PROPN
admet-2901	462	14	,	,	PUNCT
admet-2901	462	15	r.	r.	PROPN
admet-2901	462	16	venkateswarlu	venkateswarlu	PROPN
admet-2901	462	17	,	,	PUNCT
admet-2901	462	18	a.	a.	NOUN
admet-2901	462	19	pelter	pelter	PROPN
admet-2901	462	20	,	,	PUNCT
admet-2901	462	21	r.	r.	PROPN
admet-2901	462	22	ward	ward	PROPN
admet-2901	462	23	.	.	PUNCT
admet-2901	463	1	new	new	ADJ
admet-2901	463	2	lignans	lignan	NOUN
admet-2901	463	3	from	from	ADP
admet-2901	463	4	the	the	DET
admet-2901	463	5	heartwood	heartwood	NOUN
admet-2901	463	6	of	of	ADP
admet-2901	463	7	cleistanthus	cleistanthus	PROPN
admet-2901	463	8	collinus	collinus	PROPN
admet-2901	463	9	.	.	PUNCT
admet-2901	464	1	tetrahedron	tetrahedron	PROPN
admet-2901	464	2	37	37	NUM
admet-2901	464	3	(	(	PUNCT
admet-2901	464	4	1981	1981	NUM
admet-2901	464	5	)	)	PUNCT
admet-2901	464	6	3641	3641	NUM
admet-2901	464	7	-	-	SYM
admet-2901	464	8	3652	3652	NUM
admet-2901	464	9	.	.	PUNCT
admet-2901	465	1	https://doi.org/10.1016/s0040-4020(01)98893-3	https://doi.org/10.1016/s0040-4020(01)98893-3	NOUN
admet-2901	466	1	[	[	X
admet-2901	466	2	44	44	NUM
admet-2901	466	3	]	]	PUNCT
admet-2901	466	4	t.	t.	PROPN
admet-2901	466	5	govindachari	govindachari	PROPN
admet-2901	466	6	,	,	PUNCT
admet-2901	466	7	s.	s.	PROPN
admet-2901	466	8	sathe	sathe	PROPN
admet-2901	466	9	,	,	PUNCT
admet-2901	466	10	n.	n.	PROPN
admet-2901	466	11	viswanathan	viswanathan	PROPN
admet-2901	466	12	,	,	PUNCT
admet-2901	466	13	b.	b.	PROPN
admet-2901	466	14	pai	pai	PROPN
admet-2901	466	15	,	,	PUNCT
admet-2901	466	16	m.	m.	NOUN
admet-2901	466	17	srinivasan	srinivasan	NOUN
admet-2901	466	18	.	.	PUNCT
admet-2901	467	1	chemical	chemical	ADJ
admet-2901	467	2	constituents	constituent	NOUN
admet-2901	467	3	of	of	ADP
admet-2901	467	4	cleistanthus	cleistanthus	PROPN
admet-2901	467	5	collinus	collinus	PROPN
admet-2901	467	6	(	(	PUNCT
admet-2901	467	7	roxb	roxb	PROPN
admet-2901	467	8	.	.	PUNCT
admet-2901	467	9	)	)	PUNCT
admet-2901	467	10	.	.	PUNCT
admet-2901	468	1	tetrahedron	tetrahedron	NOUN
admet-2901	468	2	25	25	NUM
admet-2901	468	3	(	(	PUNCT
admet-2901	468	4	1969	1969	NUM
admet-2901	468	5	)	)	PUNCT
admet-2901	468	6	2815	2815	NUM
admet-2901	468	7	-	-	SYM
admet-2901	468	8	2821	2821	NUM
admet-2901	468	9	.	.	PUNCT
admet-2901	469	1	https://doi.org/10.1016/00404020(69)80025-6	https://doi.org/10.1016/00404020(69)80025-6	PROPN
admet-2901	470	1	[	[	X
admet-2901	470	2	45	45	NUM
admet-2901	470	3	]	]	PUNCT
admet-2901	470	4	u.-j	u.-j	PROPN
admet-2901	470	5	.	.	PUNCT
admet-2901	471	1	youn	youn	PROPN
admet-2901	471	2	,	,	PUNCT
admet-2901	471	3	y.-j	y.-j	PROPN
admet-2901	471	4	.	.	PROPN
admet-2901	471	5	lee	lee	PROPN
admet-2901	471	6	,	,	PUNCT
admet-2901	471	7	h.-r	h.-r	PROPN
admet-2901	471	8	.	.	PUNCT
admet-2901	472	1	jeon	jeon	PROPN
admet-2901	472	2	,	,	PUNCT
admet-2901	472	3	h.-j	h.-j	PROPN
admet-2901	472	4	.	.	PUNCT
admet-2901	473	1	shin	shin	PROPN
admet-2901	473	2	,	,	PUNCT
admet-2901	473	3	y.-m	y.-m	PROPN
admet-2901	473	4	.	.	PUNCT
admet-2901	474	1	son	son	PROPN
admet-2901	474	2	,	,	PUNCT
admet-2901	474	3	j.-w	j.-w	PROPN
admet-2901	474	4	.	.	PUNCT
admet-2901	475	1	nam	nam	PROPN
admet-2901	475	2	,	,	PUNCT
admet-2901	475	3	a.-r	a.-r	PROPN
admet-2901	475	4	.	.	PUNCT
admet-2901	476	1	han	han	PROPN
admet-2901	476	2	,	,	PUNCT
admet-2901	476	3	e.-k	e.-k	PROPN
admet-2901	476	4	.	.	PUNCT
admet-2901	477	1	seo	seo	NOUN
admet-2901	477	2	.	.	PUNCT
admet-2901	478	1	a	a	DET
admet-2901	478	2	pyridyl	pyridyl	ADJ
admet-2901	478	3	alkaloid	alkaloid	NOUN
admet-2901	478	4	and	and	CCONJ
admet-2901	478	5	benzoic	benzoic	ADJ
admet-2901	478	6	acid	acid	NOUN
admet-2901	478	7	derivatives	derivative	NOUN
admet-2901	478	8	from	from	ADP
admet-2901	478	9	the	the	DET
admet-2901	478	10	rhizomes	rhizome	NOUN
admet-2901	478	11	of	of	ADP
admet-2901	478	12	anemarrhena	anemarrhena	ADJ
admet-2901	478	13	asphodeloides	asphodeloide	NOUN
admet-2901	478	14	.	.	PUNCT
admet-2901	479	1	natural	natural	ADJ
admet-2901	479	2	product	product	NOUN
admet-2901	479	3	sciences	science	NOUN
admet-2901	479	4	16	16	NUM
admet-2901	479	5	(	(	PUNCT
admet-2901	479	6	2010	2010	NUM
admet-2901	479	7	)	)	PUNCT
admet-2901	479	8	203	203	NUM
admet-2901	479	9	-	-	SYM
admet-2901	479	10	206	206	NUM
admet-2901	479	11	.	.	PUNCT
admet-2901	479	12	https://www.koreascience.kr/article/jako201006159732179.view?orgid=anpor	https://www.koreascience.kr/article/jako201006159732179.view?orgid=anpor	PUNCT
admet-2901	480	1	[	[	X
admet-2901	480	2	46	46	NUM
admet-2901	480	3	]	]	X
admet-2901	480	4	g.	g.	PROPN
admet-2901	480	5	cheng	cheng	PROPN
admet-2901	480	6	,	,	PUNCT
admet-2901	480	7	x.	x.	PROPN
admet-2901	480	8	zeng	zeng	PROPN
admet-2901	480	9	,	,	PUNCT
admet-2901	480	10	x.	x.	PROPN
admet-2901	480	11	cui	cui	PROPN
admet-2901	480	12	.	.	PUNCT
admet-2901	481	1	benzoquinone	benzoquinone	NOUN
admet-2901	481	2	-	-	PUNCT
admet-2901	481	3	promoted	promote	VERB
admet-2901	481	4	aerobic	aerobic	ADJ
admet-2901	481	5	oxidative	oxidative	ADJ
admet-2901	481	6	hydroxylation	hydroxylation	NOUN
admet-2901	481	7	of	of	ADP
admet-2901	481	8	arylboronic	arylboronic	ADJ
admet-2901	481	9	acids	acid	NOUN
admet-2901	481	10	in	in	ADP
admet-2901	481	11	water	water	NOUN
admet-2901	481	12	.	.	PUNCT
admet-2901	482	1	synthesis	synthesis	NOUN
admet-2901	482	2	46	46	NUM
admet-2901	482	3	(	(	PUNCT
admet-2901	482	4	2014	2014	NUM
admet-2901	482	5	)	)	PUNCT
admet-2901	482	6	295	295	NUM
admet-2901	482	7	-	-	SYM
admet-2901	482	8	300	300	NUM
admet-2901	482	9	.	.	PUNCT
admet-2901	483	1	https://doi.org/10.1055/s-0033-1338571	https://doi.org/10.1055/s-0033-1338571	PROPN
admet-2901	483	2	[	[	X
admet-2901	483	3	47	47	NUM
admet-2901	483	4	]	]	X
admet-2901	483	5	g.	g.	PROPN
admet-2901	483	6	indrayanto	indrayanto	PROPN
admet-2901	483	7	,	,	PUNCT
admet-2901	483	8	g.s	g.s	PROPN
admet-2901	483	9	.	.	PROPN
admet-2901	483	10	putra	putra	PROPN
admet-2901	483	11	,	,	PUNCT
admet-2901	483	12	f.	f.	PROPN
admet-2901	483	13	suhud	suhud	PROPN
admet-2901	483	14	.	.	PUNCT
admet-2901	484	1	validation	validation	NOUN
admet-2901	484	2	of	of	ADP
admet-2901	484	3	in	in	ADP
admet-2901	484	4	-	-	PUNCT
admet-2901	484	5	vitro	vitro	X
admet-2901	484	6	bioassay	bioassay	NOUN
admet-2901	484	7	methods	method	NOUN
admet-2901	484	8	:	:	PUNCT
admet-2901	484	9	application	application	NOUN
admet-2901	484	10	in	in	ADP
admet-2901	484	11	herbal	herbal	ADJ
admet-2901	484	12	drug	drug	NOUN
admet-2901	484	13	research	research	NOUN
admet-2901	484	14	.	.	PUNCT
admet-2901	485	1	profiles	profile	NOUN
admet-2901	485	2	of	of	ADP
admet-2901	485	3	drug	drug	NOUN
admet-2901	485	4	substances	substance	NOUN
admet-2901	485	5	,	,	PUNCT
admet-2901	485	6	excipients	excipient	NOUN
admet-2901	485	7	and	and	CCONJ
admet-2901	485	8	related	relate	VERB
admet-2901	485	9	methodology	methodology	NOUN
admet-2901	485	10	46	46	NUM
admet-2901	485	11	(	(	PUNCT
admet-2901	485	12	2021	2021	NUM
admet-2901	485	13	)	)	PUNCT
admet-2901	485	14	273	273	NUM
admet-2901	485	15	-	-	SYM
admet-2901	485	16	307	307	NUM
admet-2901	485	17	.	.	PUNCT
admet-2901	486	1	https://doi.org/10.1016/bs.podrm.2020.07.005	https://doi.org/10.1016/bs.podrm.2020.07.005	NUM
admet-2901	486	2	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	ADJ
admet-2901	486	3	https://doi.org/10.5246/jcps.2012.05.056	https://doi.org/10.5246/jcps.2012.05.056	NOUN
admet-2901	486	4	https://sioc-journal.cn/jwk_hxxb/en/y1992/v50/i2/200	https://sioc-journal.cn/jwk_hxxb/en/y1992/v50/i2/200	PROPN
admet-2901	486	5	https://doi.org/10.1007/bf02975113	https://doi.org/10.1007/bf02975113	PROPN
admet-2901	486	6	https://doi.org/10.3390/molecules171113439	https://doi.org/10.3390/molecules171113439	PROPN
admet-2901	486	7	https://doi.org/10.1021/np50076a037	https://doi.org/10.1021/np50076a037	PROPN
admet-2901	486	8	https://europepmc.org/article/med/8328277	https://europepmc.org/article/med/8328277	NOUN
admet-2901	486	9	https://doi.org/10.1016/s2222-1808(13)60091-2	https://doi.org/10.1016/s2222-1808(13)60091-2	PROPN
admet-2901	486	10	https://doi.org/10.1016/s0031-9422(03)00112-2	https://doi.org/10.1016/s0031-9422(03)00112-2	PROPN
admet-2901	486	11	https://doi.org/10.1016/s0031-9422(03)00112-2	https://doi.org/10.1016/s0031-9422(03)00112-2	PROPN
admet-2901	486	12	https://doi.org/10.1021/np50059a026	https://doi.org/10.1021/np50059a026	PROPN
admet-2901	486	13	https://www.researchgate.net/publication/280561916_isolation_of_flavonoids_from_oroxylum_indicum_stem_bark_and_their_antioxidant_activity_using_dpph_assay#fulltextfilecontent	https://www.researchgate.net/publication/280561916_isolation_of_flavonoids_from_oroxylum_indicum_stem_bark_and_their_antioxidant_activity_using_dpph_assay#fulltextfilecontent	PROPN
admet-2901	486	14	https://www.researchgate.net/publication/280561916_isolation_of_flavonoids_from_oroxylum_indicum_stem_bark_and_their_antioxidant_activity_using_dpph_assay#fulltextfilecontent	https://www.researchgate.net/publication/280561916_isolation_of_flavonoids_from_oroxylum_indicum_stem_bark_and_their_antioxidant_activity_using_dpph_assay#fulltextfilecontent	NOUN
admet-2901	486	15	https://doi.org/10.1016/s0040-4020(01)98893-3	https://doi.org/10.1016/s0040-4020(01)98893-3	PROPN
admet-2901	486	16	https://doi.org/10.1016/0040-4020(69)80025-6	https://doi.org/10.1016/0040-4020(69)80025-6	PROPN
admet-2901	486	17	https://doi.org/10.1016/0040-4020(69)80025-6	https://doi.org/10.1016/0040-4020(69)80025-6	ADV
admet-2901	486	18	https://www.koreascience.kr/article/jako201006159732179.view?orgid=anpor	https://www.koreascience.kr/article/jako201006159732179.view?orgid=anpor	CCONJ
admet-2901	486	19	https://doi.org/10.1055/s-0033-1338571	https://doi.org/10.1055/s-0033-1338571	PROPN
admet-2901	486	20	https://doi.org/10.1016/bs.podrm.2020.07.005	https://doi.org/10.1016/bs.podrm.2020.07.005	PROPN
admet-2901	486	21	n.	n.	PROPN
admet-2901	486	22	chabang	chabang	PROPN
admet-2901	486	23	et	et	PROPN
admet-2901	486	24	al	al	PROPN
admet-2901	486	25	.	.	PROPN
admet-2901	486	26	admet	admet	PROPN
admet-2901	486	27	&	&	CCONJ
admet-2901	486	28	dmpk	dmpk	PROPN
admet-2901	486	29	13(5	13(5	NUM
admet-2901	486	30	)	)	PUNCT
admet-2901	486	31	(	(	PUNCT
admet-2901	486	32	2025	2025	NUM
admet-2901	486	33	)	)	PUNCT
admet-2901	486	34	2901	2901	NUM
admet-2901	486	35	18	18	NUM
admet-2901	487	1	[	[	X
admet-2901	487	2	48	48	NUM
admet-2901	487	3	]	]	PUNCT
admet-2901	487	4	k.	k.	PROPN
admet-2901	487	5	jearawuttanakul	jearawuttanakul	PROPN
admet-2901	487	6	,	,	PUNCT
admet-2901	487	7	p.	p.	PROPN
admet-2901	487	8	khumkhrong	khumkhrong	PROPN
admet-2901	487	9	,	,	PUNCT
admet-2901	487	10	k.	k.	PROPN
admet-2901	487	11	suksen	suksen	PROPN
admet-2901	487	12	,	,	PUNCT
admet-2901	487	13	s.	s.	PROPN
admet-2901	487	14	reabroi	reabroi	PROPN
admet-2901	487	15	,	,	PUNCT
admet-2901	487	16	b.	b.	PROPN
admet-2901	487	17	munyoo	munyoo	PROPN
admet-2901	487	18	,	,	PUNCT
admet-2901	487	19	p.	p.	NOUN
admet-2901	487	20	tuchinda	tuchinda	PROPN
admet-2901	487	21	,	,	PUNCT
admet-2901	487	22	s.	s.	PROPN
admet-2901	487	23	borwornpinyo	borwornpinyo	PROPN
admet-2901	487	24	,	,	PUNCT
admet-2901	487	25	n.	n.	PROPN
admet-2901	487	26	boonmuen	boonmuen	PROPN
admet-2901	487	27	,	,	PUNCT
admet-2901	487	28	a.	a.	NOUN
admet-2901	487	29	chairoungdua	chairoungdua	PROPN
admet-2901	487	30	.	.	PUNCT
admet-2901	488	1	cleistanthin	cleistanthin	VERB
admet-2901	488	2	a	a	DET
admet-2901	488	3	induces	induce	NOUN
admet-2901	488	4	apoptosis	apoptosis	NOUN
admet-2901	488	5	and	and	CCONJ
admet-2901	488	6	suppresses	suppress	VERB
admet-2901	488	7	motility	motility	NOUN
admet-2901	488	8	of	of	ADP
admet-2901	488	9	colorectal	colorectal	ADJ
admet-2901	488	10	cancer	cancer	NOUN
admet-2901	488	11	cells	cell	NOUN
admet-2901	488	12	.	.	PUNCT
admet-2901	489	1	european	european	ADJ
admet-2901	489	2	journal	journal	PROPN
admet-2901	489	3	of	of	ADP
admet-2901	489	4	pharmacology	pharmacology	NOUN
admet-2901	489	5	889	889	NUM
admet-2901	489	6	(	(	PUNCT
admet-2901	489	7	2020	2020	NUM
admet-2901	489	8	)	)	PUNCT
admet-2901	489	9	173604	173604	NUM
admet-2901	489	10	.	.	PUNCT
admet-2901	490	1	https://doi.org/10.1016/j.ejphar.2020.173604	https://doi.org/10.1016/j.ejphar.2020.173604	PROPN
admet-2901	491	1	[	[	X
admet-2901	491	2	49	49	NUM
admet-2901	491	3	]	]	PUNCT
admet-2901	491	4	j.	j.	PROPN
admet-2901	491	5	paha	paha	PROPN
admet-2901	491	6	,	,	PUNCT
admet-2901	491	7	p.	p.	PROPN
admet-2901	491	8	kanjanasirirat	kanjanasirirat	PROPN
admet-2901	491	9	,	,	PUNCT
admet-2901	491	10	b.	b.	PROPN
admet-2901	491	11	munyoo	munyoo	PROPN
admet-2901	491	12	,	,	PUNCT
admet-2901	491	13	p.	p.	NOUN
admet-2901	491	14	tuchinda	tuchinda	PROPN
admet-2901	491	15	,	,	PUNCT
admet-2901	491	16	n.	n.	PROPN
admet-2901	491	17	suvannang	suvannang	PROPN
admet-2901	491	18	,	,	PUNCT
admet-2901	491	19	c.	c.	PROPN
admet-2901	491	20	nantasenamat	nantasenamat	PROPN
admet-2901	491	21	,	,	PUNCT
admet-2901	491	22	k.	k.	PROPN
admet-2901	491	23	boonyarattanakalin	boonyarattanakalin	PROPN
admet-2901	491	24	,	,	PUNCT
admet-2901	491	25	p.	p.	PROPN
admet-2901	491	26	kittakoop	kittakoop	PROPN
admet-2901	491	27	,	,	PUNCT
admet-2901	491	28	s.	s.	PROPN
admet-2901	491	29	srikor	srikor	PROPN
admet-2901	491	30	,	,	PUNCT
admet-2901	491	31	g.	g.	PROPN
admet-2901	491	32	kongklad	kongklad	PROPN
admet-2901	491	33	,	,	PUNCT
admet-2901	491	34	n.	n.	NOUN
admet-2901	491	35	rangkasenee	rangkasenee	NOUN
admet-2901	491	36	,	,	PUNCT
admet-2901	491	37	s.	s.	PROPN
admet-2901	491	38	hongeng	hongeng	PROPN
admet-2901	491	39	,	,	PUNCT
admet-2901	491	40	p.	p.	NOUN
admet-2901	491	41	utaisincharoen	utaisincharoen	ADV
admet-2901	491	42	,	,	PUNCT
admet-2901	491	43	s.	s.	PROPN
admet-2901	491	44	borwornpinyo	borwornpinyo	PROPN
admet-2901	491	45	,	,	PUNCT
admet-2901	491	46	m.	m.	NOUN
admet-2901	491	47	ponpuak	ponpuak	NOUN
admet-2901	491	48	.	.	PUNCT
admet-2901	492	1	a	a	DET
admet-2901	492	2	novel	novel	ADJ
admet-2901	492	3	potent	potent	NOUN
admet-2901	492	4	autophagy	autophagy	NOUN
admet-2901	492	5	inhibitor	inhibitor	NOUN
admet-2901	492	6	ecdd	ecdd	PROPN
admet-2901	492	7	-	-	PUNCT
admet-2901	492	8	s27	s27	PROPN
admet-2901	492	9	targets	target	NOUN
admet-2901	492	10	vacuolar	vacuolar	PROPN
admet-2901	492	11	atpase	atpase	PROPN
admet-2901	492	12	and	and	CCONJ
admet-2901	492	13	inhibits	inhibit	VERB
admet-2901	492	14	cancer	cancer	NOUN
admet-2901	492	15	cell	cell	NOUN
admet-2901	492	16	survival	survival	NOUN
admet-2901	492	17	.	.	PUNCT
admet-2901	493	1	scientific	scientific	ADJ
admet-2901	493	2	reports	report	NOUN
admet-2901	493	3	9	9	NUM
admet-2901	493	4	(	(	PUNCT
admet-2901	493	5	2019	2019	NUM
admet-2901	493	6	)	)	PUNCT
admet-2901	493	7	9177	9177	NUM
admet-2901	493	8	.	.	PUNCT
admet-2901	494	1	https://doi.org/10.1038/s41598-019-45641-x	https://doi.org/10.1038/s41598-019-45641-x	NOUN
admet-2901	495	1	[	[	X
admet-2901	495	2	50	50	NUM
admet-2901	495	3	]	]	PUNCT
admet-2901	495	4	z.	z.	PROPN
admet-2901	495	5	feng	feng	PROPN
admet-2901	495	6	,	,	PUNCT
admet-2901	495	7	x.	x.	PROPN
admet-2901	495	8	lu	lu	PROPN
admet-2901	495	9	,	,	PUNCT
admet-2901	495	10	l.	l.	PROPN
admet-2901	495	11	gan	gan	PROPN
admet-2901	495	12	,	,	PUNCT
admet-2901	495	13	q.	q.	PROPN
admet-2901	495	14	zhang	zhang	PROPN
admet-2901	495	15	,	,	PUNCT
admet-2901	495	16	l.	l.	PROPN
admet-2901	495	17	lin	lin	PROPN
admet-2901	495	18	.	.	PUNCT
admet-2901	496	1	xanthones	xanthone	NOUN
admet-2901	496	2	,	,	PUNCT
admet-2901	496	3	a	a	DET
admet-2901	496	4	promising	promising	ADJ
admet-2901	496	5	anti	anti	ADJ
admet-2901	496	6	-	-	ADJ
admet-2901	496	7	inflammatory	inflammatory	ADJ
admet-2901	496	8	scaffold	scaffold	NOUN
admet-2901	496	9	:	:	PUNCT
admet-2901	496	10	structure	structure	NOUN
admet-2901	496	11	,	,	PUNCT
admet-2901	496	12	activity	activity	NOUN
admet-2901	496	13	,	,	PUNCT
admet-2901	496	14	and	and	CCONJ
admet-2901	496	15	drug	drug	NOUN
admet-2901	496	16	likeness	likeness	NOUN
admet-2901	496	17	analysis	analysis	NOUN
admet-2901	496	18	.	.	PUNCT
admet-2901	497	1	molecules	molecule	NOUN
admet-2901	497	2	25	25	NUM
admet-2901	497	3	(	(	PUNCT
admet-2901	497	4	2020	2020	NUM
admet-2901	497	5	)	)	PUNCT
admet-2901	497	6	598	598	NUM
admet-2901	497	7	.	.	PUNCT
admet-2901	498	1	https://doi.org/10.3390/molecules25030598	https://doi.org/10.3390/molecules25030598	NOUN
admet-2901	498	2	[	[	X
admet-2901	498	3	51	51	NUM
admet-2901	498	4	]	]	PUNCT
admet-2901	498	5	q.	q.	PROPN
admet-2901	498	6	huang	huang	PROPN
admet-2901	498	7	,	,	PUNCT
admet-2901	498	8	y.	y.	PROPN
admet-2901	498	9	wang	wang	PROPN
admet-2901	498	10	,	,	PUNCT
admet-2901	498	11	h.	h.	PROPN
admet-2901	498	12	wu	wu	PROPN
admet-2901	498	13	,	,	PUNCT
admet-2901	498	14	m.	m.	NOUN
admet-2901	498	15	yuan	yuan	PROPN
admet-2901	498	16	,	,	PUNCT
admet-2901	498	17	c.	c.	PROPN
admet-2901	498	18	zheng	zheng	PROPN
admet-2901	498	19	,	,	PUNCT
admet-2901	499	1	h.	h.	PROPN
admet-2901	499	2	xu	xu	PROPN
admet-2901	499	3	.	.	PUNCT
admet-2901	500	1	xanthone	xanthone	PROPN
admet-2901	500	2	glucosides	glucoside	VERB
admet-2901	500	3	:	:	PUNCT
admet-2901	500	4	isolation	isolation	NOUN
admet-2901	500	5	,	,	PUNCT
admet-2901	500	6	bioactivity	bioactivity	NOUN
admet-2901	500	7	and	and	CCONJ
admet-2901	500	8	synthesis	synthesis	NOUN
admet-2901	500	9	.	.	PUNCT
admet-2901	501	1	molecules	molecule	NOUN
admet-2901	501	2	26	26	NUM
admet-2901	501	3	(	(	PUNCT
admet-2901	501	4	2021	2021	NUM
admet-2901	501	5	)	)	PUNCT
admet-2901	501	6	5575	5575	NUM
admet-2901	501	7	.	.	PUNCT
admet-2901	502	1	https://doi.org/10.3390/molecules26185575	https://doi.org/10.3390/molecules26185575	PROPN
admet-2901	502	2	[	[	X
admet-2901	502	3	52	52	NUM
admet-2901	502	4	]	]	X
admet-2901	502	5	l.m	l.m	PROPN
admet-2901	502	6	.	.	PROPN
admet-2901	502	7	vieira	vieira	PROPN
admet-2901	502	8	,	,	PUNCT
admet-2901	502	9	a.	a.	NOUN
admet-2901	502	10	kijjoa	kijjoa	PROPN
admet-2901	502	11	.	.	PUNCT
admet-2901	503	1	naturally	naturally	ADV
admet-2901	503	2	-	-	PUNCT
admet-2901	503	3	occurring	occur	VERB
admet-2901	503	4	xanthones	xanthone	NOUN
admet-2901	503	5	:	:	PUNCT
admet-2901	503	6	recent	recent	ADJ
admet-2901	503	7	developments	development	NOUN
admet-2901	503	8	.	.	PUNCT
admet-2901	504	1	current	current	ADJ
admet-2901	504	2	medicinal	medicinal	ADJ
admet-2901	504	3	chemistry	chemistry	NOUN
admet-2901	504	4	12	12	NUM
admet-2901	504	5	(	(	PUNCT
admet-2901	504	6	2005	2005	NUM
admet-2901	504	7	)	)	PUNCT
admet-2901	504	8	2413	2413	NUM
admet-2901	504	9	-	-	SYM
admet-2901	504	10	2446	2446	NUM
admet-2901	504	11	.	.	PUNCT
admet-2901	504	12	https://doi.org/10.2174/092986705774370682	https://doi.org/10.2174/092986705774370682	X
admet-2901	505	1	[	[	X
admet-2901	505	2	53	53	NUM
admet-2901	505	3	]	]	X
admet-2901	505	4	y.	y.	PROPN
admet-2901	505	5	ren	ren	PROPN
admet-2901	505	6	,	,	PUNCT
admet-2901	505	7	e.j.c	e.j.c	PROPN
admet-2901	505	8	.	.	PUNCT
admet-2901	505	9	de	de	PROPN
admet-2901	505	10	blanco	blanco	PROPN
admet-2901	505	11	,	,	PUNCT
admet-2901	505	12	j.r	j.r	PROPN
admet-2901	505	13	.	.	PROPN
admet-2901	505	14	fuchs	fuchs	PROPN
admet-2901	505	15	,	,	PUNCT
admet-2901	505	16	d.d	d.d	PROPN
admet-2901	505	17	.	.	PROPN
admet-2901	505	18	soejarto	soejarto	PROPN
admet-2901	505	19	,	,	PUNCT
admet-2901	505	20	j.e	j.e	PROPN
admet-2901	505	21	.	.	PROPN
admet-2901	505	22	burdette	burdette	PROPN
admet-2901	505	23	,	,	PUNCT
admet-2901	505	24	s.m	s.m	PROPN
admet-2901	505	25	.	.	PROPN
admet-2901	505	26	swanson	swanson	PROPN
admet-2901	505	27	,	,	PUNCT
admet-2901	505	28	a.d	a.d	PROPN
admet-2901	505	29	.	.	PROPN
admet-2901	505	30	kinghorn	kinghorn	PROPN
admet-2901	505	31	.	.	PUNCT
admet-2901	506	1	potential	potential	ADJ
admet-2901	506	2	anticancer	anticancer	NOUN
admet-2901	506	3	agents	agent	NOUN
admet-2901	506	4	characterized	characterize	VERB
admet-2901	506	5	from	from	ADP
admet-2901	506	6	selected	select	VERB
admet-2901	506	7	tropical	tropical	ADJ
admet-2901	506	8	plants	plant	NOUN
admet-2901	506	9	.	.	PUNCT
admet-2901	507	1	journal	journal	NOUN
admet-2901	507	2	of	of	ADP
admet-2901	507	3	natural	natural	ADJ
admet-2901	507	4	products	product	NOUN
admet-2901	507	5	82	82	NUM
admet-2901	507	6	(	(	PUNCT
admet-2901	507	7	2019	2019	NUM
admet-2901	507	8	)	)	PUNCT
admet-2901	507	9	657	657	NUM
admet-2901	507	10	-	-	SYM
admet-2901	507	11	679	679	NUM
admet-2901	507	12	.	.	PUNCT
admet-2901	508	1	https://doi.org/10.1021/acs.jnatprod.9b00018	https://doi.org/10.1021/acs.jnatprod.9b00018	NOUN
admet-2901	508	2	[	[	X
admet-2901	508	3	54	54	NUM
admet-2901	508	4	]	]	PUNCT
admet-2901	508	5	x.-h	x.-h	PROPN
admet-2901	508	6	.	.	PUNCT
admet-2901	509	1	xu	xu	PROPN
admet-2901	509	2	,	,	PUNCT
admet-2901	509	3	y.-c	y.-c	PROPN
admet-2901	509	4	.	.	PUNCT
admet-2901	510	1	chen	chen	PROPN
admet-2901	510	2	,	,	PUNCT
admet-2901	510	3	y.-l	y.-l	PROPN
admet-2901	510	4	.	.	PUNCT
admet-2901	511	1	xu	xu	INTJ
admet-2901	511	2	,	,	PUNCT
admet-2901	511	3	z.-l	z.-l	PROPN
admet-2901	511	4	.	.	PUNCT
admet-2901	512	1	feng	feng	PROPN
admet-2901	512	2	,	,	PUNCT
admet-2901	512	3	q.-y	q.-y	NOUN
admet-2901	512	4	.	.	PUNCT
admet-2901	513	1	liu	liu	PROPN
admet-2901	513	2	,	,	PUNCT
admet-2901	513	3	x.	x.	PROPN
admet-2901	513	4	guo	guo	PROPN
admet-2901	513	5	,	,	PUNCT
admet-2901	513	6	l.-g	l.-g	PROPN
admet-2901	513	7	.	.	PUNCT
admet-2901	514	1	lin	lin	PROPN
admet-2901	514	2	,	,	PUNCT
admet-2901	514	3	j.-j	j.-j	PROPN
admet-2901	514	4	.	.	PUNCT
admet-2901	515	1	lu	lu	PROPN
admet-2901	515	2	.	.	PUNCT
admet-2901	516	1	garcinone	garcinone	NOUN
admet-2901	516	2	e	e	NOUN
admet-2901	516	3	blocks	block	NOUN
admet-2901	516	4	autophagy	autophagy	VERB
admet-2901	516	5	through	through	ADP
admet-2901	516	6	lysosomal	lysosomal	ADJ
admet-2901	516	7	functional	functional	ADJ
admet-2901	516	8	destruction	destruction	NOUN
admet-2901	516	9	in	in	ADP
admet-2901	516	10	ovarian	ovarian	ADJ
admet-2901	516	11	cancer	cancer	NOUN
admet-2901	516	12	cells	cell	NOUN
admet-2901	516	13	.	.	PUNCT
admet-2901	517	1	world	world	PROPN
admet-2901	517	2	journal	journal	PROPN
admet-2901	517	3	of	of	ADP
admet-2901	517	4	traditional	traditional	ADJ
admet-2901	517	5	chinese	chinese	ADJ
admet-2901	517	6	medicine	medicine	NOUN
admet-2901	517	7	7	7	NUM
admet-2901	517	8	(	(	PUNCT
admet-2901	517	9	2021	2021	NUM
admet-2901	517	10	)	)	PUNCT
admet-2901	517	11	209	209	NUM
admet-2901	517	12	-	-	SYM
admet-2901	517	13	216	216	NUM
admet-2901	517	14	.	.	PUNCT
admet-2901	518	1	https://doi.org/10.4103/wjtcm.wjtcm_83_20	https://doi.org/10.4103/wjtcm.wjtcm_83_20	NOUN
admet-2901	519	1	[	[	X
admet-2901	519	2	55	55	NUM
admet-2901	519	3	]	]	PUNCT
admet-2901	519	4	t.	t.	PROPN
admet-2901	519	5	karunakaran	karunakaran	PROPN
admet-2901	519	6	,	,	PUNCT
admet-2901	519	7	g.c	g.c	PROPN
admet-2901	519	8	.	.	PROPN
admet-2901	519	9	ee	ee	PROPN
admet-2901	519	10	,	,	PUNCT
admet-2901	519	11	k.h	k.h	PROPN
admet-2901	519	12	.	.	PROPN
admet-2901	519	13	tee	tee	PROPN
admet-2901	519	14	,	,	PUNCT
admet-2901	519	15	i.s	i.s	PROPN
admet-2901	519	16	.	.	PROPN
admet-2901	519	17	ismail	ismail	PROPN
admet-2901	519	18	,	,	PUNCT
admet-2901	519	19	n.h	n.h	PROPN
admet-2901	519	20	.	.	PROPN
admet-2901	519	21	zamakshshari	zamakshshari	PROPN
admet-2901	519	22	,	,	PUNCT
admet-2901	519	23	w.m	w.m	PROPN
admet-2901	519	24	.	.	PROPN
admet-2901	519	25	peter	peter	PROPN
admet-2901	519	26	.	.	PUNCT
admet-2901	520	1	cytotoxic	cytotoxic	PROPN
admet-2901	520	2	prenylated	prenylate	VERB
admet-2901	520	3	xanthone	xanthone	PROPN
admet-2901	520	4	and	and	CCONJ
admet-2901	520	5	coumarin	coumarin	NOUN
admet-2901	520	6	derivatives	derivative	NOUN
admet-2901	520	7	from	from	ADP
admet-2901	520	8	malaysian	malaysian	PROPN
admet-2901	520	9	mesua	mesua	PROPN
admet-2901	520	10	beccariana	beccariana	PROPN
admet-2901	520	11	.	.	PUNCT
admet-2901	521	1	phytochemistry	phytochemistry	NOUN
admet-2901	521	2	letters	letter	NOUN
admet-2901	521	3	17	17	NUM
admet-2901	521	4	(	(	PUNCT
admet-2901	521	5	2016	2016	NUM
admet-2901	521	6	)	)	PUNCT
admet-2901	521	7	131	131	NUM
admet-2901	521	8	-	-	SYM
admet-2901	521	9	134	134	NUM
admet-2901	521	10	.	.	PUNCT
admet-2901	522	1	https://doi.org/10.1016/j.phytol.2016.07.026	https://doi.org/10.1016/j.phytol.2016.07.026	PROPN
admet-2901	523	1	[	[	X
admet-2901	523	2	56	56	NUM
admet-2901	523	3	]	]	X
admet-2901	523	4	g.a	g.a	PROPN
admet-2901	523	5	.	.	PROPN
admet-2901	523	6	mohamed	mohamed	PROPN
admet-2901	523	7	,	,	PUNCT
admet-2901	523	8	a.m.	a.m.	PROPN
admet-2901	524	1	al	al	PROPN
admet-2901	524	2	-	-	PUNCT
admet-2901	524	3	abd	abd	PROPN
admet-2901	524	4	,	,	PUNCT
admet-2901	524	5	a.m.	a.m.	PROPN
admet-2901	525	1	el	el	PROPN
admet-2901	525	2	-	-	PUNCT
admet-2901	525	3	halawany	halawany	PROPN
admet-2901	525	4	,	,	PUNCT
admet-2901	525	5	h.m	h.m	PROPN
admet-2901	525	6	.	.	PROPN
admet-2901	525	7	abdallah	abdallah	PROPN
admet-2901	525	8	,	,	PUNCT
admet-2901	525	9	s.r.m	s.r.m	PROPN
admet-2901	525	10	.	.	PUNCT
admet-2901	526	1	ibrahim	ibrahim	PROPN
admet-2901	526	2	.	.	PUNCT
admet-2901	527	1	new	new	ADJ
admet-2901	527	2	xanthones	xanthone	NOUN
admet-2901	527	3	and	and	CCONJ
admet-2901	527	4	cytotoxic	cytotoxic	ADJ
admet-2901	527	5	constituents	constituent	NOUN
admet-2901	527	6	from	from	ADP
admet-2901	527	7	garcinia	garcinia	PROPN
admet-2901	527	8	mangostana	mangostana	PROPN
admet-2901	527	9	fruit	fruit	NOUN
admet-2901	527	10	hulls	hull	NOUN
admet-2901	527	11	against	against	ADP
admet-2901	527	12	human	human	ADJ
admet-2901	527	13	hepatocellular	hepatocellular	NOUN
admet-2901	527	14	,	,	PUNCT
admet-2901	527	15	breast	breast	NOUN
admet-2901	527	16	,	,	PUNCT
admet-2901	527	17	and	and	CCONJ
admet-2901	527	18	colorectal	colorectal	ADJ
admet-2901	527	19	cancer	cancer	NOUN
admet-2901	527	20	cell	cell	NOUN
admet-2901	527	21	lines	line	NOUN
admet-2901	527	22	.	.	PUNCT
admet-2901	528	1	journal	journal	NOUN
admet-2901	528	2	of	of	ADP
admet-2901	528	3	ethnopharmacology	ethnopharmacology	NOUN
admet-2901	528	4	198	198	NUM
admet-2901	528	5	(	(	PUNCT
admet-2901	528	6	2017	2017	NUM
admet-2901	528	7	)	)	PUNCT
admet-2901	528	8	302	302	NUM
admet-2901	528	9	-	-	SYM
admet-2901	528	10	312	312	NUM
admet-2901	528	11	.	.	PUNCT
admet-2901	528	12	https://doi.org/10.1016/j.jep.2017.01.030	https://doi.org/10.1016/j.jep.2017.01.030	PROPN
admet-2901	529	1	[	[	X
admet-2901	529	2	57	57	NUM
admet-2901	529	3	]	]	PUNCT
admet-2901	529	4	t.t.h	t.t.h	NOUN
admet-2901	529	5	.	.	PUNCT
admet-2901	530	1	nguyen	nguyen	PROPN
admet-2901	530	2	,	,	PUNCT
admet-2901	530	3	z.	z.	PROPN
admet-2901	530	4	qu	qu	PROPN
admet-2901	530	5	,	,	PUNCT
admet-2901	530	6	v.t	v.t	PROPN
admet-2901	530	7	.	.	PROPN
admet-2901	530	8	nguyen	nguyen	PROPN
admet-2901	530	9	,	,	PUNCT
admet-2901	530	10	t.t	t.t	PROPN
admet-2901	530	11	.	.	PROPN
admet-2901	530	12	nguyen	nguyen	PROPN
admet-2901	530	13	,	,	PUNCT
admet-2901	530	14	t.t.a	t.t.a	PROPN
admet-2901	530	15	.	.	PROPN
admet-2901	530	16	le	le	PROPN
admet-2901	530	17	,	,	PUNCT
admet-2901	530	18	s.	s.	PROPN
admet-2901	530	19	chen	chen	PROPN
admet-2901	530	20	,	,	PUNCT
admet-2901	530	21	s.t	s.t	PROPN
admet-2901	530	22	.	.	PROPN
admet-2901	530	23	ninh	ninh	PROPN
admet-2901	530	24	.	.	PUNCT
admet-2901	531	1	natural	natural	ADJ
admet-2901	531	2	prenylated	prenylate	VERB
admet-2901	531	3	xanthones	xanthone	NOUN
admet-2901	531	4	as	as	ADP
admet-2901	531	5	potential	potential	ADJ
admet-2901	531	6	inhibitors	inhibitor	NOUN
admet-2901	531	7	of	of	ADP
admet-2901	531	8	pi3k	pi3k	PROPN
admet-2901	531	9	/	/	SYM
admet-2901	531	10	akt	akt	PROPN
admet-2901	531	11	/	/	SYM
admet-2901	531	12	mtor	mtor	PROPN
admet-2901	531	13	pathway	pathway	NOUN
admet-2901	531	14	in	in	ADP
admet-2901	531	15	triple	triple	ADJ
admet-2901	531	16	negative	negative	ADJ
admet-2901	531	17	breast	breast	NOUN
admet-2901	531	18	cancer	cancer	NOUN
admet-2901	531	19	cells	cell	NOUN
admet-2901	531	20	.	.	PUNCT
admet-2901	532	1	planta	planta	PROPN
admet-2901	532	2	medica	medica	PROPN
admet-2901	532	3	88	88	NUM
admet-2901	532	4	(	(	PUNCT
admet-2901	532	5	2022	2022	NUM
admet-2901	532	6	)	)	PUNCT
admet-2901	532	7	1141	1141	NUM
admet-2901	532	8	-	-	SYM
admet-2901	532	9	1151	1151	NUM
admet-2901	532	10	.	.	PUNCT
admet-2901	533	1	https://doi.org/10.1055/a-1728-5166	https://doi.org/10.1055/a-1728-5166	ADJ
admet-2901	533	2	[	[	X
admet-2901	533	3	58	58	NUM
admet-2901	533	4	]	]	PUNCT
admet-2901	533	5	z.	z.	PROPN
admet-2901	533	6	xu	xu	PROPN
admet-2901	533	7	,	,	PUNCT
admet-2901	533	8	l.	l.	PROPN
admet-2901	533	9	huang	huang	PROPN
admet-2901	533	10	,	,	PUNCT
admet-2901	533	11	x.h	x.h	PROPN
admet-2901	533	12	.	.	PROPN
admet-2901	533	13	chen	chen	PROPN
admet-2901	533	14	,	,	PUNCT
admet-2901	533	15	x.f	x.f	PROPN
admet-2901	533	16	.	.	PROPN
admet-2901	533	17	zhu	zhu	PROPN
admet-2901	533	18	,	,	PUNCT
admet-2901	533	19	x.j	x.j	PROPN
admet-2901	533	20	.	.	PROPN
admet-2901	533	21	qian	qian	PROPN
admet-2901	533	22	,	,	PUNCT
admet-2901	533	23	g.k	g.k	PROPN
admet-2901	533	24	.	.	PROPN
admet-2901	533	25	feng	feng	PROPN
admet-2901	533	26	,	,	PUNCT
admet-2901	533	27	w.j	w.j	PROPN
admet-2901	533	28	.	.	PROPN
admet-2901	533	29	lan	lan	PROPN
admet-2901	533	30	,	,	PUNCT
admet-2901	533	31	h.j	h.j	PROPN
admet-2901	533	32	.	.	PROPN
admet-2901	533	33	li	li	PROPN
admet-2901	533	34	.	.	PROPN
admet-2901	534	1	cytotoxic	cytotoxic	ADJ
admet-2901	534	2	prenylated	prenylate	VERB
admet-2901	534	3	xanthones	xanthone	NOUN
admet-2901	534	4	from	from	ADP
admet-2901	534	5	the	the	DET
admet-2901	534	6	pericarps	pericarp	NOUN
admet-2901	534	7	of	of	ADP
admet-2901	534	8	garcinia	garcinia	PROPN
admet-2901	534	9	mangostana	mangostana	PROPN
admet-2901	534	10	.	.	PUNCT
admet-2901	535	1	molecules	molecule	NOUN
admet-2901	535	2	19	19	NUM
admet-2901	535	3	(	(	PUNCT
admet-2901	535	4	2014	2014	NUM
admet-2901	535	5	)	)	PUNCT
admet-2901	535	6	1820	1820	NUM
admet-2901	535	7	-	-	SYM
admet-2901	535	8	1827	1827	NUM
admet-2901	535	9	.	.	PUNCT
admet-2901	536	1	https://doi.org/10.3390/molecules19021820	https://doi.org/10.3390/molecules19021820	NOUN
admet-2901	536	2	[	[	X
admet-2901	536	3	59	59	NUM
admet-2901	536	4	]	]	X
admet-2901	536	5	r.a	r.a	PROPN
admet-2901	536	6	.	.	PROPN
admet-2901	536	7	castanheiro	castanheiro	PROPN
admet-2901	536	8	,	,	PUNCT
admet-2901	536	9	a.m.	a.m.	PROPN
admet-2901	536	10	silva	silva	PROPN
admet-2901	536	11	,	,	PUNCT
admet-2901	536	12	n.a	n.a	PROPN
admet-2901	536	13	.	.	PROPN
admet-2901	536	14	campos	campos	PROPN
admet-2901	536	15	,	,	PUNCT
admet-2901	536	16	m.s	m.s	PROPN
admet-2901	536	17	.	.	PROPN
admet-2901	536	18	nascimento	nascimento	PROPN
admet-2901	536	19	,	,	PUNCT
admet-2901	536	20	m.m	m.m	PROPN
admet-2901	536	21	.	.	PROPN
admet-2901	536	22	pinto	pinto	PROPN
admet-2901	536	23	.	.	PUNCT
admet-2901	537	1	antitumor	antitumor	PROPN
admet-2901	537	2	activity	activity	NOUN
admet-2901	537	3	of	of	ADP
admet-2901	537	4	some	some	DET
admet-2901	537	5	prenylated	prenylate	VERB
admet-2901	537	6	xanthones	xanthone	NOUN
admet-2901	537	7	.	.	PUNCT
admet-2901	538	1	pharmaceuticals	pharmaceutical	NOUN
admet-2901	538	2	(	(	PUNCT
admet-2901	538	3	basel	basel	PROPN
admet-2901	538	4	)	)	PUNCT
admet-2901	538	5	2	2	NUM
admet-2901	538	6	(	(	PUNCT
admet-2901	538	7	2009	2009	NUM
admet-2901	538	8	)	)	PUNCT
admet-2901	538	9	33	33	NUM
admet-2901	538	10	-	-	SYM
admet-2901	538	11	43	43	NUM
admet-2901	538	12	.	.	PUNCT
admet-2901	539	1	https://doi.org/10.3390/ph2020033	https://doi.org/10.3390/ph2020033	PROPN
admet-2901	540	1	[	[	X
admet-2901	540	2	60	60	NUM
admet-2901	540	3	]	]	PUNCT
admet-2901	540	4	a.	a.	NOUN
admet-2901	540	5	wongpan	wongpan	PROPN
admet-2901	540	6	,	,	PUNCT
admet-2901	540	7	w.	w.	PROPN
admet-2901	540	8	panvongsa	panvongsa	PROPN
admet-2901	540	9	,	,	PUNCT
admet-2901	540	10	s.	s.	PROPN
admet-2901	540	11	krobthong	krobthong	PROPN
admet-2901	540	12	,	,	PUNCT
admet-2901	540	13	b.	b.	PROPN
admet-2901	540	14	nutho	nutho	PROPN
admet-2901	540	15	,	,	PUNCT
admet-2901	540	16	p.	p.	NOUN
admet-2901	540	17	kanjanasirirat	kanjanasirirat	PROPN
admet-2901	540	18	,	,	PUNCT
admet-2901	540	19	k.	k.	PROPN
admet-2901	540	20	jearawuttanakul	jearawuttanakul	PROPN
admet-2901	540	21	,	,	PUNCT
admet-2901	540	22	t.	t.	PROPN
admet-2901	540	23	khumpanied	khumpanied	PROPN
admet-2901	540	24	,	,	PUNCT
admet-2901	540	25	s.	s.	PROPN
admet-2901	540	26	phlaetita	phlaetita	PROPN
admet-2901	540	27	,	,	PUNCT
admet-2901	540	28	n.	n.	PROPN
admet-2901	540	29	chabang	chabang	PROPN
admet-2901	540	30	,	,	PUNCT
admet-2901	540	31	b.	b.	PROPN
admet-2901	540	32	munyoo	munyoo	PROPN
admet-2901	540	33	,	,	PUNCT
admet-2901	540	34	p.	p.	NOUN
admet-2901	540	35	tuchinda	tuchinda	PROPN
admet-2901	540	36	,	,	PUNCT
admet-2901	540	37	m.	m.	NOUN
admet-2901	540	38	ponpuak	ponpuak	NOUN
admet-2901	540	39	,	,	PUNCT
admet-2901	540	40	s.	s.	PROPN
admet-2901	540	41	borwornpinyo	borwornpinyo	PROPN
admet-2901	540	42	,	,	PUNCT
admet-2901	540	43	a.	a.	NOUN
admet-2901	540	44	chairoungdua	chairoungdua	PROPN
admet-2901	540	45	.	.	PUNCT
admet-2901	541	1	cleistanthin	cleistanthin	VERB
admet-2901	541	2	a	a	DET
admet-2901	541	3	derivative	derivative	ADJ
admet-2901	541	4	disrupts	disrupt	NOUN
admet-2901	541	5	autophagy	autophagy	NOUN
admet-2901	541	6	and	and	CCONJ
admet-2901	541	7	suppresses	suppress	VERB
admet-2901	541	8	head	head	NOUN
admet-2901	541	9	and	and	CCONJ
admet-2901	541	10	neck	neck	VERB
admet-2901	541	11	squamous	squamous	ADJ
admet-2901	541	12	cell	cell	NOUN
admet-2901	541	13	carcinoma	carcinoma	NOUN
admet-2901	541	14	progression	progression	NOUN
admet-2901	541	15	via	via	ADP
admet-2901	541	16	targeted	target	VERB
admet-2901	541	17	vacuolar	vacuolar	ADJ
admet-2901	541	18	atpase	atpase	NOUN
admet-2901	541	19	.	.	PUNCT
admet-2901	542	1	scientific	scientific	ADJ
admet-2901	542	2	reports	report	NOUN
admet-2901	542	3	14	14	NUM
admet-2901	542	4	(	(	PUNCT
admet-2901	542	5	2024	2024	NUM
admet-2901	542	6	)	)	PUNCT
admet-2901	542	7	22582	22582	NUM
admet-2901	542	8	.	.	PUNCT
admet-2901	542	9	https://doi.org/10.1038/s41598-024-73186-1	https://doi.org/10.1038/s41598-024-73186-1	NOUN
admet-2901	543	1	[	[	X
admet-2901	543	2	61	61	NUM
admet-2901	543	3	]	]	X
admet-2901	543	4	h.	h.	PROPN
admet-2901	543	5	li	li	PROPN
admet-2901	543	6	,	,	PUNCT
admet-2901	543	7	w.-t	w.-t	PROPN
admet-2901	543	8	.	.	PUNCT
admet-2901	544	1	kang	kang	PROPN
admet-2901	544	2	,	,	PUNCT
admet-2901	544	3	y.	y.	PROPN
admet-2901	544	4	zheng	zheng	PROPN
admet-2901	544	5	,	,	PUNCT
admet-2901	544	6	y.	y.	PROPN
admet-2901	544	7	he	he	PRON
admet-2901	544	8	,	,	PUNCT
admet-2901	544	9	r.	r.	PROPN
admet-2901	544	10	zhong	zhong	PROPN
admet-2901	544	11	,	,	PUNCT
admet-2901	544	12	s.	s.	PROPN
admet-2901	544	13	fang	fang	PROPN
admet-2901	544	14	,	,	PUNCT
admet-2901	544	15	w.	w.	PROPN
admet-2901	544	16	wen	wen	PROPN
admet-2901	544	17	,	,	PUNCT
admet-2901	544	18	s.	s.	PROPN
admet-2901	544	19	liu	liu	PROPN
admet-2901	544	20	,	,	PUNCT
admet-2901	544	21	s.	s.	PROPN
admet-2901	544	22	lin	lin	PROPN
admet-2901	544	23	.	.	PUNCT
admet-2901	545	1	development	development	NOUN
admet-2901	545	2	of	of	ADP
admet-2901	545	3	xanthone	xanthone	PROPN
admet-2901	545	4	derivatives	derivative	NOUN
admet-2901	545	5	as	as	ADP
admet-2901	545	6	effective	effective	ADJ
admet-2901	545	7	broad	broad	ADJ
admet-2901	545	8	-	-	PUNCT
admet-2901	545	9	spectrum	spectrum	NOUN
admet-2901	545	10	antimicrobials	antimicrobial	NOUN
admet-2901	545	11	:	:	PUNCT
admet-2901	545	12	disrupting	disrupt	VERB
admet-2901	545	13	cell	cell	NOUN
admet-2901	545	14	wall	wall	NOUN
admet-2901	545	15	and	and	CCONJ
admet-2901	545	16	inhibiting	inhibit	VERB
admet-2901	545	17	dna	dna	NOUN
admet-2901	545	18	synthesis	synthesis	NOUN
admet-2901	545	19	.	.	PUNCT
admet-2901	546	1	science	science	NOUN
admet-2901	546	2	advances	advance	VERB
admet-2901	546	3	11	11	NUM
admet-2901	546	4	(	(	PUNCT
admet-2901	546	5	2025	2025	NUM
admet-2901	546	6	)	)	PUNCT
admet-2901	547	1	eadt4723	eadt4723	PROPN
admet-2901	547	2	.	.	PUNCT
admet-2901	547	3	https://doi.org/doi:10.1126/sciadv.adt4723	https://doi.org/doi:10.1126/sciadv.adt4723	PROPN
admet-2901	548	1	[	[	X
admet-2901	548	2	62	62	NUM
admet-2901	548	3	]	]	PUNCT
admet-2901	548	4	m.	m.	NOUN
admet-2901	548	5	pinto	pinto	NOUN
admet-2901	548	6	,	,	PUNCT
admet-2901	548	7	m.	m.	NOUN
admet-2901	548	8	sousa	sousa	PROPN
admet-2901	548	9	,	,	PUNCT
admet-2901	548	10	m.	m.	NOUN
admet-2901	548	11	nascimento	nascimento	PROPN
admet-2901	548	12	.	.	PUNCT
admet-2901	549	1	xanthone	xanthone	PROPN
admet-2901	549	2	derivatives	derivative	NOUN
admet-2901	549	3	:	:	PUNCT
admet-2901	549	4	new	new	ADJ
admet-2901	549	5	insights	insight	NOUN
admet-2901	549	6	in	in	ADP
admet-2901	549	7	biological	biological	ADJ
admet-2901	549	8	activities	activity	NOUN
admet-2901	549	9	.	.	PUNCT
admet-2901	550	1	current	current	ADJ
admet-2901	550	2	medicinal	medicinal	ADJ
admet-2901	550	3	chemistry	chemistry	NOUN
admet-2901	550	4	12	12	NUM
admet-2901	550	5	(	(	PUNCT
admet-2901	550	6	2005	2005	NUM
admet-2901	550	7	)	)	PUNCT
admet-2901	550	8	2517	2517	NUM
admet-2901	550	9	-	-	SYM
admet-2901	550	10	2538	2538	NUM
admet-2901	550	11	.	.	PUNCT
admet-2901	551	1	https://doi.org/10.2174/092986705774370691	https://doi.org/10.2174/092986705774370691	X
admet-2901	552	1	https://doi.org/10.1016/j.ejphar.2020.173604	https://doi.org/10.1016/j.ejphar.2020.173604	ADJ
admet-2901	552	2	https://doi.org/10.1038/s41598-019-45641-x	https://doi.org/10.1038/s41598-019-45641-x	NOUN
admet-2901	552	3	https://doi.org/10.3390/molecules25030598	https://doi.org/10.3390/molecules25030598	NOUN
admet-2901	552	4	https://doi.org/10.3390/molecules26185575	https://doi.org/10.3390/molecules26185575	PROPN
admet-2901	552	5	https://doi.org/10.2174/092986705774370682	https://doi.org/10.2174/092986705774370682	ADP
admet-2901	552	6	https://doi.org/10.1021/acs.jnatprod.9b00018	https://doi.org/10.1021/acs.jnatprod.9b00018	NOUN
admet-2901	552	7	https://doi.org/10.4103/wjtcm.wjtcm_83_20	https://doi.org/10.4103/wjtcm.wjtcm_83_20	NOUN
admet-2901	552	8	https://doi.org/10.1016/j.phytol.2016.07.026	https://doi.org/10.1016/j.phytol.2016.07.026	PROPN
admet-2901	552	9	https://doi.org/10.1016/j.jep.2017.01.030	https://doi.org/10.1016/j.jep.2017.01.030	NUM
admet-2901	552	10	https://doi.org/10.1055/a-1728-5166	https://doi.org/10.1055/a-1728-5166	ADJ
admet-2901	552	11	https://doi.org/10.3390/molecules19021820	https://doi.org/10.3390/molecules19021820	NOUN
admet-2901	552	12	https://doi.org/10.3390/ph2020033	https://doi.org/10.3390/ph2020033	VERB
admet-2901	552	13	https://doi.org/10.1038/s41598-024-73186-1	https://doi.org/10.1038/s41598-024-73186-1	NOUN
admet-2901	552	14	https://doi.org/doi:10.1126/sciadv.adt4723	https://doi.org/doi:10.1126/sciadv.adt4723	PROPN
admet-2901	552	15	https://doi.org/10.2174/092986705774370691	https://doi.org/10.2174/092986705774370691	ADJ
admet-2901	552	16	admet	admet	PROPN
admet-2901	552	17	&	&	CCONJ
admet-2901	552	18	dmpk	dmpk	PROPN
admet-2901	552	19	13(5	13(5	NOUN
admet-2901	552	20	)	)	PUNCT
admet-2901	552	21	(	(	PUNCT
admet-2901	552	22	2025	2025	NUM
admet-2901	552	23	)	)	PUNCT
admet-2901	552	24	2901	2901	NUM
admet-2901	552	25	new	new	ADJ
admet-2901	552	26	xanthone	xanthone	PROPN
admet-2901	552	27	and	and	CCONJ
admet-2901	552	28	chemical	chemical	NOUN
admet-2901	552	29	constituents	constituent	NOUN
admet-2901	552	30	from	from	ADP
admet-2901	552	31	mallotus	mallotus	ADJ
admet-2901	552	32	glomerulatus	glomerulatus	NOUN
admet-2901	552	33	doi	doi	PROPN
admet-2901	552	34	:	:	PUNCT
admet-2901	552	35	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	NOUN
admet-2901	552	36	19	19	NUM
admet-2901	552	37	[	[	SYM
admet-2901	552	38	63	63	NUM
admet-2901	552	39	]	]	PUNCT
admet-2901	552	40	y.	y.	PROPN
admet-2901	552	41	li	li	PROPN
admet-2901	552	42	,	,	PUNCT
admet-2901	552	43	h.	h.	PROPN
admet-2901	552	44	wang	wang	PROPN
admet-2901	552	45	,	,	PUNCT
admet-2901	552	46	w.	w.	PROPN
admet-2901	552	47	liu	liu	PROPN
admet-2901	552	48	,	,	PUNCT
admet-2901	552	49	j.	j.	PROPN
admet-2901	552	50	hou	hou	PROPN
admet-2901	552	51	,	,	PUNCT
admet-2901	552	52	j.	j.	PROPN
admet-2901	552	53	xu	xu	PROPN
admet-2901	552	54	,	,	PUNCT
admet-2901	552	55	y.	y.	PROPN
admet-2901	552	56	guo	guo	PROPN
admet-2901	552	57	,	,	PUNCT
admet-2901	552	58	p.	p.	PROPN
admet-2901	552	59	hu	hu	PROPN
admet-2901	552	60	.	.	PUNCT
admet-2901	553	1	cratoxylumxanthone	cratoxylumxanthone	PROPN
admet-2901	553	2	c	c	PROPN
admet-2901	553	3	,	,	PUNCT
admet-2901	553	4	a	a	DET
admet-2901	553	5	natural	natural	ADJ
admet-2901	553	6	xanthone	xanthone	NOUN
admet-2901	553	7	,	,	PUNCT
admet-2901	553	8	inhibits	inhibit	VERB
admet-2901	553	9	lung	lung	NOUN
admet-2901	553	10	cancer	cancer	NOUN
admet-2901	553	11	proliferation	proliferation	NOUN
admet-2901	553	12	and	and	CCONJ
admet-2901	553	13	metastasis	metastasis	NOUN
admet-2901	553	14	by	by	ADP
admet-2901	553	15	regulating	regulate	VERB
admet-2901	553	16	stat3	stat3	NOUN
admet-2901	553	17	and	and	CCONJ
admet-2901	553	18	fak	fak	PROPN
admet-2901	553	19	signal	signal	PROPN
admet-2901	553	20	pathways	pathway	NOUN
admet-2901	553	21	.	.	PUNCT
admet-2901	554	1	frontiers	frontier	NOUN
admet-2901	554	2	in	in	ADP
admet-2901	554	3	pharmacology	pharmacology	NOUN
admet-2901	554	4	13	13	NUM
admet-2901	554	5	(	(	PUNCT
admet-2901	554	6	2022	2022	NUM
admet-2901	554	7	)	)	PUNCT
admet-2901	554	8	.	.	PUNCT
admet-2901	555	1	https://doi.org/10.3389/fphar.2022.920422	https://doi.org/10.3389/fphar.2022.920422	PROPN
admet-2901	555	2	[	[	X
admet-2901	555	3	64	64	NUM
admet-2901	555	4	]	]	PUNCT
admet-2901	555	5	m.	m.	NOUN
admet-2901	555	6	liu	liu	PROPN
admet-2901	555	7	,	,	PUNCT
admet-2901	555	8	h.	h.	PROPN
admet-2901	555	9	yin	yin	PROPN
admet-2901	555	10	,	,	PUNCT
admet-2901	555	11	x.	x.	PROPN
admet-2901	555	12	qian	qian	PROPN
admet-2901	555	13	,	,	PUNCT
admet-2901	555	14	j.	j.	PROPN
admet-2901	555	15	dong	dong	PROPN
admet-2901	555	16	,	,	PUNCT
admet-2901	555	17	z.	z.	PROPN
admet-2901	555	18	qian	qian	PROPN
admet-2901	555	19	,	,	PUNCT
admet-2901	555	20	j.	j.	PROPN
admet-2901	555	21	miao	miao	PROPN
admet-2901	555	22	.	.	PUNCT
admet-2901	556	1	xanthohumol	xanthohumol	PROPN
admet-2901	556	2	,	,	PUNCT
admet-2901	556	3	a	a	DET
admet-2901	556	4	prenylated	prenylate	VERB
admet-2901	556	5	chalcone	chalcone	NOUN
admet-2901	556	6	from	from	ADP
admet-2901	556	7	hops	hop	NOUN
admet-2901	556	8	,	,	PUNCT
admet-2901	556	9	inhibits	inhibit	VERB
admet-2901	556	10	the	the	DET
admet-2901	556	11	viability	viability	NOUN
admet-2901	556	12	and	and	CCONJ
admet-2901	556	13	stemness	stemness	NOUN
admet-2901	556	14	of	of	ADP
admet-2901	556	15	doxorubicin	doxorubicin	NOUN
admet-2901	556	16	-	-	PUNCT
admet-2901	556	17	resistant	resistant	ADJ
admet-2901	556	18	mcf-7	mcf-7	NOUN
admet-2901	556	19	/	/	SYM
admet-2901	556	20	adr	adr	PROPN
admet-2901	556	21	cells	cell	NOUN
admet-2901	556	22	.	.	PUNCT
admet-2901	557	1	molecules	molecule	NOUN
admet-2901	557	2	22	22	NUM
admet-2901	557	3	(	(	PUNCT
admet-2901	557	4	2017	2017	NUM
admet-2901	557	5	)	)	PUNCT
admet-2901	557	6	36	36	NUM
admet-2901	557	7	.	.	PUNCT
admet-2901	558	1	https://doi.org/10.3390/molecules22010036	https://doi.org/10.3390/molecules22010036	PROPN
admet-2901	559	1	[	[	X
admet-2901	559	2	65	65	NUM
admet-2901	559	3	]	]	X
admet-2901	559	4	d.l	d.l	PROPN
admet-2901	559	5	.	.	PROPN
admet-2901	560	1	holliday	holliday	PROPN
admet-2901	560	2	,	,	PUNCT
admet-2901	560	3	v.	v.	ADP
admet-2901	560	4	speirs	speir	NOUN
admet-2901	560	5	.	.	PUNCT
admet-2901	561	1	choosing	choose	VERB
admet-2901	561	2	the	the	DET
admet-2901	561	3	right	right	ADJ
admet-2901	561	4	cell	cell	NOUN
admet-2901	561	5	line	line	NOUN
admet-2901	561	6	for	for	ADP
admet-2901	561	7	breast	breast	NOUN
admet-2901	561	8	cancer	cancer	NOUN
admet-2901	561	9	research	research	NOUN
admet-2901	561	10	.	.	PUNCT
admet-2901	562	1	breast	breast	NOUN
admet-2901	562	2	cancer	cancer	NOUN
admet-2901	562	3	research	research	NOUN
admet-2901	562	4	13	13	NUM
admet-2901	562	5	(	(	PUNCT
admet-2901	562	6	2011	2011	NUM
admet-2901	562	7	)	)	PUNCT
admet-2901	562	8	215	215	NUM
admet-2901	562	9	.	.	PUNCT
admet-2901	563	1	https://doi.org/10.1186/bcr2889	https://doi.org/10.1186/bcr2889	PRON
admet-2901	564	1	[	[	X
admet-2901	564	2	66	66	NUM
admet-2901	564	3	]	]	X
admet-2901	564	4	b.d	b.d	PROPN
admet-2901	564	5	.	.	PROPN
admet-2901	564	6	lehmann	lehmann	PROPN
admet-2901	564	7	,	,	PUNCT
admet-2901	564	8	j.a	j.a	PROPN
admet-2901	564	9	.	.	PROPN
admet-2901	564	10	bauer	bauer	PROPN
admet-2901	564	11	,	,	PUNCT
admet-2901	564	12	x.	x.	PROPN
admet-2901	564	13	chen	chen	PROPN
admet-2901	564	14	,	,	PUNCT
admet-2901	564	15	m.e	m.e	PROPN
admet-2901	564	16	.	.	PROPN
admet-2901	564	17	sanders	sanders	PROPN
admet-2901	564	18	,	,	PUNCT
admet-2901	564	19	a.b	a.b	PROPN
admet-2901	564	20	.	.	NOUN
admet-2901	564	21	chakravarthy	chakravarthy	ADJ
admet-2901	564	22	,	,	PUNCT
admet-2901	564	23	y.	y.	PROPN
admet-2901	564	24	shyr	shyr	PROPN
admet-2901	564	25	,	,	PUNCT
admet-2901	564	26	j.a	j.a	PROPN
admet-2901	564	27	.	.	PROPN
admet-2901	564	28	pietenpol	pietenpol	NOUN
admet-2901	564	29	.	.	PUNCT
admet-2901	565	1	identification	identification	NOUN
admet-2901	565	2	of	of	ADP
admet-2901	565	3	human	human	ADJ
admet-2901	565	4	triple	triple	ADJ
admet-2901	565	5	-	-	PUNCT
admet-2901	565	6	negative	negative	ADJ
admet-2901	565	7	breast	breast	NOUN
admet-2901	565	8	cancer	cancer	NOUN
admet-2901	565	9	subtypes	subtype	NOUN
admet-2901	565	10	and	and	CCONJ
admet-2901	565	11	preclinical	preclinical	ADJ
admet-2901	565	12	models	model	NOUN
admet-2901	565	13	for	for	ADP
admet-2901	565	14	selection	selection	NOUN
admet-2901	565	15	of	of	ADP
admet-2901	565	16	targeted	target	VERB
admet-2901	565	17	therapies	therapy	NOUN
admet-2901	565	18	.	.	PUNCT
admet-2901	566	1	the	the	DET
admet-2901	566	2	journal	journal	NOUN
admet-2901	566	3	of	of	ADP
admet-2901	566	4	clinical	clinical	ADJ
admet-2901	566	5	investigation	investigation	NOUN
admet-2901	566	6	121	121	NUM
admet-2901	566	7	(	(	PUNCT
admet-2901	566	8	2011	2011	NUM
admet-2901	566	9	)	)	PUNCT
admet-2901	566	10	2750	2750	NUM
admet-2901	566	11	-	-	SYM
admet-2901	566	12	2767	2767	NUM
admet-2901	566	13	.	.	PUNCT
admet-2901	567	1	https://doi.org/10.1172/jci45014	https://doi.org/10.1172/jci45014	NOUN
admet-2901	568	1	[	[	X
admet-2901	568	2	67	67	NUM
admet-2901	568	3	]	]	X
admet-2901	568	4	g.	g.	PROPN
admet-2901	568	5	bianchini	bianchini	PROPN
admet-2901	568	6	,	,	PUNCT
admet-2901	568	7	j.m	j.m	PROPN
admet-2901	568	8	.	.	PROPN
admet-2901	568	9	balko	balko	PROPN
admet-2901	568	10	,	,	PUNCT
admet-2901	568	11	i.a	i.a	PROPN
admet-2901	568	12	.	.	PROPN
admet-2901	568	13	mayer	mayer	PROPN
admet-2901	568	14	,	,	PUNCT
admet-2901	568	15	m.e	m.e	PROPN
admet-2901	568	16	.	.	PROPN
admet-2901	568	17	sanders	sanders	PROPN
admet-2901	568	18	,	,	PUNCT
admet-2901	568	19	l.	l.	PROPN
admet-2901	568	20	gianni	gianni	PROPN
admet-2901	568	21	.	.	PUNCT
admet-2901	569	1	triple	triple	ADJ
admet-2901	569	2	-	-	PUNCT
admet-2901	569	3	negative	negative	ADJ
admet-2901	569	4	breast	breast	NOUN
admet-2901	569	5	cancer	cancer	NOUN
admet-2901	569	6	:	:	PUNCT
admet-2901	569	7	challenges	challenge	NOUN
admet-2901	569	8	and	and	CCONJ
admet-2901	569	9	opportunities	opportunity	NOUN
admet-2901	569	10	of	of	ADP
admet-2901	569	11	a	a	DET
admet-2901	569	12	heterogeneous	heterogeneous	ADJ
admet-2901	569	13	disease	disease	NOUN
admet-2901	569	14	.	.	PUNCT
admet-2901	570	1	nature	nature	NOUN
admet-2901	570	2	reviews	review	VERB
admet-2901	570	3	clinical	clinical	ADJ
admet-2901	570	4	oncology	oncology	NOUN
admet-2901	570	5	13	13	NUM
admet-2901	570	6	(	(	PUNCT
admet-2901	570	7	2016	2016	NUM
admet-2901	570	8	)	)	PUNCT
admet-2901	570	9	674	674	NUM
admet-2901	570	10	-	-	SYM
admet-2901	570	11	690	690	NUM
admet-2901	570	12	.	.	PUNCT
admet-2901	571	1	https://doi.org/10.1038/nrclinonc.2016.66	https://doi.org/10.1038/nrclinonc.2016.66	PRON
admet-2901	572	1	[	[	X
admet-2901	572	2	68	68	NUM
admet-2901	572	3	]	]	PUNCT
admet-2901	572	4	l.	l.	PROPN
admet-2901	572	5	jin	jin	PROPN
admet-2901	572	6	,	,	PUNCT
admet-2901	572	7	z.	z.	PROPN
admet-2901	572	8	song	song	PROPN
admet-2901	572	9	,	,	PUNCT
admet-2901	572	10	f.	f.	PROPN
admet-2901	572	11	cai	cai	PROPN
admet-2901	572	12	,	,	PUNCT
admet-2901	572	13	l.	l.	PROPN
admet-2901	572	14	ruan	ruan	PROPN
admet-2901	572	15	,	,	PUNCT
admet-2901	572	16	r.	r.	PROPN
admet-2901	572	17	jiang	jiang	PROPN
admet-2901	572	18	.	.	PUNCT
admet-2901	573	1	chemistry	chemistry	NOUN
admet-2901	573	2	and	and	CCONJ
admet-2901	573	3	biological	biological	ADJ
admet-2901	573	4	activities	activity	NOUN
admet-2901	573	5	of	of	ADP
admet-2901	573	6	naturally	naturally	ADV
admet-2901	573	7	occurring	occur	VERB
admet-2901	573	8	and	and	CCONJ
admet-2901	573	9	structurally	structurally	ADV
admet-2901	573	10	modified	modify	VERB
admet-2901	573	11	podophyllotoxins	podophyllotoxin	NOUN
admet-2901	573	12	.	.	PUNCT
admet-2901	574	1	molecules	molecule	NOUN
admet-2901	574	2	28	28	NUM
admet-2901	574	3	(	(	PUNCT
admet-2901	574	4	2022	2022	NUM
admet-2901	574	5	)	)	PUNCT
admet-2901	574	6	302	302	NUM
admet-2901	574	7	.	.	PUNCT
admet-2901	574	8	https://doi.org/10.3390/molecules28010302	https://doi.org/10.3390/molecules28010302	PROPN
admet-2901	575	1	[	[	X
admet-2901	575	2	69	69	NUM
admet-2901	575	3	]	]	PUNCT
admet-2901	575	4	m.	m.	NOUN
admet-2901	575	5	forgac	forgac	PROPN
admet-2901	575	6	.	.	PUNCT
admet-2901	576	1	vacuolar	vacuolar	ADJ
admet-2901	576	2	atpases	atpase	NOUN
admet-2901	576	3	:	:	PUNCT
admet-2901	576	4	rotary	rotary	ADJ
admet-2901	576	5	proton	proton	NOUN
admet-2901	576	6	pumps	pump	NOUN
admet-2901	576	7	in	in	ADP
admet-2901	576	8	physiology	physiology	NOUN
admet-2901	576	9	and	and	CCONJ
admet-2901	576	10	pathophysiology	pathophysiology	NOUN
admet-2901	576	11	.	.	PUNCT
admet-2901	577	1	nature	nature	NOUN
admet-2901	577	2	reviews	review	VERB
admet-2901	577	3	molecular	molecular	ADJ
admet-2901	577	4	cell	cell	NOUN
admet-2901	577	5	biology	biology	NOUN
admet-2901	577	6	8	8	NUM
admet-2901	577	7	(	(	PUNCT
admet-2901	577	8	2007	2007	NUM
admet-2901	577	9	)	)	PUNCT
admet-2901	577	10	917	917	NUM
admet-2901	577	11	-	-	SYM
admet-2901	577	12	929	929	NUM
admet-2901	577	13	.	.	PUNCT
admet-2901	578	1	https://doi.org/10.1038/nrm2272	https://doi.org/10.1038/nrm2272	NOUN
admet-2901	579	1	[	[	X
admet-2901	579	2	70	70	NUM
admet-2901	579	3	]	]	X
admet-2901	579	4	d.	d.	PROPN
admet-2901	579	5	mijaljica	mijaljica	PROPN
admet-2901	579	6	,	,	PUNCT
admet-2901	579	7	m.	m.	NOUN
admet-2901	579	8	prescott	prescott	PROPN
admet-2901	579	9	,	,	PUNCT
admet-2901	579	10	r.j	r.j	PROPN
admet-2901	579	11	.	.	PROPN
admet-2901	579	12	devenish	devenish	PROPN
admet-2901	579	13	.	.	PUNCT
admet-2901	580	1	v	v	X
admet-2901	580	2	-	-	PUNCT
admet-2901	580	3	atpase	atpase	PROPN
admet-2901	580	4	engagement	engagement	NOUN
admet-2901	580	5	in	in	ADP
admet-2901	580	6	autophagic	autophagic	ADJ
admet-2901	580	7	processes	process	NOUN
admet-2901	580	8	.	.	PUNCT
admet-2901	581	1	autophagy	autophagy	ADV
admet-2901	581	2	7	7	NUM
admet-2901	581	3	(	(	PUNCT
admet-2901	581	4	2011	2011	NUM
admet-2901	581	5	)	)	PUNCT
admet-2901	581	6	666	666	NUM
admet-2901	581	7	-	-	SYM
admet-2901	581	8	668	668	NUM
admet-2901	581	9	.	.	PUNCT
admet-2901	582	1	https://doi.org/10.4161/auto.7.6.15812	https://doi.org/10.4161/auto.7.6.15812	NOUN
admet-2901	582	2	[	[	X
admet-2901	582	3	71	71	NUM
admet-2901	582	4	]	]	X
admet-2901	582	5	k.m	k.m	PROPN
admet-2901	582	6	.	.	PROPN
admet-2901	582	7	hooper	hooper	PROPN
admet-2901	582	8	,	,	PUNCT
admet-2901	582	9	e.	e.	PROPN
admet-2901	582	10	jacquin	jacquin	PROPN
admet-2901	582	11	,	,	PUNCT
admet-2901	582	12	t.	t.	PROPN
admet-2901	582	13	li	li	PROPN
admet-2901	582	14	,	,	PUNCT
admet-2901	582	15	j.m	j.m	PROPN
admet-2901	582	16	.	.	PROPN
admet-2901	582	17	goodwin	goodwin	PROPN
admet-2901	582	18	,	,	PUNCT
admet-2901	582	19	j.h	j.h	PROPN
admet-2901	582	20	.	.	PROPN
admet-2901	582	21	brumell	brumell	PROPN
admet-2901	582	22	,	,	PUNCT
admet-2901	582	23	j.	j.	PROPN
admet-2901	582	24	durgan	durgan	PROPN
admet-2901	582	25	,	,	PUNCT
admet-2901	582	26	o.	o.	PROPN
admet-2901	582	27	florey	florey	PROPN
admet-2901	582	28	.	.	PUNCT
admet-2901	583	1	v	v	X
admet-2901	583	2	-	-	PUNCT
admet-2901	583	3	atpase	atpase	PROPN
admet-2901	583	4	is	be	AUX
admet-2901	583	5	a	a	DET
admet-2901	583	6	universal	universal	ADJ
admet-2901	583	7	regulator	regulator	NOUN
admet-2901	583	8	of	of	ADP
admet-2901	583	9	lc3	lc3	NOUN
admet-2901	583	10	-	-	PUNCT
admet-2901	583	11	associated	associate	VERB
admet-2901	583	12	phagocytosis	phagocytosis	NOUN
admet-2901	583	13	and	and	CCONJ
admet-2901	583	14	non	non	ADJ
admet-2901	583	15	-	-	ADJ
admet-2901	583	16	canonical	canonical	ADJ
admet-2901	583	17	autophagy	autophagy	NOUN
admet-2901	583	18	.	.	PUNCT
admet-2901	584	1	journal	journal	NOUN
admet-2901	584	2	of	of	ADP
admet-2901	584	3	cell	cell	NOUN
admet-2901	584	4	biology	biology	NOUN
admet-2901	584	5	221	221	NUM
admet-2901	584	6	(	(	PUNCT
admet-2901	584	7	2022	2022	NUM
admet-2901	584	8	)	)	PUNCT
admet-2901	584	9	e202105112	e202105112	PROPN
admet-2901	584	10	.	.	PUNCT
admet-2901	585	1	https://doi.org/10.1083/jcb.202105112	https://doi.org/10.1083/jcb.202105112	PROPN
admet-2901	586	1	[	[	X
admet-2901	586	2	72	72	NUM
admet-2901	586	3	]	]	X
admet-2901	586	4	l.	l.	PROPN
admet-2901	586	5	jin	jin	PROPN
admet-2901	586	6	,	,	PUNCT
admet-2901	586	7	z.	z.	PROPN
admet-2901	586	8	song	song	PROPN
admet-2901	586	9	,	,	PUNCT
admet-2901	586	10	f.	f.	PROPN
admet-2901	586	11	cai	cai	PROPN
admet-2901	586	12	,	,	PUNCT
admet-2901	586	13	l.	l.	PROPN
admet-2901	586	14	ruan	ruan	PROPN
admet-2901	586	15	,	,	PUNCT
admet-2901	586	16	r.	r.	PROPN
admet-2901	586	17	jiang	jiang	PROPN
admet-2901	586	18	.	.	PUNCT
admet-2901	587	1	chemistry	chemistry	NOUN
admet-2901	587	2	and	and	CCONJ
admet-2901	587	3	biological	biological	ADJ
admet-2901	587	4	activities	activity	NOUN
admet-2901	587	5	of	of	ADP
admet-2901	587	6	naturally	naturally	ADV
admet-2901	587	7	occurring	occur	VERB
admet-2901	587	8	and	and	CCONJ
admet-2901	587	9	structurally	structurally	ADV
admet-2901	587	10	modified	modify	VERB
admet-2901	587	11	podophyllotoxins	podophyllotoxin	NOUN
admet-2901	587	12	.	.	PUNCT
admet-2901	588	1	molecules	molecule	NOUN
admet-2901	588	2	28	28	NUM
admet-2901	588	3	(	(	PUNCT
admet-2901	588	4	2023	2023	NUM
admet-2901	588	5	)	)	PUNCT
admet-2901	588	6	302	302	NUM
admet-2901	588	7	.	.	PUNCT
admet-2901	589	1	https://doi.org/10.3390/molecules28010302	https://doi.org/10.3390/molecules28010302	NOUN
admet-2901	590	1	[	[	X
admet-2901	590	2	73	73	NUM
admet-2901	590	3	]	]	PUNCT
admet-2901	590	4	x.	x.	PROPN
admet-2901	590	5	liu	liu	PROPN
admet-2901	590	6	,	,	PUNCT
admet-2901	590	7	b.	b.	PROPN
admet-2901	590	8	testa	testa	PROPN
admet-2901	590	9	,	,	PUNCT
admet-2901	590	10	a.	a.	PROPN
admet-2901	590	11	fahr	fahr	PROPN
admet-2901	590	12	.	.	PUNCT
admet-2901	591	1	lipophilicity	lipophilicity	PROPN
admet-2901	591	2	and	and	CCONJ
admet-2901	591	3	its	its	PRON
admet-2901	591	4	relationship	relationship	NOUN
admet-2901	591	5	with	with	ADP
admet-2901	591	6	passive	passive	ADJ
admet-2901	591	7	drug	drug	NOUN
admet-2901	591	8	permeation	permeation	NOUN
admet-2901	591	9	.	.	PUNCT
admet-2901	592	1	pharmaceutical	pharmaceutical	PROPN
admet-2901	592	2	research	research	NOUN
admet-2901	592	3	28	28	NUM
admet-2901	592	4	(	(	PUNCT
admet-2901	592	5	2011	2011	NUM
admet-2901	592	6	)	)	PUNCT
admet-2901	592	7	962	962	NUM
admet-2901	592	8	-	-	SYM
admet-2901	592	9	977	977	NUM
admet-2901	592	10	.	.	PUNCT
admet-2901	593	1	https://doi.org/10.1007/s11095-010-0303-7	https://doi.org/10.1007/s11095-010-0303-7	PROPN
admet-2901	594	1	[	[	X
admet-2901	594	2	74	74	NUM
admet-2901	594	3	]	]	PUNCT
admet-2901	594	4	l.	l.	PROPN
admet-2901	594	5	himakoun	himakoun	PROPN
admet-2901	594	6	,	,	PUNCT
admet-2901	594	7	p.	p.	NOUN
admet-2901	594	8	tuchinda	tuchinda	PROPN
admet-2901	594	9	,	,	PUNCT
admet-2901	594	10	p.	p.	NOUN
admet-2901	594	11	puchadapirom	puchadapirom	NOUN
admet-2901	594	12	,	,	PUNCT
admet-2901	594	13	r.	r.	PROPN
admet-2901	594	14	tammasakchai	tammasakchai	PROPN
admet-2901	594	15	,	,	PUNCT
admet-2901	594	16	v.	v.	PROPN
admet-2901	594	17	leardkamolkarn	leardkamolkarn	PROPN
admet-2901	594	18	.	.	PUNCT
admet-2901	594	19	evaluation	evaluation	NOUN
admet-2901	594	20	of	of	ADP
admet-2901	594	21	genotoxic	genotoxic	ADJ
admet-2901	594	22	and	and	CCONJ
admet-2901	594	23	anti	anti	ADJ
admet-2901	594	24	-	-	ADJ
admet-2901	594	25	mutagenic	mutagenic	ADJ
admet-2901	594	26	properties	property	NOUN
admet-2901	594	27	of	of	ADP
admet-2901	594	28	cleistanthin	cleistanthin	NOUN
admet-2901	594	29	a	a	PRON
admet-2901	594	30	and	and	CCONJ
admet-2901	594	31	cleistanthoside	cleistanthoside	ADJ
admet-2901	594	32	a	a	DET
admet-2901	594	33	tetraacetate	tetraacetate	NOUN
admet-2901	594	34	.	.	PUNCT
admet-2901	595	1	asian	asian	PROPN
admet-2901	595	2	pacific	pacific	PROPN
admet-2901	595	3	journal	journal	PROPN
admet-2901	595	4	of	of	ADP
admet-2901	595	5	cancer	cancer	NOUN
admet-2901	595	6	prevention	prevention	NOUN
admet-2901	595	7	12	12	NUM
admet-2901	595	8	(	(	PUNCT
admet-2901	595	9	2011	2011	NUM
admet-2901	595	10	)	)	PUNCT
admet-2901	595	11	3271	3271	NUM
admet-2901	595	12	-	-	SYM
admet-2901	595	13	3275	3275	NUM
admet-2901	595	14	.	.	PUNCT
admet-2901	596	1	https://journal.waocp.org/?sid=entrez:pubmed&id=pmid:22471465&key=2011.12.12.3271	https://journal.waocp.org/?sid=entrez:pubmed&id=pmid:22471465&key=2011.12.12.3271	X
admet-2901	597	1	[	[	X
admet-2901	597	2	75	75	NUM
admet-2901	597	3	]	]	X
admet-2901	597	4	y.	y.	PROPN
admet-2901	597	5	zhao	zhao	PROPN
admet-2901	597	6	,	,	PUNCT
admet-2901	597	7	r.	r.	PROPN
admet-2901	597	8	zhang	zhang	PROPN
admet-2901	597	9	,	,	PUNCT
admet-2901	597	10	y.	y.	PROPN
admet-2901	597	11	lu	lu	PROPN
admet-2901	597	12	,	,	PUNCT
admet-2901	597	13	j.	j.	PROPN
admet-2901	597	14	ma	ma	PROPN
admet-2901	597	15	,	,	PUNCT
admet-2901	597	16	l.	l.	PROPN
admet-2901	597	17	zhu	zhu	PROPN
admet-2901	597	18	.	.	PUNCT
admet-2901	598	1	synthesis	synthesis	NOUN
admet-2901	598	2	and	and	CCONJ
admet-2901	598	3	bioevaluation	bioevaluation	NOUN
admet-2901	598	4	of	of	ADP
admet-2901	598	5	heterocyclic	heterocyclic	ADJ
admet-2901	598	6	derivatives	derivative	NOUN
admet-2901	598	7	of	of	ADP
admet-2901	598	8	cleistanthin	cleistanthin	ADJ
admet-2901	598	9	-	-	PUNCT
admet-2901	598	10	a.	a.	NOUN
admet-2901	598	11	bioorganic	bioorganic	PROPN
admet-2901	598	12	&	&	CCONJ
admet-2901	598	13	medicinal	medicinal	ADJ
admet-2901	598	14	chemistry	chemistry	NOUN
admet-2901	598	15	23	23	NUM
admet-2901	598	16	(	(	PUNCT
admet-2901	598	17	2015	2015	NUM
admet-2901	598	18	)	)	PUNCT
admet-2901	598	19	4884	4884	NUM
admet-2901	598	20	-	-	SYM
admet-2901	598	21	4890	4890	NUM
admet-2901	598	22	.	.	PUNCT
admet-2901	599	1	https://doi.org/10.1016/j.bmc.2015.05.033	https://doi.org/10.1016/j.bmc.2015.05.033	VERB
admet-2901	600	1	[	[	X
admet-2901	600	2	76	76	NUM
admet-2901	600	3	]	]	X
admet-2901	600	4	s.	s.	PROPN
admet-2901	600	5	nhlapho	nhlapho	PROPN
admet-2901	600	6	,	,	PUNCT
admet-2901	600	7	m.h.l	m.h.l	PROPN
admet-2901	600	8	.	.	PUNCT
admet-2901	600	9	nyathi	nyathi	PROPN
admet-2901	600	10	,	,	PUNCT
admet-2901	600	11	b.l	b.l	PROPN
admet-2901	600	12	.	.	PROPN
admet-2901	600	13	ngwenya	ngwenya	PROPN
admet-2901	600	14	,	,	PUNCT
admet-2901	600	15	t.	t.	PROPN
admet-2901	600	16	dube	dube	PROPN
admet-2901	600	17	,	,	PUNCT
admet-2901	600	18	a.	a.	NOUN
admet-2901	600	19	telukdarie	telukdarie	PROPN
admet-2901	600	20	,	,	PUNCT
admet-2901	600	21	i.	i.	PROPN
admet-2901	600	22	munien	munien	PROPN
admet-2901	600	23	,	,	PUNCT
admet-2901	600	24	a.	a.	PROPN
admet-2901	600	25	vermeulen	vermeulen	PROPN
admet-2901	600	26	,	,	PUNCT
admet-2901	600	27	u.a.k	u.a.k	PROPN
admet-2901	600	28	.	.	PUNCT
admet-2901	600	29	chude	chude	NOUN
admet-2901	600	30	-	-	PUNCT
admet-2901	600	31	okonkwo	okonkwo	NOUN
admet-2901	600	32	.	.	PUNCT
admet-2901	601	1	druggability	druggability	NOUN
admet-2901	601	2	of	of	ADP
admet-2901	601	3	pharmaceutical	pharmaceutical	NOUN
admet-2901	601	4	compounds	compound	NOUN
admet-2901	601	5	using	use	VERB
admet-2901	601	6	lipinski	lipinski	PROPN
admet-2901	601	7	rules	rule	NOUN
admet-2901	601	8	with	with	ADP
admet-2901	601	9	machine	machine	NOUN
admet-2901	601	10	learning	learning	NOUN
admet-2901	601	11	.	.	PUNCT
admet-2901	602	1	sciences	science	NOUN
admet-2901	602	2	of	of	ADP
admet-2901	602	3	pharmacy	pharmacy	NOUN
admet-2901	602	4	3	3	NUM
admet-2901	602	5	(	(	PUNCT
admet-2901	602	6	2024	2024	NUM
admet-2901	602	7	)	)	PUNCT
admet-2901	602	8	177	177	NUM
admet-2901	602	9	-	-	SYM
admet-2901	602	10	192	192	NUM
admet-2901	602	11	.	.	PUNCT
admet-2901	603	1	https://doi.org/10.58920/sciphar0304264	https://doi.org/10.58920/sciphar0304264	PROPN
admet-2901	604	1	[	[	X
admet-2901	604	2	77	77	NUM
admet-2901	604	3	]	]	X
admet-2901	604	4	c.a	c.a	PROPN
admet-2901	604	5	.	.	PROPN
admet-2901	604	6	lipinski	lipinski	PROPN
admet-2901	604	7	,	,	PUNCT
admet-2901	604	8	f.	f.	PROPN
admet-2901	604	9	lombardo	lombardo	PROPN
admet-2901	604	10	,	,	PUNCT
admet-2901	604	11	b.w	b.w	PROPN
admet-2901	604	12	.	.	PROPN
admet-2901	604	13	dominy	dominy	PROPN
admet-2901	604	14	,	,	PUNCT
admet-2901	604	15	p.j	p.j	PROPN
admet-2901	604	16	.	.	PROPN
admet-2901	604	17	feeney	feeney	PROPN
admet-2901	604	18	.	.	PUNCT
admet-2901	605	1	experimental	experimental	ADJ
admet-2901	605	2	and	and	CCONJ
admet-2901	605	3	computational	computational	ADJ
admet-2901	605	4	approaches	approach	NOUN
admet-2901	605	5	to	to	PART
admet-2901	605	6	estimate	estimate	VERB
admet-2901	605	7	solubility	solubility	NOUN
admet-2901	605	8	and	and	CCONJ
admet-2901	605	9	permeability	permeability	NOUN
admet-2901	605	10	in	in	ADP
admet-2901	605	11	drug	drug	NOUN
admet-2901	605	12	discovery	discovery	NOUN
admet-2901	605	13	and	and	CCONJ
admet-2901	605	14	development	development	NOUN
admet-2901	605	15	settings1pii	settings1pii	NOUN
admet-2901	605	16	of	of	ADP
admet-2901	605	17	original	original	ADJ
admet-2901	605	18	article	article	NOUN
admet-2901	605	19	:	:	PUNCT
admet-2901	605	20	s0169	s0169	PROPN
admet-2901	605	21	-	-	PUNCT
admet-2901	605	22	409x(96)00423	409x(96)00423	NUM
admet-2901	605	23	-	-	PUNCT
admet-2901	605	24	1	1	NUM
admet-2901	605	25	.	.	PUNCT
admet-2901	606	1	the	the	DET
admet-2901	606	2	article	article	NOUN
admet-2901	606	3	was	be	AUX
admet-2901	606	4	originally	originally	ADV
admet-2901	606	5	published	publish	VERB
admet-2901	606	6	in	in	ADP
admet-2901	606	7	advanced	advanced	ADJ
admet-2901	606	8	drug	drug	NOUN
admet-2901	606	9	delivery	delivery	NOUN
admet-2901	606	10	reviews	review	VERB
admet-2901	606	11	23	23	NUM
admet-2901	606	12	(	(	PUNCT
admet-2901	606	13	1997	1997	NUM
admet-2901	606	14	)	)	PUNCT
admet-2901	606	15	3–25.1	3–25.1	NUM
admet-2901	606	16	.	.	PUNCT
admet-2901	607	1	advanced	advanced	ADJ
admet-2901	607	2	drug	drug	NOUN
admet-2901	607	3	delivery	delivery	NOUN
admet-2901	607	4	reviews	review	VERB
admet-2901	607	5	46	46	NUM
admet-2901	607	6	(	(	PUNCT
admet-2901	607	7	2001	2001	NUM
admet-2901	607	8	)	)	PUNCT
admet-2901	607	9	3	3	NUM
admet-2901	607	10	-	-	SYM
admet-2901	607	11	26	26	NUM
admet-2901	607	12	.	.	PUNCT
admet-2901	608	1	https://doi.org/10.1016/s0169-409x(00)00129-0	https://doi.org/10.1016/s0169-409x(00)00129-0	PROPN
admet-2901	608	2	[	[	X
admet-2901	608	3	78	78	NUM
admet-2901	608	4	]	]	X
admet-2901	608	5	bradley	bradley	PROPN
admet-2901	608	6	c.	c.	PROPN
admet-2901	608	7	doak	doak	PROPN
admet-2901	608	8	,	,	PUNCT
admet-2901	608	9	b.	b.	PROPN
admet-2901	608	10	over	over	PROPN
admet-2901	608	11	,	,	PUNCT
admet-2901	608	12	f.	f.	PROPN
admet-2901	608	13	giordanetto	giordanetto	PROPN
admet-2901	608	14	,	,	PUNCT
admet-2901	608	15	j.	j.	PROPN
admet-2901	608	16	kihlberg	kihlberg	PROPN
admet-2901	608	17	.	.	PUNCT
admet-2901	609	1	oral	oral	ADJ
admet-2901	609	2	druggable	druggable	ADJ
admet-2901	609	3	space	space	NOUN
admet-2901	609	4	beyond	beyond	ADP
admet-2901	609	5	the	the	DET
admet-2901	609	6	rule	rule	NOUN
admet-2901	609	7	of	of	ADP
admet-2901	609	8	5	5	NUM
admet-2901	609	9	:	:	PUNCT
admet-2901	609	10	insights	insight	NOUN
admet-2901	609	11	from	from	ADP
admet-2901	609	12	drugs	drug	NOUN
admet-2901	609	13	and	and	CCONJ
admet-2901	609	14	clinical	clinical	ADJ
admet-2901	609	15	candidates	candidate	NOUN
admet-2901	609	16	.	.	PUNCT
admet-2901	610	1	chemistry	chemistry	NOUN
admet-2901	610	2	&	&	CCONJ
admet-2901	610	3	biology	biology	NOUN
admet-2901	610	4	21	21	NUM
admet-2901	610	5	(	(	PUNCT
admet-2901	610	6	2014	2014	NUM
admet-2901	610	7	)	)	PUNCT
admet-2901	610	8	1115	1115	NUM
admet-2901	610	9	-	-	SYM
admet-2901	610	10	1142	1142	NUM
admet-2901	610	11	.	.	PUNCT
admet-2901	611	1	https://doi.org/10.1016/j.chembiol.2014.08.013	https://doi.org/10.1016/j.chembiol.2014.08.013	NUM
admet-2901	611	2	https://doi.org/10.5599/admet.2901	https://doi.org/10.5599/admet.2901	NOUN
admet-2901	611	3	https://doi.org/10.3389/fphar.2022.920422	https://doi.org/10.3389/fphar.2022.920422	PROPN
admet-2901	611	4	https://doi.org/10.3390/molecules22010036	https://doi.org/10.3390/molecules22010036	NOUN
admet-2901	611	5	https://doi.org/10.1186/bcr2889	https://doi.org/10.1186/bcr2889	PRON
admet-2901	611	6	https://doi.org/10.1172/jci45014	https://doi.org/10.1172/jci45014	PROPN
admet-2901	611	7	https://doi.org/10.1038/nrclinonc.2016.66	https://doi.org/10.1038/nrclinonc.2016.66	PROPN
admet-2901	611	8	https://doi.org/10.3390/molecules28010302	https://doi.org/10.3390/molecules28010302	PROPN
admet-2901	611	9	https://doi.org/10.1038/nrm2272	https://doi.org/10.1038/nrm2272	PROPN
admet-2901	611	10	https://doi.org/10.4161/auto.7.6.15812	https://doi.org/10.4161/auto.7.6.15812	PROPN
admet-2901	611	11	https://doi.org/10.1083/jcb.202105112	https://doi.org/10.1083/jcb.202105112	PROPN
admet-2901	611	12	https://doi.org/10.3390/molecules28010302	https://doi.org/10.3390/molecules28010302	PROPN
admet-2901	611	13	https://doi.org/10.1007/s11095-010-0303-7	https://doi.org/10.1007/s11095-010-0303-7	PROPN
admet-2901	612	1	https://journal.waocp.org/?sid=entrez:pubmed&id=pmid:22471465&key=2011.12.12.3271	https://journal.waocp.org/?sid=entrez:pubmed&id=pmid:22471465&key=2011.12.12.3271	NOUN
admet-2901	612	2	https://doi.org/10.1016/j.bmc.2015.05.033	https://doi.org/10.1016/j.bmc.2015.05.033	AUX
admet-2901	612	3	https://doi.org/10.58920/sciphar0304264	https://doi.org/10.58920/sciphar0304264	VERB
admet-2901	612	4	https://doi.org/10.1016/s0169-409x(00)00129-0	https://doi.org/10.1016/s0169-409x(00)00129-0	PROPN
admet-2901	613	1	https://doi.org/10.1016/j.chembiol.2014.08.013	https://doi.org/10.1016/j.chembiol.2014.08.013	PROPN
admet-2901	613	2	n.	n.	NOUN
admet-2901	613	3	chabang	chabang	PROPN
admet-2901	613	4	et	et	PROPN
admet-2901	613	5	al	al	PROPN
admet-2901	613	6	.	.	PROPN
admet-2901	613	7	admet	admet	PROPN
admet-2901	613	8	&	&	CCONJ
admet-2901	613	9	dmpk	dmpk	PROPN
admet-2901	613	10	13(5	13(5	NUM
admet-2901	613	11	)	)	PUNCT
admet-2901	613	12	(	(	PUNCT
admet-2901	613	13	2025	2025	NUM
admet-2901	613	14	)	)	PUNCT
admet-2901	613	15	2901	2901	NUM
admet-2901	613	16	20	20	NUM
admet-2901	614	1	[	[	SYM
admet-2901	614	2	79	79	NUM
admet-2901	614	3	]	]	X
admet-2901	614	4	d.f	d.f	PROPN
admet-2901	614	5	.	.	PROPN
admet-2901	614	6	veber	veber	PROPN
admet-2901	614	7	,	,	PUNCT
admet-2901	614	8	s.r	s.r	PROPN
admet-2901	614	9	.	.	PROPN
admet-2901	614	10	johnson	johnson	PROPN
admet-2901	614	11	,	,	PUNCT
admet-2901	614	12	h.-y	h.-y	NOUN
admet-2901	614	13	.	.	PUNCT
admet-2901	615	1	cheng	cheng	PROPN
admet-2901	615	2	,	,	PUNCT
admet-2901	615	3	b.r	b.r	PROPN
admet-2901	615	4	.	.	PROPN
admet-2901	615	5	smith	smith	PROPN
admet-2901	615	6	,	,	PUNCT
admet-2901	615	7	k.w	k.w	PROPN
admet-2901	615	8	.	.	PROPN
admet-2901	615	9	ward	ward	PROPN
admet-2901	615	10	,	,	PUNCT
admet-2901	615	11	k.d	k.d	PROPN
admet-2901	615	12	.	.	PROPN
admet-2901	615	13	kopple	kopple	PROPN
admet-2901	615	14	.	.	PUNCT
admet-2901	616	1	molecular	molecular	ADJ
admet-2901	616	2	properties	property	NOUN
admet-2901	616	3	that	that	PRON
admet-2901	616	4	influence	influence	VERB
admet-2901	616	5	the	the	DET
admet-2901	616	6	oral	oral	ADJ
admet-2901	616	7	bioavailability	bioavailability	NOUN
admet-2901	616	8	of	of	ADP
admet-2901	616	9	drug	drug	NOUN
admet-2901	616	10	candidates	candidate	NOUN
admet-2901	616	11	.	.	PUNCT
admet-2901	617	1	journal	journal	NOUN
admet-2901	617	2	of	of	ADP
admet-2901	617	3	medicinal	medicinal	ADJ
admet-2901	617	4	chemistry	chemistry	NOUN
admet-2901	617	5	45	45	NUM
admet-2901	617	6	(	(	PUNCT
admet-2901	617	7	2002	2002	NUM
admet-2901	617	8	)	)	PUNCT
admet-2901	617	9	2615	2615	NUM
admet-2901	617	10	-	-	SYM
admet-2901	617	11	2623	2623	NUM
admet-2901	617	12	.	.	PUNCT
admet-2901	618	1	https://doi.org/10.1021/jm020017n	https://doi.org/10.1021/jm020017n	PUNCT
admet-2901	619	1	[	[	X
admet-2901	619	2	80	80	NUM
admet-2901	619	3	]	]	PUNCT
admet-2901	619	4	a.	a.	NOUN
admet-2901	619	5	hernández	hernández	PROPN
admet-2901	619	6	,	,	PUNCT
admet-2901	619	7	g.s	g.s	PROPN
admet-2901	619	8	.	.	PROPN
admet-2901	619	9	bueno	bueno	PROPN
admet-2901	619	10	,	,	PUNCT
admet-2901	619	11	r.	r.	PROPN
admet-2901	619	12	herrera	herrera	PROPN
admet-2901	619	13	-	-	PUNCT
admet-2901	619	14	palau	palau	PROPN
admet-2901	619	15	,	,	PUNCT
admet-2901	619	16	j.r	j.r	PROPN
admet-2901	619	17	.	.	PROPN
admet-2901	619	18	pérez	pérez	PROPN
admet-2901	619	19	-	-	PUNCT
admet-2901	619	20	castiñeira	castiñeira	PROPN
admet-2901	619	21	,	,	PUNCT
admet-2901	619	22	a.	a.	NOUN
admet-2901	619	23	serrano	serrano	PROPN
admet-2901	619	24	,	,	PUNCT
admet-2901	619	25	v	v	NOUN
admet-2901	619	26	-	-	PUNCT
admet-2901	619	27	atpase	atpase	ADJ
admet-2901	619	28	inhibitors	inhibitor	NOUN
admet-2901	619	29	in	in	ADP
admet-2901	619	30	cancer	cancer	NOUN
admet-2901	619	31	therapy	therapy	NOUN
admet-2901	619	32	:	:	PUNCT
admet-2901	619	33	targeting	target	VERB
admet-2901	619	34	intraorganellar	intraorganellar	ADJ
admet-2901	619	35	acidification	acidification	NOUN
admet-2901	619	36	,	,	PUNCT
admet-2901	619	37	in	in	ADP
admet-2901	619	38	topics	topic	NOUN
admet-2901	619	39	in	in	ADP
admet-2901	619	40	anti	anti	ADJ
admet-2901	619	41	-	-	ADJ
admet-2901	619	42	cancer	cancer	ADJ
admet-2901	619	43	research	research	NOUN
admet-2901	619	44	:	:	PUNCT
admet-2901	619	45	volume	volume	NOUN
admet-2901	619	46	2	2	NUM
admet-2901	619	47	,	,	PUNCT
admet-2901	619	48	bentham	bentham	PROPN
admet-2901	619	49	science	science	PROPN
admet-2901	619	50	publishers2013	publishers2013	PROPN
admet-2901	619	51	,	,	PUNCT
admet-2901	619	52	p.	p.	NOUN
admet-2901	619	53	231	231	NUM
admet-2901	619	54	-	-	SYM
admet-2901	619	55	256	256	NUM
admet-2901	619	56	.	.	PUNCT
admet-2901	620	1	https://doi.org/10.2174/97816080513661130201	https://doi.org/10.2174/97816080513661130201	PRON
admet-2901	621	1	[	[	X
admet-2901	621	2	81	81	NUM
admet-2901	621	3	]	]	PUNCT
admet-2901	621	4	m.	m.	PROPN
admet-2901	621	5	huss	huss	PROPN
admet-2901	621	6	,	,	PUNCT
admet-2901	621	7	f.	f.	PROPN
admet-2901	621	8	sasse	sasse	PROPN
admet-2901	621	9	,	,	PUNCT
admet-2901	621	10	b.	b.	PROPN
admet-2901	621	11	kunze	kunze	PROPN
admet-2901	621	12	,	,	PUNCT
admet-2901	621	13	r.	r.	PROPN
admet-2901	621	14	jansen	jansen	PROPN
admet-2901	621	15	,	,	PUNCT
admet-2901	621	16	h.	h.	PROPN
admet-2901	621	17	steinmetz	steinmetz	PROPN
admet-2901	621	18	,	,	PUNCT
admet-2901	621	19	g.	g.	PROPN
admet-2901	621	20	ingenhorst	ingenhorst	PROPN
admet-2901	621	21	,	,	PUNCT
admet-2901	621	22	a.	a.	NOUN
admet-2901	621	23	zeeck	zeeck	PROPN
admet-2901	621	24	,	,	PUNCT
admet-2901	621	25	h.	h.	PROPN
admet-2901	621	26	wieczorek	wieczorek	PROPN
admet-2901	621	27	.	.	PUNCT
admet-2901	622	1	archazolid	archazolid	PROPN
admet-2901	622	2	and	and	CCONJ
admet-2901	622	3	apicularen	apicularen	ADJ
admet-2901	622	4	:	:	PUNCT
admet-2901	622	5	novel	novel	ADJ
admet-2901	622	6	specific	specific	ADJ
admet-2901	622	7	v	v	NOUN
admet-2901	622	8	-	-	PUNCT
admet-2901	622	9	atpase	atpase	ADJ
admet-2901	622	10	inhibitors	inhibitor	NOUN
admet-2901	622	11	.	.	PUNCT
admet-2901	623	1	bmc	bmc	PROPN
admet-2901	623	2	biochemistry	biochemistry	NOUN
admet-2901	623	3	6	6	NUM
admet-2901	623	4	(	(	PUNCT
admet-2901	623	5	2005	2005	NUM
admet-2901	623	6	)	)	PUNCT
admet-2901	623	7	1	1	NUM
admet-2901	623	8	-	-	SYM
admet-2901	623	9	10	10	NUM
admet-2901	623	10	.	.	PUNCT
admet-2901	624	1	https://doi.org/10.1186/1471-2091-6-13	https://doi.org/10.1186/1471-2091-6-13	X
admet-2901	625	1	[	[	X
admet-2901	625	2	82	82	X
admet-2901	625	3	]	]	PUNCT
admet-2901	625	4	t.	t.	PROPN
admet-2901	625	5	chen	chen	PROPN
admet-2901	625	6	,	,	PUNCT
admet-2901	625	7	x.	x.	PROPN
admet-2901	625	8	lin	lin	PROPN
admet-2901	625	9	,	,	PUNCT
admet-2901	625	10	s.	s.	PROPN
admet-2901	625	11	lu	lu	PROPN
admet-2901	625	12	,	,	PUNCT
admet-2901	626	1	b.	b.	PROPN
admet-2901	626	2	li	li	PROPN
admet-2901	626	3	.	.	PROPN
admet-2901	626	4	v	v	PROPN
admet-2901	626	5	-	-	PUNCT
admet-2901	626	6	atpase	atpase	PROPN
admet-2901	626	7	in	in	ADP
admet-2901	626	8	cancer	cancer	NOUN
admet-2901	626	9	:	:	PUNCT
admet-2901	626	10	mechanistic	mechanistic	ADJ
admet-2901	626	11	insights	insight	NOUN
admet-2901	626	12	and	and	CCONJ
admet-2901	626	13	therapeutic	therapeutic	ADJ
admet-2901	626	14	potentials	potential	NOUN
admet-2901	626	15	.	.	PUNCT
admet-2901	627	1	cell	cell	NOUN
admet-2901	627	2	communication	communication	NOUN
admet-2901	627	3	and	and	CCONJ
admet-2901	627	4	signaling	signal	VERB
admet-2901	627	5	22	22	NUM
admet-2901	627	6	(	(	PUNCT
admet-2901	627	7	2024	2024	NUM
admet-2901	627	8	)	)	PUNCT
admet-2901	628	1	613	613	NUM
admet-2901	628	2	.	.	PUNCT
admet-2901	629	1	https://doi.org/10.1186/s12964-024-01998-9	https://doi.org/10.1186/s12964-024-01998-9	PRON
admet-2901	630	1	[	[	X
admet-2901	630	2	83	83	NUM
admet-2901	630	3	]	]	X
admet-2901	630	4	m.t	m.t	PROPN
admet-2901	630	5	.	.	PROPN
admet-2901	630	6	donato	donato	PROPN
admet-2901	630	7	,	,	PUNCT
admet-2901	630	8	l.	l.	PROPN
admet-2901	630	9	tolosa	tolosa	PROPN
admet-2901	630	10	,	,	PUNCT
admet-2901	630	11	m.j	m.j	PROPN
admet-2901	630	12	.	.	PROPN
admet-2901	630	13	gómez	gómez	PROPN
admet-2901	630	14	-	-	PUNCT
admet-2901	630	15	lechón	lechón	PROPN
admet-2901	630	16	.	.	PUNCT
admet-2901	631	1	culture	culture	NOUN
admet-2901	631	2	and	and	CCONJ
admet-2901	631	3	functional	functional	ADJ
admet-2901	631	4	characterization	characterization	NOUN
admet-2901	631	5	of	of	ADP
admet-2901	631	6	human	human	ADJ
admet-2901	631	7	hepatoma	hepatoma	NOUN
admet-2901	631	8	hepg2	hepg2	PUNCT
admet-2901	632	1	cells	cell	NOUN
admet-2901	632	2	.	.	PUNCT
admet-2901	633	1	methods	method	NOUN
admet-2901	633	2	in	in	ADP
admet-2901	633	3	molecular	molecular	ADJ
admet-2901	633	4	biology	biology	NOUN
admet-2901	633	5	1250	1250	NUM
admet-2901	633	6	(	(	PUNCT
admet-2901	633	7	2015	2015	NUM
admet-2901	633	8	)	)	PUNCT
admet-2901	633	9	77	77	NUM
admet-2901	633	10	-	-	SYM
admet-2901	633	11	93	93	NUM
admet-2901	633	12	.	.	PUNCT
admet-2901	633	13	https://doi.org/10.1007/978-1-4939-2074-7_5	https://doi.org/10.1007/978-1-4939-2074-7_5	NOUN
admet-2901	634	1	[	[	X
admet-2901	634	2	84	84	NUM
admet-2901	634	3	]	]	PUNCT
admet-2901	634	4	s.	s.	PROPN
admet-2901	634	5	parasuraman	parasuraman	PROPN
admet-2901	634	6	,	,	PUNCT
admet-2901	634	7	r.	r.	PROPN
admet-2901	634	8	raveendran	raveendran	PROPN
admet-2901	634	9	,	,	PUNCT
admet-2901	634	10	n.g	n.g	PROPN
admet-2901	634	11	.	.	PROPN
admet-2901	634	12	rajesh	rajesh	PROPN
admet-2901	634	13	,	,	PUNCT
admet-2901	634	14	s.	s.	PROPN
admet-2901	634	15	nandhakumar	nandhakumar	PROPN
admet-2901	634	16	.	.	PUNCT
admet-2901	635	1	sub	sub	ADJ
admet-2901	635	2	-	-	ADJ
admet-2901	635	3	chronic	chronic	ADJ
admet-2901	635	4	toxicological	toxicological	ADJ
admet-2901	635	5	evaluation	evaluation	NOUN
admet-2901	635	6	of	of	ADP
admet-2901	635	7	cleistanthin	cleistanthin	PROPN
admet-2901	635	8	a	a	PRON
admet-2901	635	9	and	and	CCONJ
admet-2901	635	10	cleistanthin	cleistanthin	PROPN
admet-2901	635	11	b	b	PROPN
admet-2901	635	12	from	from	ADP
admet-2901	635	13	the	the	DET
admet-2901	635	14	leaves	leave	NOUN
admet-2901	635	15	of	of	ADP
admet-2901	635	16	cleistanthus	cleistanthus	PROPN
admet-2901	635	17	collinus	collinus	PROPN
admet-2901	635	18	(	(	PUNCT
admet-2901	635	19	roxb	roxb	PROPN
admet-2901	635	20	.	.	PUNCT
admet-2901	635	21	)	)	PUNCT
admet-2901	635	22	.	.	PUNCT
admet-2901	636	1	toxicology	toxicology	NOUN
admet-2901	636	2	reports	report	VERB
admet-2901	636	3	1	1	NUM
admet-2901	636	4	(	(	PUNCT
admet-2901	636	5	2014	2014	NUM
admet-2901	636	6	)	)	PUNCT
admet-2901	636	7	596	596	NUM
admet-2901	636	8	-	-	SYM
admet-2901	636	9	611	611	NUM
admet-2901	636	10	.	.	PUNCT
admet-2901	637	1	https://doi.org/10.1016/j.toxrep.2014.08.006	https://doi.org/10.1016/j.toxrep.2014.08.006	ADJ
admet-2901	637	2	[	[	X
admet-2901	637	3	85	85	NUM
admet-2901	637	4	]	]	X
admet-2901	637	5	y.	y.	PROPN
admet-2901	637	6	zhao	zhao	PROPN
admet-2901	637	7	,	,	PUNCT
admet-2901	637	8	y.	y.	PROPN
admet-2901	637	9	lu	lu	PROPN
admet-2901	637	10	,	,	PUNCT
admet-2901	637	11	j.	j.	PROPN
admet-2901	637	12	ma	ma	PROPN
admet-2901	637	13	,	,	PUNCT
admet-2901	637	14	l.	l.	PROPN
admet-2901	637	15	zhu	zhu	PROPN
admet-2901	637	16	.	.	PUNCT
admet-2901	638	1	synthesis	synthesis	NOUN
admet-2901	638	2	and	and	CCONJ
admet-2901	638	3	evaluation	evaluation	NOUN
admet-2901	638	4	of	of	ADP
admet-2901	638	5	cleistanthin	cleistanthin	NOUN
admet-2901	638	6	a	a	DET
admet-2901	638	7	derivatives	derivative	NOUN
admet-2901	638	8	as	as	ADP
admet-2901	638	9	potent	potent	ADJ
admet-2901	638	10	vacuolar	vacuolar	ADJ
admet-2901	638	11	h+-atpase	h+-atpase	NOUN
admet-2901	638	12	inhibitors	inhibitor	NOUN
admet-2901	638	13	.	.	PUNCT
admet-2901	639	1	chemical	chemical	NOUN
admet-2901	639	2	biology	biology	PROPN
admet-2901	639	3	&	&	CCONJ
admet-2901	639	4	drug	drug	PROPN
admet-2901	639	5	design	design	PROPN
admet-2901	639	6	86	86	NUM
admet-2901	639	7	(	(	PUNCT
admet-2901	639	8	2015	2015	NUM
admet-2901	639	9	)	)	PUNCT
admet-2901	639	10	691	691	NUM
admet-2901	639	11	-	-	SYM
admet-2901	639	12	696	696	NUM
admet-2901	639	13	.	.	PUNCT
admet-2901	640	1	https://doi.org/10.1111/cbdd.12538	https://doi.org/10.1111/cbdd.12538	NOUN
admet-2901	640	2	[	[	X
admet-2901	640	3	86	86	NUM
admet-2901	640	4	]	]	X
admet-2901	640	5	y.	y.	PROPN
admet-2901	640	6	ren	ren	PROPN
admet-2901	640	7	,	,	PUNCT
admet-2901	640	8	e.j.c	e.j.c	PROPN
admet-2901	640	9	.	.	PUNCT
admet-2901	640	10	de	de	PROPN
admet-2901	640	11	blanco	blanco	PROPN
admet-2901	640	12	,	,	PUNCT
admet-2901	640	13	j.r	j.r	PROPN
admet-2901	640	14	.	.	PROPN
admet-2901	640	15	fuchs	fuchs	PROPN
admet-2901	640	16	,	,	PUNCT
admet-2901	640	17	d.d	d.d	PROPN
admet-2901	640	18	.	.	PROPN
admet-2901	640	19	soejarto	soejarto	PROPN
admet-2901	640	20	,	,	PUNCT
admet-2901	640	21	j.e	j.e	PROPN
admet-2901	640	22	.	.	PROPN
admet-2901	640	23	burdette	burdette	PROPN
admet-2901	640	24	,	,	PUNCT
admet-2901	640	25	s.m	s.m	PROPN
admet-2901	640	26	.	.	PROPN
admet-2901	640	27	swanson	swanson	PROPN
admet-2901	640	28	,	,	PUNCT
admet-2901	640	29	a.d	a.d	PROPN
admet-2901	640	30	.	.	PROPN
admet-2901	640	31	kinghorn	kinghorn	PROPN
admet-2901	640	32	.	.	PUNCT
admet-2901	641	1	potential	potential	ADJ
admet-2901	641	2	anticancer	anticancer	NOUN
admet-2901	641	3	agents	agent	NOUN
admet-2901	641	4	characterized	characterize	VERB
admet-2901	641	5	from	from	ADP
admet-2901	641	6	selected	select	VERB
admet-2901	641	7	tropical	tropical	ADJ
admet-2901	641	8	plants	plant	NOUN
admet-2901	641	9	.	.	PUNCT
admet-2901	642	1	journal	journal	NOUN
admet-2901	642	2	of	of	ADP
admet-2901	642	3	natural	natural	ADJ
admet-2901	642	4	products	product	NOUN
admet-2901	642	5	82	82	NUM
admet-2901	642	6	(	(	PUNCT
admet-2901	642	7	2019	2019	NUM
admet-2901	642	8	)	)	PUNCT
admet-2901	642	9	657	657	NUM
admet-2901	642	10	-	-	SYM
admet-2901	642	11	679	679	NUM
admet-2901	642	12	.	.	PUNCT
admet-2901	643	1	https://doi.org/10.1021/acs.jnatprod.9b00018	https://doi.org/10.1021/acs.jnatprod.9b00018	ADP
admet-2901	643	2	©	©	PROPN
admet-2901	643	3	2025	2025	NUM
admet-2901	643	4	by	by	ADP
admet-2901	643	5	the	the	DET
admet-2901	643	6	authors	author	NOUN
admet-2901	643	7	;	;	PUNCT
admet-2901	643	8	licensee	licensee	PROPN
admet-2901	643	9	iapc	iapc	PROPN
admet-2901	643	10	,	,	PUNCT
admet-2901	643	11	zagreb	zagreb	PROPN
admet-2901	643	12	,	,	PUNCT
admet-2901	643	13	croatia	croatia	PROPN
admet-2901	643	14	.	.	PUNCT
admet-2901	644	1	this	this	DET
admet-2901	644	2	article	article	NOUN
admet-2901	644	3	is	be	AUX
admet-2901	644	4	an	an	DET
admet-2901	644	5	open	open	ADJ
admet-2901	644	6	-	-	PUNCT
admet-2901	644	7	access	access	NOUN
admet-2901	644	8	article	article	NOUN
admet-2901	644	9	distributed	distribute	VERB
admet-2901	644	10	under	under	ADP
admet-2901	644	11	the	the	DET
admet-2901	644	12	terms	term	NOUN
admet-2901	644	13	and	and	CCONJ
admet-2901	644	14	conditions	condition	NOUN
admet-2901	644	15	of	of	ADP
admet-2901	644	16	the	the	DET
admet-2901	644	17	creative	creative	ADJ
admet-2901	644	18	commons	common	NOUN
admet-2901	644	19	attribution	attribution	NOUN
admet-2901	644	20	license	license	NOUN
admet-2901	644	21	(	(	PUNCT
admet-2901	644	22	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
admet-2901	644	23	)	)	PUNCT
admet-2901	644	24	https://doi.org/10.1021/jm020017n	https://doi.org/10.1021/jm020017n	NOUN
admet-2901	644	25	https://doi.org/10.2174/97816080513661130201	https://doi.org/10.2174/97816080513661130201	NUM
admet-2901	644	26	https://doi.org/10.1186/1471-2091-6-13	https://doi.org/10.1186/1471-2091-6-13	X
admet-2901	644	27	https://doi.org/10.1186/s12964-024-01998-9	https://doi.org/10.1186/s12964-024-01998-9	NUM
admet-2901	644	28	https://doi.org/10.1007/978-1-4939-2074-7_5	https://doi.org/10.1007/978-1-4939-2074-7_5	PROPN
admet-2901	644	29	https://doi.org/10.1016/j.toxrep.2014.08.006	https://doi.org/10.1016/j.toxrep.2014.08.006	ADJ
admet-2901	644	30	https://doi.org/10.1111/cbdd.12538	https://doi.org/10.1111/cbdd.12538	NOUN
admet-2901	644	31	https://doi.org/10.1021/acs.jnatprod.9b00018	https://doi.org/10.1021/acs.jnatprod.9b00018	ADP
admet-2901	644	32	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN